Weill Cornell Department of Medicine

Department of Medicine 

Annual Report 2010 

Weill Cornell Medical College 

NewYork-Presbyterian Hospital 

Annual Report 2011 103

Dear Colleagues and Friends: 

I am pleased to present the 3rd Annual Report of the Department of 

Medicine of Weill Cornell Medical College and the NewYork-Presbyterian 

Hospital/Weill Cornell Medical Center. The past calendar year (2010) 

was one of remarkable progress. Many of our 2010 groundbreaking 

initiatives are highlighted in this report. 

Table of Contents 

Welcome from the Chairman 1 

Creating New Beginnings Out of Chaos: 2 

Dr. Jean W. Pape, A Distinguished Career 

Building a Defense Against Resistance: 6 

Hospital-acquired Infections 

Promoting Better Sleep for Better Overall Health: 8 

Weill Cornell Center for Sleep Medicine Opens 

Establishing Hospital Medicine: 10 

A New System Within the System 

ADVANCE Trial Advances: 12 

Superior Viral Response Rates Using Telaprevir 

A Front-runner of Personalized Medicine: 15 

Dr. Marcus Reidenberg Receives ASPET Award 

GHESKIO Research Leads to Change in WHO Guidelines: 16 

Earlier Treatment is Better for HIV/AIDS 

Where do Medical Research and Social Media Meet? 16 

The Physician-Scientist? 18 

Endangered but not Vanishing 

New Leadership Appointments 20 

Honors and Awards 23 

Division Profiles 35 

Faculty Members 69 

Research Highlights 77 

Medical Education 95 

Residents and Fellows on the Move 96 

Educational Opportunities in Global Health 114 

Alumni: Then and Now 119 

Financial Report 121 

Donors 124 

Contacts 136 

In the latter half of 2010, within a compressed period of six months, the Department of Medicine crafted 

a comprehensive Strategic Plan, entitled Building Cohesion and Driving Value in the 21st Century. Our Strategic 

Plan was the product of an intensive, faculty-driven analysis of the department’s current position, coupled with 

prioritized recommendations and timelines for implementing strategic directions moving forward. The process 

culminated in a series of four off-campus retreats encompassing all of our missions and involving over 140 faculty 

and staff participants. In response to powerful economic, political and scientific forces driving reform of the 

U.S. health care system, the Strategic Plan embraced two essential ideas, as its title suggests: (1) achieving high 

value for patients as the overarching goal, and (2) promoting cohesion and real teamwork in achieving this goal. 

These principles were applied, not only to our clinical mission, but also to our educational and research missions, 

all of which must exist interdependently. 

Among the year’s highlights: initiated an innovative Faculty Development Program, under the leadership 

of Dr. Art Evans; launched a clinical research infrastructure to catalyze and facilitate high-impact clinical and 

patient-oriented research in the department, under the leadership of Dr. John Leonard; expanded our vibrant 

new educational and clinical partnership with the Cayuga Medical Center in Ithaca; opened a beautiful, 12-bed, 

state-of-the-art interdisciplinary Sleep Center, under the direction of Dr. Ana Krieger and in partnership with the 

Department of Neurology; and completed the build-out of new Hematology-Oncology suites on two floors 

of the Weill Greenberg Building. 

Among new major leadership positions: we welcomed Dr. Lia Logio, recruited from Indiana University to be 

Vice Chair for Education and Director of the Internal Medicine Residency Program; Tipton (“Tip”) Ford, recruited 

from the University of Cincinnati to be Chief Administrative Officer and Vice Chair for Business Affairs; and 

Dr. Mary Crow as Chief of the Rheumatology Division and Physician-in-Chief of the Hospital for Special Surgery. 

The Department of Medicine also created 7 new endowed chairs (bringing the total to 43) and 5 new Clinical 

Scholar Awards (bringing the total to 18). 

So, it is with great pride that I share with you the accomplishments of the past year by an extraordinarily dedicated 

and gifted group of faculty, staff and trainees. I welcome your comments and thank you for your support. 

Andrew I. Schafer, M.D. 

The E. Hugh Luckey Distinguished Professor of Medicine 

Chair, Department of Medicine 


Physician-in-Chief 

NewYork-Presbyterian Hospital/Weill Cornell Medical Center 

Cover Photo: Dr. Barbara L. Hempstead (center), 

104 Co-Chief Department of the Division of Medicine of Hematology and Medical Oncology. 


Creating 

New Beginnings Out of Chaos 

Dr. Jean W. Pape: An Ongoing Journey, A Distinguished Career 

Dr. Pape is smiling because he just received an email from 

Vincent, a Lieutenant with the US Army 82nd Airborne Division. 

“Vincent and his platoon were attached to GHESKIO following 

the earthquake in Haiti. I gave him a plaque to thank him for his 

service,” explains Dr. Pape. “He’s a very nice and humane person 

who really helped us.” Completing the loop, Dr. Pape forwards 

Vincent’s email to Dr. Eric Goosby, the US Global AIDS Ambassador 

who facilitated the 82nd Airborne’s assistance in supporting 

GHESKIO’s post-earthquake field hospital. 

Anyone who has followed Dr. Pape’s career since his early days at 

Weill Cornell – four decades ago – knows that he has a knack for enlisting 

support and can create a functional operation out of chaos. Working in Haiti, 

the poorest country in the Western Hemisphere, he has faced epidemics 

of HIV/AIDS, tuberculosis, and cholera; high magnitude earthquakes resulting 

in the “worst injuries” he has “ever seen in his life”; hurricanes; floods; 

22 different changes in the Haitian government between 1986 and 2010; 

malnutrition; and gender violence. 

On the recent cholera outbreak, he affirms: “We were ready for this one 

because of our experience at GHESKIO in managing and treating the spread 

of HIV-AIDS. Preventing and treating this will be a huge undertaking. We will 

need – clean water, 200,000 gallons per day for 40,000 families, at least 

100 centers for rehydration, a patient education campaign, sanitation – four 

very important components. But, we’ll do it.” 

From “day one” Dr. Pape, Professor of Medicine, WCMC, knew that he would 

return to Haiti. He has since traveled a global journey of progress and credits 

Weill Cornell for providing the launching pad. “One of the greatest reasons I like 

Cornell is the interview I had for medical school. I had been told by my college 

advisor at Columbia that they will never accept you if you tell them you want to 

go back to Haiti. There were fewer slots for physicians at that time. Most of those 

had to go to U.S. physicians. 

So, I went for my interview at Cornell. They told me right away that they liked 

me, but they had one question: Do you plan to go back? I said yes. They looked 

at each other and went outside of the room. Well, that’s when I knew – that’s 

what I should not have said. Then they came back and told me: We heard you, 

we understand you want to go back to help, and we will not hold this against 

you. If you want to come here, we’ll accept you. A very nice interview.” 

Dr. Pape was also dedicated to improving the political future of Haiti, 

which had experienced 30 years of dictatorship from 1957 to 1986. Former 

Dean of Student Affairs, Cuban-born Dr. Charles Santos-Buch, asked to 

meet with Dr. Pape and advised: You seek “two very important things” – 

Dr. Pape with Lt. Mullen and Dr. Marie Marcelle Deschamps 

From Lt. Vincent Mullen, 82nd Airborne: 

“Dr. Pape,Congratulations on receiving the Gates 

Award and the Clinton Global Citizen Award. I don’t 

think they could have picked a better man, faculty, and 

organization to award such high accolades. First, it was 

the earthquake, then cholera, and finally Hurricane 

Tomas. These are trying times for Haiti, but I have no 

doubt in my mind that all of you will endure, especially 

with people like the GHESKIO team to lead. I see you 

have set up cholera treatment centers across Haiti. 

I wish only that I was there to help … still have these 

soccer balls and would like to send if it would not be 

a big inconvenience … just let me know the best 

way to send them.” 

“We heard you, we understand 

you want to go back to help ... 

we’ll accept you. A very nice 

interview.“ 

2 Department of Medicine Annual Report 2011 3

Bittersweet, 

the earthquake 

brought mammoth 

destruction, but 

also served as 

a catalyst for 

positive change. 

“We showed in 

a study that 

those who were 

wasted became 

normal. We 

were able to 

stop it in time.” 

one studying medicine and the other being 

a revolutionary – but you cannot do both and will 

have to choose. “If you really want to help your 

people,” he said, “you have to learn and become 

the best physician you can be.” Dr. James Curtis, 

former Dean of Minority Students, also gave support: 

“You should always go back to your community and 

never forget where you came from and do good 

there.” For Dr. Pape, this experience was “very very 

powerful” causing him “to focus” on being the best 

physician he could be. 

He began working in the laboratory of Dr. Warren 

Johnson, Jr., B. H. Kean Professor of Medicine, 

WCMC, his medical school advisor and former chief 

of infectious diseases, while preparing to return 

to Haiti. “Working with Warren has been amazing. 

He’s been my advisor, collaborator, friend. I know 

his family well and he knows mine. We started with 

Warren here and myself in Haiti. In a very small 

program, I studied infantile diarrhea.” This small 

study of infantile diarrhea led to Dr. Pape’s landmark 

paper in The New England Journal of Medicine, 

for which he is credited with the recognition and 

first comprehensive description of AIDS in the 

developing world. 

In 1982, with a staff of two, Dr. Pape and 

Dr. Johnson established the HIV-AIDS research 

and treatment center, GHESKIO, which by 2010 

has treated hundreds of thousands of patients. 

Dr. Pape introduced oral rehydration in Haiti, 

ultimately decreasing infant mortality by 50%. He 

and his team had created a treatment model, using 

the Cornell unit at GHESKIO and mobile units as 

a training base –14,000 healthcare workers were 

trained. In 2003, the Haitian government asked the 

team to extend AIDS treatment nationally. “So, we 

did it. It is exactly the same model we used for the 

children with diarrhea and dehydration – a model 

oriented towards prevention, patient care, centered 

around the family. We now work at 22 sites across 

Haiti; 52% of all patients in Haiti receiving antiviral 

therapy, about 16,000, receive it through our 

network.” GHESKIO has developed breakthrough 

antiviral therapy and investigated the use of vaccines; 

recently, Dr. Daniel Fitzgerald, Associate Professor of 

Medicine, WCMC, and the team published research 

that changed the World Health Organization guidelines 

for the treatment of HIV-AIDS. 

With continuous funding from the NIH since 1983, 

GHESKIO has expanded its work in HIV-AIDS, and 

is now pursuing tuberculosis and cervical cancer, the 

major cancer in Haitian women. 

Just as GHESKIO was reaping the benefits of 

decades of work, a natural disaster loomed. Haiti 

would be struck by a 7.0 magnitude earthquake 

on January 12, 2010. Bittersweet, the earthquake 

brought mammoth destruction, but also served 

as a catalyst for positive change. 

“The earthquake presented a lot of challenges,” 

says Dr. Pape, “as well as opportunities. Seven 

thousand people spontaneously landed on the 

doorstep of GHESKIO. For 15 years I had tried to find 

a partner to work in the slums of Port-au-Prince to 

help me build a better life for these people. They live 

across the street from GHESKIO (250,000 persons) in 

two large slums called, ironically, the City of God and 

the City of Eternity. They lead miserable lives because 

there is no work, they are subject to gangs, and do 

not have adequate food, housing or education. Now 

they had come to us. They had no choice.” 

With assistance from the Clinton Bush Fund, 

among other sources, Dr. Pape and his team built 

a tent-city for the 7,000 displaced persons. The 

tents stood on a soccer field, muddy from the rainy 

season. The solution was to obtain a piece of land 

from the Haitian president. “We got a piece of land 

and prepared the place. We drained it and moved it 

to above street level – so it doesn’t flood.” Medical 

care, food, and shelter are provided, while GHESKIO 

continues to treat patients with antiretroviral 

treatment for HIV-AIDS. Dr. Pape thanks the Clinton 

Bush Fund for its swift action and “flexibility.” 

Dr. Pape is now implementing a long list of 

improvements. Experienced in treating horrendous 

earthquake injuries, what started as a field hospital 

is now a rehabilitation center. “The rehab center 

is functioning very well with 1,200 patients being 

followed and we’re training many people to become 

physical therapists.” A tent-city committee of 15 

people has been assembled. Dr. Pape insisted that 

four women be included: “To include women on the 

committee is the only way we can eliminate gender 

Rebecca Heidkamp (PhD candidate at the Cornell University- 

Ithaca, Division of Nutrition), Dr. Marie Marcelle Deschamps 

(GHESKIO), Dr. Pape 

“Dr. Pape’s integrity makes him someone I aspire to model 

my life vision and character after.” 

– Rebecca 

violence.” An increase in the number of rapes 

of young women occurred after the earthquake. 

Including women on the committee, along with Solar 

Lights in the camp to improve safety at night, has 

curbed the problem. “Just two little things like that 

– not complicated, not rocket science.” GHESKIO 

also created a rape crisis center where women are 

encouraged to report rape and be tested for HIV-AIDS. 

“Now the next move is to create a Global Village,” 

says Dr. Pape. “We’ve partnered with Cornell 

University and have received enormous support from 

the BioMerieux Foundation in France. The idea is that 

everybody will do what they do best – engineers, 

teachers, and more.” A school currently exists at 

GHESKIO, but “the kids are sitting in classrooms that 

are not ideal.” With support from the Principality 

of Monaco, GHESKIO is taking education to the 

next level. A new school, to be called the Prince 

Albert of Monaco School, will upgrade facilities and 

organization of programs. “This will be a real school.” 

Peanuts? Peanut butter – rich in protein and 

made in Haiti – turns out to be the solution to 

another problem – malnutrition in children. GHESKIO 

has received one million dollars from the MAC AIDS 

Fund to create a nutrition center. “We started out 

creating a club for mothers, an interesting idea, not 

from me but from Rebecca Heidkamp, an Ithaca 

PhD candidate.” Ms. Heidkamp explains: “We call 

it the Caregivers Club, as there are mothers, dads, 

and other caregivers. I developed the initial plan and 

drew heavily on what I’ve learned from my mentors 

in Cornell University’s Division of Nutritional Sciences. 

We deliver preventive health services and nutrition 

support for children under two, through a clubbased 

model to improve clinical health outcomes and 

empowerment for GHESKIO parents.” In urban Haiti, 

children under two are at highest risk of malnutrition 

and mortality due to infectious diseases. More than 

one-third of child deaths due to these conditions are 

preventable with simple interventions, such as clean 

water, nutritional supplements and vaccinations. 

By giving children “manba fotifye” (between 

6 and 11 months) reversal of two major nutrition 

outcomes has been achieved: stunting and wasting. 

Dr. Pape Receives Clinton Global Citizen Award 

A recipient of the French Legion of Honor Award and the 2010 Gates Award for Global Health, 

Dr. Jean W. Pape was honored with the Clinton Global Citizen Award on September 23, 2010 in 

a ceremony televised on CNBC. Established by President William J. Clinton and the Clinton Global 

Initiative in 2007, the award recognizes individuals who have championed innovative solutions 

to pressing global problems. President Clinton introduced Dr. Pape, stating, “Your dedication 

to helping Haitians develop their public health system stands as a testament to your visionary 

leadership. For nearly 30 years, you’ve set an outstanding example through your work on primary 

care and integrated HIV-AIDS treatment in Haiti. In addition, your work in emergency care since 

the devastating earthquake has been tremendous.” 

“We showed in a study that those who were wasted 

became normal. We were able to stop it in time,” 

Dr. Pape reports. “Manba fotifye” in Haitian Creole 

means fortified peanut butter – it has its own song. 

Utilizing a new concept called “photo 

sensitization,” mothers are given disposable cameras 

and asked to take photos of their environment, good 

or bad images, then explore what the images mean 

to them and their family’s future. “You empower 

them so they are not passive. They are being actors to 

change the environment.” And the team is working 

on a “Good Habitat” project: “We are building a 

school to teach people how to be carpenters and 

masons. These are the same people who will build 

their own Global Village; they will have a vested 

interest. You give them tools for a business – the 

construction business is a booming industry.” 

In late 2010, an outbreak of cholera emerged in 

Haiti. Dr. Macarthur Charles, one of a cadre of young 

physicians with GHESKIO who trained in the Weill 

Cornell Division of Infectious Diseases, and currently 

an Assistant Professor, WCMC, is heading one of 

the cholera medical centers. “Dr. Charles has taken 

a lot of initiative with this,” says Dr. Pape. With help 

from UNICEF and other partners, Dr. Charles, set to 

work treating patients the week the outbreak began. 

Doctors Without Borders had called at that time 

asking for help, as their treatment tents were being 

blown apart by hurricane winds. There are special 

concerns in the slums because of lack of clean water. 

Drs. Pape and Charles will work with the government 

to formulate a plan to make clean water available 

to the communities. 

Dr. Pape’s work – step by step – has led to a new 

beginning for Haiti. Guiding a new generation of 

physicians and researchers, providing life-saving 

treatments that impact world health, and forming 

dynamic collaborations across the globe distinguish 

his career. These advancements are culminating in 

a dream realized – a Global Village where people can 

live in better health, share an improved quality of life, 

and receive the tools they need to determine their 

own future. 

“We’ve partnered 

with Cornell 

University and 

have received 

enormous 

support from 

the BioMerieux 

Foundation in 

France. The idea is 

that everybody will 

do what they do 

best – engineers, 

teachers, and 

more.” 


Building 

a Defense Against Resistance: Hospital-acquired Infections 

Hospital-acquired infections can result from numerous different factors, and the relative contribution of each 

depends largely on the type of infection. Certain infections are caused by the insertion of medical devices into the 

body, which interrupts a patient’s normal defense mechanisms and provides bacteria greater-than-usual access. 

Germ in the Machine? 

Examples include ventilator-associated 

pneumonias, central line-associated bloodstream 

infections (caused by catheters inserted into 

the large veins of the neck, chest or groin) and 

catheter-associated urinary tract infections. 

Particular surgeries and procedures add their own 

additional risk factors. For example, bone marrow, 

Dr. Wilson envisions a future when computers will be a more integral part of 

infection control. A geographic information system could one day be used 

to configure a three-dimensional model of the hospital that could then be 

populated with data collected by the infection control team to display current 

infections in every unit of the hospital, along with what types of bacteria are 

there and when each first appeared. 

“A picture is worth a thousand words, and such a system could quickly 

produce short-term as well as longitudinal analyses of the pattern of spread 

of infections. It’s a far more advanced system than most hospitals have, but 

geographic information systems are used to analyze and solve problems in 

many other industries. This is the future of hospital epidemiology, and it’s 

very exciting.” 

stem cell and solid organ transplant surgeries can 

compromise the patients’ immune systems, leading 

to a further increased risk of infection. 

For reasons that are not entirely understood, but 

perhaps due in part to high population density and 

world travel, hospitals in the Northeast often see the 

first outbreaks of new pathogens – or old pathogens 

with new antibiotic resistance patterns – before they 

spread to the rest of the country. In any hospital, 

however, infection risk can be compounded by many 

factors, including hand hygiene among healthcare 

staff; thoroughness of environmental cleaning and 

laundry service; and antibiotic use and misuse. 

Hospital visitors, though healthy, may unknowingly 

bring with them any number of harmful microbes 

that can then spread to patients. And patient age 

can be a factor, as both young and elderly patients 

usually have more delicate immune systems. 

There is also the issue of bacterial resistance. The 

appearance within the last decade of a class of superresistant 

bacteria that survive every known antibiotic 

means that prevention is now more essential 

than ever. As David P. Calfee, MD, MS, NewYork- 

Presbyterian’s new Chief Hospital Epidemiologist, 

explains, drug-resistant strains of bacteria can 

emerge periodically in everyday life, but in hospitals, 

they can exhibit a kind of Darwinian selection on 

overdrive. A patient may be prescribed a broadspectrum 

antibiotic that kills off a large proportion of 

the bacteria, but if some of the remaining bacteria 

are resistant to that antibiotic, the spread of those 

organisms is actually accelerated. 

Infection prevention and control, as a field of 

study, began in the late 1960s, as more and more 

hospitals opened intensive care units and physicians 

made the connection between intensive use of lifesustaining 

equipment and unforeseen infections. 

In 1970, Lewis M. Drusin, MD, MPH, Department 

of Medicine, became the college’s first hospital 

epidemiologist, a position he held for 40 years. 

Today, hospital epidemiologist Stephen J. Wilson, 

MD, MPH – another new Department of Medicine 

recruit – works with Dr. Calfee and five infection 

control nurses to monitor infections that occur in 

the hospital, analyzing which microbes are present, 

when and where, how they appeared, and where 

they may show up next. Drs. Calfee and Wilson also 

participate in the hospital’s antibiotic stewardship 

program, evaluating and reevaluating antibiotic 

prescriptions for hospital patients, to make informed 

decisions about the best use of antibiotics that will 

help curb the growth and spread of resistant strains 

of bacteria. “You don’t want to give a two-week 

course of antibiotics if the patient’s illness only 

requires a one-week course,” says Dr. Calfee. “ 

Or if you empirically prescribe a broad-spectrum 

antibiotic and then the patient’s culture comes 

back positive for a bacterium that is susceptible to 

a variety of antibiotics, it’s usually best to switch 

to a more narrow-spectrum antibiotic.” 

Drs. Calfee and Wilson are also developing formal 

hospital epidemiology training for the Infectious 

Diseases Fellowship Program. Infection control 

training initiatives will include medical students, 

residents, faculty and staff. “While many infectious 

diseases programs have the ability to train fellows 

in hospital epidemiology, we are hoping to become 

one of the few that offers this as a formal track with 

the master’s degree work seamlessly integrated into 

the fellowship years,” says Dr. Wilson. 

Drs. Calfee and Wilson are exploring numerous 

research and patient safety initiatives, in collaboration 

with sister institutions (including Cornell University, 

Ithaca, Memorial Sloan-Kettering Cancer Center, The 

Rockefeller University and the Hospital for Special 

Surgery) to investigate device-associated infections, 

surgical site infections, information technology and 

super-resistant bacteria. They are also developing 

ideas in less traditional avenues including a project 

with the Weill Cornell Department of Public Health 

on how to mathematically model various hospital 

infection control scenarios in search of new solutions. 

Preliminary discussions with microbiologists at 

the Cornell College of Veterinary Medicine focus 

on antibiotic resistance across the spectrum of 

agricultural and human use of antibiotics. 

“The questions that are out there waiting to be taken up – along 

with the technology now available to address them – provide 

innumerable opportunities for research that can directly affect 

the health not just of hospital patients, but of the public,” says 

Dr. Wilson. “We intend to keep Weill Cornell at the leading 

edge of this frontier.” 

NewYork-Presbyterian Hospital has a long 

record of relatively low infection rates compared 

to other hospitals in the state. 

Research conducted by Dr. Wilson* showed that infection control is good for 

the financial health of a medical center. Adjusting for severity of illness, length 

of hospital stay and other variables, the average direct cost to the hospital of 

a single Acinetobacter baumannii infection in the burn unit was over $98,000 per 

hospitalization. *American Journal of Infection Control, 2004 

6 Department of Medicine 

Dr. Stephen Wilson (L) Dr. David Calfee (R) 


Promoting 

Better Sleep for Better Overall Health… 

The Weill Cornell Center for Sleep Medicine Opens 

Nine thousand square feet dedicated to a good night’s sleep … 

Newly renovated and relocated, the Weill Cornell Center for Sleep Medicine opened its doors in March 

of 2010. Scheduling 100 patients per week for one of the nation’s leading health problems – lack of normal 

sleep – Medical Director, Ana Krieger, MD (Medicine) and Co-Director, Arthur Spielman, PhD (Neurology), 

are diagnosing and treating patients from all walks of life. Patients include truck drivers, assembly line 

workers, Wall Street employees, politicians, celebrities, the elderly, and babies too. The Center offers a 

multidisciplinary team of experts, a high-tech control room, sound-proofed accommodations designed with 

comfort in mind, sweeping views of New York City, and convenient on-site parking. 

“Sleep is a vital physical function for the body,” says Dr. Krieger. “The most frequent question we are 

asked is how many hours of sleep does a person need to function well. There’s no exact answer to that. 

Some people think they are functioning on a very short amount of sleep, but when we investigate, we 

usually see that the person perceives their state of sleep as being much shorter than it really is. It’s very 

individualized and personal. A host of health issues, stress, poor eating habits, medications, genetics and 

other factors, may be interfering with sound sleep. ” 

Lack of sleep, or poor sleep, has been linked as a contributor to a long list of negative health outcomes: 

cardiovascular disease, stroke, the worldwide obesity epidemic, and even a person’s longevity. Effective 

treatment requires a multidisciplinary team to uncover the exact cause of a sleep disorder. The Center’s 

team provides the expertise of many: sleep medicine specialists, and consultants in neurology, internal 

medicine, pulmonary medicine, ENT (ear, nose and 

throat ), pediatrics, psychiatry, psychology, bariatric 

surgery, cardiology, endocrinology, and nutrition. 

Sophisticated tools allow for the diagnosis of the full 

spectrum of sleep disorders, including sleep apnea 

(sleep-disordered breathing), restless legs syndrome, 

narcolepsy, parasomnias, circadian rhythm sleep 

disorders, excessive sleepiness, and insomnia. 

“The initial evaluation we use is non-invasive,” 

explains Dr. Spielman, a leading authority in 

the field of insomnia. “We understand that it’s 

important that the patient be able to trust their 

environment as we’re monitoring their sleep. Any 

fears or concerns a patient may have are addressed 

immediately. Polysomnography, a study performed 

overnight or during the daytime, is employed using 

non-invasive electrodes placed on the patient’s 

skin and scalp to monitor changes in brain activity, 

respiration, oxygen levels, heart rhythm and muscle 

activity. This monitoring may be a little annoying at 

first, but we find it does not actually interfere with 

the patient falling asleep.” 

“Lack of sleep predisposes the body to a certain 

type of inflammatory response,” according to 

Dr. Krieger. “We know there are systemic 

manifestations going on throughout the body 

due to lack of sleep. It is known that sleep 

apnea, involving a breathing disorder, creates an 

inflammatory response in the body that also affects 

the circulation. We see sleep apnea affecting the 

blood vessels. The vessels can close down, thrombosis 

may occur and impaired blood supply (ischemia) to 

areas of the body may develop. This can be a major 

concern if it affects brain function. Even a little 

bit of ischemia in the brain can cause significant 

neurological changes. Many studies have shown that 

leaving sleep apnea untreated can lead to stroke, 

other cardiovascular manifestations, and increased 

morbidity and mortality. But once patients with sleep 

apnea are treated, things get pretty close to normal.” 

A head mask to provide continuous positive 

airway pressures during sleep is often prescribed as 

the remedy for sleep apnea. “Masks are afforded 

in lots of different types for the patient’s comfort: 

over the nose, in the nose, around the face,” says 

Dr. Spielman. “The patient selects from 

one of many styles,” adds Dr. Krieger, and 

airway pressures are continually adjusted for 

personalized need as determined by the results 

of the sleep study. 

At the forefront of research in the relatively 

new field of sleep medicine, Dr. Krieger is taking 

a “mechanistic approach” to sleep apnea with 

funding from the National Institutes of Health. 

“We are researching the low oxygen levels at 

night and its effect on vascular function. We 

are asking what happens to the walls of blood 

vessels, the so-called endothelial cells. What 

happens to blood platelets which are supposed to 

coagulate the blood only when needed? Are they 

hyperfunctioning, being inappropriately activated 

because of inadequate sleep? We are trying to 

make that bridge in the mechanism to see how 

we can decrease this hemostatic and inflammatory 

response. Perhaps, we could give some patients 

something as simple as aspirin. Is giving a patient 

a mask with CPAP (continuous positive airway 

pressure) enough for the best treatment? Or could 

giving them a medicine ‘X’ ameliorate the overall 

inflammatory response effectively?” 

Combining expertise, in this collaborative 

initiative between the Departments of Medicine 

and Neurology, Drs. Spielman and Krieger are 

melding front-line research with top-line patient 

care. Dr. Spielman, who had served as director 

of the sleep center at another location, says, 

“We were fortunate indeed to have recruited Ana. 

She is the original renaissance woman. She has 

truly raised the standards for everyone at the sleep 

center.” Dr. Krieger adds, “Everyone respects 

Art so much. He’s a world authority in the field. 

I always had the ‘Dr. Spielman’ slides on insomnia 

in my presentations.” 

Poised to enter a breakthrough era in the 

understanding and treatment of sleep disorders, 

Co-Directors Krieger and Spielman have established 

a premier partnership at the Weill Cornell Center 

for Sleep Medicine that will help patients achieve 

a good night’s sleep and better health for many 

years to come. 

“The next step 

in sleep 

medicine 

research will 

be clinical 

trials,” affirms 

Dr. Krieger. 

Left to Right: 

Arthur Spielman, PhD; 

Amit Patel, MD; 

Nitin Sethi, M.B. B.S.; 

Ana Krieger, MD, MS; 

Alan Segal, MD; 

and Matthew Ebben, PhD 



Establishing 

Hospital Medicine: A New System Within the System 

Hospital Medicine – providing specialized medical care to hospitalized patients – is the 

fastest-growing specialty in the history of American medicine. The number of physicians 

(“hospitalists”) engaged in this specialty has increased over 30-fold since 1997. 

Hospitalists now have an established presence 

across the United States at hospitals large and small, 

teaching and non-teaching. This sudden growth 

suggests that hospitalists are successfully addressing 

three pervasive and interrelated needs: the needs 

of individual patients, the needs of primary care 

physicians, and the needs of hospitals. These needs 

are interrelated because they share the common 

objective of improved health outcomes. Hospitalists 

meet those needs by not only providing timely 

effective and efficient clinical care but also by leading 

efforts to improve services within the hospital. This 

requires skills not typically taught at most medical 

schools. In their role as clinician-investigators and 

clinician-leaders, they are asked to design and test 

targeted interventions to improve the processes and 

outcomes of hospital care, for example, preventing 

unnecessary returns to the hospital, sparing patients 

another round of bills and saving hospitals billions 

of dollars each year. 

“There are three forces behind hospital medicine: 

quality, costs, and education,” explains Dr. Arthur 

T. Evans. “Hospitalists are leading the effort to 

improve systems of inpatient care, increase safety, 

reduce waste and unnecessary costs, and teach 

“Hospitalists are leading the effort to improve 

systems of inpatient care, increase safety, reduce 

waste and unnecessary costs, and teach the next 

generation of physicians advanced clinical skills.” 

the next generation of physicians advanced clinical 

skills. Because their practice is focused solely on 

the inpatient setting, hospitalists have an intimate 

knowledge of the complex workings of the hospital 

and understand how to work the system to maximize 

their patients’ wellbeing. Hospital administrators 

also benefit from this intimate knowledge, because 

to improve a hospital’s systems of care you need 

people who are spending most of their time inside 

the hospital and who are totally invested.” 

Recruited in 2009, Dr. Evans, Chief of Hospital 

Medicine and Vice Chair for Faculty Development, 

launched the Department’s new Division of Hospital 

Medicine with 10 hospitalists on board. As of 2010, 

the Division has grown to 21 faculty members 

responsible for the daily care of 125 inpatients. Nine 

of the faculty have advanced training in specialized 

fields of medicine, including infectious diseases, 

medical informatics, nephrology, emergency 

medicine, geriatrics, critical care, and medical ethics. 

Two of the faculty are “nocturnists,” working 

only nights to care for critically ill patients on the 

Leukemia and Bone Marrow Transplant services. 

Because of the group’s collective expertise in 

medical informatics, the Division has been able to 

use the hospital’s electronic medical record system 

to measure and track improvements in patient 

safety and quality of care. For example, one project 

is identifying the factors that predict hospital 

readmission within 30 days. Other ongoing projects 

include using evidence-based guidelines to better 

control pain in the hospital and optimize care for 

a wide range of conditions, from pneumonia, heart 

failure and soft tissue infections, to alcohol and 

narcotic withdrawal. 

Studies indicate that hospitalists in America are 

helping to reduce overall hospital costs by up to 

20 percent and are reducing the average length of 

hospital stays by up to 30 percent. Although reducing 

costs is important, the major goal is improving 

quality and safety. Reducing waste, however, can 

accomplish both goals. Some studies also suggest 

that hospitalists can lower mortality rates, decrease 

readmissions, and improve resident training. 

“Seventy-five percent of our time is working with 

and teaching residents,” says Dr. Evans. “Hospitalists 

advance the academic mission at Weill Cornell 

by demonstrating best-practice in the care of the 

hospitalized patient and by coaching students and 

residents in the interpersonal, communication, 

clinical reasoning, and technical skills that define 

good doctoring.” 

How did the hospitalist movement evolve? 

Beginning in the 1990s, primary care physicians, 

who once visited hospitals regularly to care for their 

hospitalized patients, were facing bourgeoning case 

loads that tied them to the outpatient setting. In turn, 

their patients who required hospitalization were now 

more acutely ill, more complex, and more in need of 

intensive care than in years past. At the same time, 

hospitals themselves had become more complicated, 

with time-consuming mazes of processes that were 

increasingly difficult for a physician outside the 

system to navigate. So the hospitalist emerged – 

an on-site, continuously available physician, wellversed 

in hospital technology, procedures, high-quality 

acute care, and up-to-date clinical decision-making. 

“The skilled hospitalist will involve the patient’s 

primary care physician as an integral part of the 

team,” emphasizes Dr. Evans. “We recognize that 

we don’t know the patient as well as the patient’s 

primary care physician. This is an ongoing challenge 

that hasn’t quite been ironed out. Another 

challenge is meeting the growing need to build and 

lead teams within the hospital to improve systems 

of care. The necessary leadership and management 

skills are not taught in most medical schools or 

residency programs. Therefore, there is a continuous 

need to train hospitalists in these crucially important 

nonclinical skills.” 

The Division of Hospital Medicine is meeting 

these challenges by strengthening ties with 

primary care physicians, building relationships with 

community resources, and developing innovative 

faculty mentorship programs. 

“When the patient is in the hospital, we will 

soon test the use of laptop computers with video 

capability to allow face-to-face communication 

over the Internet with the primary care physician or 

with the relative living across the country or on the 

other side of the world. We are also partnering with 

visiting nurse organizations. After discharge, for 

patients unable to see their primary care physician 

within the first week, we will work with a visiting 

nurse to assure the patient’s first days at home 

are safe and be available to make adjustments in 

treatments until their primary care physician can 

resume responsibility. A well-trained visiting nurse 

can be the doctor’s eyes and ears.” 

A newly established system within the system, the 

Division of Hospital Medicine in the Department of 

Medicine at NYP/Weill Cornell is set to address the 

challenges that a new era in healthcare reform will 

undoubtedly present. The Division’s interdisciplinary 

approach, coupled with its faculty’s ease in using the 

hospital’s organizational and information systems, 

make them a uniquely qualified force in inpatient 

careand residency training. Their specialized mission to 

enhance value for patients in the hospital will involve 

a balance between negotiating the high-tech world 

of the modern hospital with the high-touch needs of 

sick individuals who are at their most vulnerable. 

Dr. Sean Pickering (L) with 

Dr. Arthur Evans 


Advancing 

the Advance Trial 

Superior Viral Response Rates Using Telaprevir 

Dr. Ira M. Jacobson, Chief of Gastroenterology 

and Hepatology and the lead investigator of 

the ADVANCE trial, reported breakthrough 

findings at the 61st Annual Meeting of the 

American Association for the Study of Liver 

Disease in Boston on November 2, 2010. 

Adding a protease inhibitor – telaprevir – to the 

standard first-time treatment given to patients infected 

with hepatitis C virus (HCV) resulted in a superior 

success rate in patients with genotype 1, the most 

common and most difficult-to-cure strain. In fact, 

75% of patients who received 12 weeks of therapy 

with telaprevir, in combination with the current 

standard drug treatment of peginterferon and ribavirin 

achieved a viral cure in this Phase 3 study compared 

with 44% of patients who received peginterferon and 

ribavirin alone. Telaprevir is now on the map as a new 

therapy that dramatically improves the treatment of 

hepatitis C, a highly contagious blood borne disease 

which can progress to cirrhosis and liver cancer. 

Dr. Jacobson was a coauthor on a presentation at 

the same meeting showing that boceprevir, another 

protease inhibitor, is also associated with a highly 

significant improvement in viral cure rates. 

A Vision to Cure Hepatitis C, Before it had 

a Name 

A leader in the treatment of hepatitis B and C, 

Dr. Jacobson was already aggressively investigating 

antiviral therapies during the late 1980s and 

1990s. He has served as the Principal Investigator 

of numerous clinical trials, including the original 

studies done with interferon, as well as subsequent 

studies utilizing combination therapies of a new 

formulation of interferon, known as pegylated 

interferon, with ribavirin. 

“In the 1980s, I had a vision that I wanted 

to be on the cutting edge of what was then the 

barely nascent field of antiviral therapy for what 

we called non-A and non-B hepatitis, and which by 

1989, came to be called hepatitis C. When I started 

out, we didn’t actually have a name for what we 

were investigating. We knew, though, that a virus 

was causing this disease, via such routes as blood 

transfusions or sharing of needles, resulting in 

progressive liver damage. 

By 1999, Dr. Jacobson worked with NewYork-Presbyterian Hospital to expand 

the shared vision of “establishing a major clinical and scientific center for the 

treatment and investigation of hepatitis C towards achieving a cure.” 

(L to R) Drs. Andrew Talal, Ira Jacobson, Ype de Jong, Charles Rice 

The center represents a collaboration between Weill Cornell 

Medical College, NewYork-Presbyterian Hospital, and The 

Rockefeller University, where Dr. Charles Rice, Adjunct Professor, 

Weill Cornell, directs one of the world’s leading scientific 

laboratories dedicated to the study of hepatitis C virus. 



Advancing the Advance Trial continued 

Dr. Reidenberg Receives ASPET’s Torald Sollmannn Award 

(American Society for Pharmacology and Experimental Therapeutics ) 

Dr. Jacobson with Pete Pizzuti 

“I was what they call a partial responder to treatment,” 

says Pete Pizzuti. “But Dr. Jacboson was aggressive with 

my case and advised an increase in the number of imaging 

tests, from one to two per year. He also adjusted my 

medications. Because of the increased number of imaging 

tests, Dr. Jacobson caught my liver cancer in time. I couldn’t 

enter his trial, though, because I was a liver transplant 

candidate. He really listens to you and he guided me 

through the process, sending me to all the right doctors 

for the transplant. You are treated as more than a number 

here. There is real concern for the patient, concern for 

your life, and your quality of life. ” 

By 1999, Dr. Jacobson worked with NewYork- 

Presbyterian Hospital to expand the shared vision of 

“establishing a major clinical and scientific center 

for the treatment and investigation of hepatitis 

C towards achieving a cure.” This vision became 

a reality with the opening of The Center for the 

Study of Hepatitis C in 2000, which today receives 

patients from around the world. The center is 

dedicated to a new era in the treatment of hepatitis 

C in which direct-acting antiviral drugs will play a 

central role. The Center also features a translational 

research program, directed by Dr. Andrew Talal, 

central to which is a database and large repository 

of patient-derived samples. The center represents 

a collaboration between Weill Cornell Medical 

College, New York Presbyterian Hospital, and 

The Rockefeller University, where Dr. Charles Rice, 

Adjunct Professor, Weill Cornell, directs one of the 

world’s leading scientific laboratories dedicated to 

the study of hepatitis C virus. 

“We really do believe this virus is curable and 

you cannot say that in medicine about too many 

viruses. Some viruses, like hepatitis B and HIV, have 

ways of hiding out in cells, archiving themselves 

and embedding their genome deep inside of cells. 

Even if you suppress completely the virus’s ability 

to reproduce, it’s still there and may wake up some 

other time. But we think hepatitis C does not have 

that biological avenue. We’re not aware of an 

archival form which can remain dormant.” 

The Willing Participation of Patients and 

a Successful Clinical Trial 

“Most patients joining our trials have come from 

the faculty’s clinical practices. Patients are worried 

about what the cure rate is. What would make it 

worth it to them to embark on therapy? The biggest 

obstacle is fear of the unknown. Once they are over 

that hurdle and make the decision to be treated, 

they stick with it. A few must stop, mostly because 

of side effects from interferon or ribavirin. So, we’re 

not only dedicated to increasing the cure rate, 

we want to improve tolerability and reduce side 

effects.” 

A Quarter-Century Long Focus on Hepatitis and 

Liver Disease in the Department of Medicine 

After twenty-five years of focused work in the 

field of hepatis C and liver disease, Dr. Jacobson 

played a role instrumental in the first liver transplant 

at NewYork-Presbyterian Hospital/Weill Cornell 

Medical Center. “One of my patients became the 

first person to receive a liver transplant here,” says 

Dr. Jacobson. 

Currently coined “Personalized Medicine,” Dr. Marcus Reidenberg was already researching 

the field – defining it as “Individualized Medicine”– as early as the 1960s. 

He directed a course for the American College of 

Physicians (1973) and prepared a book on the topic 

for The Medical Clinics of North America (1974). 

By 1972, he had assessed: “Clinical pharmacologists 

working in the area of individual differences in drug 

response have learned enough about the causes 

of these variations to make this information known 

to the practicing community.” 

A pioneer in many areas of clinical pharmacology 

– with more than 50 years as a physician-scientist 

continually pressing the boundaries of discovery – 

Dr. Reidenberg embodies the full meaning of the 

Torald Sollmann Award (ASPET), an award that 

honors “imaginative persons dedicated to hard 

work and self-development.” His advancements 

in pharmacology have directly benefited patients 

in the clinical setting. After preparing The Medical 

Clinics of North America book on “Individualization 

of Drug Therapy,” he directed another ACP course in 

1982, preparing a second Medical Clinics of North 

America book, “Clinical Pharmacology of Symptom 

Control,” which helped to make symptomatic therapy 

more acceptable to the medical profession. 

Not only had Dr. Reidenberg conceptualized 

“Individualized Medicine,” he was driving a number 

of other advancements in research. His studies 

showed that: proper controls are equally important 

when studying adverse drug reactions as in studying 

beneficial reactions; impaired renal function changes 

the dose-response relationships of drugs; and age is 

an important independent variable affecting doseresponse. 

The latter conclusion has since influenced 

the care of the elderly. 

“The individualization of drug therapy, now called 

personalized medicine, is to try to make the response 

more predictable. We can tailor the choice and dose 

of a drug depending on how well we understand 

an individual’s state – how best can we predict their 

response.” 

A Neglected New Frontier in Pharmacology 

Dr. Reidenberg’s ASPET talk focuses on the 

question: What can happen “after” a drug is 

discontinued? As an example, he will explore a study 

based on patients admitted to a hospital who had 

Acute Coronary Syndromes; some were on statins 

prior to admission, some not. For those who entered 

the hospital and were on statins, when the statins 

were discontinued, there was a greater incidence of 

mortality. “We talk about withdrawal for opioids or 

barbiturates, but if it’s not a mood affecting drug, 

we tend to neglect withdrawal reactions. Today, the 

science has advanced enough that we have both 

laboratory and clinical ways to assess if there are 

these withdrawal responses – either biochemically 

in the lab or by seeing what happens to patients in 

the clinical trials for the week or two after the drug 

was stopped and the trial was over.” 

New Horizons in Clinical Pharamacology 

“When I was starting out, genes were something 

in peas researched in an Austrian monastery. Before 

the explosion of knowledge in genetics, we were 

looking at disease interactions – liver disease, kidney 

disease and different rates of drug metabolism and 

how to address it. We dealt with more or less, 

more of a drug or less of it. But today, because of 

advancements in genetics, we’re looking at an all 

or nothing response. We’re seeing that a particular 

gene or mutation, when present, can give either 

an all or nothing response – either you respond to 

a drug, or not. We first started to understand this 

all or nothing response with respect to bacterial 

resistance. We saw certain changes in bacteria 

(in response to a drug) in those people who were 

receiving an antibiotic that selected for bacteria 

genetically resistant to the antibiotic. The antibiotic 

had to be changed in order to treat the infection 

that did not respond to the first drug.” 

“We have advanced to the point that, 

today, personalized medicine is working on the 

individualization of therapy (meaning choice of 

drug and the best dose) using a patient’s genetics,” 

says Dr. Reidenberg. “It’s a great time to be 

a pharmacologist.” 

“When I was 

starting out, genes 

were something 

in peas researched 

in an Austrian 

monastery.” 

Dr. Marcus Reidenberg (L) 

Dr. Sandeep Kishore (R) 

Not only had 

Dr. Reidenberg 

conceptualized 

“Individualized 

Medicine,” he 

was driving a 

number of other 

advancements in 

research. 


GHESKIO Research Leads to Change 

WHO Treatment Guidelines: Earlier Is Better for HIV Treatment 

Early initiation of antiretroviral therapy significantly 

increases survival rates among HIV-1 patients. 

Published in The New England Journal of Medicine, 

researchers at GHESKIO, Weill Cornell’s research, 

training and clinical service operation in Haiti, 

produced data between 2005 and 2008 based on 816 

HIV-1 infected subjects. Their results led to changes 

in treatment guidelines published by WHO in 2010. 

The United States Department of Health and Human 

Services also updated treatment recommendations. 

The researchers, who include several of Weill Cornell 

Medical College’s top infectious and tropical disease 

experts, also showed that early intervention is linked 

to a decreased rate of incident tuberculosis, a leading 

cause of death among HIV patients in resource-poor 

countries. Previous to this most recent GHESKIO study, standard treatment practice 

for HIV patients indicated beginning antiretroviral therapy (ART) only at a certain 

clinical threshold: when the measure of a patient’s CD4+ T cell count – a critical 

immune-system cell – dips below 200 cells per cubic millimeter. Clinical evidence 

has long shown that HIV patients become vulnerable to life-threatening illness 

long before their CD4 count hits 200, but no one had yet definitively established 

that antiretroviral therapy (ART) is effective before that crucial number. Because 

antiretroviral medications are prone – much like antibiotics – to eliciting drug 

resistance in the target disease, establishing that evidence was essential. GHESKIO 

researchers concluded that for HIV-1-infected patients, ART is best initiated as 

early as at a CD4 count of 350 or lower in order to improve survival and to reduce 

co-infection with TB, creating a new paradigm for the treatment of AIDS. 

L to R: Drs. Fitzgerald (senior author), Johnson,Gulick, 

and Severe (lead author). 

The paper’s authors include Senior Physician at GHESKIO 

Patrice Severe, MD, a graduate student in the WCMC 

Program in Clinical Epidemiology and Health Services 

Research; Associate Professor of Medicine Daniel W. 

Fitzgerald, MD, who leads clinical research and public 

health initiatives in Haiti and Tanzania; Professor of 

Medicine and Chief of the Division of Infectious Diseases 

Roy M. Gulick, MD, an early champion of antiretroviral 

“cocktail” therapy for HIV; B.H. Kean Professor of Tropical 

Medicine Warren D. Johnson, Jr., MD, who is Director of 

the Center for Global Health; and Professor of Medicine 

Jean W. Pape, MD, Founding Director of GHESKIO. 

Where do Medical Research and Social Media Meet? 

Dr. Robert Kaner (L) 

Physician-scientists in the Department of Medicine are implementing a complex of technological strategies 

tailored to educating potential recruits on clinical trials. Robert Hagerty, Subject Recruitment Manager, has 

joined the Department after 15 years at New York University serving as Senior Research 

Coordinator. He has spearheaded the development of a database-driven website where 

patients and healthy volunteers can find a wealth of information on all clinical trials 

conducted within the department. 

Mr. Hagerty and Robert J. Kaner, MD, Associate Professor of Clinical Medicine and 

an investigator in idiopathic pulmonary fibrosis (IPF), have developed a recruitment 

strategy for Dr. Kaner’s current studies centered around social media. A blog and a 

Facebook page with patient-friendly information about IPF and Weill Cornell’s research 

and treatment services has been created. “Each of these efforts helps widen our net of 

potential subjects, and they are all linked to each other on the web, so views of the blog 

increase hits to the Facebook page, which leads to more traffic on the official website, 

and so on,” says Mr. Hagerty. 

Social media is relatively new in the realm of academic medicine, but it appears to 

be a tool well suited to the task of broadening a subject recruitment base. Traditionally, investigators have relied 

largely on physicians referring their own patients to studies. The Internet brings the study right to the patient’s 

fingertips, while allowing researchers direct access to a much wider pool of potential recruits. “This is especially 

helpful in a market like New York City,” says Dr. Kaner, “where there are several academic medical centers 

appealing to the same population base and where physician-referral patterns are fairly entrenched.” 

The “first” to use social media ... 

Dr. Kaner, whose IPF trial is part of a larger, nationwide IPF study funded by the National Institutes of Health, 

was the first of the study’s 21 principal investigators to utilize social media for patient recruitment. In a meeting 

of the study principals and NIH overseers in November 2010, Dr. Kaner presented his new strategy. “The whole 

roomful of investigators was very excited, and the people from the NIH were definitely paying attention.” 


The Physician-Scientist? 

Endangered but not Vanishing 

Editor of the book, The Vanishing Physician-Scientist?, Dr. Andrew Schafer is focused 

on a departmental goal of paramount importance – to foster the careers of young 

physician-scientists. 

Dr. Schafer (L); Dr. Karl Pillemer (C), Professor of Human Development and Associate Dean 

for Extension and Outreach, College of Human Ecology, and Dr. Alan Mathios, Dean of the 

College of Human Ecology (Cornell University, Ithaca) 

As a medical student, Dr. Schafer discovered that 

it is “exhilarating to be able to take a clinical question 

into the laboratory to try to understand its underlying 

basis.” He was spurred by an inspiring clinical 

professor to devise and perform experiments with 

blood samples from a patient with sickle cell anemia 

who had unusual infectious problems to determine 

if the patient had a defect in his white blood cells 

that interfered with their ability to absorb bacteria. 

“This experience helped me decide not only to 

become a clinical hematologist but also a scientist.” 

As in Dr. Schafer’s case, physicians can directly 

bring to the medical research laboratory the unique 

perspective of being able to ask questions inspired 

by their personal experience of caring for patients. 

In this way, they ideally complement the scientific 

perspective of PhD medical investigators. Entering 

the 21st century, however, the extraordinary pace 

of discovery in biomedical sciences and the rapid 

technological advances in clinical practice have 

created a widening knowledge gap – and even 

language barrier – between practicing physicians and 

laboratory scientists. It is important to understand 

other contemporary factors – demographic, 

sociologic and economic – that have increasingly 

discouraged physicians from entering research 

careers. As a result, the number of medical doctors 

seeking research grants has been in relatively steep 

decline. 

A collaboration between the Department of Medicine and scientists at Cornell Ithaca is paving the way 

for advancements in polycythemia vera, a myeloproliferative disease that causes excess production of red 

blood cells, white blood cells, and platelets. The disease impairs blood flow to the brain by thickening the 

blood itself. Dr. Andrew Schafer and Dr. Richard Silver, Professor of Medicine and a renowned authority 

in polycythemia vera, are collaborating with Dr. Chris Schaffer and Dr. William Olbricht (Department of 

Biomedical Engineering) at Cornell Ithaca. 

The techniques being developed in the laboratory (Cornell Ithaca) involve physiologically-based 

numerical models of blood flow. Ultimately, the goal is to determine if reduced cerebral blood flow, due to 

polycythemia vera, can cause neural dysfunction; for instance, cognitive decline or dementia. Results may 

also open the door to new insights in the fields of stroke and cardiovascular diseases. 

“As medicine moves increasingly into 

a time when treatment modalities 

will be more targeted and personalized, 

the observations and insights doctors 

make while caring for patients will 

become increasingly invaluable,” 

says Dr. Schafer. “The goal is to infect 

young physicians with a passion 

to research.” 

Dr. Andrew Schafer visiting 

Dr. Christopher Schaffer in the 

Schaffer laboratory (Cornell 

University, Ithaca). They are 

working with a femtosecond 

laser system used to visualize 

the structure and function 

of individual cells, and to 

target structures of the brain, 

towards uncovering cellular 

dynamics that underlie 

neurological disease. 

(L to R) Drs. Schafer, William Olbricht (Biomedical Engineering, Cornell University), 

Christopher Schaffer; (2nd from R) Thom Puifai Santisakultarm (in the Biomedical 

Engineering PhD program at Cornell University) has received mentorship from 

Dr. Andrew Schafer and Dr. Richard Silver (Weill Cornell Medical College) on the 

polycythemia vera research project (see page 19). 

Revitalizing and Strengthening the Physician- 

Scientist Career Pipeline 

The Department of Medicine is committed to 

creating an intellectually stimulating and highly 

collaborative environment, one that joins MD and 

PhD investigators in productive medical research 

teams. With the Weill Cornell’s NIH-funded Clinical 

and Translational Science Award (CTSA), under 

the directorship of Dr. Julianne Imperato-McGinley 

(Professor of Medicine and Chief of the Division of 

Endocrinology, Diabetes and Metabolism) serving as 

a programmatic core – along with the new medical 

research building under construction providing an 

extraordinary opportunity for research expansion – 

the Department of Medicine is well positioned to 

revitalize the physician-scientist work force. 


New Leadership Appointments 

David Calfee, MD, MS 

Chief Hospital Epidemiologist 

David Calfee serves as the new Chief Hospital Epidemiologist at NewYork-Presbyterian/Weill Cornell Medical 

Center. He earned his medical degree from West Virginia University School of Medicine and completed an 

internship and residency in internal medicine and a fellowship in infectious diseases at the University of Virginia. 

He also received a master of science degree in health evaluation sciences from the University 

of Virginia. After completing fellowship training, he served on the faculty of the University 

of Virginia School of Medicine. In 2003, he relocated to New York City to become the Hospital 

Epidemiologist and Infection Control Officer for The Mount Sinai Hospital, where he was 

an Associate Professor of Medicine in the Division of Infectious Diseases. His research interests 

include the epidemiology and prevention of healthcare-associated infections and antibiotic 

resistance. He is currently receiving research funding from the Centers for Disease Control 

and Prevention to study the clinical and molecular epidemiology of carbapenem-resistant 

Enterobacteriaceae in healthcare facilities in New York City. He is on the Editorial Advisory 

Board for Infection Control and Hospital Epidemiology and serves as an advisor to the 

USAID-sponsored Program to Improve the Quality and Safety of Healthcare in Egypt. 

He has a secondary appointment in the Department of Public Health at Weill Cornell 

Medical College. 

Ana C. Krieger, MD 

Medical Director of the Weill Cornell Center for Sleep Medicine 

Dr. Ana C. Krieger has been appointed Medical Director of the new Weill Cornell Center for Sleep Medicine, 

holding concurrent appointments in the Departments of Medicine and Neurology. Under her leadership, the 

Center has focused on a multidisciplinary approach to sleep disorders, having achieved full accreditation by 

the American Academy of Sleep Medicine in 2010. Dr. Krieger has been actively involved 

in patient care and innovative educational and research initiatives. She is the principal 

investigator on NIH sponsored translational research projects investigating the mechanisms 

of cardiovascular disease and thrombosis in sleep apnea. Dr. Krieger obtained her MD from 

the Universidade Federal do Rio Grande do Sul in Brazil and completed residency training 

at the University of Chicago and a fellowship at New York University. At New York 

University, she also received an MPH with a focus on healthcare management and policy. 

She is a Robert Wood Johnson Foundation Scholar and serves as a Healthcare Policy 

Advisor for the New York Academy of Medicine. 

Mary K. Crow, MD 

Chief of Division of Rheumatology 

Mary K. Crow, M.D. is a Professor of Medicine and the new Chief of the Division of 

Rheumatology in the Department of Medicine, as well as a Professor of Immunology in the 

Weill Cornell Graduate School of Medical Sciences. Dr. Crow became Physician-in-Chief and 

Chair of the Department of Medicine at the Hospital for Special Surgery (HSS) in 2010, where 

she holds the Joseph P. Routh Endowed Chair in Medicine, is Senior Scientist, Co-Director 

of the Mary Kirkland Center for Lupus Research, and the Director of the Autoimmunity and 

Inflammation Program in the Research Division. A leader in research concerning the induction 

and regulation of autoimmune diseases, she was among the first to characterize the functional 

properties of human dendritic cells and has studied self-reactive T cells in the prototype 

systemic autoimmune diseases, systemic lupus erythematosus and rheumatoid arthritis. She 

continues to investigate the underlying triggers of autoimmune disease and the cellular and 

cytokine mediators of immune system activation and inflammation in those disorders, and 

has led advancements in the identification of the central role of type I interferon in the pathogenesis of systemic 

autoimmune diseases. Dr. Crow has served on the Medical and Scientific Committee of the Arthritis Foundation, 

on the S.L.E. Foundation’s Medical Advisory Committee, and is Chair of the Scientific Advisory Board of the Alliance 

for Lupus Research. She is a past president of the American College of Rheumatology and the Henry Kunkel Society 

and was named an “Arthritis Hero” by the Arthritis Foundation in 2001. Dr. Crow received her M.D. at Weill Cornell 

Medical College; Internal Medicine and Rheumatology subspecialty training at NewYork-Presbyterian; and postdoctoral 

research training at Rockefeller University in the laboratory of Dr. Henry Kunkel. 

Lia Logio, MD 

Vice Chair for Education and Residency Program Director 

Dr. Lia Logio is the Vice Chair for Education and Director of the Internal Medicine Residency 

Program. She is also the Herbert J. and Ann L. Siegel Distinguished Professor of Medicine. 

Previously, Dr. Logio served as the Program Director for the Internal Medicine Residency Program 

at Indiana University School of Medicine, where she was also the Assistant Dean of Faculty 

Affairs and Professional Development. She received her MD from Johns Hopkins and completed 

residency training in internal medicine at Duke. Her teaching honors include: the Sol Goldman 

Award in Geriatrics from Johns Hopkins; nomination (twice) for the Eugene A. Stead Teaching 

Award as well as the Golden Apple Teaching Award at Duke; the Haskill Schiff Award for 

Excellence in Clinical Medicine and an Engel Society Faculty Inductee at Duke; Outstanding 

Teacher Award in General Internal Medicine and Geriatrics from Indiana University; Indiana 

University’s Department of Medicine Distinguished Teacher Award; and the Society of General 

Internal Medicine Clinician Educator Award. She has served as an Associate Editor of Board 

Basics and as a Content Contributor to its Medical Knowledge Self-Assessment Program through the American 

College of Physicians. Dr. Logio has earned a national reputation as an innovator in curriculum in graduate medical 

education as well as in patient safety and inter-professional education, and has been an invited speaker at the 

national level, including the Institute of Medicine’s Forum on Quality. 


New Leadership Appointments continued 

Honors 

and Awards 

Judy Tung, MD 

Director of Weill Cornell Internal Medicine Associates (WCIMA) 

Dr. Judy Tung has been appointed Director of Weill Cornell Internal Medicine Associates (WCIMA), within 

the general medicine division of the Department of Medicine. WCIMA’s longstanding excellence in clinical 

care and medical education stems from its distinctively blended faculty-resident practice model, rich patient 

diversity and unique balance of payors. WCIMA’s faculty are amongst the most highly rated clinical teachers 

in the medical college and comprise close to a third of the faculty serving in college leadership positions. An 

NCQA recognized Patient Centered Medical Home and Diabetes 

Center of Excellence, WCIMA also leads in clinical quality. Dr. Tung 

also serves as both an associate director of the internal medicine 

residency program and the director of the primary care track. 

A graduate of Albert Einstein Medical College, she completed her 

residency training at the University of California, San Francisco, and 

her chief residency at New York University/Bellevue Hospital. Her 

teaching awards at Weill Cornell include the J.J Smith Award (given 

by the house staff to an outstanding educator), the Weill Cornell 

Medical College Award for Teaching Excellence (for the Primary Care 

Clerkship), and the Dean’s List. 

Stephen J. Wilson, MD, MPH 

Hospital Epidemiologist 

Stephen J. Wilson serves as a new Hospital Epidemiologist and is looking forward to working with 

Dr. Dave Calfee to build a robust academic hospital epidemiology program at NewYork-Presbyterian/Weill 

Cornell Medical Center. Dr. Wilson received his medical degree from Duke University School of Medicine 

and an MPH in epidemiology from the University of North Carolina School 

of Public Health, and completed clinical infectious diseases training at the 

University of California, San Francisco, Medical Center. He has held faculty 

positions at Duke University School of Medicine and Indiana University School 

of Medicine where he was a hospital epidemiologist for nine years. He has 

conducted epidemiologic research on a wide variety of infection control 

issues and mentored numerous medical students, residents, and fellows 

during his time at Indiana University. 


Research Awards 

Department of Medicine Investigator Award 

This award is presented annually to members of the Department of 

Medicine below the rank of professor who perform on outstanding 

levels in the areas of clinical and/or basic biomedical research. 

The award has been generously supported by the Michael Wolk 

Foundation. 

Winner 

Dr. Jonathan W. Weinsaft 

Topic: A Novel Segmentation Algorithm for Automated Cardiac 

MRI Assessment of Left Ventricular Diastolic Function 

Division: Cardiology 

Runners Up 

Dr. Richard R. Furman 

Topic: Interim Results from a Phase I Study of CAL-101, a Selective 

Oral Inhibitor of Phosphatidylinositol 3-Kinase P110 Isoform, in 

Patients with Relapsed or Refractory Hematologic Malignancies 

Division: Hematology and Medical Oncology 

Dr. Scott T. Tagawa 

Topic: Radiolabeled Anti-Prostate Specific Membrane Angigen 

(PSMA) Monoclonal Antibody J591 for Castration-resistant Prostate 

Cancer (CRPC) 


The David E. Rogers Memorial Research Award 

This award was established in 1995 to encourage medical 

residents to continue their investigative research in internal 

medicine. This grant was made possible through an endowment 

by the education division of Marion Merril Dow, Inc., in honor 

of Dr. David E. Rogers, a scholar dedicated to the education and 

training of young physicians for nearly 50 years. Senior medical 

residents submit research abstracts for consideration to the David 

E. Rogers Research Committee in the Department of Medicine. 

Four finalists are then chosen to present their work during Medical 

Grand Rounds and each receives a monetary prize. The award 

is bestowed on the senior medical resident who performs and 

presents the most outstanding research. 

Winner 

Dr. Jason S. Chinitz 

Topic: In Vivo Detection of Subclinical Papillary Muscle Infarction 

by Cardiac MRI — A Novel Structural Predictor of Post-MI Mitral 

Regurgitation 

Second Place 

Dr. James J. Harding 

Topic: Determination of Circulating Serum Cytokine Profiles in 

Patients with B Cell Chronic Lymphocytic Leukemia 

Fellows Research Award 

Initiated in 2002, this award is presented annually to fellows within 

the Department of Medicine who have presented outstanding 

research. 

Winner 

Dr. Elizabeth L. Alexander 

Topic: A Metabolomics-based Approach to Vancomycinheteroresistant 

Staphylococcus aureus 

Division: Infectious Diseases 

Runners Up 

Dr. Himisha Beltran 

Topic: The Molecular Basis of Neuroendocrine Prostate Cancer 


Dr. Jessica K. Gordon 

Topic: Imatinib Mesylate (Gleevec) Treatment of Patients with 

Diffuse Cutaneous Systemic Sclerosis: Changes in Histopathology 

and Gene Expression 

Division: Rheumatology 

2010 Teaching Awards 

Senior List 

This award was established by the WCMC Class of 1994 to 

recognize 17 faculty members who have made a commitment 

to and demonstrated excellence in teaching. Of those 17, the 

following faculty members were selected from the Department of 

Medicine. 

Dr. Charles L. Bardes 

Dr. Morton D. Bogdonoff 

Dr. Heather X. Cereste 

Dr. Salvatore Cilmi 

Dr. Byron P. Demopoulos 

Dr. Veronica M. LoFaso 

Dr. Susana R. Morales 

Dr. Anthony Ogedegbe 

Dr. Judy Tung 

Dr. Hooman Yaghoobzadeh 

Dr. Dana Zappetti 

Volunteer Clinical Faculty Award 

of Alpha Omega Alpha 

Recommended by the graduating class and selected by student 

members of the AOA chapter, this award is given to a voluntary 

faculty member who effectively and generously donates his/her 

time, skill and experience to teaching clinical skills. 

Recipient: Dr. Timothy C. Dutta 

House Staff Teaching Award 

This award was established by the Class of 1990 and the Alumni 

Association to honor the Weill Cornell-affiliated house officer who 

best demonstrates clinical excellence and dedication to teaching. 

Recipient: Dr. Won Kim 

The Charles L. Bardes, MD Teaching Prize 

This award was established in 2000 by David and Betty Cooper 

Wallerstein in gratitude for the excellent and compassionate 

medical care provided by Dr. Bardes to three generations of the 

Cooper-Wallerstein family. The prize is awarded annually to a 

member of the faculty who, in the opinion of the prize committee, 

has been an outstanding teacher at the Weill Cornell Medical 

College, demonstrating leadership, dedication and concern for the 

students. 

Recipient: Dr. B. Robert Meyer 

The Leonard P. Tow Humanism Award 

Presented by the Gold Foundation 

This award was first given in 1998 to recognize medical education 

that is compassionate and humanistic. By vote of a committee of 

faculty members and students, the award is presented to recognize 

and honor one faculty member and one graduating student at 

WCMC who demonstrate the highest standard of compassion and 

sensitivity in their interaction with patients. 

Faculty Recipient: Dr. Veronica M. LoFaso 

The Richard A. Herrmann, MD Teaching Award 

This award was established in 2000 by Ms. Marilyn N. Herrmann in 

loving memory of her late husband. A member of the Department 

of Medicine for many years, Dr. Herrmann was considered a gifted 

clinical teacher. The award is given to an outstanding teacher in 

the third year and is chosen by members of the third-year medical 

school class. 

Recipient: Dr. Salvatore Cilmi 

Excellence in Teaching Award 

Dr. Joseph J. Fins 

Professor of Medicine 

Dr. Keith A. LaScalea 

Assistant Professor of Medicine 

Dr. Eliot J. Lazar 

Associate Professor of Medicine 

Dr. Anthony Ogedegbe 


Runners Up 

Dr. Brendan J. Carolan 

Topic: Quantification of Cystic Fibrosis Transmembrane 

Conductance Regulator Gene mRNA Transcripts in Human Small 

Airway Epithelium 

Dr. Konstantinos Charitakis 

Topic: Defective Perinatal Myosin Produces Nemaline Myopathy 

and Embryonic Lethality: A New Role for Perinatal Myosin in 

Mammalian Growth and Development 

Dr. David N. Posnett 


Dr. Arun Rao 

Assistant Professor of Clinical Medicine 

Dr. Bruce W. Stewart 

Assistant Professor of Clinical Medicine 

Dr. Joseph Fins 


Endowed Chairs and Professorships in the 


Emilie Roy Corey Professor in Geriatrics and 

Gerontology 

Dr. Ronald D. Adelman 

Ralph A. Baer Professor of Medical Research 

Dr. Phyllis August 

Gladys and Roland Harriman Professor of Medicine 

Dr. Craig T. Basson (end date 9/2010) 

Dr. Brendan M. Reilly 

Virginia F. and William R. Salomon Chair in Musculoskeletal 

Research (HSS) 

Dr. Carl Blobel 

William T. Foley Distinguished Professor in Medicine 

Dr. Mary E. Charlson 

Joseph P. Routh Professor of Rheumatic Diseases in Medicine 

Dr. Mary K. Crow 

Dr. Stephen A. Paget (end date 3/2010) 

Benjamin M. Rosen Chair in Immunology and Inflammation 

Research (HSS) 

Dr. Mary K. Crow 

The Bruce Webster Professor of Internal Medicine 

Dr. Ronald G. Crystal 

Henry R. Erle, MD–Roberts Family Professor of Medicine 

Dr. Andrew J. Dannenberg 

Lisa and Sanford B. Ehrenkranz Professor in Women’s Health 

Dr. Orli R. Etingin 

Dr. Manikkam Suthanthiran (2nd from L) 

in his laboratory. 

E. William Davis, MD Professorship of Medical Ethics 


St. Giles Research Chair (HSS) 

Dr. Steven R. Goldring 

Stephen and Suzanne Weiss Dean 

Dr. Antonio M. Gotto, Jr. 

Revlon Pharmaceutical Professor of Pharmacology and Toxicology 

Dr. Lorraine J. Gudas 

O. Wayne Isom Professor of Medicine 

Dr. Barbara L. Hempstead 

Abby Rockefeller Mauzé Distinguished Professorship in 

Endocrinology in Medicine 

Dr. Julianne L. Imperato-McGinley 

David H. Koch Chair for Arthritis and Tissue Degeneration Research 

(HSS) 

Dr. Lionel B. Ivashkiv 

Vincent Astor Distinguished Professor of Medicine 

Dr. Ira M. Jacobson 

B.H. Kean Professor of Tropical Medicine 

Dr. Warren D. Johnson, Jr. 

Richard P. Cohen, MD Associate Professor of Medical Education 

Dr. Yoon Kang 

David S. Blumenthal Assistant Professor of Medicine 

Dr. Robert J. Kim 

The William S. Paley Professor of Clinical Medicine 

Dr. Harvey Klein 

Irene F. and I. Roy Psaty Distinguished Professor of 

Clinical Medicine 

Dr. Mark S. Lachs 

Richard T. Silver Distinguished Professor of Hematology and 

Medical Oncology 

Dr. John P. Leonard 

Hilda Altschul Master Professor of Medicine 

Dr. Bruce B. Lerman 

Herbert J. and Ann L. Siegel Distinguished Professor of Medicine 

(as of Jan 2011) 

Dr. Lia S. Logio 

Morton Coleman Assistant Professor in Multiple Myeloma 

Dr. Tomer M. Mark 

Ehrenkranz Family/Orli R. Etingin, MD Associate Professor in 

Women’s Health 

Dr. Shari R. Midoneck 

Arthur R. Ashe, Jr. Professor of Medicine 

Dr. Henry W. Murray 

Nanette Laitman Distinguished Professor of Public Health 

Dr. Alvin I. Mushlin 

Lewis Thomas University Professor 

Dr. Ralph L. Nachman 

Mark W. Pasmantier Professor of Hematology and Oncology in 

Medicine 

Dr. David M. Nanus 

Stephen A. Paget, MD, Chair in Rheumatology (HSS) 

Dr. Stephen A. Paget 

Louis and Gertrude Feil Professor of Clinical Medicine 

Dr. R.A. Rees Pritchett 

Arthur B. Belfer Professor in Genetic Medicine 

Dr. Shahin A. Rafii 

The Ida and Theo Rossi Distinguished Professor of Clinical Medicine 

Dr. Isadore Rosenfeld 

Collette Kean Research Chair (HSS) 

Dr. Jane E. Salmon 

The E. Hugh Luckey Distinguished Professor of Medicine 

Dr. Andrew I. Schafer 

Jill Roberts Associate Professor of Inflammatory Bowel Disease 

Dr. Ellen J. Scherl 

Franchellie M. Cadwell Chair (HSS) 

Dr. Sergio Schwartzman 

Mason Adams Professor of Geriatric Medicine 

Dr. Eugenia L. Siegler 

Rochelle Belfer Professor in Medicine 

Dr. Kendall A. Smith 

Howard and Carol Holtzmann Professor in Clinical Medicine 

Dr. Charles R. Steinberg 

Jack Fishman Professor of Cancer Prevention 

Dr. Kotha Subbaramaiah 

Stanton Griffis Distinguished Professor of Medicine 

Dr. Manikkam Suthanthiran 

Clinical Scholar Endowments 

The Clinical Scholar Endowment is designed to provide outstanding 

junior faculty members in the Department of Medicine with 

financial support early in their careers. Support is provided 

specifically to help young physicians balance patient care with 

research and teaching. The awards allow junior faculty to make 

a commitment to academic medicine and, as a result, support 

promising new talent. 

Nanette Laitman Clinical Scholar in Public Health/Prevention– 


Dr. William B. Borden 

Anne and Ken Estabrook Clinical Scholar in Gastroenterology 

Dr. Brian P. Bosworth 

Nanette Laitman Clinical Scholar in Public Health/Community Health 

Dr. Carla Boutin-Foster 


Charles, Lillian and Betty Neuwirth Clinical Scholar in Oncology 


Dr. Rebecca Elstrom (as of October 2010) 

James P. Smith Clinical Scholar Award 

Dr. Ben-Gary Harvey 

Bonnie Johnson Sacerdote Clinical Scholar in Women’s Health 

Dr. Elizabeth Leef Jacobson 

Bruce B. Lerman, MD Clinical Scholar 

Dr. Troy LaBounty 

The Joachim Silbermann Family Clinical Scholar 

Dr. Taryn Yeon S. Lee (ended January 2010) 

Abby Joseph Cohen Clinical Scholar 

Dr. Fay Yu-Huei Lin (as of January 2011) 

Thomas H. Meikle, Jr. Professor of Medical Education 

Michael Wolk Heart Foundation Clinical Scholar in Cardiology 

Dr. Alan M. Weinstein 

Dr. Jonathan W. Weinsaft (until end of 2010) 

Dr. Christopher F. Liu (2009 – present) 

The Irving Sherwood Wright Professor of Geriatrics 

Dr. Marc E. Weksler 


Joachim Silbermann Family Clinical Scholar in Geriatrics 

Dr. Veronica M. LoFaso 

Helen and Robert Appel Clinical Scholar 

Dr. Bassem M. Masri 

Anne Moore, MD Clinical Scholar in Hematology/Oncology 

Dr. Allyson J. Ocean (as of October 2010) 

Joachim Silbermann Family Clinical Scholar in Geriatric Palliative Care 

Dr. M. Cary Reid, Jr. 

William Randolph Hearst Foundation Clinical Scholar in 

Microbiology and Infectious Diseases 

Dr. Kyu Y. Rhee 

Madoff Family Clinical Scholar in Hematology/Oncology 

Dr. Gail J. Roboz 

Dr. Ellen Ritchie (as of October 2010) 

Madeline and Stephen Anbinder Clinical Scholar in Hematology/ 

Oncology 

Dr. Linda T. Vahdat 

Dr. Bryan J. Schneider (as of October 2010) 

Linda Horowitz Cancer Research Foundation Clinical Scholar in 

Gastroenterology 

Dr. Felice Schnoll-Sussman 

The Lila A. Wallis, MD Distinguished Visiting 

Professor in Women’s Health 

May 25, 2010 

Carolyn D. Runowicz, MD 

Professor of Obstetrics and Gynecology 

Division of Gynecologic Oncology 

Northeast Utilities Chair in Experimental Oncology 

Director, Carole and Ray Neag Comprehensive Cancer Center 

University of Connecticut Health Center 

The Holly Andersen Visiting Professor 

in Integrative Medicine 

September 28, 2010 

Bruce S. McEwen, PhD 

Alfred E. Mirsky Professor 

Head, Harold and Margaret Milliken Hatch Laboratory 

of Neuroendocrinology 

The Rockefeller University 

Dr. Holly Andersen 

Visiting Professors 

The Richard T. Silver, MD Visiting Professor 

January 12, 2010 

Clara D. Bloomfield, MD 

Distinguished University Professor 

William G. Pace III Professor of Cancer Research 

Cancer Scholar and Senior Advisor 

The Ohio State University Comprehensive Cancer Center; 

James Cancer Hospital; Solove Research Institute 

The Rogosin Institute Lecture 

March 9, 2010 

Richard P. Lifton, MD, PhD 

Chairman, Department of Genetics 

Sterling Professor of Genetics 

Professor of Medicine (Nephrology) 

Yale School of Medicine 

Investigator, Howard Hughes Medical Institute 

The Isadore Rosenfeld Visiting Professor 

April 13, 2010 

Michael J. Landzberg, MD 

Director, Boston Adult Congenital Heart (BACH) 

and Pulmonary Hypertension Service 

Associate in Cardiology 


Children’s Hospital Boston 

Dr. Joseph Ruggiero 

The Stephen Scheidt, MD Distinguished Visiting Professor 

Sponsored by the New York Cardiology Foundation 

October 26, 2010 

David A. Kass, MD 

Abraham and Virginia Weiss Professor of Cardiology 

Professor of Medicine, Professor of Biomedical Engineering 

The Johns Hopkins University School of Medicine 

The B.H. Kean–Boxer Family Foundation Lecture 

in Global Health 

November 2, 2010 

Julio Frenk, MD, MPH, PhD 

Dean, Harvard School of Public Health 

The Aaron Feder Visiting Professor 


W. Michael Scheld, MD 

The Bayer–Gerald L. Mandell Professor of Internal Medicine 

Division of Infectious Diseases 

Clinical Professor of Neurosurgery 

Director, Pfizer Initiative in International Health 

University of Virginia Health System 

The Arthur Ashe Endowment–Christopher L. Barley, MD 

Lecture 


Seth Berkley, MD 

President and CEO 

International AIDS Vaccine Initiative 

The Ralph L. Nachman, MD Distinguished Visiting Professor 


David Ginsburg, MD 

James V. Neel Distinguished University Professor of 

Internal Medicine and Human Genetics 

Research Professor, Life Sciences Institute 

University of Michigan Medical School 

Investigator, Howard Hughes Medical Institute 

The Daniel G. Miller, MD Endowed Lecture in Cancer 

Prevention 

December 14, 2010 

Douglas R. Lowy, MD 

Chief, Laboratory of Cellular Oncology 

Head, Signaling and Oncogenesis Section 

Center for Cancer Research 

National Cancer Institute 

National Institutes of Health 


New York Magazine (Best Doctors) & Castle Connolly 

Note: * In Castle Connolly; ** In both New York Magazine & Castle Connolly. 

Society Memberships 

Allergy 

Dr. Gillian Shepherd* 

Dr. Daniel Burton* 

Cardiac Electrophysiology 

Dr. Bruce B. Lerman** 

Dr. Steven Markowitz* 

Dr. Miguel Valderrabano (Texas Methodist)* 

Cardiovascular Disease 

Dr. Holly S. Andersen** 

Dr. James Blake* 

Dr. David S. Blumenthal** 

Dr. Adam Deutch* 

Dr. Richard Devereux* 

Dr. Richard Fuchs* 

Dr. Harvey Goldberg* 

Dr. Antonio Gotto, Jr.* 

Dr. David Guyer* 

Dr. Evelyn M. Horn** 

Dr. Lawrence A. Inra** 

Dr. Matteethra C. Jacob (Texas Methodist)* 

Dr. Mazen Kamen* 

Dr. Paul Kligfield* 

Dr. Karla M. Kurrelmeyer (Texas Methodist)* 

Dr. Eliot Lazar* 

Dr. John J. Mahmarian (Texas Methodist)* 

Dr. Bassem Masri* 

Dr. David Miller* 

Dr. Sherif F. Nagueh (Texas Methodist)* 

Dr. Martin Post* 

Dr. Craig M. Pratt (Texas Methodist)* 

Dr. Miguel A. Quinones (Texas Methodist)* 

Dr. Howard S. Rubin (Texas Methodist)* 

Dr. Richard Steingart (MSKCC)* 

Dr. Theodore Tyberg* 

Dr. Michael Wolk* 

Dr. William A. Zoghbi (Texas Methodist)* 

Endocrinology, Diabetes and 

Metabolism 

Dr. Richard S. Bockman (HSS)** 

Dr. David J. Brillon** 

Dr. Willa Hsueh (Texas Methodist)* 

Dr. Barry Klyde* 

Dr. Richard Mahler (Lenox)* 

Dr. Richard J. Robbins (Texas Methodist)* 

Dr. R. Michael Tuttle (MSKCC)** 

Dr. Kathleen L. Wyne (Texas Methodist)* 

Dr. Robert Kurtz (MSKCC)** 

Dr. Arnon Lambroza* 

Dr. Arnold Markowitz (MSKCC)* 

Dr. Franklin Marsh* 

Dr. Paul Miskovitz** 

Dr. Jerry Nagler* 

Dr. Mark Pochapin** 

Dr. Paul F. Miskovitz (MSKCC)** 

Dr. Ian L. Sachs (Texas Methodist)* 

Dr. Ellen Scherl* 

Dr. Moshe Shike* 

Geriatrics 

Dr. Ronald Adelman* 

Dr. Mark S. Lachs* 

Dr. Bharathi Raman* 

Dr. Eugenia Siegler* 

Dr. George E. Taffet (Texas Methodist)* 

Hematology 

Dr. Mark Brower* 

Dr. John Leonard* 

Dr. Peter Maslak (MSKCC)* 

Dr. John J. McCarthy (Texas Methodist)* 

Dr. Stephen D. Nimer (MSKCC)** 

Dr. David Wolf* 

Infectious Diseases 

Dr. Barry Brause (HSS)* 

Dr. Arthur Brown (MSKCC)* 

Dr. Barry J. Hartman** 

Dr. David Helfgott* 

Dr. Jonathan Jacobs* 

Dr. Henry Murray* 

Dr. Tobias C. Samo (Texas Methodist)* 

Dr. Kent Sepkowitz (MSKCC)* 

Dr. Paul Smith (HSS)* 

Dr. Rosemary Soave* 

Internal Medicine 

Dr. Louis Aronne* 

Dr. Christopher Barley* 

Dr. Richard Cohen* 

Dr. Symra Cohn* 

Dr. Orli Etingin* 

Dr. Laura Fisher* 

Dr. Flavia Golden* 

Dr. Catherine Hart* 

Dr. Margaret Lewin* 

Dr. Bruce Logan* 

Dr. C. Ronald Mackenzie (HSS)* 

Dr. Samuel Mann* 

Dr. Deena Nelson* 

Dr. Mark Pecker* 

Dr. Ward Cunningham Rundles* 

Dr. David Zackson* 

Dr. Susan M. Escudier (Texas Methodist)* 

Dr. Clifford Hudis (MSKCC)* 

Dr. David Ilson (MSKCC)* 

Dr. Joseph Jurcic (MSKCC)* 

Dr. David Kelsen (MSKCC)* 

Dr. Nancy E. Kemeny (MSKCC) ** 

Dr. Mark Kris (MSKCC)* 

Dr. Vincent A. Miller (MSKCC)** 

Dr. Anne Moore** 

Dr. Robert Motzer (MSKCC)* 

Dr. David Nanus* 

Dr. Larry Norton (MSKCC)** 

Dr. Kenneth Offit (MSKCC)* 

Dr. Eileen M. O’Reilly (MSKCC)** 

Dr. Mark W. Pasmantier** 

Dr. David G. Pfister (MSKCC)** 

Dr. Naiyer Rizvi (MSKCC)* 

Dr. Mark Robson (MSKCC)* 

Dr. Joseph T. Ruggiero** 

Dr. Leonard Saltz (MSKCC)* 

Dr. David Scheinberg (MSKCC)* 

Dr. Howard I. Scher (MSKCC)** 

Dr. Nancy Sklarin (MSKCC)* 

Dr. Susan Slovin (MSKCC)* 

Dr. David R. Spriggs (MSKCC)* 

Dr. David Straus (MSKCC)* 

Dr. Scott Tagawa* 

Dr. Jeffrey Tepler* 

Dr. Linda Vahdat* 

Dr. Andrew D. Zelenetz (MSKCC)** 

Nephrology 

Dr. Phyllis August** 

Dr. Jon D. Blumenfeld (Rogosin)** 

Dr. Stuart Saal (Rogosin)* 

Dr. Raymond Sherman* 

Dr. John Wang (Rogosin)* 

Pulmonary 

Dr. Joseph T. Cooke ** 

Dr. Daniel M. Libby** 

Dr. Thomas W. Nash** 

Dr. David Posner (Lenox, Adjunct)* 

Dr. Abraham Sanders * 

Dr. Diane Stover-Pepe (MSKCC)* 

Institute of Medicine of the National Academy of Sciences 




Dr. Jean W. Pape 

Dr. David J. Skorton 

Association of American Physicians 

Dr. Jeremiah A. Barondess 

Dr. Morton D. Bogdonoff 

Dr. Mary E. Charlson 

Dr. Bayard D. Clarkson (MSKCC Affiliate) 



Dr. James A. Fagin (MSKCC Affiliate) 


Dr. Katherine A. Hajjar (secondary appointment) 


Dr. Jules Hirsch (Rockefeller Affiliate) 

Dr. Alan N. Houghton (MSKCC Affiliate) 

Dr. Julianne L. Imperato-McGinley 


Dr. Attallah Kappas (Rockefeller Emeritus) 

Dr. Mary Jeanne Kreek (Rockefeller Affiliate) 

Dr. Aaron J. Marcus 

Dr. Paul A. Marks (MSKCC Affiliate) 




Dr. Carl F. Nathan (secondary appointment) 

Dr. Marcus M. Reidenberg 

Dr. Jane E. Salmon (HSS Affiliate) 

Dr. Charles L. Sawyers (MSKCC Affiliate) 


Dr. David A. Scheinberg (MSKCC Affiliate) 


Dr. Babette B. Weksler 


Dr. Sidney J. Winawer (MSKCC Affiliate) 

Dr. Alastair J.J. Wood (Courtesy) 

The American Society for Clinical Investigation 

Dr. John D. Baxter (Texas Methodist Hospital Affiliate) 

Dr. Richard S. Bockman (HSS Affiliate) 

Dr. Morton D. Bogdonoff (Emeritus) 

Dr. Ralph Carmel (New York Methodist Hospital Affiliate) 

Dr. Bayard D. Clarkson (MSKCC Affiliate) 



Dr. James A. Fagin (MSKCC Affiliate) 

Dr. Michael S. Glickman (MSKCC Affiliate) 


Dr. Roy M. Gulick 

Dr. Katherine A. Hajjar (secondary appointment) 


Dr. Jules Hirsch (Rockefeller Affiliate) 

Dr. Peter R. Holt (Rockefeller Affiliate) 

Dr. Alan N. Houghton (MSKCC Affiliate) 

Dr. Lionel B. Ivashkiv (HSS Affiliate) 

Dr. Eric A. Jaffe (Adjunct) 

Dr. Lawrence J. Kagen (HSS Affiliate) 

Dr. Attallah Kappas (Rockefeller Emeritus) 

Dr. Richard N. Kolesnick (MSKCC Affiliate) 

Dr. Ione A. Kourides 

Dr. Jeffrey C. Laurence 


Dr. Martin Lipkin 


Dr. Paul A. Marks (MSKCC Affiliate) 

Dr. Ari M. Melnick 


Dr. James M. Musser (Texas Methodist Hospital Affiliate) 



Dr. Carl F. Nathan (secondary appointment) 

Dr. Stephen D. Nimer (MSKCC Affiliate) 

Dr. Kenneth Offit (MSKCC Affiliate) 

Dr. Eric G. Pamer (MSKCC Affiliate) 

Dr. David N. Posnett 

Dr. Shahin Rafii 


Dr. Arleen B. Rifkind 

Dr. Michel Sadelain (MSKCC Affiliate) 

Dr. Charles L. Sawyers (MSKCC Affiliate) 


Dr. David A. Scheinberg (MSKCC Affiliate) 

Dr. Kendall A. Smith 


Dr. Marcel van den Brink (MSKCC Affiliate) 


Dr. Babette B. Weksler 


Dr. Alastair J.J. Wood (Courtesy) 

Rheumatology (HSS affiliates) 

Dr. Theodore R. Fields** 

Dr. Allan Gibofsky* 

Dr. Susan Goodman* 


Dr. Paul Basuk* 

Dr. Michael Cantor* 

Dr. Bradley Connor* 

Dr. Robert Cooper* 

Dr. Gulchin A. Ergun (Texas Methodist)* 

Dr. Hans Gerdes (MSKCC)** 

Dr. Howard Goldin* 

Dr. Ira M. Jacobson** 


Dr. Dean F. Bajorin (MSKCC)** 

Dr. Michael D. Lockshin** 

Dr. Steven Magid* 

Dr. Joseph Markenson* 

Dr. Stephen Paget* 

Dr. Edward Parrish* 

Dr. Jane Salmon* 

Dr. Serio Schwartzman* 

Dr. Sandra L. Sessoms (Texas Methodist)* 

Dr. Robert Spiera* 

Dr. George J. Bosl (MSKCC)** 

Dr. Richard Stern* 

Dr. Morton Coleman* 

Dr. Arthur Yee* 


Dr. Juliet B. Aizer: Member, CARE 2010 Development Group, 

American College of Rheumatology; Medical Knowledge Self 

Assessment Program Committee, Rheumatology Section, American 

College of Physicians 

Dr. Elizabeth L. Alexander: Program Committee Choice Award 

and Plenary Presentation, 48th Annual Meeting of the Infectious 

Diseases Society of America, Canada 

Dr. Phyllis August: Elected Member, American Clinical and 

Climatological Association 

Dr. Susan Clark Ball: Inaugural Andrew Swanson Memorial 

Lecturer, Hospital for Special Surgery 

Dr. Anne R. Bass: Chair, Training Resources Subcommittee 

of the Committee on Workforce and Training, American College 

of Rheumatology 

Dr. William B. Borden: Young Hearts Award for Achievement in 

Cardiovascular Science and Medicine, American Heart Association 

Young Professionals 

Dr. Brian P. Bosworth: Invited speaker, American College of 

Gastroenterology Fellows Forum; Chair, Small Bowel Abstract 

Review Committee, Education Committee, and Chair, Peer Review 

Subcommittee, American College of Gastroenterology 

Dr. Carla Boutin-Foster: Member, Public Health Council, 

New York State Department of Health 

Dr. David J. Brillon: Chair, Research Review Committee, EDIC 

Dr. David P. Calfee: Advisor, Program to Improve the Quality and 

Safety of Healthcare in Egypt, U.S. Naval Medical Research Unit and 

U.S. Agency for International Development, Cairo, Egypt; Invited 

speaker, National Academy of Infusion Therapy 

Dr. Mary E. Charlson: Invited speaker, NHLBI Conference “Future 

Research Directions to Prevent Cardiovascular Disease and its Risk 

Factors among Latinos”; Member, Scientific Review Committee, 

NIH Cardiovascular and Sleep Epidemiology Study Section; 

Invited speaker, NIH-sponsored Workshop “Translating Ideas into 

Intervention” 

Dr. David J. Christini: Invited speaker, Heart Rhythm Society 

Scientific Sessions 

Dr. Joseph T. Cooke: Invited speaker, Member, Medical Advisory 

Board, and Award of Appreciation for Efforts in Donation after 

Cardiac Death, New York Organ Donor Network; Center for the 

Performing Artist Symposium; Institute of Labor Relations, Cornell 

University; Association of American Medical College Quality 

Symposium; NYC Council Subcommittee on Quality and Safety 

in Our City Hospitals; 

Dr. Carl Crawford: Rudin Foundation Award 

Dr. Mary K. Crow: Honorary member, Interurban Clinical Club; 

Paul J. Bilka Endowed Lecturer, Mayo Foundation; Invited speaker, 

Ninth International Congress on Systemic Lupus Erythematosus; 

Chair, Scientific Advisory Board, Alliance for Lupus Research; Grand 

Opportunities Study Section, National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, National Institutes of Health; 

Member, Board of Trustees, Arthritis Foundation, New York Chapter; 

Scientific Advisory Board, Arthritis National Research Foundation 

Dr. Ronald G. Crystal: Reviewer, Simone and Cino Del 

Luca Prize, French Academy of Sciences; Co-Chair, Program 

Committee, American Society of Gene and Cell Therapy 

2010 – 2011 Annual Meeting 

Dr. Andrew J. Dannenberg: Gilda’s Club New York City 

Advancement of Cancer Research Award; Co-Chair, Scientific 

Program Committee, American Association for Cancer Research 

Frontiers in Cancer Prevention Research Conference; Chair, Head 

and Neck Cancer SPORE External Scientific Advisory Board, 

The Johns Hopkins University School of Medicine 

Dr. Maria T. DeSancho: Invited presenter, Women’s Health 2010: 

The 18th Annual Congress of the American Medical Women’s 

Association 

Dr. Richard B. Devereux: Chair, Observational Study Monitoring 

Board for the Multiethnic Study of Atherosclerosis (MESA), National 

Heart Lung and Blood Institute; Director, Eastern Regional Chapter, 

American Society of Hypertension; Invited lecturer, 39th Annual 

Meeting of the Association of American Indian Physicians 

Dr. Jennifer Downs: Invited presenter, American Society of Tropical 

Medicine and Hygiene Meeting; Invited speaker, Female Genital 

Schistosomiasis Workshop, Bill and Melinda Gates Foundation, 

Denmark 

Dr. Rebecca Elstrom: Member, Lymphoma Committee, Cancer and 

Leukemia Group B, National Cancer Institute 

Dr. Doruk Erkan: Co-Chair, Abstract Review Committee, 

Antiphospholipid Syndrome, Annual Scientific Meeting, American 

College of Rheumatology; Executive Committee, New York 

Rheumatism Association; Member, Grant Review Committee, Annual 

Scientific Grant Application, Dutch Arthritis Foundation; Member, 

Medical and Scientific Committee, New York Chapter, Arthritis 

Foundation 

Dr. Theodore R. Fields: Member, Abstract Selection Committee: 

Quality Measures and Innovations in Practice Management and Care 

Delivery, American College of Rheumatology 

Dr. Maria E. Figueroa De Alcaide: Special Fellow Award, Leukemia 

and Lymphoma Society; Invited speaker, Hematology-in-Focus 

Session on Myelodysplastic Syndromes, Fifteenth Congress of the 

European Hematology Association, Spain 

Dr. Joseph J. Fins: Elected member, Institute of Medicine (IOM); 

Elected member, American Clinical and Climatological Association; 

President-Elect, American Society for Bioethics and Humanities; 

Council Member, Europaische Akademie Bad Neuenahr-Ahrweiler 

GmbH (The European Academy), Germany; John P. McGovern 

Award Lecture in the Medical Humanities, Institute for the Medical 

Humanities, University of Texas Medical Branch; Vice Chair, Fellows 

Council, and Member of the Board of Trustees, The Hastings Center 

Dr. Daniel W. Fitzgerald: Invited speaker, Haiti: A Case Study for 

Advancing Global Health, American Society of Tropical medicine and 

Hygiene Global Health Pre-Annual Meeting 

Dr. Richard R. Furman: Chair, CLL Education Session, 2010 ASH 

Meeting, American Society of Hematology; Member, CLL Steering 

Committee, National Cancer Institute 

Dr. Joy Gelbman: Member, Medical Leadership Committee, 

American Heart Association Go Red For Women Campaign 

Dr. Paraskevi Giannakakou: Ad hoc member and Invited member, 

Basic Mechanisms of Cancer Therapeutics Study Section, National 

Cancer Institute 

Dr. Allan Gibofsky: Chair, U.S. Committee for the International 

Treat-to-Target Rheumatoid Arthritis Initiative; Consultant, Arthritis 

Advisory Committee, U.S. Food and Drug Administration 

Dr. Marshall J. Glesby: Invited speaker, 17th Conference on 

Retroviruses and Opportunistic Infections; Royal Society of Medicine 

Meeting, United Kingdom 

Dr. Steven R. Goldring: Invited speaker, European Workshop of 

Rheumatology Research; Visiting professor and speaker, University 

of Massachusetts Medical Center; Chair, Basic Science Program 

Committee, Annual Meeting, American College of Rheumatology 

Dr. Jessica K. Gordon: Arthritis Foundation Fellowship Award in 

Inflammatory Arthritis; National Scleroderma Foundation Award; 

Charles L. Christian Musculoskeletal Research Award 

Dr. Roy M. Gulick: Member, Organizing Committee, 10th 

International Congress on HIV and Drug Therapy in HIV Infection, 

Scotland, and Scientific Committee, 6th International AIDS Society 

Conference on HIV Pathogenesis, Treatment and Prevention, Rome; 

Chairman, International AIDS Society-USA Annual CME Meeting; 

Invited speaker, 48th Annual Meeting of the Infectious Diseases 

Society of America, Vancouver, and 11th Annual International 

Symposium on HIV/AIDS, Mexico; Plenary speaker: 10th National 

Conference on Infectious Diseases and Clinical Microbiology, 

Portugal; Speaker, Satellite Symposium on Hepatitis, HIV/AIDS and 

Influenza, Open Medical Institute, Almaty, Kazashstan; Visiting 

Professor, University of Kwazulu-Natal, South Africa 

Dr. Monica L. Guzman: Director’s New Innovator Award, National 

Institutes of Health; Scientific Reviewer, Breast Cancer Research 

Program, 2010 Congressionally Directed Medical Research Program; 

Invited speaker, Translational Science Roundtable discussion on 

cancer stem cells, Life Sciences Summit 2010 

Dr. Barbara L. Hempstead: Member, Board of Scientific 

Counselors, National Institute of Child Health and Development, 

National Institutes of Health 

Dr. Evelyn M. Horn: Workforce Leader, Pulmonary Hypertension 

Council Standards and Guidelines Committee, International Society 

for Heart and Lung Transplantation; Co-Chair, International Society 

for Heart & Lung Transplantation Symposium; Visiting Professor and 

Distinguished Panelist, American Heart Association Fellows Society 

of Greater New York 

Dr. Julianne L. Imperato-McGinley: Urban Health Conference 

2010; From Bench to Bedside to Community – Translating Medical 

Research into Action; Member, Clinical Research Forum 

Dr. Ira M. Jacobson: Invited speaker, American Association for the 

Study of Liver Diseases 2010 Postgraduate Course 

Dr. Steven G. Jenkins: President, New York City Branch, American 

Society of Microbiology; President, Medical Mycology Society 

of New York 

Dr. Warren D. Johnson, Jr: Tribute held in Salvador, Brazil, March 

2010, honoring 40 years of contribution to global health and 

research in Brazil 

Dr. George D. Kalliolias: The SLE Foundation Research Award 

Dr. Robert J. Kaner: Outstanding Clinician Award, New York 

State Thoracic Society; Chairman, Adjudication Committee for 

IPFNET, National Heart, Lung and Blood Institute, National Institutes 

of Health; Session Co-Chair, 2010 American Thoracic Society 

International Conference on Cases from the IPFNET Adjudication 

Committee 

Dr. Kyriakos A. Kirou: Member, Medical and Scientific Committee 

and Planning Committee, Stavros Niarchos International Fellowship 

Exchange Program, Arthritis Foundation 

Dr. Jorge R. Kizer: Invited presenter, American Heart Association 

Epidemiology and Prevention Scientific Sessions; Invited presenter, 

American Heart Association Scientific Sessions 

Dr. Paul D. Kligfield: President, International Society for 

Computerized Electrocardiology; Member, Board of Directors, 

Computing in Cardiology; Member, Executive Committee, Member, 

FDA ECG Warehouse Working Group, Cardiac Safety Research 

Consortium 

Dr. Ana C. Krieger: Invited speaker, Third International Congress on 

Sleep Medicine; New York State Representative, Board of Directors, 

and Interim President, Northeastern Sleep Society; Research 

Committee Officer, American Academy of Sleep Medicine; Health 

Policy Committee Officer, New York State Society of Sleep Medicine 

Dr. Jeffrey C. Laurence: Invited speaker, TREAT Asia AIDS 

Symposium (sponsored by NIH and amFAR/Dutch government), 

Indonesia; Plenary speaker, International Maternal Pediatric 

Adolescent AIDS Clinical Trials Impact Group, National Institutes 

of Health; Invited speaker, Keystone Conference on AIDS 

Pathogenesis, NIH 

Dr. John P. Leonard: Chair-Elect, Scientific Advisory Board, 

Lymphoma Research Foundation; Invited lecturer, Meet the Professor, 

American Society of Clinical Oncology Annual Meeting; Coordinating 

Abstract Reviewer, Oral Abstract Session Chair, and Invited speaker, 

Education Session, American Society of Hematology; Invited speaker, 

Aggressive Lymphoma Symposium, Italy; Invited lecturer, Wake 

Forest University; Invited lecturer, Tufts University 

Dr. Bruce B. Lerman: Invited speaker, Heart Rhythm Society; Invited 

speaker, International Conference of Arrhythmias, Venice; Co-Editor, 

Topics of Arrhythmia and Ischemic Heart Disease; Co-Editor, Topics in 

Structural Heart Disease 

Dr. Michael D. Lockshin: Ira M. Goldstein Memorial Lecture, 

New York University; Member, Organizing Committee, and 

Invited speaker, 13th International Congress on Antiphospholipid 

Antibodies; Editor, Arthritis and Rheumatism 

Dr. C. Ronald MacKenzie: Chair, Committee on Ethics and Conflict 

of Interest, American College of Rheumatology 

Dr. Lisa A. Mandl: Young Investigator Subcommittee, Committee 

on Research, American College of Rheumatology; Translational 

Research Advisory Committee, Study Section, National Institutes of 

Health and Study Section, Arthritis Foundation 

Dr. Aaron J. Marcus: Counselor, New York Society for the Study 

of Blood; Featured speaker, One Hundredth Anniversary, Interurban 

Clinical Club; Invited speaker, American Society of Hematology; 

Invited speaker, Gordon Conference on Hemostasis and Thrombosis 

Dr. Peter Martin: Lymphoma Core Committee, Cancer and 

Leukemia Group B, National Cancer Institute; Invited speaker, 

West Virginia Oncology Society Annual Meeting; Invited speaker, 

Cancer and Leukemia Group B; Invited speaker, Lymphoma and 

Myeloma 2010 

Dr. Ari M. Melnick: Member, Executive Committee, Scientific 

Advisory Board, and Chair, Awards Committee, Lymphoma Research 

Foundation; External Advisory Board, Lymphoma SPORE, 

MD Anderson Cancer Center 

Dr. James K. Min: Abstract of the Year, Society of Cardiovascular 

Computed Tomography Scientific Sessions; Vice-President and 

President-Elect, Society of Cardiovascular Computed Tomography; 

Member, Medicare Coverage Advisory Committee 

Dr. Anne Moore: Lifetime Achievement honoree, Cancer Survivors 

Hall of Fame, Cancer Research and Treatment Fund 

Dr. David M. Nanus: 2010 Gold DOC Award, The Arnold P. Gold 

Foundation; Program Director, Oncology Practice Reviews 2010; 

Co-Program Director, Seventh Annual Current Trends in Genitourinary 

Malignancies; Faculty member, ASCO University Renal Cell Cancer 

Tumor Board, American Society for Clinical Oncology 

Dr. Ruben Niesvizky: Honorary Chairman, Laugh for Life, Multiple 

Myeloma Research Foundation; Chair and Vice Chair, Onyx 003/004 

Independent Response Review Committee; Member, Abstract 

Review Committee, American Society of Hematology; Invited 

presenter, 2010 American Society of Clinical Oncology Annual 

Meeting; Invited presenter, American Society of Hematology 2010 

Annual Meeting and Exposition 


Dr. Stephen A. Paget: Consultant, The Rockefeller University 

Hospital; Member, National Scientific Advisory Council; American 

Federation for Aging Research; Editorial Board, Rheumatology News; 

Advisory Editor and Co-Editor, Arthritis and Rheumatism; Associate 

Editor, Clinical and Experimental Rheumatology 

Dr. Jean W. Pape: Clinton Global Citizen Award, Clinton Global 

Initiative; Weill Cornell Medical College Alumni Association Award; 

Lifetime Award for work on tuberculosis, International Union 

Against Tuberculosis and Lung Disease, North American Chapter; 

Jonathan Mann Health Human Rights Award, International 

Association of Physicians in AIDS Care; Prix Christophe Meireux, 

Institute de France; Carlos Slim Health 2010 Award, Research 

Career, Carlos Slim Health Institute 

Dr. Janey C. Peterson: Invited speaker, NHLBI Conference “The 

Sixth Mixed Methods International Conference”; Invited speaker, 

NIH-sponsored Workshop “Translating Ideas into Interventions” 

Dr. Karl Pillemer (PhD): 2010 M. Powell Lawton Award, Polisher 

Research Institute of the Madlyn and Leonard Abramson Center for 

Jewish Life/Gerontological Society of America 

Dr. Mark Pochapin: Member, Board of Trustees, American College 

of Gastroenterology; Co-Chair, Evidence-Based Education and 

Outreach Task Group, National Colorectal Cancer Roundtable; 

Co-Chair, Education and Outreach Committee, New York Citywide 

Colon Cancer Control Coalition (C5); Co-Chair, Colorectal Cancer 

Task Group, American College of Obstetricians and Gynecologists 

Dr. Marcus M. Reidenberg: Torald Sollmann Award, American 

Society for Pharmacology and Experimental Therapeutics 

Dr. Kyu Y. Rhee: Grand Challenges Explorations Grant and Grand 

Challenges TB Drug Accelerator Program Grant, Bill and Melinda 

Gates Foundation; Invited speaker, Novartis Institute for Tropical 

Diseases Symposium on Tuberculosis, Yaounde, Cameroon; U.S.- 

Japan Cooperative Medical Sciences Program, 45th Tuberculosis and 

Leprosy Research Conference, Broad Institute; World TB Day, Public 

Health Research Institute 

Dr. Richard B. Roberts: Honorary Membership, Polish Society 

of Epidemiology and Infectious Diseases; Austrian Cross of Honor 

for Science and Art, First Class 

Dr. Gail J. Roboz: Invited member, Leukemia Core Committee, 

Cancer and Leukemia Group B, National Cancer Institute; 

Coordinating Reviewer for abstracts on acute myeloid leukemia 

(AML) and AML session chair, American Society of Hematology; 

Invited speaker, Super-Friday Symposium, Invited member, Consult 

a Colleague Program, and Invited speaker, Highlights of ASH Series, 

American Society of Hematology 

Dr. Mary J. Roman: Invited speaker, North American Artery 

Inaugural Symposium; Invited speaker, American Society of 

Hypertension Annual Meeting; Member, Editorial Board, Arthritis 

& Rheumatism; Member, Executive Committee, Board of Directors, 

National Marfan Foundation 

Dr. Howard E. Rosenberg: Medical Director of Health Services, 

The Juilliard School 

Dr. Joseph T. Ruggiero: Member, Cancer Education Committee, 

and Associate Editor, ASCO Self-Evaluation Program, American 

Society of Clinical Oncology 

Dr. Jane E. Salmon: Pfizer Visiting Professor in Rheumatology, 

University of Kentucky; Invited speaker, Opening Plenary 

Session, 2010 European League Against Rheumatism Meeting; 

Laura J. Haddad Lectureship, Georgetown University Hospital; 

Invited speaker, Ninth International Congress on Systemic Lupus 

Erythematosus; Secretary-Treasurer and Member, Centers of 

Excellence Committee, Federation of Clinical Immunology Societies; 

Member, Scientific Programme Committee, European League 

Against Rheumatism; Scientific Councilor, The Henry Kunkel Society 

Dr. Andrew I. Schafer: Elected President, Association of Professors 

of Medicine; Elected Master, American College of Physicians; 

Councilor, American Clinical and Climatological Association; 

Physician-Pro-Tempore, Northwestern University 

Dr. Felice Schnoll-Sussman: Co-Chair, Quality in Endoscopy 

Initiative, New York City Department of Health and Citywide 

Colon Cancer Control Coalition (C5); President, New York Society 

for Gastrointestinal Endoscopy; Co-Director, American College of 

Gastroenterology Regional Postgraduate Course 

Dr. Richard T. Silver: Invited lecturer, Investigators Board 

Meeting, Bristol-Myers Squibb, Czech Republic; Invited lecturer, 

Nineteenth International European LeukemiaNet CML Workshop, 

German National CML Study Group, Germany; Invited lecturer, 

European School of Hematology International Conference on 

Myeloproliferative Disorders, Portugal; Fifth Annual Houston 

Conference on Myelodysplastic Syndromes and Myeloproliferative 

Neoplasms 

Dr. Robert F. Spiera: President, New York Rheumatism Association; 

International Network for the Study of Systemic Vasculitis 

Dr. Manikkam Suthanthiran: Elected Member, American Clinical 

and Climatological Association; Councilor, The Transplantation 

Council; Editor, Transplantation; Plenary orator, 23rd International 

Congress of the Transplantation Society; Andrew Lazarovitz Lecturer, 

Canadian Society of Transplantation; Inaugural lecturer, University of 

Toronto Transplant Institute 

Dr. Scott T. Tagawa: Co-Chair, Genitourinary Working Group, 

New York Cancer Consortium 

Dr. Ann Tilley: Clinical Research Award in COPD and AAT 

Deficiency, Alpha-1 Foundation and The CHEST Foundation 

Dr. Judy Tung: Recognition for Diabetes Excellence, National 

Committee for Quality Assurance 

Dr. Mary A. Vogler: Invited expert, Updated guidelines on 

antiretroviral therapy for prevention of maternal-to-child 

transmission of HIV and cholera, GHESKIO and the Haitian Ministry 

of Health 

Dr. Thomas J. Walsh: 2010 sanofi-aventis ICAAC Award and 

Lecture, American Society for Microbiology; Gilbert B. Forbes 

Visiting Scholar, Strong Children’s Research Center, University of 

Rochester Medical Center; First Miller Children’s Hospital Visiting 

Professor of Pediatric Infectious Diseases; Teaching Award, Divisions 

of Medical Microbiology and Infectious Diseases, The Johns Hopkins 

University School of Medicine; Chairman, Medical Mycology, and 

Member, Planning Committee, 2011 Annual Meeting, American 

Society for Microbiology; Moderator and invited speaker, Focus on 

Fungal Infections 20; Invited speaker, 12th International Symposium 

on Febrile Neutropenia; 110th Annual Meeting of the American 

Society for Microbiology 

Dr. Jonathan W. Weinsaft: Invited reviewer, National Institute 

for Health Research Trainees Coordinating Center, UK; Invited 

lecturer, American College of Cardiology Scientific Sessions; Invited 

presenter, American College of Cardiology 

Dr. Arthur M. Yee: Member, Advisory Board, Lupus Asian Network; 

Medical and Scientific Committee, New York Chapter, Arthritis 

Foundation; Contributing Editor, The Medical Letter 

Dr. Dana Zappetti: Invited speaker, Multiple Small Feedings of the 

Mind, American College of Physicians International Conference 

Dr. Yuan-Shan Zhu: Editorial Board Member, The Open Andrology 

Journal and The Open Prostate Cancer Journal 

Division Profiles 


Division of Cardiology 

The Maurice R. and Corrine P. Greenberg Division 

of Cardiology is a leader in cardiovascular research, 

education and clinical care. The Division’s mission is 

to be at the forefront of scientific and technological 

developments that are revolutionizing cardiology 

and to translate these findings to the clinical 

bedside. As part of our commitment to advancing 

the discipline, we have assembled internationally 

renowned programs that investigate the basic 

mechanisms of cardiovascular disease, including 

the genetics of heart disease, the cellular signals 

and transcription factors responsible for cardiac 

development, the transformation and homing of stem 

cells for myocardial regeneration and the delineation 

of the molecular bases for cardiac arrhythmias. 

Clinically, our priorities are to develop and deliver 

cutting-edge therapies for heart disease and 

to advance clinical investigation. Expert faculty 

provide mentoring, training and supervision 

that prepare medical students, internal medicine 

residents and fellows in cardiology to be tomorrow’s 

leaders. The faculty also provide a host of weekly 

conferences for internal and external colleagues. 

Three clinical fellowship programs are offered and 

the division partners with Brooklyn Hospital Center 

for an additional fellowship. Strategies are being 

implemented to enhance physical space, expand 

comprehensive clinical programs and continue our 

history of cutting-edge research. 

The Division’s mission is to be at the forefront of 

scientific and technological developments that are 

revolutionizing cardiology and to translate these 

findings to the clinical bedside. 

Dr. Bruce Lerman (L) 

Nurse Barbara Aerni, NYP (R) 

Clinically, our priorities are to develop and deliver 

cutting-edge therapies for heart disease and to 

advance clinical investigation. 


Division of Cardiology continued 

Division of Clinical Epidemiology and 

Evaluative Sciences Research 

Bruce B. Lerman, MD 

Chief, Maurice R. and 

Corinne P. Greenberg Division 

of Cardiology 

Hilda Altschul Master 




Attending Physician 

NewYork-Presbyterian 

Hospital 

Patient care 

covers all types 

of heart and 

vascular diseases, 

including, but 

not limited to, 

arrhythmias, 

coronary and 

peripheral arterial 

disease, valve 

disease, the 

Marfan syndrome 

and inherited 

heart diseases. 

From basic science investigating the mechanisms 

of arrhythmias and large population-based studies 

of new diagnostic and therapeutic approaches, to a 

vast array of cardiovascular conditions and diseases, 

the focus is on improving patient care. This involves 

a majority of faculty and almost all of cardiology 

fellows-in-training, as well as postdoctoral trainees 

and graduate and medical students, creating a rich 

intellectual milieu in which trainees can develop into 

experienced investigators. Clinical services achieve 

superior outcomes in all areas, ranging from cuttingedge 

interventional and imaging laboratories to 

outpatient consultative and ongoing care. Patient 

care covers all types of heart and vascular diseases, 

including, but not limited to, arrhythmias, coronary 

and peripheral arterial disease, valve disease, the 

Marfan syndrome and inherited heart diseases. To 

allow immediate treatment of patients presenting 

in the early stages of a heart attack, there exists 

24-hour, in-hospital coverage of the Cardiac Intensive 

Care Unit, Telemetry and Step-Down Unit and the 

interventional laboratory. 

Dr. William Borden was selected to develop, 

lead and direct the Atkins Curriculum in Metabolic 

Diseases as a new component of the medical school 

curriculum. Dr. Robert Kim was named the new 

Director of Consultative Cardiology. Many of our 

faculty maintained high-profile leadership positions 

in local, national and international organizations 

such as the American College of Cardiology, the 

American Heart Association, the European Heart 

Rhythm Association, the Society for Cardiovascular 

Angiography and Intervention and the New York 

Cardiological Society. 

It was a stellar year in research funding, for both 

new and ongoing grants. The Division received 

funding from a wide array of sources covering the 

full spectrum of cardiovascular research. 

Dr. Jonathan Weinsaft was awarded a five-year K23 

Career Development Award from NHLBI to elucidate 

novel structural mechanisms and predictive indices 

of post-myocardial infarction mitral regurgitation, 

with a focus on papillary muscle infarction detected 

by DE-MRI tissue characterization as a longitudinal 

predictor of mitral regurgitation. 

Dr. Jorge Kizer was awarded a grant from 

the NHLBI to study adipocyte- and hepatocytederived 

biomarkers, as well as advanced glycation 

endproducts and fibrotic pathways, in the 

pathogenesis of diabetes and its cardiovascular 

complications. 

Dr. James Min received a grant from the Qatar 

National Research Foundation to evaluate the 

prevalence of coronary artery plaque characteristics 

in a population-based study, and to determine the 

relationship of those characteristics to age, gender, 

ethnicity, race and cardiovascular risk factors. 

Dr. David Christini was awarded a four-year R01 

grant from NHLBI to develop a framework that will 

enable the evaluation of potential pharmacological 

and device-based atrial fibrillation therapies. He was 

also awarded a supplement to his NHLBI grant to 

extend RTXI, a software resource for drug screening 

applications developed under his leadership. 

Dr. William Borden was awarded a New York 

Community Impact grant from the American Heart 

Association/American Stroke Association to educate 

middle school students about risk factors for heart 

disease and engage them as leaders in improving 

both their own cardiovascular health and that of 

their family members. 

Dr. Fay Lin was awarded a career development 

grant form the American Heart Association to 

determine the association among Heart Failure with 

Normal Ejection Fraction (HFNEF) patients of CAD 

extent and severity with LV filling pressure, and to 

determine the association of CAD extent and severity 

with HFNEF morbidity. 

Dr. Evelyn Horn continued to expand the 

Ventricular Assist Device Program, and accreditation 

for destination therapy from the Joint Commission 

on Accreditation of Healthcare Organizations granted 

in early 2010. 

Drs. Richard Devereux, Mary Roman and Jonathan 

Weinsaft have continued to play critical leadership 

roles in the NHLBI-sponsored Genetically Associated 

Thoracic Aortic Aneurysm (GenTAC) Registry, a new 

six-year phase of which was awarded in 2010. This 

multicenter registry has enrolled over 2,200 patients 

with genetically associated thoracic aortic aneurysms, 

with Weill Cornell contributing the largest number 

of participants. New findings include delineation of 

a role of aortic annular dilatation in causing aortic 

regurgitation, clarification of systematic differences 

among methods of measuring aortic size, and 

estimation of rates of dissection/surgery in the distal 

aorta after aortic root replacement. 

Dr. James Min is the Principal Investigator of the 

Coronary CT Angiography Evaluation for Clinical 

Outcomes: An International Multicenter (CONFIRM) 

Registry, a 12-site, six-country, 27,125-patient 

consecutive cohort of patients undergoing coronary 

CT angiography and followed for downstream 

clinical outcomes. 

The new Division of Clinical Epidemiology and 

Evaluative Sciences Research draws upon the talents 

and experience of a multidisciplinary group of faculty 

based at Weill Cornell Medical College, Cornell 

University, Ithaca and other institutions. Faculty 

members are expert in qualitative and quantitative 

research methodology, health services research, 

clinical epidemiology, medical informatics, decision 

sciences, health disparities research, communitybased 

participatory research, clinimetrics, outcomes 

research, behavioral science and health education. 

They work together in a series of activities designed 

to encourage and systematically support the 

development of new research initiatives within, as 

well as outside, the division. Several related are 

as of investigation encompass: studies to improve 

clinical outcomes; behavioral science research; 

health disparities research (under the leadership 

of Dr. Carla Boutin-Foster); research on complex 

patients with a significant burden of comorbidity; 

and comparative effectiveness. In order to stimulate 

and support new clinical, health services and 

outcomes research, the division houses consultative 

services to investigators, including informatics and 

data management support, as well as the currently 

existing training programs in clinical epidemiology 

and research methodology. 

The division has continued to expand in the area 

of health disparities and community-based research 

under the auspices of two large NIH grants: the 

Comprehensive Center for Excellence in Disparities 

Research and Community Engagement (CEDREC) 

grant and the Small Changes and Lasting Effects 

(SCALE) grant. The establishment of CEDREC 

resulted in the expansion of partnerships between 

Weill Cornell, Lincoln Hospital and Mental Health 

Center, Hunter College School of Nursing-City 

University of New York, and The Center for Healthful 

Behavior Change at NYU School of Medicine. As 

a result of SCALE, the division has a new community 

partner, the Northern Manhattan Perinatal Partnership 

(NMPP), an organization that focuses on improving 

health conditions such as diabetes and obesity 

in families who reside in Northern Manhattan. In 

addition to NMPP, several faith-based organizations 

in Harlem and the South Bronx have become 

critical partners in initiatives to develop health 

disparities research. 

Mary E. Charlson, MD 

Chief, Division of Clinical 

Epidemiology and Evaluative 

Sciences Research 

Executive Director, Center 

for Complementary and 

Integrative Medicine 

William T. Foley Distinguished 






Hospital 

Faculty members are expert in qualitative and quantitative research 

methodology, health services research, clinical epidemiology, medical 

informatics, decision sciences, health disparities research, communitybased 

participatory research, clinimetrics, outcomes research, 

behavioral science and health education. 

38 Department of Medicine (L to R) Drs. Mihir Patel, Stephen Williams, Regina Jacob (fellows); Drs. James Hollenberg, Janey Peterson, Carol Mancuso (faculty) Annual Report 2011 39

Division of Clinical Epidemiology and Evaluative Sciences Research continued 

Division of Clinical Pharmacology 

Ginger Winston, MD, who also sees patients at 

Weill Cornell Internal Medicine Associates (WCIMA), 

was appointed Assistant Professor of Medicine 

after receiving a National Institutes of Health 

Minority Investigator Research Supplement to 

Dr. Mary Charlson’s multimillion dollar SCALE grant. 

Dr. Winston served her internal medicine residency 

and a Chief Residency at NYU Medical Center and 

completed a general medicine fellowship at Columbia 

University. She plans to become an independent 

clinician-investigator in cardiovascular healthcare 

disparities research with a focus on obesity reduction 

in minority communities. The NHLBI-funded SCALE 

research project involves small changes in eating and 

physical activity behavior. Body image discrepancy 

and risk knowledge about obesity are key constructs 

that will enhance our understanding and prediction 

of who will fare well with a small-change approach 

to weight loss. 

Home to its administrative, research, education 

and informatics infrastructure, the division moved 

to a new 8,000 square foot facility at 338 East 66th 

Street. The new space reunites division faculty and 

staff previously located at multiple sites and provides 

space for the additional faculty and staff recruited 

as a result of the CEDREC and SCALE grants. 

There is a conference room with teleconferencing 

capabilities and many other features that provide 

excellent resources for the division. 

The division has continued to expand in the area of health 

disparities and community-based research. 

Marcus M. Reidenberg, MD 

Chief, Division of Clinical 

Pharmacology 

Professor of Pharmacology 


Professor of Public Health 


The Division of Clinical Pharmacology remains actively involved in the World Health 

Organization (WHO) Essential Medicines program. This important global effort evaluates, updates 

and publishes a list of about 300 medicines that address the world’s major medical problems. 

The program is designed to advise countries about which drugs should be considered priority 

purchases when health care resources are limited. Since 1975, the concept of prioritizing the 

purchase of essential medicines has been accepted in principle by 156 WHO member states. 

Dr. Reidenberg mentored and supervised a group of Weill Cornell students who prepared 

three applications for adding drugs to the Model List of Essential Medicines and one application 

to change the status of a class of drugs. These were discussed at the Committee meeting at 

WHO headquarters in Geneva, Switzerland, in March 2011. 

Dr. Reidenberg is an inventor of a drug with a near-complete phase 2 clinical trial for treating 

hormone-refractory prostate cancer and ongoing trials in several other cancers. He continues 

to advise the present sponsor on further development of this drug. He also is the principal 

investigator of a study to discover a new drug to reduce fatal arrhythmias in patients with 

heart attacks. 

The prestigious Torald Sollmann Award (American Society of Pharmacology and Experimental 

Therapeutics) was given to Dr. Reidenberg based upon his outstanding and productive research 

career, significant contributions to medicine utilizing education, research and public service, 

as well as his unparalleled service to ASPET and the discipline it represents. 


(L) Dr. Regina Jacob (fellow) (R) Dr. Janey Peterson Annual Report 2011 41

Division of Emergency Medicine 

We see over 76,000 patients annually, with 

more than 18,000 subsequently admitted to 

inpatient services. 

The Division of Emergency Medicine provides 

state-of-the-art emergency care to all patients, 

while teaching residents from all specialties how to 

provide that care. We are a designated 911 Receiving 

Hospital, a Level I Trauma Center, a Psychiatric 

Emergency Receiving (9.39) Center, a Burn Center 

for the City of New York, a Chest Pain Center 

accredited by the Society of Chest Pain Centers 

and a designated Stroke Center. Our disaster 

preparedness includes extensive Hazmat, and we 

provide biological and chemical decontamination 

and treatment facilities. We see over 76,000 patients 

annually, with more than 18,000 subsequently 

admitted to inpatient services. We also receive, 

evaluate, and stabilize patients who are transferred 

to us from all over the world. The Weill Cornell 

Adult emergency department ended the year with 

a patient satisfaction score of 82.4, 2.8 points 

ahead of 2009. In February 2010, an all-time high 

mean score of 84.8 – the 90th percentile for “best 

hospital” emergency departments – was reached. 

The division’s Medical Toxicology Service began 

offering bedside and telephone consultations 

throughout the hospital for all acutely or potentially 

poisoned patients, and to those patients experiencing 

the effects of chronic overdoses, withdrawal 

syndromes, medication errors, adverse drug reactions 

and other toxicologic concerns. Since its inception 

in 2009, the “toxicology” service has consulted on 

over 300 patients. The group consists of four faculty 

members: Dr. Flomenbaum, Drs. Jane Prosser, 

Brenna Farmer, and Dr. Rama Rao (director of the 

toxicology service). Drs. Prosser and Farmer are 

currently conducting local and national research 

in acetaminophen overdoses. Dr. Prosser holds 

a grant for funded research on cocaine-induced chest 

pain. All members of this service contribute to peer 

review publications and textbook chapters. Lectures 

in medical toxicology are offered to all services. 

The service is currently developing a proposal for 

a rotation in medical toxicology for housestaff from 

several academic departments and disciplines. 

Our program in Geriatric Emergency Medicine 

(GEM), the first such fellowship in the country, is 

supported by a new state-of-the-art emergency 

department facility. Major collaborative research 

efforts have been initiated with colleagues at the 

University of Toronto and the one year clinical GEM 

fellowship has expanded to include a second year 

option culminating in a Master’s degree in Clinical 

Investigation from Weill Cornell Graduate School of 

Medical Sciences. GEM members have co-authored 

and presented abstracts at the annual American 

Geriatric Society national meetings and Michael 

Stern, Co-Director of the fellowship, co-authored 

a publication on orthogeriatrics. In addition to our 

existing didactic curriculum for EM residents, our 

educational content has been augmented with a 

monthly GEM journal club and GEM topic morning 

report. Dr. Halpern (and GEM group) have created 

a Palliative Care protocol for the ED. Development/ 

implementation is underway for three other clinical 

protocols: falls prevention, urinary tract infection 

prevention, management of agitation/delirium. 

Continuing our partnership with Cornell Outdoor 

Education (COE) on the Ithaca campus, our unique 

Wilderness Medicine Program is advancing in medical 

education, clinical research, and clinical care, with 

new courses and experiences for resident and 

attending physicians, Cornell undergraduates and 

Weill Cornell medical students. Student electives 

continue to draw participants from all over North 

America and Europe and we established a residency 

track for those seeking an elective rotation in 

wilderness medicine. We also offer an annual 

CME in Wilderness Medicine in Alaska and other 

locations for our faculty. We are collaborating with 

the Department of Botany (Ithaca) in translational 

research on botanicals throughout the world that 

may be useful medically. For the future: a training 

program for humanitarian first responders. 

Our department launched a Global Emergency 

Medicine Program. In 2010, over 23 doctors, nurses 

and PAs from our department served at the Disaster 

Recovery Center in Haiti. Overseas teaching activities 

expanded to Qatar and Lebanon, while ongoing 

research and resident electives in Guatemala and India 

continued. Global EM faculty organized Mumbai’s 

second city-wide disaster drill in collaboration with 

UN agencies, and federal and city institutions. 

The Weill Cornell Adult emergency department ended the 

year with a patient satisfaction score of 82.4, 2.8 points 

ahead of 2009. 

Educational activities in the medical school 

continue. In addition to elective courses, we serve 

on the medical school’s Global Health Curriculum 

Working Committee. Our capstone academic 

activity is the inaugural session of the Global 

Health Emergencies Course, a rigorous two-week 

CME-approved initiative to train doctors, nurses 

and mid-level providers engaged in international 

work. The Emergency Department implemented an 

electronic medical record (EMR) that it developed 

based on the hospital-wide Eclipsys EMR. Although 

components of Eclipsys had been previously utilized 

in the Weill Cornell ED for several years, now all 

nursing, physician and mid-level provider (NP, PA) 

documentation is done in Eclipsys, streamlining 

communications with all hospital staff and specialty 

services. 

Neal E. Flomenbaum, MD 

Chief, Division of Emergency 


Professor of Clinical Medicine 


Medical Director 

Emergency Medical Services 

Emergency Physician-in-Chief 




Division of Endocrinology, Diabetes 

and Metabolism 

Julianne L. Imperato- 

McGinley, MD 

Chief, Division of 

Endocrinology, Diabetes, 

and Metabolism 

Associate Dean for 

Translational Research and 

Educational Medicine 

Director, Clinical and 

Translational Science Center 

(CTSC) 

The Abby Rockefeller Mauzé 

Distinguished Professor of 

Endocrinology in Medicine 


Weill Cornell Medical 

College 



Hospital 

As part of a world-class academic medical 

center, the Division of Endocrinology, Diabetes and 

Metabolism is committed to excellence in providing 

the best quality of care to patients with endocrine 

and metabolic disorders; in conducting promising 

research to advance the frontiers of endocrinology 

and diabetes treatment; and in training highly 

dedicated physicians to become successful clinicians 

and physician-scientists. 

Faculty members are dedicated to fulfilling 

our mission of excellence in education. The 

subspecialty fellowship program in endocrinology, 

diabetes and metabolism is designed to provide 

the training and experience necessary to acquire 

all competencies required of an expert in this field. 

The two-year fellowship is a joint program of 

NewYork-Presbyterian (Weill Cornell) and Memorial 

Sloan-Kettering Cancer Center. Our faculty also 

trains internal medicine residents and leads the 

endocrinology section of the Basis of Disease course 

for medical students. 

Faculty conduct promising state-of-the-art 

research to generate new knowledge with the 

ultimate goal of applying the latest scientific and 

medical advances for the prevention, detection 

and treatment of patients with endocrine diseases. 

A hospital-wide glycemic order set was launched. 

The purpose of this order set is to improve overall 

inpatient diabetes management and decrease the 

rate of hyper- and hypoglycemia. Insulin is the 

number one cause of medical errors in the hospital 

setting. This order set required the collaboration 

of many departments including Pharmacy, Nursing, 

Nutrition, Laboratory, Information Technology 

and Medicine. 

Aaron Schulman, MD, who completed his 

fellowship at Weill Cornell in 2010 and was 

awarded a Certificate in Clinical Investigation, 

joined the Division of Endocrinology as Assistant 

Professor of Medicine. Dr. Schulman is significantly 

involved in the development, planning and execution 

of a research project studying the relationship 

of sex steroids to cardiovascular disease risk. 

Faculty conduct promising state-of-the-art research to generate 

new knowledge with the ultimate goal of applying the latest 

scientific and medical advances. 

44 Department of Medicine Dr. Aaron Schulman (R) with a fellow in training. 


Division of Gastroenterology 

and Hepatology 

Dr. Jacobson visiting Dr. Rice’s lab at The Rockefeller University. (L to R) Drs. Charles Rice, Ype deJong, Ira Jacobson, Andrew Talal 

Ira M. Jacobson, MD 


Gastroenterology and 

Hepatology 

Vincent Astor Distinguished 






Hospital 

The Division of Gastroenterology and Hepatology 

provides outstanding and compassionate patient 

care, its faculty being active in research and education, 

as well as clinical care. First-rate clinical services 

are offered in a wide range of subspecialty areas, 

including hepatology, inflammatory bowel disease, 

gastrointestinal reflux disease, endoscopic ultrasound 

and ERCP, functional bowel disorders, gastrointestinal 

infections and gastrointestinal cancer prevention 

and treatment. Numerous research studies and clinical 

trials are underway to study prevention and treatment 

of viral hepatitis, gastrointestinal cancers, Barrett’s 

esophagus, inflammatory bowel disease, pancreatic 

lesions, and other gastrointestinal diseases and 

ailments. Centers housed within the division include 

the Jay Monahan Center for Gastrointestinal Health, 

the Center for the Study of Hepatitis C, and The 

Jill Roberts Center for Inflammatory Bowel Disease. 

Dr. Ira M. Jacobson, Division Chief, presented 

pivotal phase 3 ADVANCE trial results at the 61st 

Annual Meeting of the American Association for the 

Study of Liver Diseases (AASLD) in Boston: 75 percent 

of treatment-naïve HCV genotype 1-infected patients 

treated with a telaprevir-based combination regimen 

for 12 weeks, followed by 12 or 36 weeks of the 

standard therapy of pegylated-interferon alfa-2a and 

ribavirin alone, achieved a viral cure; this compared 

to 44 percent of people treated with 48 weeks of 

pegylated-interferon and ribavirin alone. Additionally, 

62 percent of patients with advanced liver fibrosis 

(cirrhosis or scarring of the liver) achieved a viral 

cure with the telaprevir regimen, compared to 

33 percent who were treated with pegylated-interferon 

and ribavirin alone. These groundbreaking data 

highlight telaprevir as a potential new therapy that, 

if approved by the FDA, could dramatically improve 

the future treatment of hepatitis C. The results 

confirm and amplified upon the findings of the U.S. 

phase 2 PROVE1 study, which was co-authored by 

Dr. Jacobson, and the European PROVE2 study; both 

studies were published in The New England Journal 

of Medicine (2009). The PROVE3 study, evaluating 

telaprevir in nonresponders to previous therapy, 

was published with Dr. Jacobson and his colleagues 

in 2010. He also coauthored the SPRINT-1 study 

of boceprevir in treatment naïve HCV genotype 

1 patients, published in The Lancet in 2010. 

At the 2010 AASLD, Dr. Jacobson was coauthor 

of a plenary paper on the phase 3 trial results 

(SPRINT-2) of another HCV protease inhibitor, 

boceprevir, added to peginterferon and ribavirin, 

demonstrating (as with telaprevir) a highly significant 

increase in sustained virologic response compared 

with standard-of-care therapy with peginterferon 

and ribavirin alone. A critical finding in both 

studies was that half a year of therapy appears to 

be sufficient in patients receiving either protease 

inhibitor (when the virus becomes undetectable 

after four weeks of triple therapy). 

These studies are critical elements of an emerging 

body of data signifying a new era in the treatment 

of chronic hepatitis C. It is fitting that Weill Cornell 

has played a leading role in these trials, as the 

institution has participated in most of the key trials 

that have moved the field of HCV therapy forward 

since the initial trials with interferon monotherapy 

in the late 1980s. The division’s clinical trials unit 

remains active in a number of ongoing development 

programs involving a variety of classes of antiviral 

agents, including other protease inhibitors, 

polymerase inhibitors, host-targeting agents and 

immunotherapies. 

The Jay Monahan Center for Gastrointestinal 

Health was featured on The CBS Early Show, which 

aired a live broadcast of anchor Harry Smith’s 

colonoscopy performed by Dr. Mark Pochapin, 

Director of the Jay Monahan Center. CBS Evening 

News anchor, Katie Couric,, was on hand to support 

Harry Smith through the procedure, which coincided 

with National Colorectal Cancer Awareness Month. 

The Monahan Center partnered with the New York 

City Department of Health, Colon Cancer Challenge 

Foundation, Prevent Cancer Foundation, American 

College of Obstetricians and Gynecologists and 

others in numerous efforts to advance awareness 

and prevention of colorectal cancer. Moderated 

by Monahan Center social worker, Lauren Shaffer, 

LCSW, the center offers an ongoing support group 

every 6 to 8 weeks for colorectal cancer survivors, 

this in addition to regular health seminars in GI 

health (open to patients, families, the public) and 

a weekly CME Case Conference in GI Cancer 

Prevention, Treatment and Support. 

At the Jill Roberts Center for Inflammatory Bowel 

Disease, Director Dr. Ellen Scherl has implemented 

five new programs: The Scherl/Roberts IBD 

Biobank; a monthly support group for patients 

and families; the New York-Moscow IBD Journal 

Club, conducted via Skype and accredited by the 

ACG; research with Dr. Richard Silver on the role 

of certain immune cells and pathways on IBD as 

seen in myeloproliferative disorders; and research 

with Dr. Judy Cho of Yale School of Medicine on 

the genetics of IBD. Collaborations continue with 

institutes across the globe in efforts to establish 

international biobanks; explore the relationship 

between vitamin D and IBD health; and explore IBD 

genotypes. Under the leadership of Dr. Scherl, the 

Jill Roberts IBD Center continues to collaborate with 

Dr. Andrew Dannenberg, Director of the WCMC- 

NYP Cancer Center, Dr. Kenneth Simpson at Cornell 

University, Ithaca exploring the Microbiome in IBD, 

and researchers at Weill Cornell Medical College 

investigating NOD 2 genotyping, hemangiogenesis 

and animal models of colon cancer and IBD. 

There have been a number of developments 

in education. Dr. Scherl directs weekly IBD case 

discussions and Journal Clubs at both Weill Cornell 

and the Columbia Campus (GI division); a monthly 

case correlation conference with GI pediatrics, GI 

pathologists, surgeons and radiologists at NYP/ 

WCMC; and the Ellen Scherl/Jill Roberts International 

Scholar Program which invites an international IBD 

scholar to speak at the winter course each year. 

Dr. Brian P. Bosworth, the Anne and Ken 

Estabrook Clinical Scholar in Gastroenterology, was 

named Program Director of the Gastroenterology 

and Hepatology Fellowship. He was also named 

a Key Clinical Faculty member to the Department 

of Medicine Residency Training Program, currently 

sits on the Residency Evaluation and Curriculum 

committees, and has served as the Chair of the Small 

Bowel Abstract Review Committee/American College 

of Gastroenterology Education Committee, leading the 

selection of posters and oral presentations at the ACG 

Annual Meeting. His other charge on the ACG was as 

Chair of the Peer Review Sub-committee to ensure lack 

of bias in presentations at ACG events. 

Dr. Bosworth’s clinical research resulted in five 

presentations each at Digestive Disease Week (including 

an oral presentation in the Surgical Society for the 

Alimentary Tract) and the ACG annual meeting. 

Through this work, he mentored both gastroenterology 

fellows and residents on a path towards a clinical 

research career. He also led a “Meet the Professor” 

luncheon on “Dysplasia in Inflammatory Bowel Disease – 

What’s an Endoscopist to Do?” 

The division welcomed University of Amsterdam 

Medical School alumnus Ype De Jong, MD, PhD, 

to its faculty as an Assistant Professor of Medicine. 

Dr. de Jong has conducted research into the 

immunopathogenesis of Crohn’s disease at the 

Beth Israel Deaconess Medical Center in Boston. 

He completed his internal medicine internship, residency 

training, and a fellowship in gastroenterology at The 

Mount Sinai Medical Center. Dr. de Jong plays a key 

role at the Center for the Study of Hepatitis C, both 

as a physician at New York-Presbyterian Hospital 

and as a Visiting Clinical Fellow at The Rockefeller 

University. Trained in general gastroenterology, including 

endoscopy and colon cancer screening, his patient 

practice interests include viral hepatitis, primary biliary 

cirrhosis, non-alcoholic fatty liver disease and liver 

disease associated with inflammatory bowel disease. 

His research interests are geared to illuminating how 

hepatitis viruses can evade the immune system and are 

able to chronically persist in a subset of those infected. 

To this end, he is working on developing new models 

for hepatitis C virus infection in the laboratories of the 

Center for the Study of Hepatitis C. 

Dr. Mark Pochapin chaired the Evidence-Based 

Education and Outreach Task Group of the National 

Colorectal Cancer Roundtable, which developed 

an Evaluation Toolkit to assist community-based 

organizations to evaluate and report outcomes of 

their efforts to increase colorectal cancer awareness 

and screening. 

Numerous 

research studies 

and clinical trials 

are underway to 

study prevention 

and treatment 

of viral hepatitis, 

gastrointestinal 

cancers, Barrett’s 

esophagus, 

inflammatory 

bowel disease, 

pancreatic 

lesions, 

and other 

gastrointestinal 

diseases and 

ailments. 

Dr. Brian Bosworth (2nd from R) 

with fellows in training. 

Groundbreaking 

data highlight 

telaprevir as a 

potential new 

therapy that, 

if approved by 

the FDA, could 

dramatically 

improve the 

future treatment 

of hepatitis C. 


Division of Geriatrics and Gerontology 

(L) Al Greenberg, of the Upper West Side, returns home after hospitalization to enjoy going to the opera 

48 once Department again. (R) Dr. of Eugenia Medicine Siegler, recipient of the Mason Adams Professorship of Geriatric Medicine. 

The Center sees an increasing number of geriatric 

outpatients annually (average age over 80 and many 

vibrant centenarians). 

The Division of Geriatrics and Gerontology 

improves the quality of life for older people through 

the integration of high-quality clinical care, teaching 

geriatric medicine, and advancing knowledge 

through scientific research. Federal and foundation 

grants continue and several new research awards 

were received. 2010 showed a steady increase in 

patient volumes, both inpatient and outpatient 

services. U.S. News & World Report ranked NewYork- 

Presbyterian Hospital (NYP) seventh in the nation in 

geriatric medicine. 

The Irving Sherwood Wright Center on Aging, 

our ambulatory practice site, received the NYP 

Patient Centered Care Award for the highest-rated 

Department in Ambulatory Care. The Center sees an 

increasing number of geriatric outpatients annually 

(average age over 80 and many vibrant centenarians). 

Within the Ambulatory Care Network, the Center 

excels as one of the highest-ranking practices 

in patient satisfaction. Established by Dr. Sharda 

Ramsaroop, the division’s Hospital Discharge 

Follow-up Program has vastly improved patient 

care (200 patients seen since 2009). This program 

recognizes that the transition from hospital to 

home is a vulnerable time for patients. 

With generous support from the Gruss-Lipper 

Family Foundation, there has been significant 

progress in expanding our multidisciplinary and 

community-based House Call Program led by 

Dr. Veronica LoFaso, providing comprehensive services 

to the most frail, homebound elderly patients. The 

program maintains a collaborative relationship with 

DOROT, a highly regarded social services agency. 

Activities on the Palliative Care Consultation Service 

have expanded under new leadership: Division 

Co-Chief, Dr. Ronald Adelman, is Acting Director; 

Dr. Sonal Mehta, Assistant Director. 

Our NYC Elder Abuse Center is advancing in 

the field of elder justice. There are multidisciplinary 

team activities in Manhattan and Brooklyn, including 

partnerships with Maimonides Medical Center’s 

Division of Geriatrics and the Brooklyn VA. Funding 

for this new center includes: Fan Fox and Leslie 

R. Samuels Foundation, FJC, A Foundation of 

Philanthropic Funds, Laura B. Vogler Foundation, 

and Vladimir and Araxia Buckhantz Foundation. 

ThisCaringHome.org, a new interactive multimedia 

website offers tips for caregivers on adapting 

residences to the special needs of Alzheimer’s 

patients. Virtual tours of each type of room address 

the varying safety and quality-of-life issues that can 

arise as dementia progresses. Rosemary Bakker, 

Research Associate in Gerontologic Design in 

Medicine, published the AARP Guide to Revitalizing 

Your Home. Division Co-Chief, Dr. Lachs, published 

Treat Me, Not My Age, a book for “baby boomers” 

and beyond on navigating the healthcare system. 

The division received two five-year Geriatric 

Academic Career Awards (Drs. Ramsaroop and Sonal 

Mehta). Two new endowed professorships began – 

the Emilie Roy Corey Professorship in Geriatrics and 

Gerontology and the Mason Adams Professorship of 

Geriatric Medicine – held by Dr. Ronald Adelman and 

Dr. Eugenia Siegler, respectively. Educational initiatives 

and physician services in palliative care continue; 

funding sources include the Altman Foundation, the 

Ronald D. Adelman, MD 

Co-Chief, Division of 

Geriatrics and Gerontology 

Medical Director, Irving 

Sherwood Wright Center 

on Aging 

The Emilie Roy Corey 

Professor in Geriatrics and 

Gerontology 





Hospital 

Mark S. Lachs, MD, MPH 

Co-Chief, Division of Geriatrics 

and Gerontology Director, 

Geriatrics for the NewYork- 

Presbyterian Health System 

The Irene F. and I. Roy Psaty 

Distinguished Professor of 





Hospital 

New York Community Trust, the Y.C. Ho/Helen and 

Michael Chiang Foundation and the Pincus Family 

Fund. Our Consortium for Psychosocial Education 

in Geriatrics, held a conference of 18 metropolitanarea 

geriatric fellowship training programs. The 

successful medicine clerkship Fast Forward Rounds 

teaches third-year medical students key aspects of 

the discharge planning process for older adults with 

chronic illness. 

As one of 12 such centers nationally, we are in 

year two of the National Institute on Aging’s award 

(Edward R. Roybal Center for Research on Applied 

Gerontology), a grant that has created the Cornell- 

Columbia Translational Research Institute on Pain in 

Later Life (TRIPLL). TRIPLL is expected to reach more 

than 300,000 New York metro-area seniors. The new 

institute is an expansion of the Cornell Institute for 

Translational Research on Aging (CITRA) in Ithaca, NY, 

a Roybal Center since 2003. The Division of Geriatrics 

and Gerontology serves as the program’s hub, 

with other principal members comprising Cornell 

University College of Human Ecology in Ithaca, and, 

for the first time, Columbia University Mailman 

School of Public Health, a leader in healthy aging 

and palliative care research. Other newly added 

members include Memorial Sloan-Kettering Cancer 

Center, the Hospital for Special Surgery and the 

Visiting Nurse Service of New York. 

A new interactive 

multimedia 

website offers 

tips for caregivers 

on adapting 

residences to the 

special needs 

of Alzheimer’s 

patients. 

Visit ThisCaringHome.org for 

helpful tips on safety for the 

elderly. 


Division of Hematology and 


The Division of Hematology and Medical Oncology 

currently consists of three full-time clinicians (including 

one hospitalist), 24 clinical researchers with clinical 

responsibilities, five physician-scientists and 11 full-time 

scientists with no clinical responsibilities; voluntary 

faculty also participate, several with significant 

mentorship and philanthropic roles. Clinical services 

are divided into five clinical programs: Solid Tumor 

Oncology, Leukemia, Lymphoma/Myeloma, Stem Cell 

Transplant and Nonmalignant Hematology, at three 

sites of operation--NewYork-Presbyterian Hospital 

Main Campus (third floor), Oxford Building and the Iris 

Cantor Women’s Health Center, with expansion under 

way at a fourth site in the Weill Greenberg Ambulatory 

Care Building. In addition, clinical services are divided 

into disease-site specific programs. In the Solid 

Tumor Service, the programs are: Breast Oncology, 

Gastrointestinal Oncology, Genitourinary Oncology and 

Thoracic Oncology. The Lymphoma/Myeloma Service 

is subdivided into several free-standing disease-specific 

programs, including the CLL Research Center and the 

Waldenstrom’s Macroglobulinemia Program. Emerging 

smaller programs include Head and Neck Oncology, 

Neuro-Oncology and Endocrine Oncology. Each of the 

services works closely with faculty in the corresponding 

surgical oncology department, division or program. 

The Division houses the largest group of 

clinical investigators in the college, and basic and 

translational research has benefitted from newly 

Remarkable strides have been accomplished 

in the division’s basic, translational and clinical 

research missions. 

Barbara L. Hempstead, 

MD, PhD 


Hematology and Medical 

Oncology 

O. Wayne Isom Professor 

of Medicine 





Hospital 

David M. Nanus, MD 


Hematology and Medical 

Oncology 

Medical Director 

Genitourinary Oncology 

Program 

Mark W. Pasmantier Professor 

of Hematology and Oncology 

in Medicine 


Professor of Urology 




Dr. 50 Schafer Department (L) with of Dr. Medicine David Nanus. Annual Report 2011 51

Division of Hematology and Medical Oncology continued 

The Division 

houses the largest 

group of clinical 

investigators 

in the college, 

and basic and 

translational 

research has 

benefitted from 

newly renovated 

research space 

and multiple new 

recruits over the 

last four years. 

Dr. Barbara Hempstead (L) 

in her laboratory. 


renovated research space and multiple new recruits 

over the last four years, markedly expanding the 

research portfolio. Plans include expanding clinical 

and basic science areas of expertise, with a major 

emphasis on translational (bench-to-bedside) studies. 

As such, the division is poised to play a central 

role in the Cancer Center Initiative, in selective 

recruitment of translational scientists to the new 

research building, and in partnering with other 

divisions/departments to further expand the research 

base through large collaborative grants. 

Participation in conferences included Oncology 

Practice Reviews, a unique multitumor CME 

conference for medical oncologists and hematologists 

presented by Physicians’ Education Resource in 

conjunction with Weill Cornell Medical College. 

Dr. David Nanus was the program director, with 

wide participation from the division’s faculty. This 

meeting provided updates on state-of-the-art 

clinical management of a wide variety of solid 

and hematologic malignancies. It also highlighted 

cutting-edge information and emerging treatment 

strategies for breast cancer, genitourinary 

malignancies, gastrointestinal malignancies, 

lung cancer, lymphoma, multiple myeloma, 

myelodysplastic syndromes, leukemia and chronic 

lymphocytic leukemia. The Congress of Lymphoma 

and Myeloma 2010: An International Congress 

on Hematologic Malignancies was chaired by 

Dr. Morton Coleman.Dr. John P. Leonard co-chaired 

the Lymphoma Session, Dr. Ruben Niesvizky 

co-chaired the Myeloma Session and Dr. Richard R. 

Furman co-chaired the Leukemia Session. This premier 

forum was attended by some 1,000 participants 

from around the world, representing the largest CME 

activity to target hematologic malignancies apart 

from the American Society of Hematology meeting. 

Dr. Ari Melnick has had a tremendously productive 

year. His group published 14 papers in the academic 

year 2010, including in the Proceedings of the 

National Academy of Sciences, Blood, Nature 

Medicine, Cancer Cell, Journal of Experimental 

Medicine, and Cancer Research – four of these cited 

in the Faculty of 1000. Dr. Melnick was the lead 

investigator of three high profile studies that 

(a) identified new therapeutic agents for lymphomas 

(Cancer Cell and Nature Medicine) and (b) in 

a second line of investigation revealed the first 

epigenetic based classification and full epigenetic 

characterization of a human disease, in this case 

leukemia (Cancer Cell). These discoveries led to a new 

patent of a method to predict clinical outcomes in 

leukemia patients using an epigenetic biomarker. 

Dr. Melnick continues to lead the Epigenomics Core 

at Weill Cornell and has recruited computer scientists 

and a bioinformatics specialist to assist in designing 

new algorithms for epigenomics research. 

Basic and translational investigators are established 

in the totally renovated basic and translational research 

space in the Belfer Institute of Hematology and 

Oncology. Many of the aspects of its design, including 

three rooms for videoconferences, have greatly facilitated 

the interactions of the Belfer faculty with clinicians in 

our division and with faculty at Cornell University in 

Ithaca, as well as other institutions. This has enabled 

the Belfer faculty to play leadership roles in uniting new 

interdisciplinary groups to enhance the translational 

mission of the Belfer Institute. Clinical researchers in 

the Belfer Institute have focused on building their 

academic clinical studies and establishing a tissue bank 

for hematologic malignancies. The division focused 

on two major research areas: the molecular alterations 

that characterize malignant cells as related to cancer 

development; novel therapeutic targeting and 

response/resistance to current therapies; and promoting 

translational research by fostering new collaborations 

with investigators outside the Belfer faculty. 

The divisional clinical research program enrolled 

more than 400 research subjects in 104 different 

treatment studies in 2010. Of these, 27 are 

investigator-initiated clinical trials, developed and 

overseen by one of the division’s physicians. These 

studies include high-impact protocols across the entire 

spectrum of hematologic malignancies and solid 

tumors, as well as projects in areas of non-malignant 

hematology. The CLL (chronic lymphocyte leukemia) 

Research Center of Weill Cornell Medical Center has 

the largest CLL clinical research program in New York, 

currently conducting 12 trials. The Leukemia Program 

initiated research in the use of allogeneic stem cell 

transplant for patients with active acute leukemia, 

a group of patients for which allogeneic transplant 

has traditionally not been used. Under Dr. Usama 

Gergis’ direction, the division is using a transplant 

regimen that includes CPX-351, a novel liposomal 

chemotherapeutic agent. Faculty and fellows had 

several high-impact publications published in The New 

England Journal of Medicine, Blood, Lancet Oncology, 

and the Journal of Clinical Oncology. 

Our investigators are participants in National 

Cancer Institute clinical trials through the Cancer and 

Leukemia Group B, the New York Phase II consortium, 

and other investigator-initiated NIH- or foundationsponsored 

clinical studies. Drs. Rebecca Elstrom, 

Peter Martin and Gail Roboz are principal investigators 

of NCI-sponsored national clinical studies (either 

open or in development through the Cancer and 

Leukemia Group B) … Dr. Evi Giannakakou has made 

very significant strides in the molecular mechanisms 

of chemotherapeutic resistance, focusing on the 

biology of microtubules, the molecular target of 

taxane chemotherapy. She has identified a new 

mechanism of taxane-induced myelosupression and 

has applied for a patent … Dr. Peter Martin worked 

closely with NYPH to establish a tumor registry that 

includes all patients diagnosed with lymphoma. 

This retrospective, and now prospective, registry 

will enable the division to analyze patients in order 

to identify new clinical and biologic prognostic 

biomarkers. Clinical databases that prospectively 

follow patient cohorts are operational in the leukemia 

and myeloma programs … The division received 

17 new grants, including seven NIH R01 (or 

equivalent level); one R21 grant for clinical 

investigation; three nonfederal career awards for 

junior investigators; and two subcontracts from 

Memorial Sloan-Kettering Cancer Center. 

Facilities are undergoing a major upgrade. The 

division’s hospital-based oncology and hematology 

practices and infusion center are undergoing a major 

renovation to create a state-of-the-art Center for 

Oncology and Hematological Care. New exam room 

and practice space opened in January 2011, and 

estimated completion for the entire project is 2013. 

The GI Oncology Program prepared for its move 

into beautifully renovated space on the 12th floor 

of the Weill Greenberg Center – with 11 infusion 

bays and 9 exam rooms, the space is a tremendous 

opportunity for growth. Active recruitment is 

underway for a senior academic GI oncologist and 

two junior recruits to occupy the six offices available. 

New state-of-the-art technology includes: 

Flow Cytometer System; HiSeq 2000 and Genome 

Analyzer IIx (GAIIx); Axiovert Observer Epifluorescence 

microscope, with motorized stage and automated 

capabilities to take multiple channels of fluorescence, 

automated z stacks and deconvoluting capability to 

get a clearer single image or 3D perspective, and a 

Zeiss camera with optical thresholding for quantitative 

analysis; and BD LSR II (Blue laser/Red laser/Yellow- 

Green laser/Violet laser/UV laser configuration), which 

provides a solid-state Coherent Sapphire 488nm Blue 

laser (20mw), a solid-state 640nm Red laser (40mw), 

a solid-state 561nm Yellow-Green laser (50mw), 

a solid-state 405nm Violet laser (100mw) and a 

solid-state 355nm UV laser (20mw) with the ability 

to detect two colors from the Blue laser (plus FSC, 

SSC), three colors from the Red laser, five colors from 

the Yellow-Green laser, four colors from the Violet 

laser and two colors from the UV laser. Laser-control 

software allow the adjustment of laser power settings 

and monitor key performance parameters of the 

Coherent lasers. 

New recruits and several faculty received 

promotions: Doron Betel, PhD, was appointed 

Assistant Professor of Computational Biomedicine 

in Medicine, and is Co-Director of the Epigenomics 

Core with Dr. Ari Melnick … 

Paraskevi Giannakakou, PhD, Associate Professor 

of Medicine, was elected to tenure in the Department 

of Medicine, in recognition of her accomplishments 

in molecular oncology and translational cancer 

research … Monica L. Guzman, PhD, was appointed 

Assistant Professor of Pharmacology in Medicine. The 

recipient of an NIH Director’s New Innovator Award, 

Dr. Guzman is a highly promising young investigator 

who works to identify specific features of malignant 

stem cells implicated in leukemia. She works in 

close collaboration with Dr. Gail Roboz, a prominent 

leukemia clinical investigator, and participates in 

a number of highly important and collaborative 

scientific initiatives … Christopher Hillyer, MD, was 

appointed Professor of Medicine (Courtesy). A faculty 

member of Emory University and President and CEO 

of the New York Blood Center, he serves concurrently 

as the Chief Officer of the Lindsley F. Kimball Research 

Institute and the National Cord Blood Program. 

Dedicated to worldwide collaboration, academic 

scholarship, teaching and mentoring, he continues 

to advance the field of transfusion medicine. His 

current research includes the molecular biology of 

allo- and autoimmune responses to blood transfusion, 

massive transfusion for traumatic injuries, transfusion 

in regions hyperendemic for malaria, the biology of 

CMV transmission in neonates, and improvement of 

participation by underrepresented minorities in blood 

donation programs …Yariv Houvras, MD, PhD, was 

appointed Assistant Professor of Medicine (Secondary 

Appointment) and Assistant Attending Physician … 

Sebastian Mayer, MD, Assistant Professor of Medicine 

and formerly the Division’s Hospitalist, joined the 

Bone Marrow Transplant Program … Khine Zin Oo, 

MD, was appointed Instructor in Medicine, Assistant 

Attending Physician, and Hospitalist for the division 

… Shakrokh Shariat, MD, was appointed Associate 

Professor of Medicine (Secondary Appointment; 

Primary Appointment, Department of Urology). 

Dr. Monica Guzman (R) 

These discoveries 

led to a new 

patent of a 

method to predict 

clinical outcomes 

in leukemia 

patients using 

an epigenetic 

biomarker. 


Division of Hospital 


Arthur T. Evans, MD, MPH 

Chief, Division of Hospital 


Vice Chair of Faculty 

Development 





Hospital 

The Division of Hospital Medicine was founded 

in the summer of 2009 with the arrival of Dr. Arthur 

Evans, who assumed the role of Division Chief after 

20 years spent in clinical research, teaching, and both 

primary care and hospital-based internal medicine 

at Dartmouth, University of North Carolina, Rush, and 

Cook County Hospital. 

The division is dedicated to providing compassionate, 

effective, and efficient inpatient medical care and 

to advancing the profession through education, 

innovation, rigorous scientific inquiry, and continuous 

learning. With an expansion of faculty and services, 

the division members are responsible for the daily 

care of over 100 hospitalized patients. The seven 

new faculty members – Drs. Renuka Gupta, Rachel 

Dubroff, Anna Maw, Ernie Esquivel, Margaret McNairy, 

Won Kim, and Sean Pickering (Assistant Division 

Chief) – bring a wealth of experience and talent. 

Nine of the division’s 21 faculty members have 

advanced training and degrees beyond board 

certification in internal medicine, including medical 

ethics, critical care, infectious diseases, emergency 

medicine, nephrology, medical informatics, 

pediatrics, geriatrics, molecular biology, and clinical 

epidemiology. These diverse talents enhance our 

commitment to an interdisciplinary approach to 

improving systems of care in the hospital. 

Hospital Medicine faculty worked collaboratively 

with members of the Division of Cardiology to 

efficiently triage and optimally manage patients 

presenting to the Emergency Department with chest 

pain. Dr. Jennifer Lee has partnered with General 

Internal Medicine and the Readmission Task Force to 

pilot a program to allow early follow-up appointments 

for patients without easy access to primary care 

immediately after hospital discharge. Dr. Amy Chused 

has developed a template to identify patients at high 

risk for readmission, with the goal of developing 

targeted initiatives to lower the risk. Dr. Chin Tang 

launched a new program where hospitalists work 

in partnership with physician assistants to meet the 

growing demand for inpatient clinical services. 

Drs. Tang, Gupta, Richard Lin and Heather Cereste 

have promoted innovative efforts to enhance 

teamwork and communication between nurses 

and physicians on the medicine wards. 

Under the leadership of Dr. Eva Flores, the Medicine- 

Orthopedics Trauma Service (a multidisciplinary, 

co-managed service for the care of patients with 

concurrent orthopedic injuries and complicated 

medical problems) was selected by the Society 

of Hospital Medicine to participate with nine other 

centers nationwide to demonstrate models of 

excellence. 

The department’s goals of improving the quality and 

safety of patient care are a major focus of the division. 

As co-chairs, Dr. Jennifer Lee (Hospital Medicine) and 

Dr. Robert Kim (Cardiology) lead the newly expanded 

Department of Medicine Quality Improvement and 

Patient Safety Program, which works with all divisions 

to identify and implement measureable quality 

improvement and patient safety initiatives. 

Working globally, Dr. Kedar Mate, in association 

with the Institute for Healthcare Improvement, is 

reorganizing the delivery of healthcare in South Africa. 

Dr. Lin continues to lead efforts to improve pain 

control for inpatients and received a Clinical and 

Translational Science Center Planning Award for 

pain management research. Drs. Anthony Ogedegbe, 

Rachel Dubroff, and Ernie Esquivel are helping to 

develop new guidelines for note writing in the era of 

the electronic medical record. The goals are to enhance 

communication, reduce medical errors, and facilitate 

a safe transition to outpatient care at discharge. 

The division continues to play a pivotal role 

in the education of medical residents, students 

and physician extenders. In recognition of his 

outstanding teaching and for modeling compassionate 

professionalism, Dr. Sal Cilmi was awarded the 

J. James Smith Memorial Award. Dr. Ogedegbe 

was acknowledged by the medical school for his 

teaching excellence. Dr. Cereste was recognized 

for her excellence in teaching medical ethics to 

second- and fourth-year medical students. 

As Vice Chair for Faculty Development, Dr. Evans 

used the results of a department-wide faculty 

survey to initiate the first phase of a novel Faculty 

Development Program. The program provides 

intensive mentoring to a cadre of early-career 

faculty using innovative group-based techniques. 

The program will be expanded to include a greater 

number of faculty across all disciplines and all 

stages of career. 

Dr. Richard Lin 

The program 

provides intensive 

mentoring to 

a cadre of earlycareer 

faculty 

using innovative 

group-based 

techniques. 

54 Department of Medicine Drs. Pickering (L) and Evans (R) 


Division of Infectious Diseases 

The Division of Infectious Diseases provides 

expertise in research, clinical care and education. 

Internationally recognized physician-scientists 

conduct cutting-edge basic laboratory and patientoriented 

research in infectious diseases, both in 

New York City and abroad (Brazil, Haiti, India and 

Tanzania). In New York City, active areas of research 

include bacteriology (including antibiotic-resistant 

organisms), bioterrorism, food- and water-borne 

pathogens, fungi, hepatitis, HIV/AIDS, hospitalacquired 

infections, human papillomavirus, influenza, 

leishmaniasis, malaria, transplant/oncology infectious 

diseases and tuberculosis. The Division also leads 

research and training programs abroad in the areas 

of HIV/AIDS, HTLV-1, leishmaniasis, syphilis and 

tuberculosis. Divisional faculty head the Weill Cornell 

Medical College/NewYork-Presbyterian Hospital 

Infectious Diseases Inpatient Consult Service, the 

HIV/AIDS Program and Weill Cornell Infectious 

Disease Associates, an outpatient practice comprising 

Travel Medicine and faculty and fellow consultation 

services. The Infectious Diseases Fellowship Training 

Program includes individualized training through 

faculty guidance, clinical rotations, mentored 

research and didactic course work to train the 

next generation of infectious diseases specialists. 

Infectious Diseases faculty members also teach 

and train medical students, internal medicine 

residents and peer physicians in the latest strategies 

for diagnosis, management and treatment of 

infectious diseases. 

The division celebrated several research milestones. 

A study conducted at GHESKIO (its Haitian Center 

for the Study of Kaposi’s Sarcoma and Opportunistic 

Infections) published in The New England Journal 

of Medicine (NEJM) (authors: Drs. Daniel Fitzgerald, 

Roy Gulick, Warren Johnson, Jean Pape) showed 

that starting antiretroviral therapy earlier in the 

course of HIV disease is associated with a significant 

survival benefit. The results influenced changes in 

HIV treatment guidelines worldwide, including those 

of the World Health Organization. 

Division investigators also determined the efficacy 

of a new, single-dose (intravenous infusion) form 

of the drug amphotericin B in treating visceral 

leishmaniasis. Compared to the standard course of 

treatment, the new treatment was effective, efficient, 

and ensured patient compliance. This therapeutic 

strategy will likely become the mainstay of the 

Kala-Azar (leishmaniasis) Elimination Program in 

India, where more than half of the world’s cases 

appear. The study (senior author: Dr. Henry Murray) 

was published in the NEJM. 

The division’s research in Mycobacterium 

tuberculosis resulted in the publication of the first 

biochemical descriptions of TB’s unique metabolic 

architecture, including the revelation of how it 

withstands sterilization. The papers, in Chemistry 

& Biology, the Proceedings of the National 

Academy of Sciences and Nature Communications, 

also demonstrate the unique potential of mass 

spectrometry-based metabolomics to both expand 

Roy M. Gulick, MD, MPH 

Chief, Division of Infectious 

Diseases 





Division of Immunology 

Kendall A. Smith, MD 


Immunology 

Rochelle Belfer Professor 

in Medicine 



The Division of Immunology focuses on basic and 

clinical research to translate the advances that have 

been made over the last 30 years in immunology into 

new therapies for immunological disorders. Effort is 

ongoing to discover new molecules that can either 

suppress or enhance immunoreactivity. We also 

remain committed to developing new, more effective 

vaccines. 

The Division has focused on two research areas: 

the generation of an effective influenza virus vaccine 

that is broadly cross-reactive so that yearly vaccination 

would be unnecessary and pandemic influenza 

could be aborted; and the identification of small 

molecular inhibitors of transcription factors, which 

are important for lymphomas and myelomas, and 

also as inhibitors of immune reactions for the 

treatment of autoimmune diseases, hypersensitivity 

diseases as well as suppressants of allograft rejection. 

In the area of influenza vaccines we have 

successfully provided proof of principle in murine 

models that vaccines aimed at activating T-cell 

immune responses can confer broadly cross-reactive 

immunity against virus strains that are not serologically 

cross-reactive. Thus, it should be possible to create 

“T-cell vaccines” for immunization of humans. In 

addition, we have data indicating that it should be 

possible to apply interleukin-2 as an adjuvant to 

boost immune responses so that the vaccine doses 

could be attenuated, thus making it possible to 

immunize larger numbers of people. 

We are committed to the education of medical 

students and offer elective courses such as Host 

Defenses, Microbiology and Immunology, and Clinical 

Bone Marrow and Stem Cell Transplantation. 

Members of the Transplantation/Oncology Infectious Diseases Program, left to right: Drs. Michael Satlin, Maria N. Gamaletsou, David Helfgott, Rosemary Soave, 

Ruta Petraitiene, Thomas Walsh, and Vidmantas Petraitis 


Division of Infectious Diseases continued 

The Infectious 

Diseases 

Fellowship Training 

Program includes 

individualized 

training through 

faculty guidance, 

clinical rotations, 

mentored research 

and didactic 

course work to 

train the next 

generation 

of infectious 

diseases 

specialists. 

Dr. Jennifer Downs (Firstprize 

winner of the DOM 

Investigator Award (in 2011) 

and recipient of the CTSC 

second-year, KL2 Scholar 

Award in the amount of 

$256,000. 

knowledge of the basic physiology and accelerate 

the TB drug development process. Dr. Kyu Rhee, 

an author of these papers, was one of only nine 

grantees in the country to receive further funding 

from the Bill & Melinda Gates Foundation, through 

the Grand Challenges Exploration Program. 

The division launched a Transplant-Oncology 

Infectious Diseases Program, which conducts 

multidisciplinary translational research in 

immunocompromised adult and pediatric patients in 

the areas of antimicrobial pharmacology, molecular 

diagnosis and innate host defenses against medically 

important fungal pathogens and emergent drugresistant 

bacteria that infect our most vulnerable 

patients. Program investigators identified the critical 

role of antifungal therapy in improving survival in 

patients with severe aplastic anemia; described 

the pharmacology of echinocandin compounds in 

infants and lung transplant recipients; and reported 

the results of a National Heart Lung and Blood 

Institute-sponsored study of antifungal prophylaxis 

in hematopoietic stem cell transplantation recipients. 

Papers were published (Dr. Thomas Walsh as senior 

or first author) in Clinical Infectious Diseases, Clinical 

Pharmacology Therapeutics, Antimicrobial Agents 

and Chemotherapy, and Blood. 

Infectious Diseases Associates, the outpatient 

practice of the Division of Infectious Diseases, 

expanded its hours, hired new staff members, and 

continued to add faculty practices that provide 

infectious diseases consultations. The Center for 

Special Studies (the HIV primary care clinic) joined the 

Ambulatory Care Network of NewYork-Presbyterian 

Hospital. The Center for Global Health secured 

a major three-year grant from the Mulago 

Foundation to support health innovations at Weill 

Bugando Medical School in Tanzania. The Transplant- 

Oncology Infectious Diseases Program inaugurated 

its clinical service with the first full-time faculty 

(Drs. Rosemary Soave and Thomas Walsh) to support 

the Hematopoietic Stem Cell Transplant and Solid 

Organ Transplantation NYPH services. 

The division hosted the CME course Update on 

Infectious Diseases 2010, with presentations by 

WCMC faculty Drs. Anne Moscona, Henry Murray, 

and Audrey Scheutz; panelists Drs. Barry Hartman, 

David Helfgott, and Kristin Marks; and Course 

Directors Drs. Marshall Glesby and Roy Gulick, and 

attended by over 100 healthcare providers. The 

HIV Clinical Trials Unit hosted the Sixth Annual 

HIV Update Symposium: Special Populations, 

Special Needs – Growing Up with HIV (Dr. Mary 

Vogler, Course Director) attended by more than 

140 people. The American Austrian Foundation 

infectious diseases course was held in Salzburg, 

Austria. Divisional faculty (Course Director 

Dr. Richard Roberts, and including speakers 

Drs. Gulick, Steven Jenkins, and Rosemary Soave) 

supported the week-long program attended by more 

than 40 Eastern European physicians focusing on 

topics such as antibiotics, drug-resistant bacteria, 

infections in immunocompromised hosts, influenza, 

and tuberculosis. The HIV Clinical Trials Unit hosted 

the 13 th Annual CME Conference on Controversies 

in the Management of the HIV-Infected Patient, 

attended by more than 100 health professionals 

from the tri-state area. Divisional speakers included: 

Drs. Glesby, (Course Director), Gulick, (Course 

Co-Director), Marks, and Timothy Wilkin. The 

Arthur Ashe Endowment for the Defeat of AIDS, 

directed by Dr. Murray, includes as its centerpiece 

the International Healthcare Workers Training 

Program in which six other division faculty 

participate as instructors. 

Collette Kean and the Rollin Browne Fund from 

the The Auxiliary of New York Weill Cornell Medical 

Center made a generous contribution to upgrade 

the divisional conference room to provide state-ofthe-art 

audiovisual equipment. Among other things, 

the division plans to develop videoconferencing 

of divisional clinical and research conferences with 

participation by fellow faculty at remote sites. 

Several new recruits were welcomed to the 

division: Drs. Elizabeth Alexander and Jennifer 

Downs were recruited from the division’s fellowship 

program, both appointed to Instructor in Medicine. 

Dr. Alexander conducts translational research on 

drug-resistant Staphylococcus aureus. Dr. Downs 

is based full-time at the Weill Bugando Medical 

Center in Mwanza, Tanzania, conducting research 

in female genital schistosomiasis. Dr. David Calfee, 

recruited from Mount Sinai Medical Center, was 

appointed to Chief Hospital Epidemiologist at 

Weill Cornell/NewYork-Presbyterian Hospital. He 

co-leads a new clinical and research program in 

hospital epidemiology and infection control with 

Dr. Stephen Wilson, recruited from Indiana University 

and appointed to Hospital Epidemiologist. Dr. Andy 

Miller was appointed to Assistant Professor of Clinical 

Medicine, focusing on clinical infectious diseases at 

the Hospital for Special Surgery. Dr. Thomas Walsh 

was recruited after serving more than 25 years at 

the National Institutes of Health to become Director 

of the newly established Transplantation-Oncology 

Infectious Diseases Program. 

Division of Medical Ethics 

Dr. David Berlin (L) with Dr. Fins, Medical Intensive Care Unit. 

Joseph J. Fins, MD, FACP 

Chief, Division of Medical 

Ethics 

E. William Davis, Jr., M.D. 

Professor of Medical Ethics 


Professor of Public Health 

Professor of Medicine in 

Psychiatry 


Director of Medical Ethics and 

Chair, Ethics Committee 



Hospital 

The Division of Medical Ethics examines how to 

balance competing goods in health care and medical 

research. Our goal is to blend disciplinary approaches 

from the sciences and medical humanities to promote 

patient and subject welfare, foster integrity and 

innovation in medical research, and provide the next 

generation of physicians and biomedical researchers 

with the values and analytical skills necessary for 

ethical professional lives. The Division is located in 

both the Departments of Medicine and Public Health, 

jointly administered by the two departments. 

Clinical faculty members direct a clinical Ethics 

Consultation Service at NewYork-Presbyterian/ 

Weill Cornell Medical Center to assist clinicians, 

patients and their families in assessing and resolving 

ethical issues that arise from clinical practice. The 

service works with colleagues in the Patient Services 

Administration to help elucidate facts and issues, 

and resolve misunderstandings, miscommunications, 

and conflicts. The Clinical Ethics Consultation 

Service consulted on over 185 cases in 2010, 

assisting patients, families and staff in analyzing 

and mediating difficult decisions and conflicts. 

Taking a leadership role in the national arena, the 

division has become one of the first centers to 

credential its medical ethicists, with the support of 

the NewYork-Presbyterian Hospital medical board. 

Research initiatives explore a wide range of topics 

both in the practice of medicine and in medical 

research, including neuroethics, clinical ethics, endof-life 

care and ethical issues in reproductive medicine 

and genomics. The Ethics Core of the medical 

Our goal is to blend disciplinary 

approaches from the sciences and 

medical humanities to promote 

patient and subject welfare. 

college’s Clinical and Translational Science Center 

is available to researchers and subjects to address 

issues involving subject rights and safety through the 

Research Ethics Consultation Service and Research 

Subject Advocacy Program. Members of the division 

conduct pioneering research in neuroethics, 

research ethics in neurology and psychiatry, ethics 

case consultation and the ethics of molecular 

medicine. The division receives funding from the 

Clinical and Translational Science Center to direct 

the Research Ethics Core. 

Medical ethics education is integral to the mission 

of the division, and all faculty members are involved 

in educational initiatives. The division continues to 

play a pivotal role in the education of our medical 

students, providing a longitudinal curriculum here 

and in Doha, coordinating the introduction to 

Medical Ethics in Medicine, Patient, Society II, and 

leading the third-year clerkship in ethics and endof-life 

care, which has been recognized as a singular 

curricular offering. A Fellowship in Medical Ethics 

has been established by the Department of Medicine 

and Rheumatology at the Hospital for Special Surgery 

and is being conducted in partnership with the 

Weill Cornell Division of Medical Ethics. The division 

continued its series of monthly seminars for faculty, 

students and clinicians with “Ethics, Technology and 

Dignity: What 20th-century Philosophy Can Teach 

Us about Medical Humanities in the 21st Century” 

in 2009 – 10, and for 2010 – 11, “Justice in 

Medicine: A Philosophical Introduction amidst 

Healthcare Reform.” 


Division of Nephrology and Hypertension 

Dr. Suthanthiran’s 

Research Group 

The Division of Nephrology and Hypertension 

provides compassionate, comprehensive, state-ofthe-art 

care to every patient afflicted with kidney 

disease and/or high blood pressure. The Weill 

Cornell nephrology program has been consistently 

ranked in the top five programs in the country by 

U.S. News and World Report, and again in 2010. 

The NewYork-Presbyterian Hospital kidney disease 

program was ranked fourth, one of the highestranked 

specialties at NewYork-Presbyterian. The 

Hypertension Center is the only center in the greater 

New York metropolitan area devoted exclusively 

to patients with disorders of blood pressure and 

circulation. 

In November 2010, NewYork-Presbyterian/ 

Weill Cornell was one of eleven recipients (chosen 

from 199 hospitals) of the Health Grades Kidney 

Transplant Excellence Award. Based on SRTR 

calculations, hospitals were recognized for statistically 

significantly higher three-year graft survival rates and 

waitlist mortality, either not significantly different 

than expected or significantly lower than expected. 

(Source: SRTR Center and OPO-Specific Report: 

www.ustransplants.) 

The division’s nephrology program excels in renal 

consultation services; dialysis therapy (about 6,000 

dialysis procedures per year at the hospital); and 

kidney and pancreas transplantation services (more 

than 200 kidney transplants per year) with patient 

and transplant survival rates superior to U.S. National 

Standards. Our faculty have achieved innovations in 

transplantation including: making transplant feasible 

for high-risk patients; minimizing the amount of 

drugs patients need for successful transplantation; 

developing treatment protocols to reduce serious 

post-transplant complications, such as infection 

and malignancy; and development of noninvasive 

molecular assays for assessing transplant status and 

reducing the need for invasive biopsy procedures. 

The division’s clinical care for patients afflicted 

with acute or chronic kidney disease is evidence 

based. We actively investigate factors predisposing 

individuals with hypertension to the development of 

kidney failure. Research pursued by the hypertension 

faculty include pregnancy induced hypertension, the 

mind-body link in hypertension, and individualized 

drug therapy for hypertension control. Ongoing 

research has identified a new and treatable mechanism 

for kidney injury; we hope to translate our scientific 

discovery into clinical practice. 

Molecular Medicine: The Weill Cornell Division 

of Nephrology and Hypertension has pioneered the 

development of noninvasive gene-based assays to 

ascertain transplant status (published in The New 

England Journal of Medicine), previously requiring an 

invasive biopsy procedure. The results from our NIHsponsored 

molecular studies of transplant recipients 

were selected for presentation at national (American 

Society of Nephrology and American Transplant 

Congress) and international (The Transplantation 

Society) meetings. Our original study, first conducted 

at WCMC, has led to an NIH-sponsored multicenter 

Cooperative Clinical Trial in Transplantation composed 

of 750 subjects from major transplant centers in 

the United States. Our Gene Expression Monitoring 

Laboratory is functioning as the molecular core for 

this extensive study. Based on a bench-to-bedside 

approach, this study should lead to state-of-theart, 

individualized care (personalized medicine) of 

transplant recipients. 

Transplantation without Immunosuppressive 

Therapy: The ultimate goal in organ transplantation 

is transplant tolerance, that is, transplantation 

of organs without any drug therapy. The division 

contributed to the first ever report on tolerance 

of mismatched kidney transplants, which was 

published in The New England Journal of Medicine. 

The ability to transplant a human organ without 

drug therapy is of exceptional significance. In 

recognition of our contribution, NYP/Weill Cornell 

has been selected by the NIH (one of three centers 

in the U.S. along with Harvard Medical School and 

University of Pennsylvania) to conduct the innovative 

transplant tolerance trials. Recently, we identified 

a molecular signature in the urine of patients who 

are tolerant of kidney transplants, the findings 

published in The Journal of Clinical Investigation. 

Our renal fellowship program is highly competitive 

with hundreds of applications received for the four 

available positions every year. We remain dedicated 

to educating and training the next generation of 

leading renal and hypertension specialists. 

Manikkam Suthanthiran, MD 

Chief, Division of Nephrology 

and Hypertension 

Chief, Department of 

Transplantation Medicine and 

Extracorporeal Therapy 

Stanton Griffis Distinguished 



Professor of Biochemistry 

Professor of Medicine in Surgery 




Hospital 

Our original 

study, first 

conducted at 

WCMC, has led to 

an NIH-sponsored 

multicenter 

Cooperative 

Clinical Trial in 

Transplantation 

composed of 750 

subjects from 

major transplant 

centers in the 

United States. 



Division of Pulmonary and Critical Care 


Ronald G. Crystal, MD 

Chief, Division of Pulmonary 

and Critical Care Medicine 

Chairman, Department of 

Genetic Medicine 

Bruce Webster Professor of 



Professor of Genetic Medicine 




Hospital 

The Division of Pulmonary and Critical Care 

Medicine has expertise that is highly skilled in 

the diagnosis and treatment of patients with all 

types of breathing or lung disorders, as well as 

all disorders related to sleep. Physicians of Weill 

Cornell Pulmonary Associates provide advanced 

diagnostic and therapeutic services in a state-ofthe-art 

medical facility. The division provides 

24-hour, in-hospital coverage of the Medical 

Intensive Care Unit and the Medical Step-Down 

Unit by both Pulmonary/Critical Care faculty 

and fellows. Research interests focus on genetic 

medicine – the development of strategies for 

understanding and modifying gene expression in 

the treatment and/or prevention of human disease. 

Full-time faculty members provide an outstanding, 

multifaceted educational program by participating 

in the training of students, residents, and fellows, 

teaching courses, and hosting weekly case 

conferences. 

It was another year of remarkable 

accomplishments in clinical care, education, 

and research. Clinical programs continued 

to flourish. Under the direction of Dr. David Berlin, 

the Medical Intensive Care Unit (MICU) realized 

notable advancements in patient care. Clinical 

care in the MICU was further enhanced by 

an increase in faculty attending services during 

overnight hours. Under the leadership of 

Drs. Olumayowa Abe and Oren Friedman, specialists 

in critical care medicine, world-class care was 

provided to critically ill patients not only in the MICU 

but throughout the hospital through consultation 

and procedural services during overnight hours. 

Physicians of Weill Cornell Pulmonary Associates 

provide advanced diagnostic and therapeutic services 

in a state-of-the-art medical facility. 

The Pulmonary Inpatient Consult Service has 

developed into a robust program providing expert 

clinical care seven days a week. This service, which has 

experienced a significant increase in volume, enhances 

the continuity of care for patients transitioning 

from inpatient to outpatient management and has 

led to many clinically successful interdisciplinary 

collaborations with specialists throughout the 

institution. The division welcomed to the faculty 

Dr. Kirana Gudi, whose primary focus is the 

further expansion and enhancement of the consult 

service through the development of strong clinical 

partnerships throughout the institution. 

The Pulmonary Outpatient Service, led by Dr. Dana 

Zappetti, has also experienced significant growth 

and enhancement, beginning with its relocation to a 

new, beautifully appointed, state-of-the-art facility in 

Weill Greenberg Center. Strong emphasis has been 

placed on the development of a patient-centered 

continuum of care through which patient services 

are coordinated within the division and throughout 

the larger health system. The Pulmonary Procedure 

Service, under the direction of Dr. Ben-Gary Harvey, 

has remained cutting-edge by embracing innovations 

in diagnostic and treatment services such as “EBUS” 

(endo-bronchial ultrasound) for the diagnosis and 

staging of mediastinal masses, lymphadenopathy and 

lung cancer, in addition to traditional bronchoscopy 

and laryngoscopy services. The Pulmonary Function 

Laboratory, led by Dr. Abraham Sanders, continues as 

a vital component of the division’s continuum of care 

by providing expert and timely diagnostic services to 

patients throughout the institution. 

Weill Cornell’s newly relocated and expanded, 

state-of-the-art Center for Sleep Medicine (run jointly 

by the Department of Medicine/Division of Pulmonary 

and Critical Care Medicine and the Department of 

Neurology), is staffed by a multidisciplinary team 

led by Medical Director Dr. Ana Krieger, expert in 

evaluating the full range of sleep problems, whether 

they arise from an underlying medical problem – such 

as sleep apnea or restless leg syndrome – or other 

underlying medical and psychiatric conditions, 

physical airway obstruction, or from poor sleep 

habits, stress or anxiety. Patients treated at the 

Center for Sleep Medicine are under the care of 

a comprehensive team that includes specialists 

in pulmonary medicine, neurology, internal 

medicine, ear nose and throat (ENT), pediatrics, 

psychiatry, psychology, bariatric surgery, nutrition, 

and endocrinology. The Center accommodates 

patients for outpatient visits and overnight studies 

promptly and at their convenience. Patients are 

monitored by use of advanced sleep-recording 

equipment in private rooms. Because pediatric and 

bariatric patients require special care, the center has 

sleep study rooms with specialized furniture and 

monitoring equipment dedicated to their needs. 

By increasing the availability of physician services, 

the center has been able to accommodate 

immediate requests for evaluation, diagnosis 

and treatment and has become a provider of choice 

for patients and referring physicians on a local, 

national and international level. The Center welcomed 

Dr. Amit Patel to the faculty. 

A major focus of the division is the expert 

training of pulmonary and critical care clinical 

fellows in all aspects of pulmonary and critical care 

medicine, including sleep disorders. The division 

provides a multifaceted educational program and 

maintains a daily schedule of intensive teaching 

rounds in the MICU with fellows, residents, and 

students. Teaching award-winning faculty provide 

comprehensive training in pulmonary and critical 

care medicine to fellows, residents, and students 

through regular lectures, course teaching, and 

hosting of weekly case conferences. 

Dr. Dana Zappetti 



Division of Rheumatology 



Rheumatology 

Joseph P. Routh Professor 

of Rheumatic Diseases in 






Hospital 

With a 50-year 

tradition of 

excellence in 

research, the 

Division is widely 

recognized for 

its contributions 

to defining 

the underlying 

mechanisms of 

autoimmune and 

musculoskeletal 

conditions. 

Based at the Hospital for Special Surgery (HSS), 

the Division of Rheumatology fosters world-class 

rheumatology care throughout the York Avenue 

institutions; provides autoimmunity and musculoskeletal 

education at all levels; and conducts cutting-edge 

basic, translational, clinical, and drug trial investigations. 

With a 50-year tradition of excellence in research, the 

Division is widely recognized for its contributions to 

defining the underlying mechanisms of autoimmune 

and musculoskeletal conditions. The rheumatology 

training is second to none, developing superb clinical 

rheumatologists. 

Dr. Mary K. Crow became the Physician-in-Chief 

and Chief of the Division of Rheumatology at HSS in 

2010. She is also the Director of the Autoimmunity 

and Inflammation Program and Co-Director of 

the Mary Kirkland Center for Lupus Research at 

HSS. As the new Chief of Rheumatology, her vision 

emphasizes leadership, innovation, standards, 

academic approach, optimal outcomes, opportunities 

for faculty advancement, collaboration, and 

communication. The emphasis is on disease-focused 

Centers of Excellence as a mechanism to organize 

the division’s clinical care, education, and research 

activities. The Systemic Lupus Erythematosus (SLE) 

and Antiphospholipid Syndrome (APS) Center of 

Excellence, directed by Dr. Jane Salmon, and the 

Inflammatory Arthritis Center, directed by Dr. Sergio 

Schwartzman, are well along in their development. 

Planning for a Scleroderma, Vasculitis and Myositis 

Center of Excellence has been initiated, and other 

centers will follow. Dr. Crow led the development 

of a divisional plan that will guide clinical and 

academic activities to be incorporated into the 

overall Strategic Plan of the Department of Medicine. 

Quality initiatives, led by Steven Magid, MD, are 

a high priority and are being recommended by the 

Centers of Excellence and monitored by hospital 

administration. HSS has committed to expanding 

the physical space allocated to the Division of 

Rheumatology by 50 percent in the next two years. 

Plans are under way for aggregation of physician 

practices based on disease focus and on consolidation 

of rheumatology education activities on a designated 

education floor. 

Academic and research achievements included 

the successful competitive renewal of a T32 National 

Institutes of Health Rheumatology Research Training 

Grant; election of three faculty members – Drs. Stephen 

Paget, Steven R. Goldring, and Joseph Markenson – 

as Masters of the American College of Rheumatology; 

recruitment of a new basic research faculty member, 

Dr. Alessandra Pernis, who studies mechanisms 

of lymphocyte function in systemic autoimmune 

diseases, and a new clinical research faculty member, 

Dr. Jessica Gordon, who is developing a Scleroderma 

Clinic (and pursuing studies of new therapies for 

patients with scleroderma); and important research 

advances related to mechanisms of rheumatoid 

arthritis and lupus, prediction of pregnancy outcomes 

in patients with antiphospholipid antibodies, and 

testing of tyrosine kinase inhibitors in patients with 

scleroderma. 

HSS scientists were awarded more than 

$2.8 million in research grants via the federal 

stimulus package (initiated in 2009), funded by the 

NIH. Dr. Carl Blobel has been researching ADAM 

family metalloproteinases, which play critical roles in 

rheumatoid arthritis, and Dr. Jane E. Salmon received 

a grant supplement for gene expression studies 

in patient samples from her multicenter study on 

pregnancy complications and loss in patients with 

SLE and APS, and a second grant to examine the 

role of antiphospholipid antibodies in pregnancy 

complications and loss using an animal model of 

APS. Dr. Lionel Ivashkiv furthered his record of 

outstanding NIH support for his studies of cytokine 

signaling pathways in inflammation with funding 

through six R01 research grants. 

In developing our disease-focused centers of 

excellence, the division continues to establish links 

among basic, translational and clinical research 

investigators and providers of clinical care. 

Dr. Goldring, Chief Scientific Officer, is advancing 

the HSS research mission to translate basic science 

findings into new ways of treating and preventing 

inflammatory diseases and musculoskeletal disorders. 

A major focus of research efforts is the creation 

of disease registries that will drive improvements 

in patient outcomes. Among the division’s current 

registries are a multicenter NIH-funded registry of 

biomarkers of pregnancy outcomes in patients with 

SLE and APS led by Dr. Salmon; a longitudinal lupus 

registry that includes disease activity data and DNA, 

RNA and serum samples on SLE patients directed by 

Drs. Kyriakos Kirou and Crow; a Scleroderma Registry 

and Repository directed by Drs. Robert F. Spiera 

and Jessica K. Gordon; and a Rheumatoid Arthritis 

Registry developed by Dr. Sergio Schwartzman. HSS 

has created an Osteoarthritis Initiative to establish an 

integrated basic, translational and clinical research 

program that focuses on each stage of the disease. 

Division faculty are collaborating with surgeons who 

perform anterior cruciate ligament and total joint 

arthroplasty procedures to characterize the molecular 

and cellular composition of synovial tissue at various 

stages of OA and relate those results to clinical 

manifestations of disease. 

Additional highlights include: Identification of 

a potential biomarker to define rheumatoid arthritis 

patients likely to demonstrate a good response 

to TNF antagonist therapies (Dr. Mary K. Crow); 

characterization of a macrophage signaling pathway 

that regulates cytokine responses (Dr. Lionel B. Ivashkiv); 

description of the gene expression profile of primary 

venous endothelial cells isolated from patients with 

SLE (a collaboration of Drs. Jane E. Salmon, Mary 

K. Crow, and Paolo Colombo, a cardiologist from 

The emphasis is on disease-focused Centers of Excellence 

as a mechanism to organize the division’s clinical care, 

education, and research activities. 

64 Department of Medicine Dr. Mary Crow 


Division of Rheumatology continued 

Weill Cornell Internal Medicine Associates (WCIMA) 

The Quality 

Research Center 

facilitates a 

system to gather 

and share data 

and data sources, 

and link quality 

outcomes with 

laboratory 

systems, 

demographics 

and financial 

systems. 

(L to R) Drs. Kyriakos Kirou, 

Mary Crow, Jane Salmon 

Columbia University College of Physicians and 

Surgeons); development of a comprehensive gene 

expression and proteomics dataset derived from 

analysis of longitudinal blood samples from wellcharacterized 

lupus patients (Drs. Mary K. Crow and 

Kyriakos Kirou); identification of lupus anticoagulant 

as an informative biomarker of pregnancy outcomes 

in patients with APS (Drs. Jane E. Salmon and 

Michael D. Lockshin); completion of the first clinical 

study of imatinib mesylate (Gleevec), a tyrosine kinase 

inhibitor, in a phase II open-label study of patients 

with scleroderma (Drs. Robert Spiera, Jessica Gordon, 

Kyriakos Kirou, and Mary K. Crow); and investigation 

of outcomes of total joint arthroplasty based on data 

collected through a collaborative project between 

HSS and WCMC Department of Public Health, funded 

by the Agency for Healthcare Research and Quality 

Center for Education and Research on Therapeutics 

(Dr. Lisa Mandl). 

Clinical care of patients with rheumatic disease 

is implemented through the Mary Kirkland Center 

for Lupus Care, the Inflammatory Arthritis Clinic 

and the general rheumatology clinic. The lupus 

clinic, led by Drs. Doruk Erkan and Kyriakos Kirou, 

has incorporated novel approaches to patient 

access, including Lupus Fast Track, which facilitates 

patient triage to appropriate specialty care. 

The center has also developed a unique patient 

education program focused on prevention of 

cardiovascular disease. The Inflammatory Arthritis 

Clinic, led by Dr. Sergio Schwartzman, incorporates 

management of patients with rheumatoid arthritis, 

psoriatic arthritis and ankylosing spondylitis and is 

developing quality indicators and research priorities 

relevant to those diseases. As a component of the 

Department of Medicine and through collaborations 

with the Department of Orthopaedic Surgery, the 

Comprehensive Arthritis Program provides medical 

and surgical care in one setting for patients who 

have a systemic disease with a major musculoskeletal 

manifestation, as well as important educational 

experiences for residents and fellows. These patients 

are at higher risk of infection than the typical surgical 

patient and are more likely to have cardiovascular 

disease and other co-morbidities. 

Achieving the highest levels of quality care 

and patient safety is a high priority at Hospital 

for Special Surgery. In support of this mission, the 

hospital has created a Quality Research Center 

with an innovative structure for applying research 

methodologies to healthcare quality issues. Under 

the direction of Dr. Steven K. Magid, the center 

brings together physicians, nurses, biostatisticians 

and other healthcare professionals to work together 

on research in patient care quality and safety. The 

Quality Research Center facilitates a system to gather 

and share data and data sources, and link quality 

outcomes with laboratory systems, demographics 

and financial systems. 

The Division of Rheumatology has created an 

HSS Education Council, led by Dr. Stephen A. Paget, 

which is dedicated to the advancement of the highest 

quality of medical education and educational research 

in the areas of rheumatology, musculoskeletal 

perioperative medicine, and musculoskeletal 

disorders. Its goals include: an educational needs 

assessment; enhance an educational culture of 

excellence and best practices; ensure that expert 

medical care is delivered to every rheumatology 

patient; define the structure, content, and conduct of 

medical education; support cutting-edge educational 

research; develop world-class scholar-clinicians, 

scholar-educators, and scholar-investigators. 

Dr. Juliet Aizer was been awarded a Clinician 

Scholar Educator Award from the Research and 

Education Foundation of the American College of 

Rheumatology to develop a curriculum in metabolic 

bone disease for training of rheumatology fellows. 

Dr. Jessica Berman, a previous recipient of this 

award, continues to advance research in training 

and assessment of rheumatology trainees through 

her development of an Objective Structured Clinical 

Examination tool and basic musculoskeletal training 

modules that incorporate joint anatomy, physical 

exam of the joints and joint injections. 

The Rheumatic Disease Fellowship remains 

dedicated to training the academic rheumatology 

leaders of tomorrow. With in-depth interdisciplinary 

training in management of both common and rare 

autoimmune, inflammatory and musculoskeletal 

disorders, combined with a requirement for 

completion of a basic or clinical research project, 

HSS rheumatology fellows are competitive for faculty 

positions at leading academic centers. In 2010, the 

division successfully competed for renewal of its NIHfunded 

T32 Rheumatology Research Training Grant, 

supporting trainees headed for a career in rheumatic 

disease research. Nine adult rheumatology fellows – 

three per year of the three-year program – and one 

or two pediatric rheumatology fellows are accepted 

as trainees and gain experience in the outpatient 

clinics at HSS and through rotations as rheumatology 

consultants at NewYork-Presbyterian Hospital and 

Memorial Sloan-Kettering Cancer Center. Dr. Berman 

coordinates the educational program for secondyear 

medical residents, and Dr. Michael D. Lockshin 

is developing a course for Weill Cornell medical 

students on caring for patients with chronic illness. 

Weill Cornell Internal Medicine Associates continued 

its tradition of excellence in primary care and medical 

education. Clinical programs, such as a Heart Healthy 

curriculum developed and administered by our nursing 

staff, were added to the already rich array of patient 

self-management support activities. Our longstanding 

multidisciplinary program in diabetes care resulted in 

National Committee for Quality Assurance (NCQA) 

recognition for Diabetes Excellence. We anticipate our 

NCQA application as a Medical Home will shortly follow. 

Renovations begun last year of our exam rooms were 

completed in 2010 providing state-of-the-art patientcentered 

equipment in every exam room. Excellence 

in the education of medical students and residents 

continues to distinguish our faculty by leadership 

in innovations. Quality initiatives including work on 

improving inpatient to outpatient transitions have 

been added to our list of priorities. 

WCIMA reorganized its leadership infrastructure 

to enhance staff and provider engagement and 

accountability. Dr. Christina Harris joins Dr. Fred Pelzman 

as Associate Medical Director. Mission leaders to support 

core strategic initiatives were appointed; Dr. Robert Savillo 

as clinical leader, Dr. Christina Harris as educational leader, 

Dr. Fran Ganz as quality leader, and Dr. Carla Boutin-Foster 

as research leader. Area directors were also chosen to 

partner with WCIMA staff on practice improvement pilots; 

Dr. Johanna Martinez, blue director, Dr. Fred Pelzman, 

green director, and Ms. Stasi Lubansky, red director. 

New recruits include two joint recruits with the 

Department of Public Health, Tara Bishop, MD and 

Matthew Press, MD. Dr. Press recently published “The 

Impact of Resident Duty Hour Reform on Hospital 

Readmission Rates Among Medicare Beneficiaries” in the 

Journal of General Internal Medicine. As new Medical 

Director, Travis Gossey, MD has been recruited jointly with 

POIS (Physician’s Organization of Information Systems). 

Carmen Ramis, MD has joined WCIMA after serving as an 

experienced clinician educator at St. Vincent’s Hospital. 

Dr. Anne Kastor has been appointed as Director 

of the Weill Cornell Community Clinic (WCCC). 

WCCC is a Weill Cornell student initiative to provide 

care to patients who are under- or uninsured. 

WCCC, a robust student service-learning activity 

sponsored by a faculty steering committee, operates 

out of the Weill Cornell Internal Medicine Associates 

(WCIMA) practice on Monday evenings. Working 

with local social service programs, this clinic provides 

an important patient care service for the local 

community. Dr. Charles Bardes wrote a chapter, “The 

Doctor in Middle Age,” published in the new book 

Becoming a Doctor, W.W. Norton & Company, Inc., 

in which doctor-writers share their experiences from 

“student to specialist.” 

Dr. Ginger Winston was awarded a four-year 

Minority Investigator Research Supplement (IRS) 

by the NHLBI as part of the parent grant, “Small 

Changes and Lasting Effects (SCALE).” The 

association between body image discrepancy, health 

risk knowledge of obesity and success with weight 

loss will be examined. 

The Macy Foundation awarded a 2010 planning 

year grant called ITEACH (Integrating Transdisciplinary 

Education at Cornell/Hunter), a collaboration 

between Weill Cornell Medical College and three 

schools of Hunter College (Nursing, Public Health, 

and Social Work). The proposal is to design and 

institute a program of integrated, interprofessional 

educational experiences involving medical students 

and nursing, public health and social work 

students with new competencies in collaborative 

teamwork. Students will learn the roles of different 

disciplines to hospital and clinic based care, 

community outreach, and interdisciplinary care in the 

home setting at a very early point in their training. 

Weill/Cornell-based recipients of this grant are 

Drs. Carol Storey-Johnson, Byron Demopoulos, and 

Joseph Murray. 

Judy Tung, MD 

Director, Weill Cornell 


Associates 

Associate Chair of 

Educational Affairs 

Associate Director, 


Residency Program 

Program Director, 

Primary Care Track 

Assistant Professor of 


Weill Cornell Medical 

College 

Assistant Attending 

Physician 


Hospital 

WCCC, a robust 

student servicelearning 

activity 

sponsored by a 

faculty steering 

committee. 


(table 3rd from R) with 

the WCCC team. 



Iris Cantor Women’s Health Center 

Orli R. Etingin, MD 

Director, Iris Cantor Women’s 

Health Center 

Lisa and Sanford B. 

Ehrenkranz Professor in 



Professor of Clinical Obstetrics 

and Gynecology 




Hospital 

The Iris Cantor Women’s Health Center (ICWHC) 

offers the most comprehensive array of healthcare 

services, designed specifically for women, in a 

single location in New York City. This facility is 

a collaboration between NewYork-Presbyterian 

Hospital and Weill Cornell Medical College. 

All of the Center’s physicians are full-time faculty 

members of Weill Cornell Medical College and 

attending physicians at NewYork-Presbyterian 

Hospital/Weill Cornell Medical Center. A team of 

nurses, technicians and other healthcare professionals 

provide superb coordinated care at the Center. 

With more than forty thousand square feet 

of clinical space occupying four floors under one 

roof, women can access prevention, screening and 

treatment services in one convenient location. Over 

the past year, physicians at the Iris Cantor Women’s 

Health Center (ICWHC) continued to provide 

comprehensive clinical care to both women and men. 

A comprehensive Health Education Resource Center 

is also available on-site to educate and empower 

women to achieve their optimal level of health. 

In October, Dr. Cathleen London, a Family Medicine 

practitioner, joined the Center from Boston, where 

she maintained a private practice for over ten 

years and instructed at Boston University and Tufts 

University School of Medicine. 

We continued to assist in the development of 

the Iris Cantor Men’s Health Center, which is slated 

to open in summer 2012. Dr. Etingin has been 

intimately involved in the planning, fundraising, and 

implementation phases. The men’s health practice will 

solidify and enhance this primary care practice site 

within Weill Cornell and allow access to more than 

seven internists. 

Women’s Health sponsored a number of 

community events in 2010. Monthly free-to-thepublic 

health education seminars were attended 

by more than two hundred community members. 

Topics include a wide array of health conditions and 

patient concerns, including thyroid disease, genetic 

testing, cosmetic surgery, memory disorders and 

more. A recent seminar highlighted Dr. Mark S. Lachs’ 

new book, Treat Me, Not My Age, providing helpful 

advice for baby boomers and beyond. This year’s 

annual Women’s Health Symposium hosted over 

350 women in the Citicorp Center, with the topic 

“Accentuating the Positive – Small Changes Make Big 

Differences.” Drs. Lisa Callahan, Louis Aronne and 

Gail Saltz spoke about their respective areas of fitness, 

weight/nutrition management and stress. Plans 

are under way for next year’s symposium to cover 

“Nutrition in Menopause.” 

Faculty 

Members 

The 28th Annual Women’s Health Symposium welcomed 350 

guests at the Citigroup headquarters. 

(L to R) Ms. Charlotte Ford, Mrs. Anita Gotto, Dr. Aronne, Dr. Saltz, Mrs. Joan Weill, 

Dr. Herbert Pardes (President, NewYork-Presbyterian Hospital), Dr. Callahan, Dr. Orli Etingin 

Featured speakers at the event entitled – Accentuate the Positive: 

Small Changes, Big Results – included well-known authorities 

in their fields: Dr. Louis Aronne, an internationally recognized 

obesity specialist and Director of the Comprehensive Weight 

Control Program (affiliated with NYP/WC); Dr. Lisa Callahan, 

a frequently interviewed expert on women’s sports medicine; 

and Dr. Gail Saltz, a psychiatrist at Weill Cornell and regular 

contributor for CNN and NBC’s “TODAY” show. 

Small Changes Leading to Big Results for Better Health. 


Department of Medicine Faculty 

Professors 

Ronald D. Adelman, MD 

Phyllis August, MD, MPH 

Charles L. Bardes, MD 

James B. Bussel, MD 

Mary E. Charlson, MD 

Pamela Charney, MD 

David J. Christini, PhD 

Ronald G. Crystal, MD 

Andrew J. Dannenberg, MD 

Richard B. Devereux, MD 

Lewis M. Drusin, MD, MPH 

Orli R. Etingin, MD 

Arthur T. Evans, MD, MPH 

Oliver T. Fein, MD 

Eric J. Feldman, MD 

Joseph J. Fins, MD 

Neal E. Flomenbaum, MD 

Linda M. Gerber, PhD 

Menard M. Gertler, MDCM, DSc 

Patricia Giardina, MD 

Stanley J. Goldsmith, MD 

Antonio M. Gotto, Jr., MD, DPhil 

Lorraine J. Gudas, PhD 

Roy M. Gulick, MD, MPH 

Katherine A. Hajjar, MD 

Barbara L. Hempstead, MD, PhD 

Evelyn M. Horn, MD 

Julianne L. Imperato-McGinley, MD 

Jonathan L. Jacobs, MD 

Ira M. Jacobson, MD 

Stephen G. Jenkins, PhD 

Warren D. Johnson, Jr., MD 

Harvey Klein, MD 

Paul D. Kligfield, MD 

Mark S. Lachs, MD, MPH 

Jeffrey C. Laurence, MD 

John P. Leonard, MD 

Bruce B. Lerman, MD 

Martin Lipkin, MD 

Lia S. Logio, MD 

Samuel J. Mann, MD 

Aaron J. Marcus, MD 

B. Robert Meyer, MD 

Anne Moore, MD 

Henry W. Murray, MD 

Alvin I. Mushlin, MD 

Ralph L. Nachman, MD 

David M. Nanus, MD 

Carl F. Nathan, MD 

Peter Michael Okin, MD 

Jean W. Pape, MD 

Mark S. Pecker, MD 

Karl Pillemer, PhD, MA 

David N. Posnett, MD 

R.A. Rees Pritchett, MD 

Shahin A. Rafii, MD 

Marcus M. Reidenberg, MD 

Brendan M. Reilly, MD 

Mary J. Roman, MD 

Isadore Rosenfeld, MD 

Andrew I. Schafer, MD 

Eugenia L. Siegler, MD 

Richard T. Silver, MD 

David J. Skorton, MD 

Kendall A. Smith, MD 

James P. Smith, MD 

Charles R. Steinberg, MD 

Kotha Subbaramaiah, PhD 

Manikkam Suthanthiran, MD 

Linda T. Vahdat, MD 

Alan M. Weinstein, MD 

Babette B. Weksler, MD 

Marc E. Weksler, MD 

Shing-Chiu Wong, MD 

Associate Professors 

Geoffrey W. Abbott, PhD 

Holly Andersen, MD 

Souraya (a.k.a.) 

Thurayya Arayssi, MD 

Susan Clark Ball, MD 

Geoffrey W. Bergman, MBBS 

Carla Boutin-Foster, MD 

David J. Brillon, MD 

Carol Capello, PhD 

Juan Emilio Carrillo, MD, MPH 

Wallace A. Carter, Jr., MD 

Adam D. Cheriff, MD 

Ellen Chuang, MD 

Curtis Leland Cole, MD 

Joseph T. Cooke, MD 

Byron Paul Demopoulos, MD 

Maria T. DeSancho, MD 

Ruchuang Ding, MD 

Daniel W. Fitzgerald, MD 

Christine L. Frissora, MD 

Paraskevi Giannakakou, PhD 

Marshall Jay Glesby, MD, PhD 

Linnie M. Golightly, MD 

David E. Guyer, MD 

Ben-Gary Harvey, MD 

James Paul Hollenberg, MD 

Ingrid Hriljac, MD 

Nathaniel Hupert, MD, MPH 

Erica C. Jones, MD 

Robert Jeffrey Kaner, MD 

Yoon Kang, MD 

Rainu Kaushal, MD 

Jason S. Kendler, MD 

Lisa M. Kern, MD 

Thomas K.C. King, MD 

Jorge R. Kizer, MD, MSc 

Eliot J. Lazar, MD 

Hsiou Chi Liou, PhD 

Steven M. Lipkin, MD, PhD 

Veronica M. LoFaso, MD 

Charles Maltz, MD, PhD 

Carol A. Mancuso, MD 

Steven M. Markowitz, MD 

Ari M. Melnick, MD 

Samuel T. Merrick, MD 

Shari R. Midoneck, MD 

David H. Miller, MD 

Robert M. Minutello, MD 

Susana R. Morales, MD 

Ruben Niesvizky, MD 

Roger Niles Pearse, MD, PhD 

Fred N. Pelzman, MD 

Mark B. Pochapin, MD 

Barrie L. Raik, MD 

M. Cary Reid, Jr., MD, PhD 

Arleen B. Rifkind, MD 

Gail J. Roboz, MD 

Joseph T. Ruggiero, MD 

Abraham Sanders, MD 

Diana L. Santini, MD 

Robert A. Schaefer, MD 

Ellen J. Scherl, MD 

Stephen M. Scott, MD, MPH 

Tsiporah B. Shore, MD 

Rosemary Soave, MD 

Carol L. Storey-Johnson, MD 

Adam Reed Stracher, MD 

Andrew H. Talal, MD, MPH 

Mary A. Vogler, MD 

Jonathan W. Weinsaft, MD 

Suzanne Wenderoth, MD 

Timothy Wilkin, MD 

Hua Yang, MD 

Yuan-Shan Zhu, MD, PhD 

Michael A. Zullo, MD 

Assistant Professors 

Josyann Abisaab, MD 

Lauren Acinapura, MD 

Jason Baker, MD 

John Thomas Barnard, MD 

Cindy H. Baskin, MD 

David Berlin, MD 

Doron Betel, PhD 

Tara F. Bishop, MD 

William B. Borden, MD 

Abraham B. Bornstein, MD 

Brian Bosworth, MD 

Risa Breckman, MSW 

Cynthia Bristow, PhD 

Juliet Caldwell, MD, BA 

David P. Calfee, MD 

Julia Cassetta, MD 

Heather X. Cereste, MD 

Macarthur Charles, MD, PhD 

Jim W. Cheung, MD 

Harold Chin, MD 

Amy E. Chused, MD 

Tessa Cigler, MD 

Salvatore Cilmi, MD 

Heidi P. Cordi, MD 

Carl Crawford, MD 

Ype P. de Jong, MD, PhD 

Randi R. Diamond, MD 

Vishal H. Dodia, MD 

Niels Dua, MD 

Rebecca Elstrom, MD 

Ernie L. Esquivel, MD 

Brenna Farmer, MD 

Dmitriy V. Feldman, MD 

Jose L. Fernandez, MD 

Edgar Figueroa, MD, MPH 

Emily S. Finkelstein, MD 

Eva K. Flores, MD 

Ann Foley, PhD 

Richard R. Furman, MD 

Maya Gambarin-Gelwan, MD 

Fran A. Ganz-Lord, MD 

Flavio G. Gaudio, MD 

Joy Gelbman, MD 

Usama Gergis, MD 

John Travis Gossey, MD 

Peter W. Greenwald, MD 

Kelly Griffin, MD 

Rebekah G. Gross, MD 

Kirana Gudi, MD 

Renuka Gupta, MBBS 

Monica L. Guzman, PhD 

Sandra M. Hall-Ross, MD 

Alexis Halpern, MD 

Christina Elaine Harris, MD 

Cathy J. Greene Hatcher, PhD 

Caren Heller, MD, MBA 

Doodnauth Hiraman, MD 

Margaret L. Hoffman, MD 

Hanson Hsu, MD 

Vinita E. Jacob, MD 

Elizabeth Leef Jacobson, MD 

Sian Jones, MD 

Sarah Kaplan, MD 

Helen Karakelides, MD 

Anne S. Kastor, MD 

Melissa Dee Katz, MD 

Robert J. Kim, MD 

Laura Kirkman, MD 

Ronald B. Kraft, MD 

Ana C. Krieger, MD 

Trine Krogh-Madsen, PhD, MSc 

Charles O. Kwon, MD 

Troy LaBounty, MD 

Maureen E. Lane, PhD 

Richard I. Lappin, MD, PhD 

Gina LaRocca, MD 

Keith A. LaScalea, MD 

Meredith F. Lash-Dardia, MD 

Taryn Yeon S. Lee, MD 

Jennifer I. Lee, MD 

John (Jay) M. Lemery, MD 

Richard Liebowitz, MD 

Sophia Lin, MD 

Fay Yu-Huei Lin, MD 

Richard J. Lin, MD, PhD 

Mei-Ling Liou, PhD 

Christopher F. Liu, MD 

Cathleen G. London, MD 

Mai A. Mahmoud, MBBS 

Tomer M. Mark, MD 

Kristen M. Marks, MD 

Peter Martin, MD 

Johanna Martinez, MD 

Bassem M. Masri, MD 

Kedar S. Mate, MD 

Sebastian Mayer, MD 

Margaret L. McNairy, MD 

Sonal S. Mehta, MD 

Joseph P. Mele, MD 

Carlyle H. Miller, MD 

James K. Min, MD 

Renu Chawla Mital, MD 

Thangamani Muthukumar, MD 

Nancy N. Nealon, MD 

Allyson J. Ocean, MD 

Anthony Ogedegbe, MD 

Sonja Olsen, MD 

Lucy N. Painter, MD 

Amit Vinod Patel, MD 

Robert N. Peck, MD 

Janey C. Peterson, EdD 

John Pfeifer, MD 

Erica G. Phillips, MD 

Sean P. Pickering, MD 

Ian Pinto, MBBS 

Elizabeta C. Popa, MD 

Zoran Popmihajlov, MD 

Matthew J. Press, MD 

Jane Prosser, MD 

Pouneh Kermani 

Rabbany, PhD, MSc 

Bharathi Raman, MD 

Carmen M. Ramis, MD 

Sharda D. Ramsaroop, MD 

Rama B. Rao, MD 

Kyu Young Rhee, MD, PhD 

Ellen Ritchie, MD 

Eric A. Rosenberg, MD 

Jia Ruan, MD, PhD 

Mirella Salvatore, MD 

Savreet Sarkaria, MD 

Robert L. Savillo, MD 

Joseph M. Scandura, MD, PhD 

Ronald J. Scheff, MD 

Bryan J. Schneider, MD 

Felice Schnoll-Sussman, MD 

Audrey Schuetz, MD 

Aaron P. Schulman, MD 

Marco Seandel, PhD, MD 

Sam Senturia, MD 

Rita Shaknovich, MD, PhD 

Shahrokh Shariat, MD 

Rahul Sharma, MD 

Harjot K. Singh, MD 

Naina Sinha, MD 

Duane M. Smith, MD 

Vivian Sobel, MD 

Irina Sobol, MD 

Jeremy Sperling, MD 

Dora J. Stadler, MD 

Carolyn Robb Steinberg, MD 

Michael E. Stern, MD 

Massimiliano Szulc, PhD, MS 

Scott Tadashi Tagawa, MD 

Chin C. Tang, MD 

Kenneth Teng, PhD 

George Thomas, MD 

Ann Tilley, MD 

Judy Tung, MD 

Carlos M. Vaamonde, MD, MS 

Mohamud Verjee, MBChB 

Jaclyn Van Lieu Vorenkamp, MD 

Thomas J. Walsh, MD 

Luise L. Weinstein, MD 

Stephen Wilson, MD 

Ginger J. Winston, MD 

Franklin J. Wong, MD 

Jennifer K. Wright-McCarthy, MD 

Cecilia J. Yoon, MD 

David A. Zackson, MD 

Dana Zappetti, MD 

Instructors 

Olumayowa Abe, MBBS 

Maria Aini, MD 

Elizabeth L. Alexander, MD 

William J. Ameres, PA-C, BS 

Caitlin Anderson, MD 

Valerie Antoine-Gustave, MD 

Philip Baird, MD 

Satchit Balsari, MBBS 

Gary J. Bouchard, PhD, PA-C 

Amanda S. Carmel, MD 

Leandro Cerchietti, MD 

Karis Cho, MD 

Jennifer A. Downs, MD 

Rachel P. Dubroff, MD 

Mamoon M. Elbedawi, MBBS 

Ronald Englert, DO 

Maria E. Figueroa, MD 

Oren A. Friedman, MD 

Hina Ghory, MD 

Elizabeth Haskins, MD 

Rachana Jani, MD 

Won Kim, MD 

Thomas Lee, MD 

Michelle Lieberman Lubetzky, MD 

Jacqueline Mahal, MD 

Anna Myint Maw, MD 

Alia (a.k.a.) Maria Menezes, MD 

Raffaele Milizia, MD 

Zarina Motorwala, MD 

Oksana Ocheretina, PhD 

Matthew T. O’Neill, MD 

Khine Zin Oo, MBBS 

Anjali Tripathi Pant, MD 

Manisha Patel, MD 

Mayra Ramirez, MA, PA-C 

Lawrence Siegel, MD 

Vishwas A. Singh, MD 

Jonathan St. George, MD 

Dean Straff, MD 

Medea Y. Valdez, PA-C, BS 

Michael J. Vortmann, MD 

Jonathan A. Waitman, MD 

Robert Wilson, MD 

Natasha Withers, DO 

Christine Zink, MD 

Gerardo L. Zullo, MD 

Network, Affiliate, 

Voluntary, and Emeritus 

Faculty 

Theophine Abakporo, MBBS 

Omar I. Abdel-Wahab, MD 

Ahmad Salih Abdulhadi, MBChB 

Michael L. Abott, MD 

Ghassan Khaled Abou-Alfa, MD 

Ali Aboufares, MD 

Ursino S. Abucay, MD 

Niraj N. Acharya, MBBS, MD 

Katafan Achkar, MD 

Alberto M. Acosta, MD, PhD 

Dana Spivak Adler, MD 

Om Parkash Aggarwal, MBBS 

Carol A. Aghajanian, MD 

Jugal Agrawal, MBBS, MD 

Mohammad Abdul Ahad, MBBS 

Meena Ahluwalia, MBBS 

Hisham Abdul Aleem Abdul 

Ahmed, MBChB 

Juliet B. Aizer, MD 

Corina E. Akerele, MD 

Olakunle Akinboboye, MBBS 

David P. Akman, MD 

Safaa Hassan Ali Al Azewei, MBChB 

Salih Ali A. Hadi Al Marri, MBBCh 

Abdulwahab Al Musleh, MD 

Ibrahim Yousif Mahmood Al Omary, 

MBChB 

Buthina Ibrahim Al Owainati, MBBS 

Ibrahim Al Shaar, MBBCh 

Hussam Al Soub, MBBS 

Jassim Al Suwaidi, MBChB 

Jameela Al-Khowaiter Al-Ajmi, MD 

Ahmed A.R. Muhamad Al-Ani, 

MBChB 

Rafid Fayadh Mohammed Al-Aqeedi, 

MBChB 

Salah Abdul Aziz Al-Azab, MBBCh 

Khalid Al-Badr, MD 

Alaa K. Al-Badran, MBChB 

Ralph A. Baer, MD 

Michael H. Alderman, MD 

Louis M. Aledort, MD 

Samar Al-Emadi, MBBS 

Mushtak Talib Abbas Algherbawe, 

MBChB 

Abdulzaiz A. Al-Hashemi, MBBS 

Waleed Muhsin Ali, MBChB 

Rana Ali, MBBS 

Sawsan H. Al-Izzi, MBChB 

Abdullatif Mohamed Alkhal, MBChB 

Robert Allan, PhD 

Mona Hass Al-Langawi, MBBS 

John P. Allegrante, MS, PhD 

Muna A.S. Almaslamani, MBBS 

Abdelrahman Almasri, MBBCh 

Ahmed A.A. Al-Mohammed, MBBCh 

Azza Awad Al-Mujalli, MD 

Noora Ahmad Al-Mutawa, MBChB 

Abdulrahman D. Alnabti, MD 

Saad Abdulfatah A. Al-Nuaimi, 

MBChB 

Reynaldo H. Alonso, MD 

Mourhege M. Al-Saloum, MD 

Hashim Mohamed Al-Sayed, MBBCh 

Suryanarayan Anand, MBBS 

Nanarao Anandarao, MBBS 

Suzanne Anderson, MD 

Francis P. Arena, MD 

Carlos O. Arevalo, MD 

Farhad Arjomand, MD 

Louis J. Aronne, MD 

Jodh S. Arora, MD, MBBS 

Pablo A. Arteta, MD 

David R. Artz, MD, MBA 

Vijaypal Arya, MBBS 

Nidal Ahmed Asaad, MBBS 

Amanda Falick Ascher, MD 


Network, Affiliate, Voluntary, and Emeritus Faculty continued 

Dalit Ashany, MD 

Muhammad Asim, MBBS 

Deborah S. Asnis, MD 

Frederick Ast, MD 

TuTu Aung, MBBS 

Sulaiman Azeez, MBBS 

Christopher Gerard Azzoli, Jr., MD 

Philip Baird, MD 

Dean F. Bajorin, MD 

Wallace Baker, MD 

Jean Balzora, MD 

Deepa Bangalore, MBBS 

Juliet Barker, MBBS 

David Barlas, MD 

Christopher L. Barley, MD 

Jeremiah A. Barondess, MD 

Peter R. Barra, MD 

Alberto O. Barroso, MD 

Dorota Bartniczuk, MD 

Amanda W. Basford, MD 

Baquar Bashey, MBBS, MD 

Zelaikha Mohsin Bashwar, MBBS 

Riyad J. Basir, MBChB 

Anne R. Bass, MD 

Paul M. Basuk, MD 

Michael Seth Baum, MD 

Carol Grossman Baum, MD 

Thomas L. Baxter, III, MD 

Shamim A. Begum, MBBS 

Garth A. Beinart, MD 

Rita Bellevue, MD 

Paul C. Bellman, MD 

Katherine Bell-McGuinn, PhD, MD 

Ethan S. Ben-Sorek, MD 

Kalman J. Berenyi, MD 

Barbara J. Berger, MD 

Jack J. Berger, MD 

Ivan Bergstein, MD 

Samarth Beri, MD 

Israel Berkowitz, MD 

Arnold Berlin, MD 

Ellin Berman, MD 

Jessica Berman, MD 

Nathaniel Berman, MD 

Allan E. Beyda, MD 

Rekha Bhandari, MBBS 

Thayyullathil Bharathan, MBBS 

Kiran K. Bhat, MBBS 

Bhaswati Bhattacharya, MD, MPH 

Harry Bienenstock, MD 

Robert H. Birkhahn, MD 

Richard B. Birrer, MD 

Rachel D. Bishop, MD 

Ana L. Blackmon, MD 

James A. Blake, MD 

Carl P. Blobel, MD, PhD 

Jon David Blumenfeld, MD 

David S. Blumenthal, MD 

Mitchell J. Blutt, MD 

Richard S. Bockman, MD, PhD 

Morton D. Bogdonoff, MD 

Roxana M. Bologa, MD 

J. Scott Bomann, DO, BA 

Joseph Bonanno, DO, BS 

Marc L. Boom, MD, MBA 

Lisa Borg, MD 

George Joseph Bosl, MD 

Joseph Bove, MD 

Norman Brachfeld, MD 

Terence M. Brady, MD 

Barry D. Brause, MD 

Melvin Breite, MD 

Sorin J. Brener, MD 

Peter T. Brennan, MD 

Renier J. Brentjens, MD, PhD 

Donald Briscoe, MD 

Neil M. Brodsky, MD 

Jacqueline Francoise 

Bromberg, MD, PhD 

Mark S. Brower, MD 

Arthur E. Brown, MD 

John L. Brown, Jr., MD 

Robert S. Brown, Jr., MD, MPH 

Matthew L. Buchalter, MD 

John Buergler, MD 

Daniel Arthur Burton, MD 

Mohammed Tariq Butt, MBBS 

Ahmar A. Butt, MBBS 

Daniel J. Byrns, MD 

Magdalena Cadet, MD 

Lisa Rowland Callahan, MD 

Annamaria Calleo-Cross, BS, DO 

Robert D. Campagna, MD 

Salvatore J. Cannizzo, MD 

Michael C. Cantor, MD 

Elizabeth Capezuti, PhD, MSN 

Ralph Carmel, MD 

Philip Charles Caron, MD, PhD 

Richard Carvajal, MD 

Edgar Marcelino Carvalho 

Filho, MD, PhD 

David B. Case, MD 

Ephraim S. Casper, MD 

Ann Castello, MD 

Hugo R. Castro-Malaspina, MD 

Silvio Ceccarelli, MD 

Andrea Cercek, MD 

Hakim Chalabi, MD 

Sarat Chandarlapaty, MD, PhD 

Pradeep Chandra, MBBS 

Su Min Chang, MD 

Woo-Taek Chang, MD 

Michael L. Chang, MD 

Raymond Yeesung Chang, MD 

Fang Chang, MD, PhD 

Paul B. Chapman, MD 

Antoine V. Charles, MD 

Richard Charney, MD 

Chaim Charytan, MD 

Bansidhar M. Chauhan, MBBS 

Mohit Chawla, MD 

Jhoong S. Cheigh, MD, MS 

James Chevalier, MD 

Karis Cho, MD 

Allen Chodock, MD 

Edward Won Choi, MD 

Charles L. Christian, MD 

James P. Christodoulou, MD 

Paul J. Chrzanowski, MD 

Sedgundina N. Chua-Gan, MD 

Penelope Chun, MD 

Miriam Chung, MD 

David J. Chung, MD, PhD 

Bayard D. Clarkson, MD 

J. Marietta Clewing, MD 

Alana Cohen, MD 

Barry A. Cohen, MD 

Richard P. Cohen, MD 

Symra A. Cohn, MD 

Morton Coleman, MD 

Lara M. Colton, MD 

Rick Conetta, MD 

Bradley A. Connor, MD 

John Cooke, MD 

Robert B. Cooper, MD 

Engracio P. Cortes, MD 

Steven J. Corwin, MD 


Ward F. Cunningham-Rundles, MD 

Dana M. Cutzu, MD 

Lisa M. Czanko, MD 

Wafer Amen Kasim Dabdoob, MD 

Clifford C. Dacso, MD, MPH 

David R. D’Adamo, MD, PhD 

Darshana M. Dadhania, MD 

Jane Daly, MD 

Gabriella M. D’Andrea, MD 

Chau T. Dang, MD 

Jean Pratt Daniel, MD 

Daniel C. Danila, MD 

James Darling, MD 

Lloyd A. Darlow, DMD, MD 

Malay Das, MBBS 

Anita R. Datta, MD 

Amish S. Dave, MD, PhD 

Yonette Davis, MD 

James Davis, MA 

Giovanni de Simone, MD 

Barbara Ann DeBuono, MD, MPH 

Julian A. Decter, MD 

Mary L. DelMonte, MD 

Moutaz Derbala, MBBCh, MD 

Sylvie D. DeSouza, MD 

Adam Deutsch, MD 

Gerard Devas, MBBS 

Lekshmi Dharmarajan, MBBS 

Maura N. Dickler, MD 

Bruno F. DiCosmo, MD 

Hajir Ely Dilmanian, MD 

Christopher J. DiMaio, MD 

Stephen J. DiMartino, MD, PhD 

Vihren Dimitrov, MD 

Leonard DiRe, MD 

Joshua A. Donis, MD 

Alan Dosik, MD 

David C. Dosik, MD 

Harvey Dosik, MD 

R. Gordon Douglas, Jr., MD 

James J. Doyle, MD 

Ashley L. Drews, MD 

Joseph Claude Dreyfus, III, MD 

Joan H.F. Drosopoulos, PhD 

Natalie J. Dryden, MD 

William M. Duke, MD 

Elinor Greenspun Dulit, MD 

Mark Dursztman, MD 

Timothy C. Dutta, MD 

Murray Dworetzky, MD 

Jay M. Edelberg, MD, PhD 

Brian R. Edlin, MD 

William T. Edwards, MD 

Petros Efthimiou, MD 

Barbara C. Egan, MD 

John F. Eichelberger, MD 

Cristiano Eirale, MD 

Howard B. Eison, MD 

Isam El Bagi, MBChB 

Mohamed Ezzat El Beheary, MBBCh 

Abdel Haleem Ahmed 

El Hiday, MBBS 

George C. Ellis, MD 

Ayman A. El-Menyar, MBBCh 

Marie Eloi-Stiven, MD 

Elhadi Elouzi, MBBCh 

Abdul M.T. El-Qawasameh, MBBCh 

Mohamed S. El-Tawil, MBBCh 

Roger Ira Emert, MD 

Angie M. Eng, MD 

Ronald Englert, DO 

Gulchin A. Ergun, MD 

Doruk Erkan, MD 

Henry R. Erle, MD 

Irina V. Erlikh, MD 

Mehdi Mohammed Errayes, MBBS 

Atilla Ertan, MD 

Susan M. Escudier, MD 

Maria T. Espejo, MD 

Jorge I. Esquivel, MD 

Jerry D. Estep, MD 

David G. Evelyn, MD, MPH 

Monte Ezratty, MD 

James A. Fagin, MD 

Thomas J. Fahey, Jr., MD 

Victor Fainstein, MD 

Samya Ahmed Falamerzi, MBBS 

George A. Falk, MD 

Albert Fano, MD 

Azeez Farooki, MD 

Arthur E. Feinerman, MD 

Leonard Feingold, MD 

Marc B. Feinstein, MD 

Darren Feldman, MD 

Stuart Feldman, MD 

David Feldshuh, MD 

Michael J. Feltovich, MD 

John Fernandez, MD 

Lauren Ferrante, MD 

Frederick J. Feuerbach, III, MD 

Theodore R. Fields, MD 

Stanley R. Fine, MD 

Wilmore B. Finerman, Jr., MD 

Scott A. Fink, MD 

Jeremy Paul Finkelstein, MD 

Christopher J. Finnila, MD 

Jeffrey D. Fisher, MD 

Laura L. Fisher, MD 

Edward Flaschner, MD 

Robert Fleming, MD 

Gloriande Fleurimont, MD 

Carlos D. Flombaum, MD 

Rebecca L. Florsheim, MD 

John T. Flynn, MD 

Arthur L. Forni, MD 

Monica N. Fornier, MD 

Susan C. Fox, MD 

Andrew Francella, MD 

Joseph A. Franciosa, MD 

Richard H. Frankel, DPM 

Kenneth W. Franklin, MD 

John E. Franklin, Jr., MD 

Mark G. Frattini, MD, PhD 

James Dermot Frengley, MBChB, MS 

Mark S. Friedman, MD 

Samuel Friedman, MD 

Erika Friedmann, PhD 

Todd M. Friend, DO 

Abraham Fruchter, MD 

Nancy S. Fu, MD 

Richard M. Fuchs, MD 

Matthew G. Fury, PhD, MD 

Jacobo Futran, MD 

Theodore J. Gaeta, DO, MPH 

Marina Gafanovich, MD 

Fiona E. Gallahue, MD 

Marilyn Galler, MD 

Ronald W. Galluccio, MD 

Boris Gambarin, MD, PhD 

Sandhya G. Ganti, MBBS 

Sandy B. Ganz, DSc, BS 

Aaron Garber, MD 

Delfino Garcia, III, MD 

Christopher Garrett, MD 

Bruce A. Garrison, MD 

Mitchell L. Gaynor, MD 

Abdurrazzak Gehani, MBBCh 

Mitchell Geizhals, MD 

Brian D. Gelbman, MD 

Robert M. Gelfand, MD 

Jeremiah Gelles, MD 

Edward P. Gelmann, MD 

Richard L. Geltman, MD 

Ronnie Alan Gentry, MD 

Liziamma George, MBBS 

Paul Gerardi, MD 

Hans Gerdes, MD 

John Frank Gerecitano, MD, PhD 

Joel R. Gernsheimer, MD 

Janet A. Gershengorn, PhD 

Wisam K. Ghadban, MBBCh 

Issa Mousa Ghanem, MBBCh 

Allan Gibofsky, MD 

Holly Gilbert, MD 

Teresa Ann Gilewski, MD 

Monica Girotra, MD 

Ellen Spielman Gitler, MD 

Joel S. Gitlin, MD 

Paul A. Glare, MBBS, MD 

Robert H. Glassman, MD 

Clifford F. Glatzer, MD 

Ilya G. Glezerman, MD 

Michael S. Glickman, MD 

David L. Globus, MD 

Isaiarasi Gnanasekaran, MBBS 

David H. Goddard, MD, MBBS 

Joshua M. Gold, MDCM, PhD 

Seth Goldbarg, MD 

Harvey L. Goldberg, MD 

Jenna Dey Goldberg, MD 

Robert S. Goldblatt, MD 

Flavia A. Golden, MD 

Owen Golden, MD 

Ronald A. Golden, MD 

Grigoriy Goldenberg, MD, PhD 

Shari Goldfarb, MD 

Daniel Goldin, MD 

Howard Goldin, MD 

Steven R. Goldring, MD 

Natalya Goldshteyn, MD 

Jonas Goldstone, MD 

Stephanie M. Goodman, DO 

Susan M. Goodman, MD 

Bruce R. Gordon, MD 

Jessica K. Gordon, MD 

George W. Gorham, MD 

Richard S. Gottfried, MD 

Benjamin V.G. Gozun, MD 

Venera Grasso, MD 

Michele G. Greene, DrPH 

Irina Gressel, MD 

William R. Griffo, MD, PhD 

Kevin A. Grimes, MD, MPH 

Jeffrey S. Groeger, MD 

Harry L. Gruenspan, MD, PhD 

Gregory Grunberg, MD 

Madhav A. Gudi, MBBS 

Rebecca S. Guest, MD 

Kim A. Guishard, MD 

Subhash C. Gulati, MD, PhD 

Ramesh S. Gulrajani, MBBS 

Shellie Gumbs, MD 

Sanjey Gupta, MD 

Gregory Miner Gustafson, MD 

Neil A. Halpern, MD 

Brian Halpern, MD 

Nachida Hamidi-Sitouah, MD 

Dale J. Hamilton, MD 

Bruce Hamilton, MBChB 

Paul Anthony Hamlin, MD 

Costas Hanjis, MD 

George Haralambou, MD 

Robert B. Harooni, MD 

Melanie Jane Harrison, MD 

Catherine C. Hart, MD 

Barry J. Hartman, MD 

Choli Hartono, MD 

Debra K. Harvey, MD 

Kristen A. Harvey, MD 

Shaikh Hasan, MBBS 

Nadyabanu Hasham, DO 

Elizabeth Haskins, MD 

Azza Adel Ibrahim Hassan, 

MBBCh, PhD 

Hani Hassoun, MD 

Thomas L. Hau, MD 

Joseph G. Hayes, MD 

Kirsten Healy, MD 

Mark Lawrence Heaney, MD, PhD 

David C. Helfgott, MD 

Arthur D. Heller, MD 

William F. Heneghan, MD 

Karen Hennessey, MD 

Martee L. Hensley, MD 

Lawrence L. Herman, MD 

Edmund M. Herrold, MD, PhD 

Robert Hesson, MD 

Christopher D. Hillyer, MD 

Jules Hirsch, MD 

Yashar Hirshaut, MD 

Stuart E. Hisler, MD 

Alan Loh Ho, MD, PhD 

Melvin C. Hochman, MD 

Magdelena Hohn, MD 

Wesley P. Hollomon, MD, MBA 

Peter R. Holt, MD 

John W. Hon, DO 

Thomas E. Hong, MD 

Lisa A. Honkanen, MD 

Jaleh E. Hoorfar-Nathan, DPM 

Steven M. Horwitz, MD 

Karlene Hosford, MD 

Alan N. Houghton, MD 

Katherine C. Hsu, PhD, MD 

John T. Hsueh, BM 

Willa Hsueh, MD 

Xiaoyu Hu, BM, PhD 

Zheng-Bo Huang, BM 

Lisa Cooper Hudgins, MD 

Clifford Alan Hudis, MD 

I-Lo Hung, MD, MS 

James R. Hurley, MD 

Barry N. Hyman, MD 

Chul Soo Hyun, PhD, MD 

Frank Michael Iacovone, Jr., MD 

Abdulsalam Saif Ibrahim, MBBS 

Wanis Hamad Ibrahim, MBBCh 

David H. Ilson, PhD, MD 

Barton Inkeles, MD 

Lawrence A. Inra, MD 

Muhammad Z. Iqbal, MBBS 

Lisandro Irizarry, MD, MPH 

Lionel B. Ivashkiv, MD 

Richard A. Jackson, MD 

Robert E. Jackson, MD 

Tranice D. Jackson, MD 

Matteethra C. Jacob, MD 

Michael Jacobson, MD 

Alan H. Jaffe, MD 

Eric A. Jaffe, MD 

Ann A. Jakubowski, MD, PhD 

Morris L. Jampol, MD 

Yelena Janjigian, MD 

Fernando Jara, MD 

Charles I. Jarowski, Jr., MD 

Robert Ray Jenq, MD 

Anil K. John, MBBS 

Erik Kent Johnson, MD 

Michelle N. Johnson, MD 

Edith I. Jones, MD 

Thomas C. Jones, MD 

Elaine Josephson, MD 

George J. Juang, MD 

Joseph G. Jurcic, MD 

Alan B. Kadet, MD 

Samuel K. Kajubi, MBChB, MD 

Marcia F. Kalin, MD 

Jeffrey E. Kalina, MD 

George Kalliolias, MD 

Anna Kaltsas, MD 

Mini Kamboj, MBBS 

Mazen Kamen, MD 

Ahmad Abd. El Moniem Kamha, 

MBBCh 

Lewis Jay Kampel, MD 

Aladdin Kanbour, MBChB 



S. Balavenkatesh Kanna, MBBS 

Barry H. Kaplan, MD, PhD 

Morrie A. Kaplan, MD 

Rana Kaplan, MD 

Attallah Kappas, MD 

Stephen R. Karbowitz, MD 

Abdool Salim Karim, MBChB, MS 

Amin H. Karim, MBBS 

Simon G. Kassabian, MBChB, MD 

Moiz M. Kasubhai, MBBS 

Lawrence Alton Katz, MD, MPH 

Noah D. Kauff, MD 

Martin M. Kay, MD 

Saka A. Kazeem, MD 

Raymond S. Keller, MD 

Seth Keller, MD 

David P. Kelsen, MD 

Nancy E. Kemeny, MD 

Robert Owen Kenet, MD, PhD 

Denis J. Keohane, MD 

David J. Kerr, MD, PhD 

Todd Kerwin, MD 

Srinivas Kesanakurthy, MBBS 

Sandra Kesh, MD 

George J. Kessler, DO 

Amsale Ketema, MD 

Muayad Kasim Khalid, MBChB 

Abdul-Jabbar Asim Khan, MBBS 

Azeem Khan, MD, MBBS 

Fahmi Yousef Khan, MBBS 

Farida Khan, MBBS 

Izzat Khanjar, MD 

Galina Kharash, MD 

Dirar Shafiq Khoury, PhD 

Timothy E. Kiehn, PhD 

Back Kim, MD 

Chung Eun Kim, MD 

Robin S. Kim, MD 

Susan Kim, MD 

Woo Sup Kim, BM 

Yong Rak Kim, MD 

Kyriakos A. Kirou, MD, DSc 

Neal S. Kleiman, MD 

Ludwig Klein, MD 

William A. Klepack, MD 

Harold N. Klestzick, DO 

Virginia M. Klimek, MD 

Adam David Klotz, MD 

Barry J. Klyde, MD 

Zoulficar A. Kobeissi, MD 

Drew Koch, DO 

Guenther Koehne, MD, PhD 

Iosif Kolbovsky, MD 

Richard N. Kolesnick, MD 

Mary Kollakuzhiyil, MBBS 

Vasantha Kumari Kondamudi, MBBS 

Jason Konner, MD 

Douglas J. Koo, MD, MPH 

Edward Koppel, MD 

Beatriz Korc-Grodzicki, MD, PhD 

Anthony F. Korosi, MD 

Constantine E. Kosmas, MD, PhD 

Gamil S. Kostandy, MBChB 

Emanuel L. Kouroupos, MD 

Elizabeth Kozora, PhD 

Lawrence S. Kraftowitz, MD 

Robert C. J. Krasner, MD 

Daniel Krauser, MD 

Mary Jeanne Kreek, MD 

Mark G. Kris, MD 

Muthuswamy Krishnamurthy, MBBS 

Sarada Krishnamurthy, MBBS 

Padmanabhan Krishnan, MBBS 

Lee M. Krug, MD 

Bernard M. Kruger, MD 

Anuradha Kumar, MBBS 

Chhavi B. Kumar, MD 

Suresh Kumar, MBBS, MD 

Karla M. Kurrelmeyer, MD 

Robert C. Kurtz, MD 

Karen LaFace, MD 

Eseng Lai, MD, PhD 

Diana Lake, MD 

Nicole Lamanna, MD 

Arnon Lambroza, MD 

Heather J. Landau, MD 

Thomas K. Landau, MD 

Brian R. Landzberg, MD 

Edith J. Langner, MD 

Stephan C. Lansey, MD 

Jose R. Lapa e Silva, PhD, MD 

Janice L. Lau, MD 

Adam Law, MBBS, MD 

Mark J. Leber, MD 

Marvin A. Leder, MD 

Jun Lee, MD 

Robert P. Lee, MD 

Thomas Lee, MD 

David Lefkowitz, MD 

Daniel E. Lehane, MD 

Monika J. Leja, MD 

Herbert S. Lempel, MD 

Nikoletta Lendvai, MD 

Paul J. Leo, DO 

Michael Richard Leonard, MD 

Alfred Ba Tun Leong, MBBS 

Alexander M. Lesokhin, MD 

Wai L. Leung, MD 

Jay M. Levat, MD 

Lali Levi, MD 

Lawrence F. Levin, MD 

Ross L. Levine, MD 

Suzanne Marin Levine, DPM 

Carol J. Levy, MD 

Margaret Lewin, MD 

Daniel M. Libby, MD 

Warren B. Licht, MD 

Amy Dale Lichtenfeld, MD 

Stuart M. Lichtman, MD 

Lilli B. Link, MD 

Stephen H. Little, MD 

Frank Ming-Shi Liu, MD 

Philip O. Livingston, MD 

Michael D. Lockshin, MD 

Bruce D. Logan, MD 

Raghu S. Loganathan, MBBS 

George Vincent Lombardi, MD 

Gerard T. Lombardo, MD 

Juanita Lo-Ngeo, MD 

Olivia A. Lopez, MD 

Jorge A. Lopez-Ovejero, MD 

Daniel Louis Lorber, MD 

Jonathan Lorch, MD 

Emmy Ludwig-Miller, MD 

Preston Lurie, MD 

Jasminder Luthra, MD 

Joseph H. Ma, MD 

Luis R. Maceira-Rodriguez, MD 

C. Ronald MacKenzie, MD 

Nicholas T. Macris, MD 

Norman M. Magid, MD 

Steven K. Magid, MD 

Richard J. Mahler, MD 

John J. Mahmarian, MD 

Vicky Makker, MD 

Mariam Abdul Malik, MBBS 

Lisa A. Mandl, MD, MPH 

Debra A. Mangino, DO 

Jack M. Mann, MD 

AnnaRita Marcelli, MD 

Joseph A. Markenson, MD 

Arnold Jay Markowitz, MD 

Martin H. Markowitz, MD 

Paul A. Marks, MD 

Stephen J. Marks, MD 

Franklin Marsh, Jr., MD 

William A. Martimucci, MD 

George T. Martin, MD 

Melissa Martin, MD 

Andrew Martorella, MD, MS 

Robert J. Mascitelli, MD 

Peter G. Maslak, MD 

Issa Matar, MBChB 

Matthew J. Matasar, MD 

S. Anjani D. Mattai, MD 

Nirmal K. Mattoo, MBBS 

Jacqueline Mayo-Morris, MD 

Eileen P. McAleer, MD 

Heather L. McArthur, MD 

John J. McCarthy, MD 

Moira Kathleen McCarty, MD 

Michael R. McDevitt, PhD 

Carl J. McDougall, MD 

John C. McKechnie, MD 

Philip E. McPherson, MD 

Allen W. Mead, MD 

John-Paul Mead, MD 

Parag Mehta, MBBS, MD 

Kenneth R. Meisler, DPM 

Jennifer A. Meller, MD 

Adrianne H. Mellos, MD 

Ellen M. Mellow, MD 

Lawrence A. Melniker, MD 

Jay Ivan Meltzer, MD 

Laura Melville, MD 

Antonio Mendez, MD 

Charis Fan-Hui Meng, MD 

Raymond D. Meng, MD, PhD 

Chandra Menon, MBBS 

Jean-Paul Menoscal, MD 

Frank V. Meriano, MD 

Frank Messineo, MD 

David B. Messinger, MD 

Jennifer K. Meyer, MD 

Mark L. Meyer, MD 

Fausto S. Meza, MD 

Spyros G.E. Mezitis, MD, PhD 

Rameen M. Miarrostami, MD 

Ollie S. Miettinen, MD, PhD 

Andy O. Miller, MD 

Susan M. Miller, MD 

Vincent Amory Miller, MD 

Nancy E. Mills, MD 

Matthew Ivan Milowsky, MD 

Paul F. Miskovitz, MD 

Subhada Mithilesh, MBBS 

Abraham M. Mizrahi, MD 

Shanu Modi, MD 

Vinuta Mohan, MD 

Ana Maria Molina, MD 

Thomas G. Molnar, MD 

Abdul S. Mondul, MD 

Donald E. Moore, MD 

Michael J. Morris, MD 

Natalie Moryl, MD 

Lori J. Mosca, MD, PhD 

Jeffrey W. Moses, MD 

Eliot P. Moshman, MD 

Alison Moskowitz, MD 

Craig H. Moskowitz, MD 

Robert J. Motzer, MD 

Emmanuel N. Moustakakis, MD 

Lawson A. Moyer, III, MD 

Mary Ellen Moynahan, MD 

Richard L.P. Mueller, MD 

Brigitte Mueller-Morel, MD 

James E. Muntz, MD 

John Munyak, MD 

Skender Murtezani, MD 

Elizabeth C. Muss, MD 

Amy T. Mynderse, MD 

Faisal Nabi, MD 

Viswanathan Nagarajan, MBBS 

Jerry Nagler, MD 

Sherif F. Nagueh, MBBCh 

Parathasarathy Narasimhan, MD 

Laurie Claire Nash, MD 

Thomas W. Nash, MD 

George M. Nassar, MD 

Sam N. Natarajan, MD 

Ethan A. Natelson, MD 

Devi Navamani, DO 

Asha D. Nayak, MBBS 

Kotresha H. Neelakantappa, MBBS 

Deena J. Nelson, MD 

Christopher L.B. Nevins, MD 

Barney D. Newman, MD 

Kaman Ng, MD 

Kenneth K. Ng, MD 

Julie C. Nguyen, MD 

Thuyen T. Nguyen, MD 

Jeffrey N. Nichols, MD 

John P. Nicholson, Jr., MD 

Susan C. Nicholson, MD 

Aryel Nicoleau, MD 

Carl Andre Nicoleau, MD, PhD 

Stephen David Nimer, MD 

Rudolph H. Nisi, MD 

Larry Norton, MD 

Michelle K. Nowak-Logozzo, MD 

Ariela Noy, MD 

Parirokh Nozad, MD 

Steve Esfandiar Nozad, MD 

Michel Ernest Nussbaum, MD 

Irwin Nydick, MD 

Martin Nydick, MD 

Roisin O’Cearbhaill, MBBCh 

Herbert F. Oettgen, MD 

Kenneth Offit, MD, MPH 

Adesuwa Okesanya, MD 

Ion Oltean, MD 

Anas Ahmed Omer, MBChB 

Kenneth Ong, MD 

Eileen M. O’Reilly, MBBCh 

Carlos M. Orrego, MD 

Aneta Ostrowska, MD 

Laszlo Osvath, MD 

Vellore T. Padmanabhan, MD 

Stephen A. Paget, MD 

Joseph Thomas Paglia, MD 

Jeffrey E. Paley, MD 

Maria Lia Palomba, MD 

Eric G. Pamer, MD 

Justin Paoloni, MBBS 

Esperanza B. Papadopoulos, MD 

Genovefa A. Papanicolaou, MD 

Benoit Jerry Papon, MD 

Chong H. Park, MD 

Sonal Shah Parr, MD 

Edward J. Parrish, MD 

Mark W. Pasmantier, MD 

Mina Pastagia, MD 

Raymond D. Pastore, MD 

Stephen M. Pastores, MD 

Arunbhai G. Patel, MD 

Harish J. Patel, MBBS 

Hirmanshu A. Patel, MBBS 

Naveena Pathmakumar, MBBS 

Doru Paul, MD 

George W. Pelebecky, Jr., MD 

Miguel-Angel Perales, MD 

Orlando Perales, MD 

Jose A. Perez, Jr., MD 

Alan S. Perlman, MD 

Francis S. Perrone, MD 

Lynne V. Perry-Bottinger, MD 

Ralph E. Peterson, MD 

Manana Petrov, MD 

David Gerard Pfister, MD 

Patricia Phan, MD 

Maria C. Pietanza, MD 

Anush S. Pillai, DO, BA 

Riccardo Pini, MD 

Heidi M. Pinkert, MD 

John Pizzolla, MD 

Martin Poliak, MD 

Doris M. Ponce, MD 

Jovan M. Popovich, MD 

Carol S. Portlock, MD 

John A. Posey, Jr., MD, PhD 

Rock Gerard Positano, DPM 

David H. Posner, MD 

Martin R. Post, MD 

Craig M. Pratt, MD 

Jacek J. Preibisz, DMSc, MD 

Joanna M. Preibisz, MD 

Luminita Pricop, MD 

Fernando Arturo Pujol-Morato, MD 

Miguel A. Quinones, MD 

Sina Y. Rabbany, PhD 

Michael R. Rabinowitz, MD 

Stephen H. Rabinowitz, MD 

Michael Stavros Radeos, MD, MPH 

Allen Robert Radin, MD 

Arthur I. Radin, MD 

Russell N. Radoff, MD 

Linda Radomski, MD 

James J. Rahal, MD 

Ali Rahil, MBBCh 

Ritesh Raichoudhury, MD 

Marwan Ramadan, MBChB 

Ramya Ramakrishnan, MD 

Dharmarajan Ramaswamy, MBBS 

Gumpeni Rammohan, MBBS 

Elizabeth Ramos, MD 

Dragos Rancea, MD 

James A. Rand, MD 

Suhail Raoof, MBBS 

Kakil Ibrahim Rasul, MBChB 

Dana Rathkopf, MD 

Kanwar S. Rauhila, MBBS 

Carroll A. Rayner, MD 

Tasleem Raza, MBBS 

Rose A. Recco, MD 

Steven G. Reed, PhD 

Abdul Rehman, MBBS 

J. Douglas Reich, MD 

Lilian M. Reich, MD 

Steven F. Reichert, MD 

Bonnie S. Reichman, MD 

Diane Reidy-Lagunes, MD 

Daniel Reingold, JD 

Marshal Scott Reminick, MD 

Michael T. Rendel, MD 

Gene D. Resnick, MD 

Charles M. Rice, PhD 

Lawrence Rice, MD 

Jack Richard, MD 

Jill M. Rieger, MD 

Gregory J. Riely, MD, PhD 

Robert R. Riggio, MD 

Lee Woodland Riley, MD 

Deborah L. Rimler, MD 

Edgardo Rivera, MD 

Naiyer A. Rizvi, MD 

Keith W. Roach, MD 

Christopher P. Robben, MD 

Laura Robbins, DSW 

Richard J. Robbins, MD 

William C. Robbins, MD 

Richard B. Roberts, MD 

Mark E. Robson, MD 

Arnold M. Rochwarger, MD 

John S. Rodman, MD 

A. Arturo Rodriguez, MD, MBA 

Steven A. Rogers, MD 

Nancy Roistacher, MD 

Herman Rosen, MD 

Neal Rosen, MD, PhD 

Howard E. Rosenberg, MD 

Peter M. Rosenberg, MD 

Todd Rosenblat, MD 

Michael A. Rosenbluth, MD 

Albert M. Ross, MD 

Gary E. Rothbart, MD 

Debasish Roychoudhury, MBBS 

Marina Rozenberg, MD 

David Scott Rubin, MD 

Howard S. Rubin, MD 

Moshe Rubin, MD 

Linda A. Russell, MD 

Carlo Russo, MD 

James G. Ryan, MD 

Mary T. Ryan, MD 

Mabel M. Ryder, MD 

Stuart D. Saal, MD 

Paul Joseph Sabbatini, MD 

Reza Sabet, MD 

Ian L. Sachs, MD 

Michel Sadelain, MD, PhD 

Nagham D. Sadik, MBChB 

R. Benjamin Saldana, DO 

Anthony Saleh, MD 

Mansoura Fawaz Salem, MBChB 

Jane E. Salmon, MD 

Leonard B. Saltz, MD 

Lori Beth Saltzman-Gabelman, MD 

Cori Salvit, MD 

Lisa R. Sammaritano, MD 

Tobias C. Samo, MD 

Nelson Sanchez, MD 

Donna Sandidge, MD 

Jean T. Santamauro, MD 

Thomas Santucci, Jr., MD 

Housam Aldeen Sarakabi, MD 

Barry I. Saul, MD 

Craig Sauter, MD 

Charles L. Sawyers, MD 

Wendy Schaffer, MD, PhD 

Liviu Schapira, MD 

Elaine J. Schattner, MD 

Mark A. Schattner, MD 

Jonathan Harry Schatz, MD 

David Schechter, MD 

David A. Scheinberg, MD, PhD 

Howard I. Scher, MD 

Lawrence Scherr, MD 

Andrew N. Schiff, MD 

David Ross Schifter, MD 

Ralph E. Schlossman, MD 

Michael J. Schmerin, MD 

H. Alan Schnall, MD 

William J. Schneider, MD, MPH 

Steven J. Schneider, MD 

Melissa P. Schori, MD 

George Schroth, MD 

Eliot Schuster, MD 

Leonard H. Schuyler, MD 

Ernest Schwartz, MD 

Fred S. Schwartz, MD 

Gary K. Schwartz, MD 

Joseph S. Schwartz, PhD 

Natalie Star Schwartz, MD 

Simeon Schwartz, MD 

Sergio Schwartzman, MD 

John C. Sciales, MD 

Richard F. Scofield, MD 

Corey J. Scruggs, MD 

Jean E. Sealey, DSc 

Neil H. Segal, MD, PhD 

Sorana Segal-Maurer, MD 

Andrew D. Seidman, MD 

Susan Seo, MD 

Kent A. Sepkowitz, MD 



Joshua D. Septimus, MD 

David Serur, MD 

Sandra L. Sessoms, MD 

Kenneth K. Sha, MBBS 

Nehad Shabarek, MD 

Alpesh R. Shah, MBBS 

Dipan J. Shah, MD 

Manish A. Shah, MD 

Monika Kanu Shah, MD 

Rajendra C. Shah, MBBS 

Nooruldin F. Shakir, MBBS 

Benson H. Shalette, MD 

Neil F. Shallish, MD 

Jerome B. Shapiro, MD, PhD 

Neil H. Shapiro, MD 

Atul Sharma, MD 

Manish Sharma, DO 

Pradeep Sharma, MBBS 

Vijay Kumar Sharma, PhD 

Nitya Sharma (Srinivasan), MD 

Gillian M. Shepherd, MD 

Stanley Sherbell, MD 

Bruce E. Sherling, MD 

Eric J. Sherman, MD 

Raymond L. Sherman, MD 

Christopher P. Shields, MD 

Moshe Shike, MD 

Maurice E. Shils, MD, DSc 

Rony Y. Shimony, MD 

Tiana Shiver, MD 

Morris A. Shorofsky, MD 

Meenal Shukla, MBBS 

Abdul Rahim M. Siam, MBBS 

Jonathan Siegal, MD 

Steven E. Siegel, MD 

Vasilios Sierros, MD 

Samuel H. Sigal, MD 

Lyra Sihra, MD 

Steven H. Silber, DO 

Jeffrey I. Silberzweig, MD 

Todd L. Simon, MD 

Amit Singh, MD 

Ghansham Singh, MD 

Dinesh Chandra Sinha, MD, MBBS 

Steven Jay Siskind, MD 

Diane M. Sixsmith, MD 

Nancy T. Sklarin, MD 

Alexander J. Slotwiner, MD 

Susan Faith Slovin, MD, PhD 

Paul T. Smith, MD 

Stephanie M. Smith, MD 

Charles Smithen, MD 

Alan G. Snart, MBBS, MD 

Benny Soffer, MD, MBA 

Won Sohn, MD 

David B. Solit, MD 

Meyer N. Solny, MD 

Henry A. Solomon, MD 

Anthony A. Somogyi, MD 

Anita Soni, MBBS 

Prabhat Soni, MBBS 

Girish M. Sonpal, MBBS 

Alan J. Sonsky, MD 

Julio E. Sotelo, MD 

Allison Spatz, MD 

Gabriel Spergel, MD 

Harry Spiera, MD 

Robert Forman Spiera, MD 

Bruce S. Spinowitz, MD 

Irving M. Spitz, MD 

David R. Spriggs, MD 

Emmanuel L.G. St. Louis, MD 

Stacy Stabler, MD, PhD 

Zsofia K. Stadler, MD 

Martin Stallone, MD 

Lawrence E. Stam, MD 

Ioannis A. Stathopoulos, MD, PhD 

Randy Stein, MD 

Herman Steinberg, MD 

Richard M. Steingart, MD 

Kurt H. Stenzel, MD 

Richard Stern, MD 

Mark Y. Stoeckle, MD 

Diane E. Stover, MD 

Mitchell S. Strand, MD 

David J. Straus, MD 

Joan A. Stroud, MD 

Sheena G. Stubbers, MD 

Alison E. Suarez, MD 

Steven M. Sugarman, MD 

Chang Ho Suk, MD 

Mohammed Abd El-Sattar Suliman, 

MBChB 

John F. Sullivan, MD 

Sung Wu Sun, BM 

Arthur W. Sung, MD 

Wei Fun Sung, MD 

Ranjit Suri, MBBS 

George C. Surla, MD 

Lynn Swisher, MD 

Andrew J. Szabo, MD 

John L. Szalyga, MD 

M. Javad Tabaee-Zadeh, MD 

George E. Taffet, MD 

Avraham Tal, MD 

Kenneth C. Tam, MD 

Steve C. Tam, MD 

Silvio Robert Tasso, MD 

Ying Taur, MD, MPH 

William John Tenet, MD 

Jeffrey Tepler, MD 

Mark J. Tessler, MD 

William Tew, MD 

Maria Theodoulou, MD 

George E. Thibault, MD 

Carolyn H. Thompson, MD 

Roma Tickoo, MBBS 

Jitendra Tolia, MBBS 

Alexander Tomasz, PhD 

Emily S. Tonorezos, MD 

Frantz Torchon, MD 

Guillermo Torre-Amione, MD, PhD 

Michael Torres, MD 

Tiffany A. Traina, MD 

Claude Tremblay, MD 

Nicholas Triantafillou, MD 

Theodore J. Trumble II, MD 

Tien-Tsai Tsai, BM 

Calogero Tumminello, MD 

Robert M. Tuttle, MD 

Theodore I. Tyberg, MD, MSc 

Sudhir P. Vaidya, MBBS, MS 

Miguel Valderrabano, MD 

Emmanuel Valery, MD 

Marcel Rudolf M. van den Brink, 

MD, PhD 

Nicholas Jon Vander Els, MD 

Nitza A. Vanga, MD 

Lisa Catherine Vasanth (Varley), MD 

Stephen R. Veach, MD 

Saimamba Veeramachaneni, MBBS 

Sindhaghatta K. Venkatram, MBBS 

Vasundhara Vidyarthi, MBBS 

Adrienne Vincenzino, MD 

Annette M. Visconti, MD 

Thomas T. Vo, MD, MBA 

Nicholas G. Vogiatzis, MD 

Rachel Waldron, MD 

Lila A. Wallis, MD 

Mary Beth Walsh, MD 

Frederick A. Walther, MD 

Rimda Wanchoo, MBBS 

John C.L. Wang, MD, PhD 

Craig Warschauer, MD 

Carolyn Wasserheit-Lieblich, MD 

Muhammad Wattoo, MBBS 

Geoffrey Webber, MD 

Arnold L. Weg, MD 

Wehbeh A. Wehbeh, MD 

Clinton G. Weiman, MD 

Jeremy A. Weingarten, MD 

Howard Weinstein, MD 

Jessica M. Weiser-McCarthy, MD 

Stephen R. Weiss, MD 

Gil Weitzman, MD 

David Wentzel, DO 

Mary H. White, MD 

Hendricks H. Whitman, III, MD 

Joseph Wiesel, MD 

Pamela G. Williams-Russo, MD, MPH 

Sidney J. Winawer, MD 

William L. Winters, Jr., MD 

Ruth L. Wintz, MD 

Natasha Withers, DO 

Robert E. Wittes, MD 

James F. Wittmer, MD 

Jedd Wolchok, MD, PhD 

David H. Woldenberg, MD 

David J. Wolf, MD 

Steven Wolinsky, MD 

Michael J. Wolk, MD 

John Eu-Li Wong, MBBS 

Alastair J.J. Wood, MBChB 

Anton Wray, MD 

Steven Wright, MD 

David Lynn Wuest, MD 

Kathleen L. Wyne, MD, PhD 

Jiaqiong Susan Xu, PhD 

Hooman Yaghoobzadeh, MD 

Henry Jiann-Cherng Yan, MBBS 

Anthony Yang, MD 

Christine Yang-Kauh, MD 

Mohamed Abdel Daem M. Yassin, 

MBBS 

Arthur M.F. Yee, MD, PhD 

Benson Yeh, MD 

Diana A. Yens, MD 

Xiaoshuang Nancy Yin, BM 

Linus Yoe, MBBS 

Bernard Yonk, MD 

Serena Yoon, MD 

James W. Young, MD 

Christine Yu, MD 

Florence Yu, MD 

Kenneth Ho-ming Yu, MD 

Howard S. Yudin, MD 

Tasneem Zahra, MBBS 

David Zakim, MD 

Andrew D. Zelenetz, MD, PhD 

Jinghua Zhang, BM 

Ming Zhu, MD, MS 

Wendy S. Ziecheck, MD 

Janice L. Zimmerman, MD 

Michael G. Zimmerman, MD 

Mahmoud A. Zirie, MBBS 

William A. Zoghbi, MD 

Research 

Highlights 


Research Highlights 

Christini Lab: Frances Ortega investigates electrophysiological instability 

in isolated cardiac myocytes using calcium fluorescence. 

Cardiology 

Molecular Mechanisms of Idiopathic Ventricular Tachycardia 

We identified a unique somatic mutation in the adenosine A 1 

receptor, originating from a focal right ventricular source that is 

responsible for some forms of idiopathic right ventricular outflow 

tract tachycardia. This arrhythmia is mediated by cAMP-mediated 

intracellular calcium overload. 

Principal Investigator: B. Lerman, MD 

Funding: Sackler Grant 

ADAPTIVE CRT Clinical Trial 

Multicenter, industry-sponsored trial of an investigational algorithm 

to optimize cardiac resynchronization therapy by altering RV-LV 

pacing timing cycles. 

Principal Investigator (Weill Cornell Site): J. Cheung, MD 

Funding: Medtronic 

Mechanisms of Cardiac Alternans 

Cardiac alternans is an electrophysiological instability that can 

trigger lethal cardiac arrhythmias. We are using a synergistic 

computational and experimental (patch clamping and subcellular 

calcium imaging) approach to determine its mechanism. In the past 

year we have provided new insight into the critical role that calcium 

dynamics play in triggering alternans at the cellular to tissue levels. 

Principal Investigator: D. Christini, PhD 

Funding: NIH 

Predictive Multiscale Modeling of a trial Fibrillation for 

Therapy Development 

We are using multiscale computational modeling, informed 

by electrophysiological experiments, to predict the efficacy of 

pharmacological agents in controlling paroxysmal, persistent 

and chronic atrial fibrillation in the presence of common human 

ion-channel polymorphisms. 

Principal Investigators: D. Christini, PhD and G. W. Abbott, PhD 

Funding: NIH 

Genetics of Coronary Artery Disease in Alaska Natives, 

Phase II 

This study enrolled 1,214 western Alaskan Eskimos in extended 

families who had carotid ultrasound studies and computerized 

ECGs read at Weill Cornell, and re-evaluated them and additional 

key family members in the second phase. Novel analyses have 

shown that individual saturated fatty acids are associated with 

different components of insulin resistance and glucose metabolism, 

and that genetic variation in APOJ, LPL and TNFRSF10B genes affect 

plasma fatty acid distribution in Alaska Eskimos. 

Principal Investigator (Weill Cornell Subcontract): 

R. Devereux, MD 

Funding: NHLBI 

Cardiovascular Evaluation for the Strong Heart Study, Phase V 

This study re-evaluated by echocardiography, carotid ultrasound 

and computerized ECGs and performed initial popliteal ultrasound 

studies in ~3,200 members of 64 multigeneration American Indian 

families. Novel results include demonstration of closer relations of 

central than brachial arterial pressure to cardiovascular structure 

and function; identification of association of the KIAA1797 gene; 

and development of methods to take into account relatedness 

within extended families in genetic epidemiology studies. 

Principal Investigator: R. Devereux, MD 


Genetic Epidemiology of Left Ventricular Hypertrophy 

This study utilizes data from echocardiograms read at Weill 

Cornell to identify genes contributing to abnormalities of left 

ventricular (LV) structure and function. The most recent discovery 

identifies strong genome-wide associations of SNPs in the NCAM1, 

ADAMTS14 and KIF6 genes for adverse LV phenotypes in 1,258 

African-American HyperGEN participants that were replicated 

in 989 hypertensive participants in the GENOA study whose 

echocardiograms had also been read at Weill Cornell. 


R. Devereux, MD 


Randomized Clinical Trial of Beta Blocker Therapy (Atenolol) 

vs. Angiotensin II Receptor Blocker Therapy (Losartan) in 

Individuals with Marfan Syndrome 

This study has enrolled all of the targeted 604 participants. 

Follow-up of participants has exceeded expectations and the 

independent Data and Safety Monitoring Board has recommended 

study continuation after an interim review. 


M. Roman, MD 

Funding: NHLBI; National Marfan Foundation 

Genetically Associated Thoracic Aortic Aneurysm (GENTAC) 

Registry 

This multicenter registry is obtaining biological samples and 

longitudinal data from individuals with inherited aortic disease 

so as to identify biologic, imaging and clinical predictors of aortic 

aneurysm progression. The registry has enrolled over 2,200 patients, 

with Weill Cornell contributing the largest number of participants. 

New findings include delineation of a role of aortic annular 

dilatation in causing aortic regurgitation, clarification of systematic 

differences among methods of measuring aortic size and estimation 

of rates of dissection/surgery in the distal aorta after aortic root 

replacement. 

Principal Investigator (Weill Cornell Site): R. Devereux, MD 

Co-Investigators : M. Roman, MD, J. Weinsaft, MD 



Research Highlights continued 

Near-term Downstream Outcomes of CCTA vs. Myocardial 

Perfusion SPECT (MPS) for Initial Diagnosis of Stable 

Chest Pain 

The downstream outcomes of CCTA versus MPS have not been 

directly compared. We performed a randomized, controlled pilot 

study of CCTA versus MPS for near-term resource utilization, 

quality of life, cost, and radiation exposure. 

Principal Investigator: J. Min, MD 

Funding: Tennessee Heart and Vascular Institute (subcontract) 

Presentation, Treatment and Outcomes of Early, Late and 

Very Late Stent Thrombosis: A Report from the American 

College of Cardiology National Cardiovascular Data Registry 

The goal of this study is to examine the current frequency, 

presenting clinical symptoms, current therapy and in-hospital 

outcomes in patients presenting with angiographically documented 

stent thrombosis in the American College of Cardiology National 

Cardiovascular Data Registry. 

Principal Investigators: D. Feldman, MD, E. Armstrong, MD 

(Boston) 

Funding: American College of Cardiology 

TAO (Treatment of Acute Coronary Syndrome with 

Otamixaban) Trial 

Investigation of a novel anti-Xa inhibitor (Otamixaban) in patients 

with acute coronary syndromes. Multicenter, randomized, doubleblind 

trial of otamixaban versus unfractionated heparin plus 

eptifibatide in patients with moderate-to-high-risk non-ST elevation 

acute coronary syndromes with a planned early invasive strategy. 

Principal Investigator: D. Feldman, MD 

Funding: Sanofi Aventis 

TBX5 and Histone Deacetylases in Cardiogenesis 

Congenital heart malformations are the most common birth 

defects. Mutations in the gene encoding the TBX5 transcription 

factor are causative for congenital cardiac septation and 

conduction system defects. We have identified a novel TBX5 

downstream target gene, HDAC2, that may be responsible 

for mediating some of the deleterious effects caused by TBX5 

haploinsufficiency during abnormal cardiac development. We seek 

to identify the mechanisms by which TBX5 influences HDAC2 

expression and activity in order to regulate cardiogenesis. 

Principal Investigator: C. Hatcher, PhD 

Funding: NIH 

Let-7 miRNA in Cardiac Development 

MicroRNAs are novel post-transcriptional regulatory elements that 

provide precise and subtle regulation of target genes, including 

transcription factors. We have identified a novel microRNA circuit 

that controls heart development and relates to congenital heart 

disease. Through experimental models, we will identify interactions 

between the let-7 microRNA and the TBX5 transcription factor 

to determine how this microRNA pathway regulates heart 

development. 


Funding: NIH 

ATHENA-1: A Randomized, Multicenter Study of 

Ambrisentan and Sildenafil Combination Therapy in 

Subjects with Pulmonary Arterial Hypertension Who Have 

Demonstrated a Suboptimal Response to Sildenafil 

This Phase 4, open-label study will evaluate the efficacy and safety 

of ambrisentan/PDE-5i combination therapy in patients with 

pulmonary arterial hypertension (PAH) who have demonstrated 

a suboptimal response to PDE-5i therapy alone. 

Principal Investigator: E. Horn, MD 

Funding: Gilead Sciences 

Rapid Switch from Intravenous Epoprostenol to Intravenous 

Remodulin ® (Treprostinil Sodium) Using the Crono Five 

Ambulatory Infusion Pump in Patients with Stable Pulmonary 

Arterial Hypertension: Safety, Efficacy and Treatment 

Satisfaction 

Pulmonary arterial hypertension (PAH), which is defined as an 

elevation in pulmonary arterial pressure and pulmonary vascular 

resistance, is a severe hemodynamic abnormality common to a 

variety of diseases and syndromes. Elevation of pulmonary arterial 

pressure causes an increase in right ventricular tension during heart 

contraction, impairing right ventricular function and ultimately 

leading to inactivity and death. The goal of PAH treatment is to 

lengthen survival time, ameliorate symptoms of PAH and improve 

health-related quality of life.The effects of switching from intravenous 

Flolan to intravenous Remodulin therapy will be compared. This 

eight-week study will also assess the effect that changing to 

Remodulin has on treatment satisfaction and patient quality of life. 


Funding: United Therapeutics 

Interagency Registry of Mechanically Assisted Circulatory 

Support (INTERMACS) 

Mechanical circulatory support devices (MCSDs) have been 

developed to augment or supplant failing myocardial performance. 

This therapy has been used most recently as permanent 

implantation or “destination therapy” for intractable heart failure. 

INTERMACS is an observational registry of patients with end-stage 

heart failure who receive an FDA-approved MCSD. 



Lipoprotein-Associated Phospholipase A2, Myeloperoxidase 

and Risk of Cardiovascular Disease in American Indians: The 

Strong Heart Study 

This ancillary project of the Strong Heart Study consists of a nested 

case-control study to examine the role of lipoprotein-associated 

phospholipase A2 and myeloperoxidase as risk factors for coronary 

heart disease and stroke in American Indians. 

Principal Investigator: J. Kizer, MD 

Funding: DiaDexus 

Delayed Enhancement MRI for Detection of Sub-Clinical 

Papillary Muscle Infarction 

The goal of this study is to elucidate novel structural mechanisms 

and predictive indices of post-myocardial infarction mitral 

regurgitation (MR), with focus on papillary muscle infarction 

detected by DE-MRI tissue characterization as a longitudinal 

predictor of mitral regurgitation. 

Principal Investigator: J. Weinsaft, MD 

Funding: NHLBI; NIH 

Molecular Genetics of Carney Complex 

We seek to define the molecular genetic etiologies for human 

cardiac myxoma syndromes, including Carney complex. Cardiac 

myxomas arise from pluripotent stem cells in the heart, and 

deciphering the genetic mechanisms underlying their growth and 

differentiation not only fosters new diagnostic and treatment The PARTNER (US) Trial: Placement of AoRtic TraNscathetER 

strategies, but also suggests new approaches to manipulate stem Valves Trial 

cells for a wide variety of cardiomyopathies. 

Percutaneous aortic valve replacement – 30 patients. 

Dr. David Christini discussing the behavior of aberrant 


Principal Investigator: S.C. Wong, MD 

electrical waves in a computer simulation of atrial fibrillation 

Funding: NIH 

Funding: Edwards Lifesciences 

80 with Department a collaborator, of Medicine Dr. Trine Krogh-Madsen. Annual Report 2011 81


Gauging Responsiveness with A VerifyNow assay – Impact 

on Thrombosis And Safety (GRAVITAS) 

Effects of single versus double dose of Plavix on patients post PCI 

(54 patients). 

Principal Investigator: R. Minutello, MD 

Funding: Accumetrics 

Closure of Atrial Septal Defects with the Amplatzer Septal 

Occluder Post-approval Study 

Evaluation of hemodynamic post closure of ASD with Amplatzer 

device (20 patients). 

Principal Investigator: G. Bergman, MBBS 

Funding: AGA Medical Corporation 

A Study of the Evalve Cardiovascular Valve Repair System 

(CVRS) Endovascular Valve Edge-to-Edge REpair Study II 

(EVEREST II) Protocol # 401 Continued Access Registry 

Reducing MR with a Clip (four patients). 

Principal Investigator: S.C. Wong, MD 

Funding: Abbott Vascular 

Clinical Epidemiology and Evaluative Sciences 

Research 

Center of Excellence in Disparities Research and Community 

Engagement 

The Center for Excellence in Health Disparities Research and 

Community Engagement (CEDREC) currently has over $8 million 

in funding from the NIH, and involves Weill Cornell Medical 

College, Hunter College School of Nursing, Lincoln Medical Center/ 

Renaissance Health System and NYU Medical Center – Center for 

Healthful Behavior Change. Faculty from the Department of Public 

Health at Weill Cornell who are also collaborating on CEDREC 

include: Dr. Alvin Mushlin, Dr. Heejung Bang, and Dr. Linda Gerber. 

The specific aims of CEDREC are: to create an interdisciplinary 

academic and community research enterprise that will expand 

the capacity for conducting cutting-edge and transdisciplinary 

research and contribute to improving minority health and reducing 

health disparities in cardiovascular disease and cancer in Central 

Harlem and the South Bronx; to train new minority investigators 

to conduct original minority health and health disparities research 

and foster their ability to obtain independent NIH funding; to build 

upon existing community-academic partnerships and forge new 

collaborations that will accelerate the dissemination of research 

findings to community stakeholders, inform novel communitybased 

programs and build their capacity for research. 

Principal Investigator: C. Boutin-Foster, MD, MS 

Co-Principal Investigator: M. E. Charlson, MD 

Funding: NIH/NCMHD (2009–14) 

Minority Investigator Research Supplement to SCALE: Small 

Changes and Lasting Effects 

Body image discrepancy and risk knowledge about obesity are key 

constructs that will enhance our understanding and prediction 

of who will fare well with a small change approach to weight 

loss. We will also explore the relationship of the body size of the 

social network and the social network health impact of obesity/ 

overweight in relation to success in weight loss. 

Principal Investigator: M. E. Charlson, MD 

Recipient: G. Winston, MD 

Funding: NIH/NHLBI (2010–14) 

Post-Master’s Degree Research Supplement to SCALE: Small 

Changes and Lasting Effects 

This project is largely embedded in the parent grant, SCALE: Small 

Changes and Lasting Effects. The classification of programs in 

faith-based settings is a logical extension of the parent grant that 

evaluates environmental influences that may be impacting the 

uptake of mindful eating intervention. 


Recipient: J. Hippolyte, MPH 


SCALE: Small Changes and Lasting Effects 

Part of the NIH-funded Center for Behavioral Research in Obesity, 

SCALE is a partnership between the Departments of Sociology, 

Behavioral Psychology, Nutrition and Statistics at Cornell University 

in Ithaca and Lincoln Medical Center/Renaissance Health System in 

the Bronx. It builds upon the work of Drs. Boutin-Foster and Phillips- 

Caesar, who are co-investigators on the project, as well as on 

the work of Drs. Devine, Wansink, Wethington and Wells. This 

multimillion dollar grant focuses on developing individual, family and 

faith-based mindful eating interventions targeted at reducing obesity 

in minority communities. The project is designed to develop and 

test different multilevel interventions in proof-of-concept trials to lay 

the basis for evaluating its effectiveness in large-scale clinical trials. 

SCALE now has two minority supplements that were successfully 

awarded in 2010. 



Autoregulation and Systemic Blood Pressure: A New View 

of Normal Tension Glaucoma 

This study aims to determine whether a larger prospective 

cohort study should be undertaken, and to help define optimal 

monitoring strategies for patients with normal tension glaucoma. 

Now in the final year of the study, the division is in the process of 

completing the follow-up data. 


Funding: NEI (2008–11) 

Clinical Pharmacology 

New Drug to Activate Peripheral Histamine 3 Receptors 

Activating the histamine 3 receptor lowers the epinephrine in the 

ischemic heart and should reduce arrhythmias. A series of novel 

compounds are being made and screened to find a drug that will 

reduce arrhythmias in ischemic hearts. 

Principal Investigator: M. M. Reidenberg, MD 

Funding: NIH 

Emergency Medicine 

Neurological Emergencies Treatment Trials (NETT) 

A five-year grant to create a network of tertiary care emergency 

departments capable of conducting research in neurological 

emergency care. This year the first two trials were initiated: Rapid 

Anticonvulsant Medication Prior to Arrival Trial (RAMPART) and 

Albumin in Acute Stroke (ALIAS). 

Principal Investigators: N. Flomenbaum, MD, and 

M. Fink, MD (site) 

Funding: NIH/ NINDS 

An International Multicenter Study to Evaluate a Six-Hour 

Observation Period for Cocaine-Associated Chest Pain 

A two-year grant to determine if six hours of observation 

combined with a six-hour troponin and ECG is an adequate 

length of time to determine which patients are at risk for serious 

complications of cocaine-associated chest pain. 

Principal Investigator: J. Prosser, MD 

Funding: American Academy of Clinical Toxicology 

Endocrinology, Diabetes and Metabolism 

American Recovery and Reinvestment Act Administrative 

Supplements for Comparative Effectiveness Research 

Workforce Development 

This supplement has two objectives: to strengthen current formal 

educational opportunities in CER by increasing the scope and 

offerings in the track in outcomes and health services research; 

to offer an additional year of training in CER as a KL2 scholar 

to students who are enrolled in, or who have obtained, either a 

master’s degree or certificate in clinical and translational research. 

These trainees will work with faculty who are developing these 

courses and will engage in tutorials, selective electives and 

personalized learning experiences. They will pursue a year of 

mentored research with faculty in the area of CER. 

Principal Investigator: J. L. Imperato-McGinley, MD 

Co-Principal Investigator: A. Mushlin, MD 

Funding: NIH 

DEFEND‐2: Durable-response Therapy Evaluation for Earlyor 

New-onset Type 1 Diabetes 

A randomized, placebo-controlled, double-blind, international 

study of the efficacy and safety of otelixizumab in adolescents 

and adults with new-onset type 1 diabetes mellitus. 

Principal Investigator: H. Karakelides, MD 

Funding: Tolerx 

NIH T32 Training Grant 

The Endocrine Research Training Program at Weill Cornell is 

a Tri-Institutional endeavor with participation from Memorial 

Sloan-Kettering Cancer Center and The Rockefeller University. 

The overarching goal of this program is to provide multidisciplinary 

translational endocrine research training to postdoctoral trainees 

to prepare them for independent careers in biomedical research. 

The program has two tracks: a laboratory/preclinical track and 

a clinical research track. 


Funding: NIH 

Epidemiology of Diabetes Intervention and Complications 

(EDIC) Trial 

The EDIC trial is a continuation study involving the Diabetes 

Control and Complications Trial (DCCT) cohort. The EDIC study 

has now followed nearly 1,400 individuals with type 1 diabetes for 

over 30 years. 

Principal Investigator: D. Brillon, MD 

Funding: NIH/NIDDK 

Action to Control Cardiovascular Risk in Diabetes 

(ACCORD) Study 

The ACCORD trial compares intensive blood glucose, lipid 

and blood pressure control in over 10,000 persons with 

type 2 diabetes. 

Principal Investigator: D. Brillon, MD 

Funding: NIH/NHLBI 

A Randomized, Placebo-controlled, Double-blind 

Investigation of the Effects of Potassium Citrate on Bone 

Metabolism in Postmenopausal Osteopenia 

To determine the effects of administration of an alkaline 

compound, potassium citrate, on bone turnover and bone 

mineral density. 

Principal Investigator: N. Sinha, MD 

Funding: CTSC and Acidosis Research Fund 

Sex Steroids and Cardiovascular Disease Risk 

To study the effects of sex steroids on cardiovascular disease by 

examining surrogate markers of cardiovascular disease in patients 

with complete androgen insensitivity and 5α-reductase-2 deficiency, 

and comparing these to normal controls. 


Funding: NIH 

Androgen Regulation of Endothelial Progenitor Cells and 

Endothelial Cells 

The major goal of this project is to study the effects and 

mechanisms of androgens on the regulation of endothelial 

progenitor cells and endothelial cells using human and animal 

models with defects in androgen actions as well as in vitro cell 

cultures. 

Principal Investigator: Y.S. Zhu, MD, PhD 

Funding: CTSC/NIH 

Dual Action of NSC606985 on LAPC-4 Prostatic Tumor Cell 

Growth is Mediated via PKCd 

NSC606985 is a potential chemotherapeutic agent for prostate 

cancer. However, in LAPC-4 cells, NSC606985 produces a dual 

action on cell growth. The investigators have revealed that this 

dual action is mediated via PKCd, mainly due to the differential 

activation of PKCd in different cell compartments. 

Principal Investigators: Y.S. Zhu, MD, PhD and 

J. L. Imperato-McGinley, MD 

Funding: Cohen Fund 

Dietary Fat on the Regulation of Prostate Grp78 Expression 

and Prostate Tumorigenesis in the Rat 

A continuing exploration of dietary effect on the regulation of 

prostate gene expression. The team has demonstrated that a high 

dietary fat intake increases prostate tumorigenesis and prostate 

Grp78 level without a significant alteration in Grp78 mRNA 

concentration. 

Principal Investigator: Y.S. Zhu, MD, PhD 

Funding: United Soybean Board 

Genotype-Phenotype Analysis of CAH in the Dominican 

Population 

A continuing effort to elucidate the genotype-phenotype 

relationship of CAH in the Dominican population. The team has 

identified various mutations in the 21-hydrolase (CYP21) gene, and 

a specific mutation is identified in the Dominican population. 

Principal Investigators: J. L. Imperato-McGinley, MD and 

Y.S. Zhu, MD, PhD 

Funding: Argenbright Research Fund 



Gastroenterology and Hepatology 

A Randomized, Parallel Group, Dose-ranging Study to 

Evaluate Efficacy, Safety, Pharmacokinetics and Antiviral 

Activity of VX 222 and Telaprevir in Combination with 

and without Peginterferon Alfa 2a (Pegasys) and Ribavirin 

(Copegus) in Treatment-naïve Subjects with Genotype 1 

Chronic Hepatitis C 

The primary objective of this study is to assess the safety and 

tolerability of combination treatment with VX-222 and telaprevir 

administered for 12 weeks with and without pegylated interferon 

alfa-2a and ribavirin. 

Principal Investigator: I. M. Jacobson, MD 

Funding: Vertex Pharmaceuticals 

A Randomized, Open-label, Multicenter, Dose and Duration 

Finding Study to Evaluate the Sustained Virologic Response 

of the HCV Protease Inhibitor Danoprevir Boosted with Low 

Dose Ritonavir (danoprevir/r) in Combination with Pegasys 

and Copegus vs. Pegasys and Copegus Alone in Treatment- 

Naïve Patients with Chronic Hepatitis C Genotype 1 or 4 

Virus Infection. NV22776 

The primary objective of this trial is to study the different doses 

and durations of danoprevir ritonovir treatment combination with 

Pegasys and Copegus on the proportion of patients who achieve 

sustained virological response versus the currently approved 

combination of Pegasys and Copegus in treatment-naïve patients 

with chronic hepatitis C genotype 1 or 4 virus infection. 


Funding: Roche/Genitech 

TMC435-TiDP16-C206(ASPIRE) 

A Phase IIb, randomized, double-blind, placebo-controlled trial to 

investigate the efficacy, tolerability, safety and pharmacokinetics 

of TMC435 as part of a treatment regimen including PegIFN -2a 

and ribavirin in HCV genotype 1 infected subjects who failed to 

respond or relapsed following at least one course of PegIFN -2a/b 

and RBV therapy. 


Funding: Johnson and Johnson 

Identification of Early Biomarkers/Targets for Cancer 

Prevention Using Metabolomic Screening 

The goal of this project is to identify molecular biomarkers/ 

targets for cancer prevention using metabolomic profiling in 

morphologically normal and neoplastic tissues. The impact of a 

tumor-suppressor gene on the metabolic profile will be defined. 

Principal Investigator: A.J. Dannenberg, MD 

Funding: NIH/NCI 

Molecular Determinants of Intestinal Inflammation 

This project seeks to elucidate the mechanisms that control 

mucosal homeostasis with the goal of developing new strategies to 

prevent or treat inflammatory bowel disease. 

Principal Investigator: A.J. Dannenberg, MD 

Funding: New York Crohn’s Foundation 

Mechanisms of Notch Signaling in Colon Cancer Initiating Cells 

This project studies the role of the NOTCH signaling pathway in 

colon cancer initiating cells and the potential roles of NOTCH 

inhibition in colon cancer chemoprevention and combination 

chemotherapy. 

Principal Investigator: S. Lipkin, MD, PhD 

Funding: NIH 

Metabolomic Biomarkers of DFMO and Sulindac in Colon 

Adenoma Prevention 

This project uses metabolomics to identify novel metabolic 

biomarkers and potential dietary questions to be incorporated into 

the SWOG S0820 phase III trial of DFMO/Sulindac in the prevention 

of secondary colorectal adenomas and cancers. 


Funding: NIH 

Pharmacogenetics of HMGCR in Colon and Prostate Cancer 

Chemoprevention 

This project studies the role of HMGCR genetic variants affecting 

alternative splicing in modulating efficacy of statin drugs in colon 

and prostate cancer risk reduction. 


Funding: NIH 

A Multicenter, Placebo-controlled, Dose-ranging Study to 

Investigate the Safety, Tolerability, Pharmacokinetics and 

Pharmacodynamics Following Oral Administration of PSI- 

7977 in Combination with Pegylated Interferon and Ribavirin 

in Treatment-naïve Patients with Chronic HCV Infection 

Genotype 1, and an Open-label Assessment of PSI-7977 in 

Patients with HCV Genotype 2 or 3 (Pharmasset P7977-0422) 

The primary objective of this study is to assess the safety and 

tolerability of PSI-7977 for 12 weeks, administered in combination 

with standard-of-care in treatment-naïve patients with HCV 

genotype 1, 2 or 3. 


Funding: Pharmasset 

Boceprevir and Peginterferon/Ribavirin for the Treatment 

of Chronic Hepatitis C in Treatment-naïve Subjects: A 

Comparison of Erythropoietin Use vs. Ribavirin Dose 

Reduction for the Management of Anemia 

The primary objective of this trial is to compare the effect on 

efficacy of erythropoietin use versus ribavirin dose reduction for the 

management of anemia in subjects who become anemic during 

the treatment of chronic hepatitis C genotype 1 infection with 

boceprevir plus peginterferon alfa-2b and ribavirin therapy. 


Funding: Merck and Company 

Risks Factors for AIDS among IV Drug Users 

These studies seek to identify the mechanism by which high-risk 

exposed individuals are protected from HIV infection. 

Co-Investigator: A. Talal, MD 

Funding: NIH/NIDA 

Assessment by Meta-analysis of Treatment of Addiction as a 

Determinant of Successful Treatment Response for Hepatitis 

C Virus Infection in Drug Users 

The goal of this study is to assess the effect of treatment of 

addiction on obtaining a successful treatment outcome to therapy 

for hepatitis C, using techniques of meta-analysis. 

Co-Principal Investigator: A. Talal, MD 


Association between IL28B Genetic Variation and Sustained 

Response to PEG-IFN and RBV in American HIV/HCV Coinfected 

Patients 

The goal of this study is to analyze the association between IL28B 

and treatment outcome among HIV/HCV co-infected patients. 

Principal Investigator: A. Talal, MD 


Phase IIA Trial Testing Erlotinib as an Intervention against 

Intraductal Pancreas Mucinous Neoplasms 

A phase IIA observational single-arm study of 100 mg/d of erlotinib 

in patients with intraductal papillary mucinous neoplasms. 

Principal Investigator: F. Schnoll-Sussman, MD 

Funding: NIH 

Phase Ib Study of Polyphenon E in Patients with Barrett’s 

Esophagus 

A consortium study with MD Anderson Cancer Center and 

Columbia University to evaluate green tea extract (polyphenon E) 

in the potential prevention of progression to esophageal cancer in 

patients with Barrett’s esophagus. 


Funding: NCI 

Familial Pancreatic Cancer Family Registry 

Evaluation of MRCP and EUS procedures as screening tools in 

the early detection of pancreatic cancer in people with a family 

history of this disease, along with collection and analysis of DNA 

from patients with pancreatic cancer and their families to identify 

potentially inherited genetic mutations that may contribute to the 

development of pancreatic cancer. 


Funding: Partial funding from Hayes Foundation and Helen 

Kaufman Memorial Fund 

Study of Biomarkers of Colorectal Cancer 

Analysis of novel biomarkers in the blood of people diagnosed 

with colorectal cancer, which could contribute to the development 

of improved and/or less invasive colon cancer screening. 


Funding: GeneNews 

The Changing Epidemiology of Clostridium difficile Infection 

in Inflammatory Bowel Disease Patients 

The purpose of this study is to identify the risk factors and 

incidence for C. difficile infection and its severity in the IBD 

population. 

Principal Investigator: C. Crawford, MD 

Funding: Rudin Foundation 

Clostridium difficile Infections in Patients with Hematologic 

Malignancies 

The purpose of this study is to identify and evaluate the risk factors 

for C. difficile infection in patients with hematologic malignancies 

before, during and after their treatment. 

Principal Investigator: C. Crawford, MD 

Funding: Rudin Foundation 



Geriatrics and Gerontology 

Edward R. Roybal Center for Research on Applied 

Gerontology 

This grant created the Cornell-Columbia Translational Research 

Institute on Pain in Later Life (TRIPLL), a multi-institutional and 

interdisciplinary collaboration focused on implementing innovative 

strategies for improving pain management among older adults. 

Principal Investigator: M. Carrington Reid, MD 

Funding: NIH 

New York City Elder Abuse Center 

The New York City Elder Abuse Center is using a collaborative 

approach to establish a much-needed multidisciplinary team (MDT) 

of experts to coordinate care and create solutions for the growing 

number of complex cases of elder abuse in NYC. The first MDT will 

begin work in Brooklyn and, if successful, MDTs will be instituted 

in other boroughs, starting next with Manhattan. As it matures 

and grows, the center will also serve a larger role as a training 

ground and central resource for technical assistance, innovative 

best practices, multidisciplinary training, research and policy 

development in NYC. 

Principal Investigators: M. S. Lachs, MD, MPH and 

R. Breckman, LCSW 

Funding: The Fan Fox and Leslie R. Samuels Foundation 

Resident-to-resident Elder Mistreatment in Long-term Care 

Resident-to-resident elder mistreatment (RREM) in nursing homes 

remains unstudied despite staff beliefs that aggressive verbal and 

physical interactions between residents is common. The aims of 

this research are to develop and refine a case-finding method for 

identifying episodes of RREM, determine the extent and nature of 

RREM in a sample of six nursing homes in NYC, and to conduct an 

observational cohort study comparing longitudinal rates of diverse 

outcomes. 

Principal Investigator: M. S. Lachs, MD, MPH 

Funding: NIH 

Hartford Center of Excellence in Geriatric Medicine 

The overarching goal of the Hartford Center of Excellence (initially 

funded in 2005) is to attract and train future academic leaders in 

geriatric medicine. 

Principal Investigator: M. Carrington Reid, MD 

Funding: The John A. Hartford Foundation 

Advancing the Quality of Palliative Care through Clinician 

Education 

The goal of this work is to develop, implement and seek ways 

to sustain a palliative care educational program at the NewYork- 

Presbyterian Hospital/Weill Cornell Medical Center that will 

establish a campus-wide educational initiative to complement and 

enhance the provision of palliative care services. 

Principal Investigators: R. D. Adelman, MD, E. Siegler, MD 

Funding: Altman Foundation 

Hematology/Medical Oncology 

Targeted Inhibition of BCL6 for Leukemia Stem Cell 

Eradication 

This project tests the spectrum of lymphomas responsive to RI-BPI, 

translated RI-BPI for use in clinical trials. 

Principal Investigator: A. Melnick, MD 


Radiolabeled Anti-PSMA Monoclonal Antibody to Target 

Nonprostate Solid Tumor Neovasculature 

We propose to use In-J591 to initially identify sites of PSMApositive 

metastatic disease in subjects with nonprostate cancer. 

It is hypothesized that an infusion of Lu-J591 will function as an 

anti-neovasculature agent to change tumor blood flow, which may 

result in regression of tumor growth. 

Principal Investigator: S. Tagawa, MD 

Funding: Pardee Foundation 

Targeting of Human Acute Myelogenous Leukemia 

Stem Cells 

This project aims to define putative anti-LSC-specific compounds 

with the potential for clinical translation from known FDAapproved 

drugs. 

Principal Investigator: M. Guzman, PhD 

Funding: Lauri Strauss Leukemia Foundation 

The Molecular Basis of Neuroendocrine Prostate Cancer 

The broad objectives of this proposal are to discover the genetic 

alterations found in NEPC, identify therapeutically targetable 

somatic mutations and develop new treatment strategies for 

patients with NEPC. 

Principal Investigator: H. Beltran, MD 

Funding: Prostate Cancer Foundation 

Receptor-mediated Control of Cell Differentiation 

To identify signal transduction pathways downstream of proNGF, 

to evaluate the role of sortilin ectodomain shedding in modulating 

proNGF function and to generate and evaluate mice overexpressing 

proNGF or proBDNF. 

Principal Investigator: B.L. Hempstead, MD, PhD 

Funding: NIH/NINDS 

Fractionated, Dual-targeted Radioimmunotherapy for 

Follicular Lymphoma 

This project aims to determine the biodistribution, tumor 

localization and pharmacokinetics of radiolabeled epratuzumab 

therapy, determine any changes in targeting due to pretreatment 

with veltuzumab, and establish the safety and efficacy of 

fractionated 90Y-epratuzumab tetraxetan (anti-CD22) given 

in combination with veltuzumab (anti-CD20) in patients with 

previously untreated, intermediate or high-risk FL. 

Principal Investigator: R. Elstrom, MD 


Geriatric Mental Health Integration into Primary Practice 

This program provides screening and assessment of all ambulatory 

patients at the Irving Sherwood Wright Center on Aging for 

depression and anxiety as well as providing mental health care 

for those in need. In conjunction with mental health clinical 

services, this program provides an opportunity to develop a unique 

database of mental health findings in this population, which will 

be a rich resource for further research. 

Principal Investigator: R. D. Adelman, MD 

Funding: New York State Office of Mental Health 

Characterization of Epigenomic Deregulation in Acute 

Myeloid Leukemia 

A career award project focusing on studies of epigenetic 

compartments of genetic material of myeloid leukemia. 

Principal Investigator: M. Figueroa, MD 

Funding: The Leukemia and Lymphoma Society 

Transcriptional Silencing by the BCL6 Oncoprotein 

This project aims to determine the mechanism of action of the 

BCL6 transcriptional repressor. 





HSP70 as a Novel Target to Specifically Ablate and Detect 

AML Stem Cells 

This project aims to determine whether HSP70 plays an important 

role in LSC maintenance during chemotherapy and therefore 

represents a novel target to ablate LSCs without harming HSCs. 

Given the cell surface presentation of HSP70 and increased HSP70 

expression in AML, the investigators may further determine the 

potential use of HSP70 as a marker to identify chemoresistant LSCs 

during minimal residual disease. 


Funding: The Leukemia and Lymphoma Society 

A Mouse Model for Human Gastrointestinal Stromal Tumor 

This project aims to investigate changes taking place during tumor 

development and progression with age in KitV558?/+ mice. 

Principal Investigator: J.M. Scandura, MD, PhD 

Funding: NIH/NCI (subcontract from MSKCC) 

Prostate Cancer Research at Weill Cornell Medical College 

This project uses a prototype PSMA-based cell-capture device to 

isolate and analyze circulating prostate cancer cells from the blood 

of patients who are receiving docetaxel and similar chemotherapy. 

Additionally, it will investigate the molecular basis of the clinical 

response of prostate cancer patients by assessing androgen 

receptor entrapment within the cancer cell and correlating the data 

with patients’ clinical progress and seeking drug-resistance-causing 

mutations at the site within the cancer cell where docataxel should 

be active. 

Principal Investigator: D.M. Nanus, MD 

Funding: Charles Henry Leach II Foundation 

Selection of Novel Therapies to Ablate Chemoresistant 

Myeloid Leukemia Stem Cell 

This project aims to advance the targeting of LSCs and reduction of 

relapse by: determining whether ex vivo treatments of LSCs more 

realistically reflect therapeutic outcome in patients compared to 

AML blast populations; defining the gene expression signatures 

of drug sensitivity and drug resistance of LSCs to identify better 

therapies; identifying cell lines that best mimic the chemosensitivity 

of LSCs, to have a readily available LSC surrogate in drug screens. 


Funding: NIH Office of the Director 

Transcriptional and Epigenetic Characterization of the Drug 

Resistance in Acute Myelogenous Leukemia Stem Cells 

This project aims to understand the epigenetic mechanisms 

that lead to LSC chemoresistance to optimize the selection and 

identification of drugs that can ablate LSCs that drive leukemia 

relapse. 


Funding: The V Foundation for Cancer Research 

Mechanisms Determining Disease Relapse in Older Patients 

with Acute Myeloid Leukemia 

This is a collaborative project with Drs. Ross Levine (Memorial 

Sloan-Kettering Cancer Center), Christopher Park, Gail Roboz, 

Christopher Mason and Monica Guzman. The goal is to determine 

the genetic and epigenetic lesions associated with and causative 

of AML relapse. 


Funding: The Starr Foundation 

Unraveling the Breast Cancer Metastasis Epigenome 

Large-scale characterization of the epigenetic landscapes 

underlying breast cancer metastasis using a human breast cancer 

cell line metastasis model and primary breast tumor samples. 

This project will determine the functional significance of genes 

implicated by this epigenomic analysis. 

Principal Investigator: L. Vahdat, MD 

Funding: The Starr Foundation (subcontract from Memorial 

Sloan-Kettering Cancer Center) 

Novel Therapeutics in Lymphoma 

This project supports further assessment of novel monoclonal 

antibodies in B cell malignancies; evaluation of combination regimens 

with rituximab and biologic agents; studies of radioimmunotherapy 

as part of initial therapy for lymphoma; novel initial therapies for 

aggressive lymphoma; new chemotherapy regimens; new efforts in 

evaluation of lymphoma prognosis and use of imaging. 

Principal Investigator: J.P. Leonard, MD 

Funding: The Lymphoma Foundation 

Hospital Medicine 

Systemic Barriers to Quality Pain Management in General 

Medical Inpatients 

We seek to establish the current state, and to identify system level 

barriers, to quality pain management for adult general medical 

inpatients with a special focus on the geriatric population, using 

a qualitative approach composed of patient interviews and 

provider focus groups. 

Principal Investigator: R. Lin, MD, PhD 

Funding: NIH CTSA Planning Award (2010-2011) at WCMC 

Clinical and Translational Science Center (CTSC); NIA (National 

Institute on Aging) Pilot Grant (2010-2011) at Cornell-Columbia 

Translational Research Institute on Pain in Later Life (TRIPLL). 

Immunology 

Strategies to Prevent Death from Influenza Virus Infection 

This project is a collaborative project between Imperial College 

London and Weill Cornell Medical College focusing on the 

development of anti-inflammatory treatments to prevent death 

after influenza virus infection (London), and generating 

a “T-cell vaccine” for influenza virus (New York). 

Principal Investigators: K. A. Smith, MD (New York) and 

M. Feldmann, MD (London) 

Funding: NIH/NIAID 

Developing Novel Therapeutics for CLL 

Our previous studies have shown that tumor samples derived 

from chronic lymphocytic leukemia (CLL) patients constitutively 

express Rel/NF-kB activity, which may provide tumor cell survival 

advantage. This project investigates the mechanism underlying CLL 

tumorigenesis mediated by the constitutive Rel/NF-kB activity and 

develop inhibitors of Rel/NF-kB as potential therapy for CLL. 

Principal Investigator: H. C. Liou, PhD 

Funding: Leukemia & Lymphoma Society 

Validation of Pyrimidine Trione Compounds as Novel 

Therapy for Multiple Myeloma 

Recent studies have shown that multiple myeloma expresses high 

levels of Rel/NF-kB activity which contribute to tumor cell survival 

and drug resistance. Our team has identified several Rel/NF-kB 

inhibitors. We propose to optimize one class of NF-kB inhibitors as 

a potential lead compound for multiple myeloma. 

Principal Investigator: H. C. Liou, PhD 

Funding: Multiple Myeloma Research Foundation 


Gut Microbiota and Visceral Adiposity in HIV-Infected 

Patients 

This study is testing the hypothesis that there are differences in the 

bacterial composition of the gastrointestinal tracts of HIV-infected 

patients with excess abdominal fat compared to controls. 

Co-Principal Investigators: M. Glesby, MD, PhD and 

M. Kamboj, MD (MSKCC) 

Funding: Weill Cornell Clinical and Translational Science Center 

HIV/AIDS Clinical Trials Unit: New York City 

This seven-year ongoing project supports the design, implementation 

and conduct of clinical trials in HIV/AIDS centered in several areas: 

antiretroviral treatment, complications of HIV/AIDS and its therapies, 

immune-based therapies, and co-infections such as human 

papillomavirus (HPV) and hepatitis B and C. A newer initiative 

seeks to study the HIV prevention strategy of PREP (pre-exposure 

prophylaxis) – administering HIV drugs to at-risk HIV-uninfected 

individuals to prevent them from acquiring HIV infection. 

Principal Investigator: R. Gulick, MD, MPH 

Funding: NIH 

HIV/AIDS Clinical Trials Unit: Port-au-Prince, Haiti 

This seven-year ongoing project supports clinical research in HIV/ 

AIDS on treatment strategies, prevention of mother-to-child 

transmission of HIV and studies of investigational HIV vaccines. 

Principal Investigator: J. Pape, MD 

Funding: NIH 

Human Papillomavirus (HPV) Test and Treat in HIV-Infected 

Women 

This project will conduct a clinical trial in Africa, Peru, India 

and Haiti. The study will randomize women to a conventional 

cytology-based cervical cancer screening strategy or a novel 

strategy using HPV testing and cervical cryotherapy. Funded in part 

by the President’s Emergency Plan for AIDS Relief (PEPFAR)/NIH 

collaboration. 

Principal Investigator: T. Wilkin, MD, MPH 

Funding: NIH 

Human Papillomavirus Vaccination in HIV-1-Infected Men 

This study evaluated the safety and immunogenicity of the 

quadrivalent HPV vaccine in HIV-1-infected men. The study found 

that the vaccine is safe and highly immunogenic. An extension of 

the clinical trial will evaluate whether this vaccine induces immune 

memory. A follow-up clinical trial is being developed that will test 

the efficacy of this vaccine in this population. 

Principal Investigator: T. Wilkin, MD, MPH 

Funding: NIH 



Human Papillomavirus (HPV)/HIV Co-Infection in Haiti 

Cervical cancer is the most common cause of cancer death in HIVinfected 

women in Haiti (three deaths per 1,000 patient-years) and is 

causally linked to HPV infection. Investigators will determine the effect 

of antiretroviral therapy and immune reconstitution on the natural 

history of HPV infection in HIV-infected women, and study the 

effect of HIV/HPV co-infection on prostaglandin E2, an inflammatory 

molecule that is an important mediator of cancer development. 

Principal Investigator: D. W. Fitzgerald, MD 

Funding: NIH 

Immunochemotherapy for Visceral Leishmaniasis 

This long-term project is directed at understanding T celldependent, 

macrophage-mediated host defense mechanisms 

in experimental Leishmania donovani infection. The goal is to 

combine these mechanisms with conventional chemotherapy to 

produce more rapid, complete initial parasite killing and prevent 

subsequent relapse of infection. 

Principal Investigator: H. W. Murray, MD 

Funding: NIH 

Influenza Research Collaboration Protocol 001: A Pilot Study 

for Collection of High-Titer Anti-Influenza A H1N1 2009 

Plasma 

The goal of this study is to develop a plasma product for potential 

therapeutic use in patients with severe H1N1 influenza. Eligible 

subjects (who will donate plasma by undergoing apheresis) have 

high levels of antibodies to the 2009 H1N1 strain of influenza 

either due to prior infection or vaccination. 

Principal Investigator: M. J. Glesby, MD, PhD 

Funding: NIH 

Metabolomics Approaches to Tuberculosis Drug 

Development 

This study proposes to apply global metabolite profiling approaches 

to deduce the mycobactericidal mechanism of action of reactive 

nitrogen intermediates against Mycobacterium tuberculosis. 

Principal Investigator: K.Y. Rhee, MD, PhD 

Funding: NIH 

Metabolomics-Based Approaches to Tuberculosis Drug 

Development 

This study proposes to develop metabolomics-based tools to 

enable intrabacterial pharmacokinetic and pharmacodynamic 

analysis of novel antimycobacterial compounds identified through 

whole-cell screening approaches. 


Funding: Bill and Melinda Gates Foundation, TB Drug Accelerator 

Program 

Metabolosome-Mediated Control of Tuberculosis Latency 

This study represents follow-on funding of the prior Grand 

Challenges Exploration award, which proposed to test the 

hypothesis that Mycobacterium tuberculosis operates its 

metabolism by regulating the assembly of metabolic modules that 

are organized into protein microcompartments, and that these 

microcompartments facilitate entry into and exit from latency. 


Funding: Bill and Melinda Gates Foundation, Grand Challenges 

Exploration 

KPC-Producing Enterobacteriaceae (Drug-Resistant Bacterial 

Infections) in New York City 

This project is investigating the clinical and molecular epidemiology 

of Klebsiella pneumoniae carbapenemase (KPC)-producing 

Enterobacteriaceae (KPC-E) in healthcare facilities in which these 

organisms have become endemic, in order to provide information 

that can be used in developing effective prevention strategies. The 

project will identify the prevalence and incidence of colonization 

with KPC- E among patients in various types of healthcare settings 

in New York City; describe the transmission dynamics of KPC-E; 

and identify independent predictors of colonization with KPC-E 

among patients. 

Principal Investigator: D. Calfee, MD, MS 

Funding: Centers for Disease Control and Prevention, Association 

of American Medical Colleges 

Malaria: Genomic Instability and Copy Number Variation 

This study is using new techniques for manipulating the genome 

of the malaria parasite to directly study the effects of copy number 

variation of different genes found to be amplified in field and 

laboratory isolates. Genes of study are implicated in parasite drug 

resistance. 

Principal Investigator: L. Kirkman, MD 

Funding: NIH 

Mechanisms of Vancomycin Resistance in Staphylococcus 

aureus 

This study investigates the use of a novel mass spectrometry-based 

metabolite profiling technique (metabolomics) to elucidate the 

metabolic pathways involved in the expression of vancomycin 

resistance in Staphylococcus aureus. 

Principal Investigator: E. Alexander, MD, with K. Y. Rhee, MD, PhD 

Funding: Weill Cornell Clinical and Translational Science Center 

Medical Ethics 

Minds Apart: Severe Brain Injury and Health Policy 

The major goals of this project are to explore attitudes and 

practices toward brain injury that will yield important lessons 

for the care of patients with severe brain injury, as well as other 

marginalized populations with chronic conditions, and to produce 

a book-length manuscript to inform health policy. 

Principal Investigator: J. J. Fins, MD 

Funding: The Robert Wood Johnson Foundation 

Neuroethics and Disorders of Consciousness II: Expanding 

Research Infrastructure and Scholarship 

We seek to assess the scope of misdiagnosis and neglect of 

patients with disorders of consciousness, address the ethical 

imperative to develop new measures of diagnosis and treatment, 

and to aid in the development of the Center for the Advanced 

Study of Brain Injury (CASBI) at Weill Cornell Medical College and 

The Rockefeller University Hospital. 

Principal Investigator: J. J. Fins, MD 

Funding: The Buster Foundation 

Nephrology and Hypertension 

Biomolecular Markers for Safe Minimization of 

Immunosuppression 

The aim of this project is to investigate whether urinary cell/ 

peripheral blood cell/allograft mRNA/miRNA profiles are 

informative of clinical outcomes in renal allograft recipients 

randomized to a standard dose tacrolimus versus low dose 

tacrolimus regimen. 

Principal Investigator: M. Suthanthiran, MD 

Funding: NIH 

FoxP3 Regulatory Network mRNA Profiles and Human Renal 

Transplant Outcomes 

The central goal is to test the hypotheses that levels of mRNA 

for Foxp3 and levels of mRNAs for a mechanistically linked Foxp3 

regulatory gene network are predictive of post-transplant allograft 

function, acute rejection severity and outcome and chronic 

allograft nephropathy. 

Principal Investigator:: M. Suthanthiran, MD 

Funding: NIH 

Noninvasive Prediction and Prognostication of Acute 

Rejection with the Use of miRNA Profiles 

The overall objective of this study is to investigate the hypothesis 

that levels of urinary cell miRNAs, ascertained in urine specimens 

collected at the time of clinically indicated renal allograft biopsies: 

predict acute rejection severity and prognosticate the outcome of 

an episode of acute rejection. 


Funding: NIH 

Noninvasive Diagnosis of BKV Nephropathy 

The overall objective of this study is to develop a 

noninvasive diagnostic test that is predictive, diagnostic and 

prognostic of BK virus-associated nephropathy. 


Funding: NIH 

Renal Allograft Tolerance through Mixed Chimerism 

The objective of this study is to achieve transient mixed chimerism 

and induce tolerance of HLA-mismatched human renal allograft 

recipients. 


Funding: NIH 



Biomolecular Markers Predictive/Diagnostic of Renal 

Allograft Status 

The main objective of this study is to test the hypothesis that 

mRNA/miRNA expression patterns of intraoperative renal allograft 

biopsies are predictive of acute rejection and chronic allograft 

nephropathy. 


Funding: Qatar National Research Fund 

Clinical Trials in Organ Transplantation: Molecular Profiling 

and Immunomodulatory Intervention (CTOT-4) 

The aims of this project are to investigate whether systemic and/ 

or intragraft molecular profiles may be used to monitor immuneand 

inflammatory-mediated injury to the allograft in the setting of 

human solid organ transplantation. 

Principal Investigator: M. Suthanthiran, MD (Weill Cornell 

Molecular Core) 

Funding: NIH 

Clinical Trials in Organ Transplantation: Molecular Profiling 

and Immunomodulatory Intervention 

The overall objective of this study is to investigate whether 

circulating levels of miRNAs are diagnostic of: acute rejection of 

liver allografts and recurrent hepatitis C. 

Principal Investigator: M. Suthanthiran, MD (Weill Cornell 

Molecular Core) 

Funding: NIH 

Bypass Angioplasty Revascularization Investigation in Type 2 

Diabetes (BARI2D) 

In the Bari 2D trial, 2,368 patients with both T2DM and heart 

disease were randomly assigned to undergo either prompt 

revascularization with intensive medical therapy or intensive 

medical therapy alone and to undergo either insulin-sensitization or 

insulin-provision therapy. 

Principal Investigator (Weill Cornell Site): P. August, MD 

Funding: NIH 

MessengerRNA Profiling for the Diagnosis of Acute Rejection 

of Human Renal Allografts: A Validation Project 

The overall objective of this study is to evaluate the diagnostic 

utility of urinary and peripheral blood cell mRNA profiles for the 

noninvasive diagnosis of acute rejection of human renal allograft. 


Funding: Quest Diagnostics 

The Action to Control Cardiovascular Risk in Diabetes Study 

Group: Effects of Intensive Glucose Lowering in Type 2 

Diabetes 

In the ACCORD Study, 10,000 T2DM subjects were randomly 

assigned to an intensive regimen for glycemic control or standard 

therapy and followed by investigators for five years. 

Principal Investigator (Weill Cornell Site): P. August, MD 

Funding: NIH 

Targeting Inflammation Using Salsalate for Type 2 Diabetes 

Stage II (TNSAL –T2DM) 

The primary objective of this study is to determine whether 

salicylates represent a new pharmacological option for diabetes 

management. 

Co-Principal Investigator (Weill Cornell Site): P. August, MD 

Funding: NIH 

Nebivolol vs. Metoprolol: Comparative Effects on Fatigue 

and Quality of Life 

A frequently encountered side effect of beta-blockers is fatigue. 

Nebivolol, a new beta-blocker with vasodilating effects due to 

increased secretion of nitric oxide, appears less likely to cause side 

effects such as fatigue, impairment of glucose metabolism and 

sexual dysfunction. This study is a double-blind crossover trial of 

nebivolol versus metoprolol (the best-selling beta-blocker), eight 

weeks on each drug, with the end points of fatigue and treadmill 

time. 

Principal Investigator: S. J. Mann, MD 

Funding: Forest Research Institute 

Pulmonary and Critical Care Medicine 

Smoking-Mediated Up-Regulation of GAD 67 

Expression in the 

Human Airway Epithelium 

Up-regulation of airway epithelium expression of GAD 67 

may 

contribute to the increase in mucus production observed in 

association with cigarette smoking. In the context of these 

observations, it is a promising pharmacological target for inhibiting 

airway mucus overproduction. 

Principal Investigator: R. G. Crystal, MD 

Funding: NIH 

Cigarette Smoking Reprograms Apical Junctional Complex 

Molecular Architecture in the Human Airway Epithelium 

This study suggests that the overall apical junctional complex 

molecular architecture in the airway epithelium in COPD is 

reprogrammed in a smoking-dependent manner from its normal 

gene expression pattern essential for maintaining an appropriate 

barrier function toward a cancer-like molecular phenotype. 


Funding: NIH 

The Air-Liquid Interface and Use of Primary Cell Cultures Are 

Important to Recapitulate the Transcriptional Profile of In 

Vivo Airway Epithelia 

The air-liquid interface and use of primary cell cultures are 

important to recapitulate the transcriptional profile of in vivo 

airway epithelia. This study focuses on the high level of similarity 

between cells of tracheal and bronchial origin within and between 

different human donors, which suggests a very robust expression 

profile that is specific to airway. Use of primary cells for culture and 

the presence of an air-liquid interface play an important role in cell 

differentiation. These data also establish a baseline for comparing 

airway epithelia in health and disease. 


Funding: NIH 

Smoking-Induced Up-Regulation of AKR1B10 Expression in 

the Airway Epithelium of Healthy Individuals 

The up-regulation of AKR1B10 (an aldo-keto reductase that 

eliminates retinals) and its function in detoxification and the 

retinoic acid pathway are suggestive that it may play an early role 

in carcinogenesis. 

Principal Investigator: R. G. Crystal , MD 

Funding: NIH 

Threshold of Biologic Responses of the Small Airway 

Epithelium to Low Levels of Tobacco Smoke 

This study adds to the field that an analysis of the small airway 

epithelial transcriptome of individuals exposed to low-dose tobacco 

smoke versus those not exposed demonstrates biologic changes 

that are likely the earliest biologic abnormalities in the lung leading 

to lung disease. 


Funding: NIH and the Flight Attendant’s Medical Research Institute 

AAVrh.10-Mediated Genetic Delivery of Bevacizumab to the 

Pleura to Provide Local Anti-VEGF to Suppress Growth of 

Metastatic Lung Tumors 

Study to test that AAV-mediated genetic delivery of bevacizumab 

(humanized monoclonal anti-VEGF antibody, approved as a 

treatment for non-squamous, non-small cell lung cancer) to the 

pleura, to deliver locally to the lung, represents a novel alternative 

approach to conventional monoclonal antibody therapy for 

metastatic lung cancer. 


Funding: NIH 

Do Airway Epithelium Air-Liquid Cultures Represent the In 

Vivo Airway Epithelium Transcriptome? 

This study adds to the field that air-liquid interface cultures are 

useful tools to study the airway epithelium in vitro. 


Funding: NIH and The Starr Foundation/Starr Cancer Consortium 

Predictors of Oxidative Stress in Heart Failure Patients with 

Cheyne-Stokes Respiration 

Study of the role of increased levels of oxidative stress in patients 

with heart failure and Cheyne-Stokes respiration compared with 

healthy controls. 

Principal Investigator: A. C. Krieger, MD 

Funding: American Heart Association National Center and NIH 

Acoustic Rhinometry in Pediatric Sleep Apnea 

This study tests the difference between obstructive sleep apnea 

(OSA) and primary snoring groups during acoustic rhinometry 

measurements of the nasopharynx. Positional airway changes were 

previously reported in adults with OSA and further evaluation of 

the airway function in pediatric OSA is warranted. 

Principal Investigator: A. C. Krieger, MD 

Funding: NIH 

Prednisone, Azathioprine and N-Acetylcysteine: A Study 

That Evaluates Response in Idiopathic Pulmonary Fibrosis 

(PANTHER-IPF) 

The purpose of the PANTHER study is to determine how effective 

the drug N-acetylcysteine (NAC), alone and in combination with 

prednisone and azathioprine, is in preventing the loss of lung 

function in people with idiopathic pulmonary fibrosis (IPF). 

Principal Investigator: R. Kaner, MD 


Anticoagulant Effectiveness in Idiopathic Pulmonary Fibrosis 

(ACEIPF) 

This is a randomized, double-blind, placebo-controlled, multicenter 

study that will compare warfarin and placebo in subjects with 

idiopathic pulmonary fibrosis (IPF). 





Adenovirus Vectors Block Human Immunodeficiency Virus-1 

Replication in Human Alveolar Macrophages by Inhibition of 

the Long Terminal Repeat 

Study is based on our finding that Ad vectors are inhibitory to 

HIV-1 replication in human alveolar macrophages based, in part, on 

their ability to inhibit long terminal repeat-driven transcription. 


Funding: NIH and the Will Rogers Memorial Fund 

Mechanisms of Endothelial Cell Dysfunction in Sleep Apnea 

Sleep apnea is a common sleep disorder characterized by 

temporary stops in breathing during sleep and has been associated 

with the development of cardiovascular disease. This research will 

investigate potential mechanisms leading to the development of 

vascular problems in patients with sleep apnea. 

Principal Investigator: A.C. Krieger, MD, MPH 

Funding: NIH 

Sleep Bruxism and Central Sensitization in Myofascial 

Face Pain 

The purpose of this project is to evaluate the presence of sleeprelated 

bruxism in patients with myofascial face pain. Patients 

recruited for this study undergo a battery of tests to evaluate the 

potential underlying mechanism for their face pain under the 

guidance of the Project’s Principal Investigator (Karen Raphael, 

PhD), followed by an overnight sleep study to assess the presence 

of bruxism while qualifying and quantifying facial movements. 

Principal Investigator (Weill Cornell Site): 

A.C. Krieger, MD, MPH 

Funding: NIH 

Regulation of Vascular Thrombosis in Sleep Apnea 

This study investigates the presence of a specific genetic 

polymorphism in patients with sleep apnea as compared to 

healthy controls. This polymorphism causes the production of 

an alternative form of deaminase, which may alter patients’ 

susceptibility to developing vascular thrombosis. 

Principal Investigator: A.C. Krieger, MD, MPH 

Funding: Robert Wood Johnson Foundation 

Mechanism of aPL Antibody-induced Pregnancy Loss 

The major goals of this project are to determine which 

complement components and receptors are necessary or sufficient 

to mediate aPL antibody-induced placental injury, fetal loss and/or 

IUGR and to define the role of aPL antibody-mediated complement 

activation within the overall inflammatory cascade in order to 

identify complement-dependent versus complement-independent 

mechanisms. 

Principal Investigator: J. E. Salmon, MD 

Funding Agency: NIH/NIAID (RO1 AR 38889) 

(07/01/2007- 6/30/2011) 

Indirect Inhibition of Toll-Like Receptor and Type I Interferon 

Responses by ITAM-Coupled Receptors and Integrins 

An important function of immunoreceptor tyrosine-based 

activation motif (ITAM)-coupled receptors is cross-regulation 

of heterologous receptor signaling, but mechanisms of crossinhibition 

are poorly understood. 

Principal Investigator: L. B. Ivashkiv, MD 

Funding: NIH 

Phosphorylation of IRF4 by ROCK2 Regulates IL-17 and IL-21 

Production and the Development of Autoimmunity in Mice 

Deregulated production of IL-17 and IL-21 plays a key pathogenic 

role in many autoimmune disorders. A delineation of the 

mechanisms that underlie the inappropriate synthesis of IL-17 and 

IL-21 in autoimmune diseases can thus provide important insights 

into potential therapies for these disorders. We have shown that 

the serine-threonine kinase Rho-associated, coiled-coil-containing 

protein kinase 2 (ROCK2) becomes activated in mouse T cells under 

Th17 skewing conditions and phosphorylates interferon regulatory 

factor 4 (IRF4), a transcription factor that is absolutely required 

for the production of IL-17 and IL-21. Our findings uncovered a 

crucial link among ROCK2, IRF4 and the production of IL-17 and 

IL-21, supporting the idea that selective inhibition of ROCK2 could 

represent an important therapeutic regimen for the treatment of 

autoimmune disorders. 

Principal Investigator: A. Pernis, MD 

Funding: NIH 

Medical 

Education 

Rheumatology 

Predictors of Response to TNF Antagonist Therapy in 

Rheumatoid Arthritis 

Despite substantial clinical efficacy of tumor necrosis factor-a 

(TNF)-antagonist therapy in patients with rheumatoid arthritis (RA), 

some patients respond poorly to such agents. Since an interferon 

(IFN) signature is variably expressed among RA patients, the study 

is designed to investigate whether plasma type I IFN activity might 

predict response to TNF-antagonist therapy. 

Principal Investigator: M. K. Crow, MD 

Funding: NIH 

Predictors of Pregnancy Outcome in SLE and APS 

A prospective observational study of over 400 pregnant 

patients, enrolled at 6 major medical centers, grouped and 

analyzed according to the presence of aPL and preexisting SLE to 

provide insights into the mechanisms of complement-mediated 

inflammatory disorders and to suggest means to prevent, arrest, or 

modify these conditions. 

Principal Investigator: J. E. Salmon, MD 

Co-Investigator: M.D. Lockshin, MD 

Funding: NIH/NIAMS (12/01/2003-11/30/2012) 

WCIMA 

Small Changes and Lasting Effects (SCALE) Minority 

Investigator Research Supplement 

Examines the association between body image discrepancy, health 

risk knowledge of obesity, and success with weight loss in the 

SCALE trial parent grant. 

Principal Investigator: G. Winston, MD 


Integrating Transdisciplinary Education at Cornell/Hunter – 

ITEACH 

This collaboration between Weill Cornell Medical College and three 

Hunter College schools (Nursing, Public Health, and Social Work) 

proposes to design and institutionalize a program of integrated, 

interprofessional educational experiences that will provide medical 

students and nursing, public health, and social work students with 

new competencies in collaborative teamwork. This initiative will 

expose students of different disciplines to hospital and clinic-based 

care, community outreach, and interdisciplinary care in the home 

setting at a very early point in their training. 

Principal Investigators: C. Storey-Johnson, MD (Weill Cornell) 

and J. Griffin-Sobel, PhD, RN 

Funding: Josiah Macy, Jr. Foundation 

94 Department of Medicine Co-Chief, Dr. Devang Dave (2010); Dr. Lia Logio (Director, Internal Medicine Residency Program; Co-Chief, Dr. Won Kim (2010) Annual Report 2011 95

Residents and Fellows 

on the Move… 

Kunal Karia, MD, Resident 

When I reflect upon the journey of becoming an intern, I am reminded of Robert Frost’s “The Road 

Not Taken.” I started residency training in pathology but quickly realized my true passion resided in 

clinical medicine and made the unconventional move to switch residencies. I chose NYP-Weill Cornell 

because of its tremendous faculty, diverse patient population, unlimited array of research opportunities, 

and the camaraderie of the house staff. The Department of Medicine has surpassed my expectations 

with wonderful didactic conferences, clinical teaching, and support from program leadership to make 

changes the residents feel are important. I couldn’t have imagined a smoother transition, and though I 

took the road less traveled, choosing NYP-WC has made all the difference. 

Nikhil Kumta, MD, Resident 

I have been impressed with the commitment of the faculty to providing the highest quality of patient 

care and medical education. The volume of patients and diversity of diseases provide an enriched clinical 

experience that is unparalleled. Training here affords the opportunity to not only learn about the “bread 

and butter” of medicine, but allows exposure to more rare entities. I have been particularly impressed 

with the work ethic of my peers, who are equally devoted to patient care and education, yet still find time 

to conduct and present research at national conferences. The camaraderie among the residents 

is truly one of the strengths of the program. Living in New York City is simply amazing. 

No matter what your interests are, there is always something to do – sports, food, fashion, 

or the arts. Your precious free time is never wasted! 

(L) Dr. Kumta (R) Dr. Karia 

Patricia Myers-Gurevitch, MD, Resident 

When I interviewed for a position in Internal Medicine Residency, I was searching for a program that would offer me a well-rounded 

education, be intellectually stimulating as well as challenging, and give me the opportunity to provide care to a diverse patient 

population. I also wanted to become an integral part of the medical team that would give me autonomy to develop my unique style 

as a physician. I have found Weill Cornell to be the perfect match. I love the institution and have felt instantly comfortable here. 

We are given a balance of responsibility and autonomy throughout the training experience. The daily lectures and conferences are 

led by attending physicians who are leaders in their fields. My colleagues also contribute to the quality of education, each of them 

bringing with them varied educational and research experience. We complement one another. The residency program includes 

traditional and unique possibilities for inpatient and outpatient rotations, with options for both rural and international health 

electives. Many of us plan a rotation during our 3 rd year of residency at a medical facility associated with Weill Cornell in Eastern 

Africa. All this opportunity is provided to me, as I live in one of the greatest cities in the world! I have found Weill Cornell has 

offered me the building blocks necessary to succeed as I plan for a demanding fellowship in Nephrology. 


John Egan, MD, Resident 

As I advance in my training and evolve as a physician, I have found it helpful to stop and reflect on what 

values originally led me to pursue a career in medicine: love of humanity and pursuit of the truth. Every day 

I find these values are supported at Weill Cornell. The house staff and faculty are incredibly dedicated to the 

needs of our patients, and I have always been supported in making decisions I felt were in the best interest 

of my patient. There is a true commitment to medical education and advancing research. Whether it be on 

attending rounds, at noon conference, or just running a case by a fellow resident, there is always something 

new to learn. House staff research is also strongly supported and encouraged. I have been fortunate enough 

to work with two different attendings on projects I contributed to, even as a busy resident. 

Annie Garment, MD, Assistant Chief Resident Primary Care 

I originally applied for and matched in Weill Cornell’s “categorical” medicine residency, a traditional program 

focused on hospital medicine. But by the end of my intern year, having spent two months in the outpatient setting, 

I transferred into the Primary Care Track to focus my training on ambulatory care. Inspired by the academic rigor and 

compassionate care demonstrated by so many of our outpatient attending physicians, I have subsequently had the 

great fortune to work with them as a trainee and an Assistant Chief Resident. None of us knows exactly what primary 

care in America will look like in the years to come. We do know that being a primary care provider will mean much 

more than serving as a gatekeeper. It will require practicing true evidence-based medicine, considering a vast array of 

socioeconomic factors in caring for individuals, and realizing how our decision-making patterns will affect society as 

a whole. My outpatient training experience has motivated me to pursue a career as a primary care clinician educator 

and has prepared me for taking on whatever the future may bring for primary care in America. 


Joseph Marmora, MD, Resident 

There are obvious reasons for pursuing residency training at Weill Cornell. The bustling hospital 

is a leader in our nation’s largest city; the training experience is unique and challenging; the 

accomplished staff offers a first-rate medical education; and world-class resources facilitate 

the finest care a patient could receive. Then there is the reason that is more subtle, but most 

compelling: there are simply good people here. Talented people, compassionate people, 

dedicated people who drive me to become better, who have taught me that above all else is 

the patient. It is something I uncovered at my initial interview here, and it is the primary reason 

I sought a spot in the program. I am frankly awed by what my predecessors and peers have 

created and continue to create here. 

Paula Roy-Burman, MD, Resident 

As we adjust our lenses to reflect upon our own national health care system, we also shift focus to transcend 

national borders and consider populations on a global scale. With increasing successes in maternal-fetal health 

and infectious disease, life expectancies in the third world are extending. Strategizing how we can create 

reliable avenues of health care in the third world is where my professional interest falls. Cornell University and 

WCMC were early adopters in the field of Global Health. I was initially drawn to the NYP-WCMC Medicine 

program for the breadth of structured opportunity offered in the nations of Brazil, Haiti and Tanzania in 

addition to scholarships available to pursue non-affiliated projects. I recall once coming upon a young refugee 

at the Thai-Burmese border. She had a red rash bridging across her nose and involving both cheeks. The team 

of medics, well-versed in landmine wounds, malaria and tuberculosis, were perplexed -- was it cellulitis? As it 

turned out, it was lupus. I look forward to a time when non-infectious diseases, be it coronary artery disease or 

diabetes, can be managed despite geographic limitations. 


Jonathan Gordin, MD, Resident 

As a medical student at the Weill Cornell Medical College, 

I was excited at the prospect of a residency in the Internal 

Medicine program, and the past six months have not 

disappointed. The most striking aspect has been the 

atmosphere of collegiality and teamwork. Rounds focus 

on the combined goals of excellent clinical education and 

unparalleled patient care. The extended multidisciplinary 

team helps facilitate the complex management of healthcare 

beyond that of mere diagnosis and treatment. Our program 

leaders have continuously reached out to the house staff 

on both the informal and formal levels for comments and 

feedback, and they have implemented suggested changes for 

the better. Our program encourages us to follow through on 

our research interests, gives us ample elective time in our first 

year, and provides us with the means to get connected with 

investigators – I was even able to present work at a major 

conference as an intern. 

Jyoti Mathad, MD, Fellow, Infectious Diseases 

I chose NYP-Weill Cornell’s Division of Infectious Diseases for my 

fellowship because of their long track record of groundbreaking 

work in such far-flung locations as Brazil, Tanzania, and Haiti. 

While I knew the hospital’s global research presence would set 

me on the right track for a career in international health, I’ve 

been particularly impressed by the broad exposure to rare and 

emerging diseases I’ve received during my clinical year here in 

New York City. I see a diverse patient population with diseases 

both typical and tropical, including several that most doctors 

only know from textbooks. Those experiences gave me the 

skills I needed to establish my own research project in India 

-- an endeavor that the department has supported tirelessly. 

Even when I’m 8,000 miles and ten time zones away, the 

faculty are always available and willing to offer their wisdom. 

The collaborative spirit I have experienced at NYP-Weill Cornell 

will be instrumental in forging my own career in international 

infectious diseases. 


2010 Graduate 

Medical Education 

Residency Training Program 

The NewYork-Presbyterian Hospital/Weill Cornell Internal 

Medicine Residency Program has a long-standing tradition of 

excellence in its commitment to training physician-leaders. 

The residency program’s 36-month curriculum provides rich 

opportunities to learn clinical medicine in both the inpatient 

and outpatient setting as well as an environment for academic 

scholarship. Our graduates are highly capable physicians 

whichever career trajectory they choose – clinical educator, 

physician-scientist or academic clinician. 

The faculty in the Department of Medicine provides teaching 

with an emphasis on bedside learning and evidence-based 

practice. The daily morning report is a favorite of the house 

staff, when they get to generate broad differential diagnoses 

or delve into the nuances of management issues for complex 

adult patients. The patient population is multicultural with a 

broad array of presentations of human disease that provide 

a phenomenal educational milieu for trainees. Both clinical 

and nonclinical rotations include unique features that support 

innovative research projects, mentorship by renowned 

investigators and interaction with expert faculty. Forty-three 

positions were filled in 2009–2010: four each in primary care 

and medical research, along with 35 categorical positions. 

Residents-in-training benefit from our strong affiliations 

with the three other premier institutions immediately adjacent 

to the hospital, creating one of the world’s great academic 

medical communities: Memorial Sloan-Kettering Cancer Center, 

the Hospital for Special Surgery and The Rockefeller University 

Hospital. Medical house staff rotate through the medical and 

neurological services at the NewYork-Presbyterian Hospital/Weill 

Cornell Medical Center, the preeminent rheumatology service at 

the Hospital for Special Surgery and various medical oncology 

services at Memorial Sloan-Kettering Cancer Center. These 

sites expose our residents to an extraordinarily diverse patient 

population in all areas of internal medicine. Though common 

diseases predominate, residents also encounter a wide range 

of rare and unusual clinical problems. All rotations emphasize 

independent, clinical decision-making, critical thinking and best 

practices. Innovations within the curriculum focus on patient 

safety, quality improvement, transition-of-care practices and 

teamwork training. 

Research and Global Health Opportunities 

Residents in the NewYork-Presbyterian Hospital (Weill Cornell 

Campus) Graduate Training Program have a unique opportunity 

to participate in ongoing research at some of the world’s foremost 

settings for academic medicine: Weill Cornell Medical College, 

The Rockefeller University, Memorial Sloan-Kettering Cancer 

Center and the Hospital for Special Surgery. This year, 20 to 

25 residents conducted research projects, 12 of which were 

submitted for the David E. Rogers Memorial Research Award. The 

recipient and finalists of this award present their work at Medical 

Grand Rounds. Senior residents are encouraged to do a rotation 

at Weill Bugando Medical Center in Tanzania. This is a challenging 

learning experience under the tutelage of full-time faculty 

from Weill Cornell Medical College. In addition, the Division of 

Infectious Diseases sponsors research electives in Brazil and Haiti, 

among other overseas locations. 

104 (Center) Department Dr. Erica Jones of Medicine with residents in training. Annual Report 2011 105

2010 Graduate Medical Education continued 

Current Residents 

Chief Residents 

Devang Dave, Tufts University SOM 

Won Kim, Weill Cornell Medical College 

Senior Residents (PGY3) 

Rini Abraham, New Jersey Medical School/UMDNJ 

Subhi AlAref, Weill Cornell Medical College, Qatar 

Kelly Axsom, Temple University SOM 

Oren Bernheim, Albert Einstein COM, Yeshiva University 

Sonica Bhatia, RW Johnson Medical School/UMDNJ 

Jill Blumenthal, Weill Cornell Medical College 

James Calloway, SUNY–Syracuse 

Delia Calo, SUNY–Stony Brook 

Marianne Camargo, New Jersey Medical School/UMDNJ 

Jonathan Clarke, Harvard Medical School 

Sean Collins, Weill Cornell Medical College 

Brian Cullingford, Georgetown University SOM 

Elan Diamond, Weill Cornell Medical College 

Brian Eiss, Georgetown University SOM 

Laura Fanucchi, Emory University SOM 

Ann Garment, New York University SOM 

Ari Grinspan, Albert Einstein COM, Yeshiva University 

Lindsay Lally, Weill Cornell Medical College 

Jean Lee, Albert Einstein COM, Yeshiva University 

Deborah Yvette Lim, Temple University SOM 

Julie MacPhee, Albert Einstein COM, Yeshiva University 

Kathleen Mahoney, University of Connecticut SOM 

Barbara Mendez, SUNY–Buffalo 

Lourdes Mendez, Albert Einstein COM, Yeshiva University 

Tshaka Muchiteni, University of North Carolina SOM 

Samantha Nazareth, Brown University SOM 

Marissa Newman, RW Johnson Medical School/UMDNJ 

Crystal North, University of Washington 

Alyssa Parian, New Jersey Medical School/UMDNJ 

Charlesse Pondt, New Jersey Medical School/UMDNJ 

Lhasa Ray, Albert Einstein COM, Yeshiva University 

Gabrie Rebick, McGill University Faculty of Medicine, Canada 

Elizabeth Schulman, SUNY–Stony Brook 

Ummara Shah, University of Rochester School of Medicine 

and Dentistry 

Albert Shieh, Weill Cornell Medical College 

Magdalena Slosar, University of Massachusetts Medical School 

Aaron Small, Mayo Medical School 

Kakra Soadwa, University of Pittsburgh SOM 

Sasha Stanton, Albert Einstein COM, Yeshiva University 

Raja Taunk, New Jersey Medical School/UMDNJ 

Florian Toegel, University of Hamburg, Germany 

Amy Tyberg, New York Medical College 

Jacqueline Yuen, University of Michigan Medical School 

Benjamin Zaniello, University of Kentucky COM 

Junior Residents (PGY2) 

Melissa Accordino, Penn State COM 

Jose Aleman, Harvard Medical School 

John Allan, Saint Louis University SOM 

Brian Anderson, The George Washington University SOMHS 

Medha Barbhaiya, Weill Cornell Medical College 

Nisha Bavalia, RW Johnson Medical School/UMDNJ 

Samantha Brenner, New York University SOM 

Scott Cameron, SUNY–Syracuse 

Sean Campbell, Albert Einstein COM, Yeshiva University 

Liesl Carey, Drexel University COM 

Andrew Cohen, University of Pennsylvania SOM 

Samantha Dias, New York Medical College 

John Egan, The George Washington University SOMHS 

Obinna Eneanya, RW Johnson Medical School/UMDNJ 

Jarett Feldman, The George Washington University SOMHS 

Viviana Figueroa Diaz, Boston University SOM 

James Flory, University of Pennsylvania SOM 

Peter Forsberg, University of Colorado SOM 

Swathi Gopalakrishnan, SUNY–Buffalo 

Scott Greenberg, University of Colorado SOM 

Poonam Hosamani, Feinberg SOM, Northwestern University 

Andrew Intlekofer, University of Pennsylvania SOM 

Flonza Isovski, New York University SOM 

Connie Jung, University of Illinois COM 

Nikhil Kumta, Jefferson Medical College, Thomas Jefferson University 

Tara Lautenslager, RW Johnson Medical School/UMDNJ 

Chung Han (Joe) Lee, University of Michigan Medical School 

Daneng Li, Weill Cornell Medical College 

Eugene Licht, Weill Cornell Medical College 

Susanne Luedtke, Humboldt University, Germany 

Lauren Maragh, Case Western Reserve University SOM 

Ashley Maranino, Albert Einstein COM, Yeshiva University 

Mamta Mehta, SUNY Downstate Medical Center 

Neha Mehta, Feinberg SOM, Northwestern University 

Patricia Myers-Gurevitch, Wayne State University SOM 

Shaji Philip, Jefferson Medical College, Thomas Jefferson University 

Ravin Ratan, Tufts University SOM 

Farid Razavi, New York Medical College 

Paula Roy-Burman, Keck SOM, University of Southern California 

Geethan Sivananthan, New Jersey Medical School/UMDNJ 

Aaron Viny, Case Western Reserve University SOM 

Ethan Weinberg, University of Maryland SOM 

Joshua Weisbrot, Albany Medical College 

Melanie Zuo, The University of Texas Medical School at Houston 

Interns (PGY1) 

Daniel Amoruso, New Jersey Medical School/UMDNJ 

Muhamed Baljevic, Weill Cornell Medical College, Qatar 

Karl Bezak, Vanderbilt University SOM 

Dara Bier, Albert Einstein COM, Yeshiva University 

Isaac Bowman, University of Texas Southwestern Medical School 

Natalie Cheng, University of Rochester SOMD 

Augustine Chung, Case Western Reserve University SOM 

Robert Daly, Harvard Medical School 

Anthony Daniyan, Miller SOM, University of Miami 

Mark Diamond, Washington University SOM in St. Louis 

David Fernandez, SUNY – Syracuse 

Timothy Ferng, Wayne State University SOM 

Eugene Festa, New Jersey Medical School/UMDNJ 

Jessica Furst, Albert Einstein COM, Yeshiva University 

Jacob Glass, Albert Einstein COM, Yeshiva University 

Timothy Glew, Tulane University SOM 

Jonathan Gordin, Weill Cornell Medical College 

Parag Goyal, University of Massachusetts Medical School 

Elizabeth Greig, Miller SOM, University of Miami 

Leon Igel, Albert Einstein COM, Yeshiva University 

Kunal Karia, Virginia Commonwealth University SOM 

Scott Kramer, Weill Cornell Medical College 

Joseph Krepp, SUNY–Stony Brook 

Dr. Emil Kuriakose (fellow) 

Michael Lerario, University of Pennsylvania SOM 

Andrea Li, Vanderbilt University SOM 

Frank Lin, Albany Medical College 

Lenette Lu, Case Western Reserve University SOM 

Carolina Maciel, Fluminense Federal University, Brazil 

Justin Marcus, Miller SOM, University of Miami 

Sharayne Mark, University of Rochester SOMD 

Joseph Marmora, Stritch SOM, Loyola University Chicago 

Alexander Merkler, New York University SOM 

John Morris, University of Maryland SOM 

Michael Mulock, Jefferson Medical College, Thomas Jefferson University 

Karla Nieves, University of Puerto Rico SOM 

Olanma Okoji, The George Washington University SOMHS 

Vikram Palanivel, University of Pennsylvania SOM 

Chiti Parikh, RW Johnson Medical School/UMDNJ 

Stephen Rotman, New York Medical College 

Kira Ryskina, Mount Sinai Medical Center, New York University 

Rachel Sanford, Harvard Medical School 

Lourdes Sanso, New York University SOM 

Maryam Shafaee, Weill Cornell Medical College, Qatar 

Stephanie Tang, Feinberg SOM, Northwestern University 

Louis Waldman, University of Pennsylvania SOM 

Frances West, Jefferson Medical College, Thomas Jefferson University 

Casey Wong, Weill Cornell Medical College 

Micheas Zemedkun, Harvard Medical School 

Class of 2011 

Subspecialty Fellowship Appointments 

Cardiology 

Kelly Axsom 

New York University, New York, NY 

Scott Cameron* 

University of Rochester Medical Center, Rochester, NY 

Jonathan Clarke 

Massachusetts General Hospital, Boston, MA 

Tshaka Muchiteni 

Montefiore Medical Center, Bronx, NY 

Endocrinology 

Jose Aleman* 


James Flory* 



Rini Abraham 


Oren Bernheim 

Mount Sinai Medical Center, New York, NY 

Delia Calo 

Memorial Sloan-Kettering Cancer Center, New York, NY 

Ari Grinspan 

Mount Sinai Medical Center, New York, NY 

Alyssa Parian 

The Johns Hopkins Hospital, Baltimore, MD 

Aaron Small 

University of Pennsylvania, Philadelphia, PA 

Raja Taunk 

Lenox Hill Hospital, New York, NY 

Amy Tyberg 

Westchester Medical Center, Valhalla, NY 

Ethan Weinberg* 


Hematology and Medical Oncology 

Andrew Intlekofer* 


Jean Lee 


Joe Lee* 


Kathleen Mahoney 

Beth Israel Deaconess Medical Center, Boston, MA 

Lourdes Mendez 

Beth Israel Deaconess Medical Center, Boston, MA 

Charlesse Pondt 


Sasha Stanton 

University of Washington Medical Center, Seattle, WA 



Infectious Disease 

Jill Blumenthal 

University of California, San Diego Medical Center, San Diego, CA 

Gabriel Rebick 

University of Toronto, Toronto, Canada 

Magdalena Slosar 


Ben Zaniello 

University of Washington Medical Center, Seattle, WA 

Rheumatology 

Lindsay Lally 

Hospital for Special Surgery, New York, NY 

Barbara Mendez 


*Medical Research Track 

Fellowships 

The Department of Medicine offers a variety of fellowship training 

opportunities in each of our divisions. All of our fellowships 

emphasize clinical and research training. These programs provide 

a challenging educational experience under the supervision and 

guidance of noted experts in their fields and demonstrate our 

commitment to ensuring that our physicians-in-training emerge 

as tomorrow’s leaders in their chosen fields. 

Cardiology 

Under the auspices of the Maurice R. and Corinne P. Greenberg 

Division of Cardiology, this three- or four-year program prepares 

highly qualified candidates for careers in investigative and clinical 

cardiology. Fellows receive comprehensive experience in all major 

clinical and laboratory aspects of contemporary cardiology under 

the close supervision of full-time staff. Each fellow is expected to 

participate in one or more areas of ongoing research during their 

training. Clinical care is the focus of the first two years, while 

the third and fourth years involve a more intensive, mentored 

experience in a particular clinical subspecialty or in basic research. 

An additional year (or more) of training/research in a subspecialty 

area can be arranged, as indicated/appropriate. 

Program Director: Erica C. Jones, MD 

Program Coordinator: Lisa Brooks, (212) 746-2218 

Duration of Training: 3 years 

Number of Positions: 19 

2010–2011 Fellows 

George Bell, MD 

The University of Chicago Hospital 

Seth Bender, MD 

NewYork-Presbyterian Hospital (Weill Cornell Campus) 

Ryan Broderick, MD 

Brigham and Women’s Hospital 

Konstantinos Charitakis, MD 

NewYork-Presbyterian Hospital (Weill Cornell Campus); Venizeleion 

Hospital, Greece 

Abiola Dele-Michael, MD, MPH 

University of Michigan Hospital 

James Horowitz, MD 


Albert Jung, MD, PhD 


Arvindh Kanagasundram, MD 

Stanford University Hospital 

Maria Karas, MD 


Helina Kassahun, MD 

The Johns Hopkins Hospital 

Joseph Lee, MD 


Alex Mauskop, MD 


Danielle Nicolo, MD, PhD 

Temple University Hospital 

Lynn Punnoose, MD 


Lisa Rosenbaum, MD 

Massachusetts General Hospital 

Ashish Shah, MD 

NewYork-Presbyterian Hospital (Columbia Campus) 

Rajesh Swaminathan, MD 


Sean Wilson, MD 

Harvard University/Winthrop University Hospital 

David Yang, MD 


Cardiology Brooklyn Program 

Program Director: Frank Iacovone, Jr., MD 

Program Coordinator: Julie Quinonex, (718) 250-6952 

2010–2011 Fellows 

Brooklyn Hospital Center: 

Amgad Botros 

Samir Garyali 

Sameer Kaul 

Praveen Kormerla 

Chirag Patel 

Mohammad Ansari 

Beth Israel Medical Center 

Clinical Cardiac Electrophysiology (CCEP) 

This fellowship within the Maurice R. and Corinne P. Greenberg 

Division of Cardiology provides advanced training in all aspects 

of invasive electrophysiology. Fellows attain expertise in catheter 

ablation of complex arrhythmias, including atrial fibrillation 

and ventricular tachycardias, as well as device implantation and 

management, with an emphasis on implantable defibrillators and 

cardiac resynchronization. The core of the fellowship consists of 

(2nd from L) Clinical Co-Director (WCCC), Daniel Belkin, MD (Class of 2012) 




rotations in the Invasive Electrophysiology Laboratory, but fellows 

also rotate through the device clinic and inpatient and outpatient 

consultations. Fellows also participate in the ongoing basic and 

clinical research programs conducted within the electrophysiology 

laboratory. 

Program Director: Steven Markowitz, MD 


Duration of Training: 1 year 


are actively involved in shaping their education, gain hands-on 

experience teaching residents and medical students and receive 

individualized instruction from nationally renowned clinicians and 

researchers. As appropriate, fellows may continue their training 

with an optional third year devoted to further research. 

Program Director: David Brillon, MD 

Program Coordinator: Helen Carey, (212) 746-9939 



2010–2011 Fellows 

Jeffrey Chung, MD 


James Ip, MD 


Seth Lessner, MD 

Yale New Haven Hospital 

Interventional Cardiology 

A one-year advanced training fellowship in all aspects of 

interventional cardiology is also available through the Maurice R. 

and Corinne P. Greenberg Division of Cardiology. The program 

emphasizes a systematic, evidence-based approach to diagnostic 

and therapeutic coronary procedures, and enables fellows to 

develop expertise in pre- and postprocedural patient care in 

both inpatient and outpatient settings. Fellows are trained to 

perform percutaneous coronary interventions using state-of-theart 

technologies, and are expected to participate in active clinical 

research efforts. 

Program Director: Robert Minutello, MD 


Duration of Training: 1 year 


2010–2011 Fellows 

Babak Hassid, MD 

North Shore University Hospital 

Luke Kim, MD 


Apurva Motivala, MD 

Sinai-Grace Hospital, Wayne State University 

Endocrinology, Diabetes and Metabolism 

This program is a comprehensive two-year training program 

that provides unique, in-depth clinical and academic experience 

in the field of endocrinology. Endocrine fellows receive a wide 

range of didactic instruction and clinical training in the inpatient 

and ambulatory facilities of three premier medical institutions: 

NewYork-Presbyterian Hospital, Memorial Sloan-Kettering Cancer 

Center and the Hospital for Special Surgery. The first year of the 

fellowship focuses on intensive clinical training, while the second 

year emphasizes clinical, translational or basic research. Fellows 

2010–2011 Fellows 

Peter Dahl, MD 

North Shore University Hospital, NYU School of Medicine 

Jonathan Hugo, MD 

Barnes-Jewish Hospital, Washington University School of Medicine, 

St. Louis 

Rekha Kumar, MD 


Vivien Leung, MD 

Montefiore Medical Center 

Gastroenterology and Hepatology 

This three-year program attracts some of the best and brightest 

trainees who are interested in pursuing a career in academic 

gastroenterology and hepatology. Currently, two fellows are 

accepted into the program annually. The first year is largely 

consultative, and fellows maintain a weekly ambulatory patient 

practice. Second-year fellows are expected to be involved in basic 

or clinical research. Third-year fellows continue the research projects 

developed in their second year, and have an opportunity to pursue 

specific areas of interest in inflammatory bowel disease, hepatology, 

liver transplantation and cancer screening and prevention. Over the 

course of their training, fellows generally perform more than 600 

upper endoscopies, 300 colonoscopies and a significant number 

of EUSs (endoscopic ultrasound) and ERCPs (endoscopic retrograde 

cholangio pancratography). 

Program Director: Brian Bosworth, MD 

Program Coordinator: Ming Su, (646) 962-4700 



2010–2011 Fellows 

Richard Blatt, MD 

Emory University School of Medicine 

Arun Jesudian, MD 


AnnMarie Liapakis, MD 

Mount Sinai Medical Center 

Yasmin Metz, MD 


Manan Shah, MD 

Beth Israel Deaconess Medical Center 

Subha Sundararajan, MD 


Geriatric Medicine 

This comprehensive fellowship program integrates outstanding, 

nationally recognized academic and clinical resources with the 

goal of training future clinical and academic leaders in geriatric 

medicine. Clinical training occurs in all appropriate geriatric 

settings: acute hospitals, long-term care facilities, patients’ homes, 

hospices, continuing care communities and ambulatory clinics. The 

second year of training focuses on completing an independent 

research project. Fellows can participate in a third year of training 

as clinician-researchers or clinician-educators through our Hartford 

Center of Excellence. One-year fellowship positions also become 

available from time to time for those unable to do the second year. 

Board certification can be obtained after completing a one-year 

fellowship. 

Program Director: Barrie Raik, MD 

Program Coordinator: David Aronson, (212) 746-3539 


Number of Positions: 2 each year, total 4 

Ne Win, MD 

Memorial University Medical Center 

Patricia Wu, MD 

Saint Luke’s-Roosevelt Hospital Center 

Health Services Research 

Dr. James Hollenberg (L) with 

fellow in training. 

The goal of the T32 fellowship training program funded by the 

Agency for Healthcare Research and Quality is to train postresidency 

physicians to conduct interdisciplinary health services research. 

The objective is to train new physician-investigators to become 

independent researchers, using methodologically rigorous 

approaches to meet emerging health services research priorities: 

specifically, improving the effectiveness and outcomes of clinical 

practice, improving our ability to provide high-quality, cost-effective 

care and assessing the effectiveness of health systems changes 

on outcomes, quality, cost and access to healthcare. The program 

emphasizes theoretical, methodological and practice foundations in 

health services research, clinical research and behavioral sciences to 

enable physician-investigators to conduct research that will improve 

practice. A special emphasis of the program is to train researchers 

from diverse backgrounds so that they will have the skills to address 

the health problems and challenges faced by minority populations 

in our unique urban environment. Graduates from our program are 

principal or co-principal investigators on 110 grants totaling more 

than $47 million. 

2010–2011 Fellows 

Program Director: Mary E. Charlson, MD 

Administrator of Educational Programs: Alison Kenny, 

Melissa Rosen, MD 

Lina Fellizar, MD 

(212) 746-1608 


Saint Peter’s University Hospital 


Tzivia Moreen, MD 

Number of Positions: Number varies 




2010–11 Fellows 

Jennifer Downs, MD 

Columbia University College of Physicians and Surgeons 

Regina Jacob, MD 

Temple University Hospital 

Lisa Moreno, MD 

Schneider Children’s Hospital 

Kristine Olson, MD 

Yale University School of Medicine 

Mihir Patel, MD 

Jefferson Medical College, Thomas Jefferson University 

Stephen Williams, MD 



This three-year fellowship consistently attracts outstanding 

fellows from a large national pool. A majority of the first year 

is spent on monthly rotations at various clinical services of the 

NewYork-Presbyterian Hospital/Weill Cornell Medical Center. 

The second year consists mostly of supervised laboratory and/ 

or clinical research. The third year allows fellows to consolidate 

their educational experiences in diagnosis and management 

of hematologic/neoplastic disorders, and to continue research 

training. 

Program Director: Ronald Scheff, MD 

Program Coordinator: Karen Goldfarb, (212) 746-2061 



2010–2011 Fellows 

Paul Basciano, MD 


Himisha Beltran, MD 

Hospital of the University of Pennsylvania 

Karen-Sue Carlson, MD, PhD 


John Chapin, MD 


Francine Garrett-Bakelman, MD, PhD 


Sarika Jain, MD 

University of Michigan Health System 

Christopher Keir, MD 

Tufts New England Medical Center 

Emil Kuriakose, MD 

University of Texas Southwestern Medical Center at Dallas 

Ewelina Morawa, MD 

Advocate Lutheran General Hospital 

Adriana Rossi, MD 

Thomas Jefferson University Hospital 

Ashish Saxena, MD/PhD 


Yazl Zack, MD 



Designed to foster clinical and academic excellence, this fellowship 

program provides individualized training through faculty guidance, 

clinical rotations, mentored research and didactic course work. 

Graduates of the program are highly qualified for the practice of 

infectious diseases medicine, bench and clinical research, and for 

leadership roles in medicine. The minimum fellowship duration is 

two years (ACGME-required); however, most fellows complete three 

years of training. Inpatient and ambulatory care are emphasized 

during the first year. The second and third years of fellowship 

emphasize clinical and basic laboratory research both at home 

and abroad in Haiti, Brazil, Ghana and Tanzania. In addition, 

fellows have the opportunity to pursue master’s degrees in clinical 

epidemiology and clinical investigation at Weill Cornell. 

Program Director: Kristen Marks, MD 

Program Coordinator: Leyla Pistone, (212) 746-7587 



2010–2011 Fellows 

Kathryn Dupnik, MD 


Samantha Jacobs, MD 


Jyoti Mathad, MD 

University of Maryland Medical Center 

Daniel Shirley, MD 

University of Colorado Health Sciences Center 

Matthew Simon, MD 



Nephrology and Hypertension fellows receive clinical training to 

treat patients with complicated acid-base and fluid and electrolyte 

problems, hypertension, acute and chronic kidney diseases and 

renal failure requiring replacement therapy with dialysis and 

kidney transplantation. Our fellows benefit from the vast clinical 

and research resources of NewYork-Presbyterian Hospital, Weill 

Cornell Medical College, Rogosin Kidney Center and Memorial 

Sloan-Kettering Cancer Center. Fellows undertake a minimum of six 

months of dedicated elective time in clinical or bench research. 

Program Director: Phyllis August, MD 

Program Coordinator: Frances Gillen, (212) 746-0822 




Minhson Bui, MD 


Stanley Crittenden, MD 

The University of Chicago Medical Center 

David Epstein, MD 

Rhodes Island Hospital/Miriam Hospital/Brown University 

Medical School 

Sumie Iwasaki, MD 


John Lee, MD 


Neil Manek, MD 


Pallavi Patri, MD 


Sharad Sathyan, MD 

University of Connecticut Health Center 

Pulmonary and Critical Care Medicine 

This three-year training program offers a structured curriculum 

encompassing rotations in the medical and surgical intensive 

care units, as well as the opportunity to care for inpatients and 

outpatients under the supervision of the division’s renowned 

clinical faculty. All fellows participate in 18 months of clinical or 

bench research in ongoing studies that include gene therapy for a 

variety of human diseases such as cystic fibrosis, lung cancer and 

cardiovascular disease. 

Program Director: Ronald G. Crystal, MD 

Program Coordinator: Diane Hawkins, (212) 746-2908 




Anees F. Afroze, MBBS 

University of Oklahoma Medical Center 

Brendan Carolan, MBBch 

Mater Miseriocordiae University Hospital 

Sanjay Dhar, MBBS 

Lincoln Medical and Mental Health Center/Mount Sinai Medical 

Center 

Mary E. Harris, MD 


Ibrahim M. Hassan, MD 


Justina M. Hessel, MD 


David H. Kung, MD 

Yale-New Haven Hospital 

Lindsay Lief, MD 


Nida Qadir, MD 

NYU School of Medicine 

Kapil K. Rajwani, MD 


Eugene Shostak, MD 

Lahey Clinic Medical Center 

Rheumatology 

The Hospital for Special Surgery (HSS) rheumatology fellowship 

combines broad-based, in-depth clinical and research experiences 

to deliver superb training to medical professionals. The clinical 

experience focuses on outpatient rheumatology clinics and 

inpatient Rheumatic Disease Unit (HSS), and inpatientconsultative 

services at NewYork-Presbyterian Hospital and Memorial Sloan- 

Kettering Cancer Center. In addition, fellows have access to clinics 

in office-based orthopedics and other musculoskeletal areas 

(osteoporosis, neuromuscular disease, radiology and rehabilitation). 

They also participate in divisional research advancing knowledge in 

the basic and clinical sciences. 

Program Director: Anne R. Bass, MD 

Program Coordinator: Janine Fernandez, (212) 774-2189 




Elana Bernstein, MD 


Soumya Chakravarty, MD, PhD 


Lindsy Forbess, MD 


Beverly Johnson, MD 


Susan Kim, MD 


Alana Levine, MD 

Selin Somersan, MD 

Igor Z. Barjaktarevic, MD, MSc 



Cabrini Medical Center (Mount Sinai SOM/New York University) 


Educational Opportunities 

in Global Health 

The Center for Globwal Health has long-standing research and training programs in Brazil, Haiti and Tanzania. 

In 2010, more than 70 students, residents and faculty members participated in programs at one of these 

Weill Cornell sites. Participants have an extraordinary opportunity to work with an outstanding cadre of 

international investigators, deepening their knowledge of medicine from a global perspective. 

Haiti 

Nearly 30 years ago, a team from Weill Cornell 

was instrumental in the formation of GHESKIO: 

Groupe Haitien d’Etude du Sarcome de Kaposi et 

des Infections Opportunistes (the Haitian Group for 

the Study of Kaposi’s Sarcoma and Opportunistic 

Infections). Significant support from the National 

Institutes of Health has enabled Weill Cornell and 

GHESKIO to produce more than 100 publications, 

including the first detailed description of AIDS in 

a developing country (The New England Journal 

of Medicine, 1983). In addition to the established 

AIDS program, Weill Cornell-GHESKIO provides 

STD and tuberculosis screening and treatment, 

as well as family planning, health education and 

counseling programs to more than 125,000 people 

each year. Weill Cornell-GHESKIO also conducts 

NIH-sponsored clinical trials for HIV vaccines and 

antiretroviral therapy. The success of this program is 

due in large measure to the leadership of Dr. Jean 

W. Pape, Professor of Medicine, and Dr. Warren 

D. Johnson, Jr., the B.H. Kean Professor of Tropical 

Medicine. In 2010, The GHESKIO Center won 

the Gates Award for Global Health as the most 

outstanding global health institution in the world. 

Brazil 

This year marks the 47th anniversary of the 

collaboration between Cornell University and the 

Federal University of Bahia. Still growing after four 

decades, with partners in Natal, Fortaleza, Rio and 

the Fiocruz, the Cornell-Bahia program may be the 

longest-running collaboration of its type in the world. 

To date, more than 20 Cornell faculty members and 

100 students and fellows have participated in the 

program, and more than 250 peer-reviewed journal 

articles have emerged from its research. The program 

has been funded by The Commonwealth Fund and 

The Rockefeller Foundation, and since 1979, by 

the NIH. Current NIH funding supports the Tropical 

Medicine Research Center and a leptospirosis research 

program in Salvador, Brazil. 

(L to R): Dr. Susan Briggs (Massachusetts 

General Hospital), Dr. Pape, Lt. Mullen, 

Dr. Deschamps 

Tanzania 

Weill Cornell Medical College and NewYork- 

Presbyterian Hospital established a formal affiliation 

with Bugando in 2006 with support from Dean 

Antonio M. Gotto, Jr. and the Touch Foundation. 

Dr. Robert Peck is currently based in Tanzania to 

coordinate the educational exchange. Physicians 

from Weill Cornell provide hands-on training on 

the wards, while Tanzanian residents and faculty 

have the opportunity to train in New York. Faculty 

from both institutions work together on curriculum 

development. In 2010, 54 Weill Cornell clinical 

residents and faculty visited Bugando to teach in 

anatomy, internal medicine, neurology, obstetrics and 

gynecology, ophthalmology, pediatrics, physiology, 

psychiatry and surgery. Father Peter Le Jacq, MD, 

an alumnus of Weill Cornell and a Maryknoll priest, 

worked in Mwanza, Tanzania, between 1987 and 

1997 and helped to found the medical college at 

Bugando Medical Center. BMC is an 850-bed tertiarycare 

hospital serving a population of 12 million. 

The GHESKIO Center 

won the Gates Award 

for Global Health 

as the most outstanding 

global health institution 

in the world. 


Training in Tanzania: 

A Transforming Experience 

for Medical Students and Residents 

The art and science of practicing medicine in a resource-limited country presents unique challenges, 

not the least of which is witnessing death and dying on a regular basis. “We have a 20% inpatient 

mortality rate at Bugando Medical Center (BMC), and I think, by far, that this is the hardest part for 

medical students and residents to deal with during their training experience,” says Dr. Robert N. Peck. 

“The number one phrase I hear from medical students about their training at Bugando is: This has 

been a transforming, life-changing experience.” 

“It’s a shock for students to come to a place like 

this where they will see death on a day-to-day basis, 

where people die of what could be preventable 

disease. It is shocking and it should be shocking. 

It should be shocking because it is something that 

should not occur in this world. But I always tell them, 

this is part of the learning experience; this is part of 

understanding medicine in Africa. The hope is that 

it will motivate them to try to do something about it 

– to try to make a difference.” 

As a medical student at Vanderbilt University, 

Dr. Peck made two separate visits to Haiti working 

on an HIV research project with Dr. Dan Fitzgerald 

at GHESKIO (Port-au-Prince) as well as another 

project involving an anthrax outbreak in the 

Artibonite Valley. During these medical school 

rotations, he met Drs. Warren Johnson, Jean Pape, 

and Dan Fitzgerald. By 2006, Drs. Johnson and 

Fitzgerald invited Dr. Peck to join them in Tanzania 

where, together, they would forge a new vision – 

to create a bona fide medical school at Bugando. 

“It all started with Fr. Doctor Peter LeJacq and the 

Touch Foundation as part of a larger fundraising 

effort,” explains Dr. Peck. “A growing number of 

medical students in Bugando needed faculty support 

and assistance with developing a curriculum. They 

went to Father LeJacq and asked if he could help 

them get Weill Cornell involved.” 

Dr. Peck and his wife, Elizabeth, a nurse 

practitioner, visited Tanzania and “fell in love with the 

place.” In 2007, they packed their bags, along and, 

along with their two children, moved to Tanzania. 

Since then, they have had another child, a daughter 

named Amani, meaning “peace” in Swahili. 

Dr. Peck arrived in Tanzania directly from completing 

his residency training at Massachusetts General 

Hospital, and set to work on two primary goals: one, 

to develop an outstanding curriculum to educate 

medical students and residents; two, to coordinate 

various collaborations for visiting residents, which 

numbered 30 to 40 per year, a large number 

even in the beginning years. Many wide-ranging 

interdepartmental collaborations exist at Bugando 

today, including neurosurgery, pediatrics, psychiatry, 

Dr. Robert Peck with his wife, 

Elizabeth, and children (L to 

R) Amani (baby), Jack (above), 

Bridget. 



Weill Bugando is affiliated 

with Bugando Medical 

Centre, a 900-bed referral 

hospital dedicated to 

providing compassionate 

and equitable patient care 

to alleviate suffering in the 

Mwanza region. 

ophthalmology, nephrology, radiology, nursing, and 

pharmacology. There is also a Master’s in Public 

Health program and training available in Problem 

Based Learning (Dr. Mary Charlson’s course in 

epidemiology). Over time, more funds were raised to 

ensure that Bugando residents and faculty can travel 

to Weill Cornell in New York City for rotations. 

A massively growing number of medical students 

Not only have programs and collaborations grown, 

but the number of Tanzanian medical students 

has increased exponentially. The stats speak for 

themselves. In 2004, there were 10 medical students 

in Bugando. By 2009, 145. “We are now part of 

a larger dynamic collaboration that I think could 

make Bugando one of the very best medical schools 

in East Africa,” says Dr. Peck. 

Crystal North, Resident - Medicine 

Dr. David Skorton, President of Cornell University, 

visited Bugando Medical Center for four days. 

“It was fantastic for the students,” Dr. Peck said. 

“Dr. Skorton visited with hospital administration, 

came on rounds, met with students and residents 

to get their feedback, and spent time working in 

the hospital. He realized that the students needed 

basic text books on medicine, so he made a personal 

donation to make sure that medical students have 

the basic text books they need.” 

As Dr. Peck points out, nothing replaces hands-on 

learning, and the students at Bugando are learning 

from a plethora of divergent patient cases. A referral 

hospital for the entire western third of Tanzania, 

some 12 million people, Bugando receives many 

patients through its emergency room who are 

then admitted to wards consisting of 900 beds. 

In medicine alone, there is an average of 400 

admissions per month, the most common diagnosis 

being HIV-AIDS. Dr. Peck lists the other most common 

diagnoses in descending order: malaria; hypertension 

(e.g. stroke and heart disease); heart failure; and 

schistosomiasis (a waterborne disease). 

“Our medical students are seeing a very wide 

range of problems – including the diseases of the 

West. They need to know everything. As well as 

learning about all tropical diseases and diseases that 

we think of as being poverty-related diseases, they 

are seeing diseases of the West such as hypertension, 

stroke, diabetes, cardiovascular disease, and obesity. 

These are becoming epidemic, especially in the cities. 

So we’re now seeing the ‘diseases of affluence’ 

moving into the cities.” 

For Dr. Peck, teaching at Bugando has brought 

an unexpected bonus. “What’s really interesting and 

fun for me is the reconnecting with patients. Before 

coming to Tanzania, typically I would work at my 

desk and enter information about the patient into 

my computer. But here I’m reminded that we’re more 

than medical clerks. I am interacting with patients 

at their bedside all the time. Despite the horrible 

deficits around them, in general, Tanzanians are kind, 

generous, good people. It’s a matter of seeing how 

the rest of the world lives and dies – which can be 

both tragic and inspiring.” 

Dr. Peck is a Lecturer, Weill Bugando University College of 

Health Sciences; a Consultant, Bugando Medical Center; and 

an Assistant Professor of Medicine and Assistant Professor of 

Pediatrics, WCMC. 

A large part of my decision to come to Weill Cornell for residency was an established connection with an 

international hospital. I anticipated my trip to Tanzania since I was an intern; the experience did not disappoint. 

The best piece of advice I received prior to leaving for Tanzania was to spend the first week simply standing back 

and observing. I was told to watch how the residents think about disease and management, how they work 

patients up, how they interact with one another and with the rest of the staff, how Dr. Peck interacts with the 

residents. Dr. Peck is an amazing example of what it means to completely immerse oneself in a different culture, 

working within the confines of that culture to effect positive change. I saw an autopsy and was able to follow 

it through to the histologic diagnosis. I learned about the common medical problems that face the population 

in that region of Tanzania, and how they adapt to providing medical care in a setting where the optimum 

treatment is rarely available. I learned about patience. 

Alumni 

Then and Now 

John Oates, MD 

The Medicine faculty at NewYork-Presbyterian/Weill Cornell recruited and led an outstanding House Staff. 

A commitment to excellence in patient care ran deep among the Residents with whom I was privileged to 

work. Because these were the values of our close colleagues, they became indelible influences on how each 

of us later cared for our patients. Those of us who later became engaged in research found encouragement 

for scientific inquiry in the hospital’s environment. The residents were enthusiastic about advances in medical 

science, curiosity was valued, and the research of the faculty held an attraction for us. I was particularly 

inspired by the pioneering research of Dr. Barr and his colleagues at the Rockefeller Institute that identified 

high density lipoproteins as protective against coronary artery disease. During a lunch with Dr. Richard 

Silver in the Physicians Dining Room, he told me that he had fulfilled the then obligatory military service 

requirement by serving as a Clinical Associate at the Clinical Center, NIH. Learning of this opportunity opened 

an appealing option for me. When I told David Barr of my interest in the prospect of research training at the NIH, he immediately 

picked up his telephone and made it happen. The Department of Medicine was like a family for my wife, Meredith, and me. 

Dr. John A. Oates received his MD degree from Wake Forest University and was a resident in medicine and cardiology at the 

New York Hospital-Cornell Medical Center. At the NIH (Clinical Center), he was a Clinical Associate and Senior Investigator 

prior to joining the faculty of the Vanderbilt University School of Medicine where he founded the Hypertension and Clinical 

Pharmacology programs. He was Chair of Vanderbilt University’s Department of Medicine from 1983 to 1997 and is the Thomas 

F. Frist, Sr. Professor of Medicine and Professor of Pharmacology. Dr. Oates has been elected to the Institute of Medicine of the 

National Academy of Sciences, the American Academy of Arts and Sciences, and to Fellowship in the American Association 

for the Advancement of Science. He received the Excellence in Clinical Research Award from the NIH GCRC program, the Earl 

Sutherland Prize for Research from Vanderbilt University, the Novartis Award from the Council on High Blood Pressure Research 

of the American Heart Association and the Award of Merit from the American Heart Association. 

Robert M. Carey, MD 

Residency in medicine at The New York Hospital-Cornell Medical Center was an exciting period of personal 

and professional growth for me. The diverse patient population was truly an exceptional base from which 

to learn. I was inspired by outstanding faculty members, such as Aaron Feder, Jerry Barondess, Tom Killip, 

Carl Muschenheim, Ed Hook, Ralph Nachman and many others, who were role models for the best in patient care 

and teaching. Exposure to such great chief residents as Harvey Klein and Chuck Steinberg was also important in 

my learning and maturation as a clinician. The Cornell experience stimulated me to enter subspecialty fellowship 

and pursue a career in academic medicine. Indeed, Cornell provided me with outstanding medical training and 

leadership skills for success. I will be forever grateful to Cornell for such an outstanding residency experience. 

Dr. Carey is David A. Harrison III Distinguished Professor of Medicine; Dean, Emeritus; and University Professor 

at the University of Virginia. He is one of the world’s foremost endocrinologists, specializing in cardiovascular 

endocrinology and hypertension. After leaving Cornell, Dr. Carey completed fellowships in 

endocrinology at Vanderbilt and in hypertension at the University of London in England. At the 

University of Virginia, Dr. Carey was Head of the Division of Endocrinology and Metabolism (1978-86) 

and Dean of the School of Medicine (1986-2002). He has received over 35 years of continuous 

funding for research from the National Institutes of Health. He has been President of The Endocrine 

Society and of the American Clinical and Climatological Association and Chair of the Council for 

High Blood Pressure Research of the American Heart Association. Dr. Carey has received the Thomas 

Jefferson Award of the University of Virginia, the Distinguished Physician Award of The Endocrine 

Society, the Irvine Page-Alva Bradley Lifetime Achievement Award of the Council for High Blood 

Pressure Research, the Distinguished Achievement Award of the American Heart Association and 

the Robert Tigerstedt Distinguished Scientist Award of the American Society of Hypertension. 


Alumni Then and Now continued 

Financial Report 

and Donors 

Gerald L. Mandell, MD 

I am very privileged to have had the opportunity to be a six-times Cornelian (undergraduate, medical 

school, internship, residency, fellowship and instructor). My time in Ithaca and at The Medical College 

was instrumental in focusing my goals on a career in academic medicine. Cornell Medical College was 

great! The basic science professors and the clinical faculty taught and inspired me. My classmates were 

superstars from all over the country with varied backgrounds and career interests. I was enthralled by 

the program in the Department of Medicine and elected to take all of my postgraduate training there. 

My experiences as an intern and resident (on duty every other night!) were exceptional. I finally did 

forgive my wife for having our first son (a Weill Cornell MD, PhD) on my internship night off so I was 

up working three days in a row. Patients, from the very ill with common diagnoses to “fascinomas” 

with obscure conditions, came from all over to “the Mecca.” My fellow house officers were a pleasure 

to work with. We really were a team. The clinical faculty and the full time faculty were wonderful 

teachers and role models. When family or friends needed to see a physician – there was no question – 

NewYork-Cornell was the place to be. One of the legends illustrating the excellence of the department 

was that a former Chair of Medicine could tell how many people were in a room by percussing the 

closed door. 

Infectious disease appealed to me because of the breadth of the conditions, and it meshed nicely 

with my research interest in polymorphonuclear neutrophils. After completing my fellowship in 

Infectious Diseases at Cornell, Dr. Edward Hook, who was the chief of the division and my hero and 

mentor, invited me to join him at his new position as Chair, Department of Medicine, University of 

Virginia. That was 41 years ago. 

Dr. Mandell is a Phi Beta Kappa honors graduate of Cornell University and an AOA graduate 

of the Medical College. His many honors and awards include membership in ASCI and AAP, Master 

of the American College of Physicians, Weill Cornell Medical College Alumnus of Distinction, President 

of the Infectious Diseases Society of America (IDSA), receipt of their highest award – the Alexander 

Fleming award, the IDSA Feldman award, Council of the NIH for Infectious Diseases, Chair of the 

American Board of Internal Medicine section on Infectious Diseases, NIH merit award for research, 

Inventor of the Year at the University of Virginia. The University of Virginia 

established a chair in his name. Dr Mandell has authored more than 

300 scientific publications; served as President of the American Clinical 

and Climatologic Association; is founding editor of the leading Infectious 

Diseases book in the world, “Principles and Practice of Infectious 

Diseases”; and was elected to membership in the Institute of Medicine 

of the National Academy of Sciences. At University of Virginia he is the 

emeritus Owen R. Cheatham Professor of the Sciences, Chief of the 

Division of Infectious Disease and Professor of Medicine. 


2010 Financial Report 

Admissions 

16000 

7.5 

The DOM experienced financial growth in 2010. Total income and clinical revenue continued to increase, 

along with institutional overhead from funded research. Outpatient visit volume capped at 180,000 

15000 

7.25 

encounters, with Cardiology and Gastroenterology-Hepatology experiencing the most growth. Total 

admissions peaked at 15,000, while length of stay (LOS) increased slightly by less than 1%. While outpatient 

14000 

7.0 

encounters remain steady, our inpatient encounters increased 19.7% (85,924 to 102,811 encounters) that 

partly attributed to our increase in clinical revenue. Most of the inpatient increase is from our newly created 

13000 

6.75 

Division of Hospital Medicine. 

12000 

Admissions 

Average Length of Stay 

6.0 

Total Income 

(dollars in millions) 

Clinical Revenue 


Total Outpatient Visit Volume 

(thousands) 

Cardiology Outpatient Visit Volume 

(thousands) 

180 

100 

200 

20 

160 

75 

175 

15 

140 

50 

150 

10 

120 

25 

125 

5 

100 

2007 2008 2009 2010 

0 

2007 2008 2009 2010 

100 

2007 2008 2009 2010 

0 

2007 2008 2009 2010 

Department of Medicine Research 

Expenditures 

FY 2010 

Institutional Indirect Costs 

Generated by Medicine 


Gastroenterology Outpatient 

Visit Volume 

(thousands) 

Hematology – Oncology Outpatient 

Visit Volume 

(thousands) 

Cardiology 

11.7 


13.0 

12 

25 

50 

Hematology/ 

Oncology 

28.5 

Nephrology & 

Hypertension 

7.3 

9 

20 

40 

Immunology 

5.7 

15 

30 

Geriatrics 6.3 

6 

Infectious Diseases 19.1 

GIM 4.7 

Pulmonary 1.0 

Endocrinology 2.6 

3 

10 

5 

20 

10 

0 

2007 2008 2009 2010 

0 

2007 2008 2009 2010 

0 

2007 2008 2009 2010 

Grants, Clinical Trials, Donations 

122 Department of Medicine ■ Physician Organization 


2010 Donors 

Fund for Medicine 

The Fund for Medicine raises money 

to support critical resources and 

innovative programs in education, 

patient care and biomedical research 

at New York-Presbyterian Hospital 

and Weill Cornell Medical College. 

These resources and programs enable 

our physicians and scientists to carry 

on a long tradition of excellence in 

medicine with the ultimate goal in 

mind: to provide superior patient 

care to the communities they serve. 

Ms. Harriet Abramson 

Advanced Research Foundation, Inc. 

AIG Matching Grants Program 

Mr. and Mrs. Murray Alon 

The Applebaum Foundation 

Mrs. Patricia Balsamo 

Ms. Patricia A. Banks 

Ms. Rena Bartos 

Ms. Joan S. Beir 

The Beir Foundation 

Mr. Charles E. Binder 

Ms. Rita S. Brause 

Ms. Roberta C. Brause 

Ms. Karen Brenner 

Mr. Clyde Brownstone 

Mrs. Diane Brownstone 

Brownstone Family Foundation 

Mr. John B. Caddell, II 

Mrs. John L. Cady 

Mrs. Korda H. Caplan 

Carl and Fay Simons Donor 

Advised Fund 

The Charlene and David Howe 

Foundation 

Charles & Lucille King Family 

Foundation 

Mr. William R. Coleman 

Coleman Family Charitable Foundation 

Ms. Ann B. Copeland 

Ms. Marion Cowan-Loh 

D’Agostino Foundation 

Mr. Joseph R. Daly 

Ms. Shirley W. Della Vecchia 

Mr. Bruce Dorskind 

Mrs. Phyllis M. Feinert 

Mr. Robert E. Feldbaum 

Ms. Harriet Feldmann 

Mr. and Mrs. Richard Feldstein 

Feldstein Family Charitable Foundation 

Dr. Bernard T. Ferrari 

Ferrari Consultancy 

Fidelity Charitable Gift Fund 

Ms. Constance F. Fischer 

Friman & Stein, Inc. 

Mr. Henry Fruhauf 

Mr. Robert L. Gipson 

Mr. Marvin S. Gittes 

Mrs. Helene Gleeman 

The Grace R. and Alan D. Marcus 

Foundation 

Mr. John A. Griffin 

Ms. Arlene Solomon Haas Guerra 

Dr. and Mrs. Subhash C. Gulati 

Ms. Rose Haas 

The Harold and Mimi Steinberg 

Charitable Trust 

Dr. Barry J. Hartman 

Mr. Joel Hoffman 

Mr. David S. Howe 

Mr. Henry H. Hoyt, Jr. 

Mrs. Mary O. Hughes 

Jerome and Laura Dorfman 

Charitable Foundation 

The Jewish Communal Fund 

The Joseph R. Daly Foundation 

Mrs. Leah I. Kantor 

Ms. Diana King 

Korda Herskovits Caplan 

Philanthropic Fund 

Ms. Joan Kron 

Lebensfeld Foundation 

Ms. Jacqueline S. Leeds 

Ms. Catherine P. May 

Ms. Barbara B. McGhie 

Mr. Robert B. Menschel 

Mr. and Mrs. Morris A. Mondschein 

The Murray Alon Charitable 

Foundation 

Oceanic Heritage Foundation 

Ambassador Herbert S. Okun 

Mr. Sabino S. Pace 

Mr. Creighton H. Peet 

Ms. Vita L. Pellettieri 

Mr. Andrew G. Pietrini 

Mr. Edward K. Portnof 

Mr. and Mrs. Robert M. Poss 

Mr. Michael H. Ratner 

Mr. and Mrs. Richard Roob 

Mr. Arnold S. Root 

Dr. Howard Rosenberg 

Mrs. Aviva Rosenberg 

Dr. Benjamin A. Rosenberg 

Mr. Jack E. Rosenfeld 

Felice Rovelli 

Mr. Michael B. Sapik 

Mr. Ernest Schaal 

Mrs. Ernestyna Schenker 

Mr. Charles B. Selden 

Dr. Melvin R. Shevach 

Ms. Nancy G. Shor 

Ms. Helene Silverman 

Mr. Carl Simons 

Mr. Daniel Soba 

Mr. Arnold R. Sollar 

The Sollar Foundation, Inc. 

Mr. Robert Stein 

Mr. Mark Stitzer 

Mr. and Mrs. Fred C. Stoll 

Ms. Geraldine Stover 

The Tianaderrah Foundation 

Vital Projects Fund, Inc. 

Mrs. Bertha Weiser 

Mr. Warren A. Weiss 

Ms. Dana A. Weiss 

Ms. Marjorie Weller 

William T. Foley Foundation 

The Winston Foundation, Inc. 

Dr. James F. Wittmer 

Dr. David J. Wolf 

Mr. William D. Zabel 

Ms. Robin F. Zwerling 

Friends of the Department 

The Department of Medicine is 

deeply grateful to the Friends of 

Medicine. These individuals have 

generously contributed to furthering 

the department’s advances in 

patient care, education of physicianscientists, 

and bench-to-bedside 

breakthroughs in research. There are 

a large number of contributors, some 

1,350 former patients and friends, 

who have given donations below 

the level of $100. Due to space 

limitations, we cannot list these 

donors, but we express our sincerest 

thanks for their loyal support. 

72nd Street Medical Associates, P.C. 

A Taste of Honey, Inc. 

A.L. Murphree M.D., Inc. 

Mrs. Nancy C. Abbott 

Mr. Preston H. Abbott 

Ms. Judith Aberg 

Ms. Lynn R. Abraham 

Ms. Alice J. Abraham 

Mr. Robert Abramovitz 

Ms. Harriet Abramson 

ABTCC Developmental Studies 

Department 

Accordia Global Health Foundation 

Ackerman Family Fund 

Dr. Alberto M. Acosta 

Mr. John M. Adams 

Ms. Lois Adelman 

Dr. Ronald Adelman 

Ms. Sherril Aden 

Ms. Ann Adenbaum 

Mrs. Mary Anne Adkins 

Adolph & Ruth Schnurmacher 

Foundation, Inc. 

Advanced Research Foundation, Inc. 

Ms. Rebecca Ahrens-Nicklas 

AIDS Celebrity Golf & Tennis Classic 

AIG Matching Grants Program 

Dr. John Aldous 

Mrs. Jeannette Aldous 

Ms. Gillian Aldred 

Dr. Hanna Alemayehu 

Mrs. Kim K. Alexander 

Ms. Sarah Alexander 

Ms. Annetta Alexandridis 

Mr. Stephen M. Alfieri 

Mr. Vincent Allegretti 

Mrs. Ethel S. Allen 

Ms. Esther Allen 

Ms. Margaret Allen 

Mr. and Mrs. Murray Alon 

Mr. Jerome Alpern 

Alpha Delta Phi at Cornell, Inc. 

Mr. Joseph Alsberge 

Ms. Kathryn Altman 

Ms. Resa Alvord 

Mr. William W. Ambrose 

American International Educators, Inc. 

American Society of Colon & Rectal 

Surgeons 

America’s Choice, Inc. 

Mrs. Donna B. Amico 

Ms. Susan Amighi 

Amir & Rosita Manocherian Family 

Foundation 

Mrs. Fran Amirsaleh 

Mr. Philip Ammirati 

Ms. Carol B. Amos 

Anchorage Charitable Fund 

Ms. Linn Anderson 

Mrs. Cynthia T. Anderson 

Mr. M. E. Anderson 

Mr. and Mrs. Alan M. Anderson 

Mr. Takeshi Ando 

Ms. Camille Andrews 

Andrews Kurth, LLP 

Ms. Julia Andrukonis 

Mr. Christopher C. Angell 

Angelo Donghia Foundation 

Anonymous 

Mr. Andrew Ansaldi 

Mr. Aaron Ansaldi 

Anil Antony 

The Applebaum Foundation 

Mr. Ryan Applegate 

Appleman Foundation, Inc. 

Mrs. Gwen S. Aquadro 

Shivaun D. Archer 

Mrs. Adamandia Arestou 

Ms. Severine Armand 

Mr. Paul D. Armstrong 

Ms. Mary L. Arnold 

Ms. Nydia Arocho 

Dr. Louis J. Aronne 

Mrs. Susan B. Arroyo 

Mr. Greg Arvesen 

The Asen Foundation 

Ms. Sara E. Asher 

Aubrey’s Inc. 

Ms. Justine E. Auchincloss 

Ms. Susan M. Aull 

Ms. Meredith J. Aull 

Avedis Zildjian Company 

Mr. Jesse Aversano 

Avian Securities 

B 

Mrs. Kathleen Babkow 

Dr. Sateesh C. Babu 

Ms. Melanie C. Bacon 

Mrs. Christine Bagin 

Mr. John Bai 

Mr. Mark Bailey 

Mr. Julian C. Baker 

Mr. Mike Baker 

Mrs. Andrea Baker 

Ms. Felicie R. Balay 

Mrs. Sallie Baldwin 

Ms. Martha Balladares 

Mr. Jeffrey Ballyns 

Mr. Arthur E. Balsamo, P.A. 

Mrs. Patricia Balsamo 

Dr. Heejung Bang 

Bank of America Foundation 

The Bank of Tokyo-Mitsubishi UFJ, Ltd. 

Ms. Nancy Banks 

Ms. Patricia A. Banks 

Mr. and Mrs. John Bannon 

Mr. Anthony N. Baratta 

Ms. Virginia P. Barber 

Mr. Brian Barber 

Dr. Jean T. Barbey 

Dr. and Mrs. Jack D. Barchas 

Mr. Michael Barclay 

Bard College 

Barkan Management Company, Inc. 

Ms. Janae Barker 

Mr. Edward L. Barlow 

Ms. Annette Barlow 

Mr. Gordon S. Barr 

Mr. and Mrs. Joseph P. Barreriro 

Ms. Leigh Barrett 

Mr. Jon Barrett 

Mr. Gregory Barton 

Mr. Dale Barton 

Ms. Mary Bartos 

Ms. Rena Bartos 

Yuliy Baryshnikov 

Mr. Thomas Bashore 

Ms. Barbara J. Bastow 

Dr. Paul M. Basuk 

Mrs. Elizabeth A. Bates 

Mr. Richard J. Bauer 

Beacon School 

Mr. Robert Bean 

Ms. Brenda Bear 

Joseph A. Beck, III 

Dr. David S. Becker 

Mr. Scott W. Becker 

Ms. Dotty Beckwith 

Becton Dickinson and Company 

Mr. Harry Beda 

Mr. Gerald A. Bednarski 

Ms. Wilfreda Behets 

Mr. Ruediger Behmel 

Ms. Joan S. Beir 

The Beir Foundation 

Ms. Lori K. Beizer 

Ms. Bonnie Belkin 

Mr. Christopher J. Bell 

Mr. Matthew G. Bell 

Mr. Sanford A. Bell 

Mr. Sergey Belomestnykh 

Mr. Noel Beninati 

Mr. John Bennett 

Mr. Richard A. Bennett 

Mrs. Leslie P. Bennison 

Mr. Julian M. Benscher 

Dr. Constance Benson 

Mr. Carter Bentley 

Ms. Kellie Bentz 

Dr. Ivan Bergstein 

Mr. Marc Berk 

Dr. Israel S. Berkowitz 

Ms. Linda Beth Berman 

Mr. Nicholas Berry 

Ms. Susanna L. Bertelsen 

Mrs. Linda Beynon 

Mr. Jaydeep Bhat 

Ms. Evelyn Bhumitra 

Dr. Celso Bianco 

Ms. Sheila Bienemann 

Ms. Tracey Biggers 

Mr. Charles E. Binder 


2010 Donors continued 

Ms. Marissa R. Bishop 

Blackbaud, Inc. 

Ms. Barbara Blackmond 

Mr. William M. Blair, Jr. 

Dr. James A. Blake 

Mr. Jason M. Blau 

Mr. Max Blekhter 

Ms. Heide-Marie Bliss 

Mr. James A. Block 

Mr. Jonathan Block 

Ms. Gilda Block 

Ms. Kathleen Blomquist 

Blue Hill Road Leshkowitz & Co. 

Ms. Lois D. Blumenfeld 

Dr. David S. Blumenthal 

Ms. Jasmin Blunck 

Ms. Marsha N. Boasso 

Ms. Anne Bodkin 

Mr. Leonard B. Boehner 

Mr. Elijah Bogart 

Mrs. Stefni Bogard 

Ms. Esther Bogin 

Dr. Jerome Bogin 

Ms. Eve S. Bogle 

Mr. Luc Bomans 

Ms. Trina Bombardier 

Ms. Kathryn Boor 

Mr. Michael Bopp 

Mr. Mark Borchert 

Dr. William B. Borden 

Mr. William Borden 

Mr. Joseph L. Boren 

Ms. Ghislaine Borno 

Ms. Beverly Bortner 

Mrs. Catherine C. Bosch 

Ms. Pamela Boschert 

Dr. George J. Bosl 

Boston Consulting Group, Inc. 

Dr. Susan B. Bostwick 

Dr. Brian P. Bosworth 

Ms. Olga Boudker 

Ms. Jennifer H. Bourdain 

Ms. Sharon Bovie 

Ms. Amelia A. Bower 

Mr. Steven Boxer 

Ms. Geraldine M. Boxer 

Mr. Haig J. Boyadjian 

Mr. Adam Boyd 

Mr. Lawrence C. Boyd 

Mr. William J. Boyd, Jr. 

Mrs. Constance E. Boyle 

Ms. Katharine Boyle 

Ms. Mary Boyle 

Bracewell & Giuliani, LLP 

Mrs. Marike J. Bradford-Toothaker 

The Braewold Fund 

Ms. Patsy Brannon 

Dr. Barry D. Brause 

Ms. Rita S. Brause 

Ms. Roberta C. Brause 

Ms. Karen Brenner 

Mr. Timothy F. Brewer 

Mr. Kenneth Bridbord 

Dr. Mary F. Bridge 

Ms. Susan Briggs 

Dr. David J. Brillon 

Mr. James Brinkley 

Bristol-Myers Squibb Company 

Mrs. Beverly U. Brodsky 

The Brooke Janis Living Trust 

Mr. Bart B. Brown 

Ms. Carole R. Brown 

Ms. Dolores Brown 

Mr. Luvaghn Brown 

Mrs. Marjorie W. Brown 

Ms. Nancy E. Brown 

Ms. Nancy L. Brown 

Ms. Sara H. Browne 

Ms. Marcy Brownson 

Mr.Clyde Brownstone 

Mrs. Diane Brownstone 

Brownstone Family Foundation 

Bruce A. Gimbel Foundation 

Ms. Karen Brummund 

Ms. Doris Bry 

Ms. Susan Buchanan 

Ms. Andrea Buffara 

Ms. Angela Buffenn 

Mr. William Buffie 

Ms. Jeannine M. Buono 

Mr. Harry J. Buonocore 

Ms. Jane Bupp 

Dr. Amelia L. Burgess 

Mr. William L. Burke 

Ms. Pamela Burks 

Burleson Research Technologies, Inc. 

Ms. Jeanette Busch 

Dr. James B. Bussel 

Mr. Victor Bustos 

Mrs. Carol L. Butler 

Ms. Margaret Butler 

Ms. Kathy Byrnes 

Ms. Robin Byrt 

C 

Mr. John B. Caddell, II 

Mr. Oliver Cadogan 

Mrs. John L. Cady 

Ms. Joanna Cahill 

Mr. Charles C. Cahn, Jr. 

Ms. Nancy S. Calcagnini 

Ms. Bettie Caldwell 

Mr. Carl C. Caldwell 

Mr. Joseph P. Califano 

Mr. Jeremiah M. Callaghan 

Mr. Edward W. Callahan 

Calliope and Manuel Kulukundis 

Foundation 

Mr. Nicholas Cambas 

Mrs. Denise Camilleri 

Mr. Chris Campos 

Cancer Research and Treatment 

Fund, Inc. 

Capital Care Medical Group, LLC 

Mrs. Korda H. Caplan 

Mr. Bernard C. Caplan 

Mr. Daniel Capps 

Ms. Joyce Capuano 

Cardillo & Corbett 

Cardiology Consultants of NY, PC 

Cardiology Consultants of Philadelphia 

Cardionet, Inc. 

Carl and Fay Simons Donor Advised 

Fund 

Mr. Paul V. Carlucci 

Mr. Kenneth Carmel 

Ms. Dianne V. Carnegie 

Carolina Digestive Health Associates 

Carolina Wholesale Office Machine 

Company, Inc. 

Mr. Curt C. Carpenter 

Ms. Angela Carpenter 

Ms. Amanda Carreiro 

Ms. Lois Carroll 

Mr. Jay W. Carter 

Ms. Dorothy A. Carter 

Mr. Marvelle B. Carter 

Ms. Constance B. Cartwright 

Cary L. Guy Foundation 

Dr. Mario B. Castillo 

Celgene Corporation 

Central Park Boat House, LLC 

Mr. and Mrs. Clive Chajet 

Mr. Kevin Chang 

The Charlene and David Howe 

Foundation 

Charles & Lucille King Family 

Foundation 

Charles and Mildred Schnurmacher 


Charles Hertzig Foundation 

Kuei-Chiu Chen 

Dr. Adam Cheriff 

Cheryl A. Gallant, Inc. 

Children’s Hospital of Los Angeles 

Mr. Russell Chin 

Chios Navigation (Hellas) Ltd. 

Dr. Hearn J. Cho 

Dr. Sunghee Cho 

Ms. Lubna Choudhury 

Mrs. Carole A. Christensen 

Dr. Charles L. Christian 

Ms. Marian Christie 

Ms. Anne M. Christner 

Dr. James P. Christodoulou 

Dr. Edmond K. Chu 

Ms. Laura Chunosoff 

Dr. Amy E. Chused 

Ms. Brenda Cialone 

Mr. Salvatore Cilmi 

Ms. Marilynn D. Civic 

Claire & Meyer Frank and Leann 

Frank Charitable Foundation, Inc. 

Mr. David Clapp 

Nancy Clapp-Channing 

Clarfeld Financial Advisors, Inc. 

Mr. Gerald Clark 

Mr. James M. Clawson 

Ms. Kathleen Cochrane 

Mr. Edmund Coffin 

Mr. John D. Coffin 

Mr. William Coggin 

Mr. Joel I. Cohen 

Mr. Richard N. Cohen 

Dr. Richard P. Cohen 

Cohen Hacker Rothstein & Pearl, LLC 

Dr. Symra A. Cohn 

Dr. Susan E. Cohn 

Dr. Curtis L. Cole 

Mrs. Allison H. Coleman 

Dr. Morton Coleman 

Mr. William R. Coleman 

Coleman Family Charitable Foundation 

Coles Family Foundation 

Ms. Anne Coletti 

Ms. Ann Collier 

Mrs. Anne B. Collins 

Dr. Pamela Y. Collins 

Mr. Richard J. Collins 

Ms. Hilda Collins 

Ms. Eileen Collins 

Mrs. Joanne Colon 

Ms. Josephine D. Colon 

Colon Cancer Challenge Foundation 

Mr. Bruce Colville 

Community Foundation for 

Southeast Michigan 

Community Foundation of 

Chattahoochee Valley, Inc. 

Community Foundation of Middle 

Tennesse 

Community Foundation of New Jersey 

Community Health Systems 

Foundation 

Comprehensive Care Center 

Mr. Kenneth Conboy 

Ms. Sheila Congdon 

Mr. Bryan Coniglio 

The Connell Company 

Mr. Christopher Connelly 

Ms. Wendy L. Conrad 

Ms. Sophie C. Consagra 

Consulting Cardiologists, P.C. 

Mr. Edward B. Conway 

Mr. John N. Conyngham, III 

Mr. David Cooper 

Ms. Esther Cooper 

Ms. Ann B. Copeland 

Ms. Sharon Copeland 

The Corey Foundation 

Ms. Alexandra Coria 

Ms. Louise Coria 

Cornell Black Professional Women’s 

Forum 

Cornell Cinema 

Cornell University College Democrats 

Ms. Sylvia R. Corrigan 

Mr. Nathan D. Cortright 

Ms. Alice M. Costas 

Mr. Basil A. Costas 

Mrs. Susan Costas 

Cove Point Foundation 

Ms. Marion Cowan-Loh 

Ms. Hanley B. Cox 

Mr. Guy W. Cox, III 

Mr. Charles M. Crane 

Ms. Dana L. Cranmer 

Mr. Gerald Crawford 

Crawford Doyle Charitable Foundation 

Ms. Caroline Crim 

Ms. Anne Crisci 

Ms. Christina Croll 

Mr. Kevin Crosby 

Ms. Eliana Crosina 

Ms. Anna E. Crouse 

Mr. Jeffrey Crowley 

Ms. Judith M. Crowther 

Mr. Stephen Crumb 

Ms. Catherine L. Crumbo 

Mr. Juan R. Cruz 

Dr. Ward F. Cunningham-Rundles 

Ms. Barbara Curtis 

Mrs. Cynthia Cycon 

D 

D’Addario & Company, Inc. 

Mr. Anthony F. Daddino 

D’Agostino Foundation 

Ms. Mary Dague 

Ms. Marta C. Daire 

Dale C. Christensen Family Foundation 

Mr. Joseph R. Daly 

Selasi Dankwa 

Ms. Peggy Danziger 

Mr. Richard D’Aquila 

Rev. Joseph L. Darbouze 

Mr. Michael Dardia 

Ms. Gabrielle Darnell 

Mr. J. F. Dash 

Ms. Joanne Davenport 

Mr. William H. David 

David & Sarah Jane Charitable Trust 

The David and Alan Greene Family 

Foundation 

David Gotterere Charitable Trust 

David Zwirner, Inc. 

Mr. Robert C. Davidson,Jr. 

Mrs. Judy Davidson 

Ms. Susan Davis 

Dr. and Mrs. C. E. Davis 

Mr. Malcolm Davis 

Mrs. JoAnne Davis 

Mr. Hillel Davis 

Ms. Cornelia Davis 

Davita, Inc. 

Ms. Ellen Dawson 

Dr. Ype De Jong 

Ms. Carolyn C. De Wilde 

Ms. Laura Dechter 

Ms. Christine Decker 

Mr. and Mrs. Charles M. Defuccio 

Ms. Audrey Degutz 

Mr. Coloman DeHegedus 

Dr. Kirk W. Deitsch 

Mr. Mark Delaney 

Mr. Lyman Delano 

Ms. Mallory Delehanty 

Ms. Eileen Delgado 

Mr. Donald L. Dell 

Ms. Shirley W. Della Vecchia 

Ms. Yvette M. Delph 

Delta Partners Employees 

Delta Upsilon Fraternity - Cornell 

Chapter 

Ms. Candace DeMatteis 

Mrs. Maxine Denmark 

Mr. Joseph Depaola 

Dr. Maria T. DeSancho 

Mrs. Kathleen DeSavino 

Mr. Paul H. Deschamps 

Mr. Neil V. Desena 

Ms. Edwine Desnoyers 

Mrs. Stefanie J. Detwiler 

Mr. Martin Deutsch, CPA 

Deutsche Bank North America 

Dr. Richard B. Devereux 

Mr. Richard A. Devine 

Mr. James Devine 

Ms. Marilyn J. Devine 

Mr. Peter Di Giulio 

Dr. Donna Di Michele 

Mr. William Diamond 

Ms. Teresa DiBernardino 

Ms. Samantha Dickinson 

Mr. Derek Dieter 

Dr. Joann Difede 

Ms. Helene R. Dillard 

Ms. Rebecca Dillingham 

Dr. Aihao H. Ding 

Ms. Andrea Dispigno 

Mr. Michael D. Ditzian 

Mrs. Ute A. Dobrick-Westwood 

Ms. Betty Doerfler 

Ms. Julie E. Dolan 

Mr. Matthew Dolan 

Ms. Pamela C. Donner 

Ms. Elizabeth Dorfman 

The Doris B. Goodwin Trust 

Doris Bry Trust 

The Dorothy and Arnold Neustadter 

Foundation 

Mrs. Patricia A. Dorph 

Mr. Bruce Dorskind 

Mrs. Ellen R. Doskow 

Ms. Diane M. Dougherty 

Ms. Kimberley Dow 

Ms. Amber Downer 

Mr. David Downs 

Dr. Robert C. and Veronica Atkins 

Foundation 

Mr. Arthur Dresner 

Ms. Helene Drobenare-Horwitz 

Mr. Mark T. Drooks 

Dr. Jeanine D. Dropkin, 

Mr. Arnold M. Drucker 

Dr. Lewis M. Drusin 

Ms. Joyce S. Dubensky 

Ms. Elizabeth D. Dufree 

Duke University 

Mr. Alan Dulit 

Mr. Alan S. Duncan 

Mr. Brian J. Dunlop 

Mrs. Barbara A. Dunn 

Ms. Kathryn Dupnik 

Mr. Richard Durst 

Mr. Leonid Duzhansky 

E 

E & R Rosenman Charitable 

Foundation 

East Side Cardiology, PLLC 

Dr. Gary E. Eddey 

Edelman Foundation 

Ms. Claire Edersheim 

Dr. Terri G. Edersheim 

Mr. David L. Edgerly 

Mrs. Linda Z. Edie 

Edith Baldinger Charitable Lead 

Annuity Trust 

Edward P. Evans Foundation 

Mrs. Zina S. Egol 

Mrs. Norma Ehrlich 

Mr. George P. Eichen 

Mr. Roger W. Einiger 

Mr. L. C. Einwick, Jr. 

Mr. Stanley S. Eisenstat 

Mr. Edgar Eisner 

Eissa A. Bateh and Brothers 


Elberon Development Company 

Ms. Gertrude Elins 

Ms. Marjorie Ellenbogen 

Mr. Peter W. Elliott 

Mrs. Ruth Elsner 

Dr. Rebecca L. Elstrom 

Mr. Ben A. Emanuel 

Mrs. Carol Emberson 

The Emily Davie and Joseph S. 

Kornfeld Foundation 

Emily L. and Robert E. Smith 

Foundation 

Mrs. Linda R. Emory 

Ms.Christine E. Endicott 

Dr. Angie M. Eng 

Ms. Theresa L. Enk 

Mr. Chris Enock 

Mr. Tom Enroth 

Entertainment Industry Foundation 

Mr. Alan Epstein 

Epstein Teicher Philanthropies 

Ernst Foundation, Inc. 

Ms. Deborah J. Esser 

Estate of Anne Ellen Wigmore 

Estate of George H. Dunning 

Estate of Gilberto Zaldivar 

Estate of Suzanne C. Murphy 

Ms. Paige Etter 

Dr. Arthur T. Evans 

F 

Evelyn Y. Davis Foundation 

Mr. Stephen Everett 

Ms. Ilaria Falciatori 

Wei Fan 

Ms. Elizabeth Fansher 

Ms. Mary Farag 

Ms. Vivian S. Farah 

Mr. and Mrs. Frank Farinella 

Blue Farms 

Mr. Joseph R. Favata 

Ms. Gail M. Federici 

Dr. Oliver T. Fein 

Mrs. Phyllis M. Feinert 

Mr. Robert E. Feldbaum 

Dr. Eric J. Feldman 

Ms. Harriet Feldmann 

Mr. and Mrs. Richard Feldstein 

Feldstein Family Charitable Foundation 

Mr. Thomas H. Ferguson 

Dr. Bernard T. Ferrari 

Ferrari Consultancy 

Ms. Lucille Ferraro 

Richard Ferri 

Fidelity Charitable Gift Fund 

Mr. A. G. Fieger 

Mr. Brent Field 

Filomen M. D’Agostino Foundation 

Corp 

Ms. Kay Findlater 

Jamie Findlater 

Ms. Ilene Fine 

Mr. Marion Finizio 

Dr. Madelon L. Finkel 


Mr. Christopher Fiorese 

Ms. Edmee D. Firth 

Ms. Constance F. Fischer 

Mr. John Fisher 

Mrs. Dena Fisher 

Ms. Carol A. Fisher 

Fisher-Raviv Family Foundation 

Mr. Magnus Fiskesj 

Mr. John W. Fitzgerald 

Mr. Maurice J. Fitzgerald 

Mr. Robert F. Fitzgerald 

Mrs. Winifred M. Fitzgerald 

Mr. Stephen M. Fitzgibbons 

Ms. Lisa A. Fitzgibbons 

Mr. John Flanagan 



Fleischaker Family Foundation 

Mr. Eric G. Fleming 

Ms. Phyllis Fliederbaum 

Mrs. Eva K. Flores 

Mr. Philip Flowers 

Dr. John T. Flynn 

Ms. Sabrina Fondren 

Mr. Thomas M. Fontana 

Ms. Sarah Foote 

Ms. Charlotte M. Ford 

Mr. Bryan Ford 

Ms. Patty Forgham-Thrift 

Mr. Mark Forman 

Formatech, Inc. 

Mr. Christopher A. Forster 

Mr. Mark Foster 

Foster Davis Foundation, Inc. 

Ms. Abigail Foulk 

Ms. Diane L. Fowlkes 

Mrs. Arlene M. Fox 

Ms. Lissete A. Fox 

Ms. Kathy G. Frank 

Dr. Maura D. Frank 

Mrs. Phyllis Frankel 

Ms. Elisabeth Franklin 

Mr. H. M. Fraser 

Mr. Laurence Freedman 

Ms. Martina Frey 

Mr. Francoise Freyre 

Mr. Sam Friedlander 

Mr. Mitchell R. Friedman 

Mr. Peter R. Friedman 

Friedwald Center for Rehabilitation 

and Nursing, LLC 

Friman & Stein, Inc. 

Mr. Jules B. Fromm 

Frontier Science and Technology 

Research Foundation, Inc. 

Mr. Henry Fruhauf 

Ms. Susan Frye 

Ms. Sachiko Funaba 

Mr. Pincus F. Fund 

Mr. Nelson T. Fung 

Mrs. Beth Furman 

Ms. Margaret L. Furman 


G 

Mrs. Ava-Dawn Gabbidon 

Mrs. Elfriede M. Galicich 

Mrs. Catherine A. Gallagher 

Mr. Joel Gallant 

Ms. Donna Galloway 

Dr. and Mrs. Daniel Gardner 

Mr. Pierce Gardner 

Mr. Samual Garner 

Ms. Susan Garwood 

Mr. David Gasser 

Mrs. Louise M. Gatanas 

Gateway School of New York 

Mrs. Virginia B. Gausden 

Ms. Robin Gauthier 

Mohan Gawande 

Ms. Richa Gawande 

Dr. Mitchell L. Gaynor 

GCC Travel, LLC 

Ms. Leah Geach 

Ms. Maria Geffen 

Mr. Anthony Geiss 

Dr. Brian Gelbman 

Ms. Victoria Gelfand 

Ms. Sandra M. Genelius 

Genentech USA 

General Atlantic Service Company, LLC 

Georgescu Family Foundation 

Georgetown University 

Mr. Angelos Georgopoulos 

Ms. Vivian C. Georgousis 

Dr. Darin J. Geracimos 

Dr. Linda M. Gerber 

Mr. Kevin J. Gershfeld 

Ms. Erica Gersowitz 

Ms. Suzanne Gervais 

Ms. Nikki Gettinger 

Mr.Partho Ghosh 

The Giammalva Family 

Foundation 

Mrs. and Mrs. Constance B. Gibb 

Mrs. Margot S. Gibson-Beattie 

Ms. Kristin Gilbert 

Ms. Edes P. Gilbert 

Mr.James G. Gilbert 

Ms. Tara Gilhooly 

Mr. S. H. Gillespie 

Mr. Carl Ginet 

Mr. Christopher Ginter 

Ms. Megan Gioiella 

Mr. Robert L. Gipson 

Mr. Daniel Gitlin 

Mr. Marvin S. Gittes 

Mr. Michael O. Gittlesohn 

Ms. Diane Giulio 

Mrs. Jennifer Given 

Ms. Gelila Gizaw 

Mr. Bruce Gladden 

Mr. Edward F. Glassmeyer 

Ms. Elizabeth Glater 

Mr. Peter H. Gleason 

Mrs. Helene Gleeman 

Dr. Marshall J. Glesby 

Ms. Frances Glick 

Global Health Strategies 

Dr. David L. Globus 

Mr. John F. Glynn 

Ms. Barbara Godard 

Ms. Catherine C. Godfrey 

Ms. Pamela Gokemeijer 

Ms. Karen B. Gold 

Ms. Lori Goldberg 

Ms. Marcia B. Goldberg 

Ms. Michele D. Goldberg 

Ms. Leslie E. Goldblatt 

Mr. Marc Goldfarb 

Mr. Andrew Goldfine 

Mr. and Mrs. Edward Goldman 

Goldman Sachs & Co. 

Goldman Sachs & Co. Matching Gift 

Program 

Goldman Sachs Gives 

Mr. Herman C. Goldsmith 

Mr. Walter R. Gonzales 

Mr. Anthony C. Gooch 

Mrs. Jennifer Goodman 

Goodman Charitable Trust 

Ms. Ann Goodrich 

Mr. Matthew Goodwin 

Mr. Stephen Goodwin 

Mr. Lawrence E. Gore 

Dr. Kenneth J. Gorelick 

Mr. Samuel Gorovitz 

Gotham Yard Corp. 

Mr. Robert J. Gotterer 

Mr. Gene Gottesman 

Ms. Katherine Gottschalk 

Hariprasad Govinda 

Mrs. Mary B. Grace 

The Grace R. and Alan D. Marcus 

Foundation 

Mr. Donald E. Graham 

Parrie Graham 

Mr. David Green 

Mrs. Margaret Greenberg 

Ms. Julie Greenman 

Dr. Alan Greenspan 

Dr. Ruth B. Greer 

Mr. Robert Greer 

Ms. Jennifer Grenier 

Mr. John A. Griffin 

Miss Jeanne A. Grifo 

Mrs. Kendra Grosso 

Mr. William C. Gruber 

Ms. Pamela Gruber 

Mr. William Grueskin 

Ms. Arlene Solomon Haas Guerra 

Mrs. Nancy B. Guerrant 

Mr. Eileen Guida 

Dr. and Mrs. Subhash C. Gulati 

Dr. Roy M. Gulick 

Mrs. Catherine L. Gunsbury 

Mr. Ilya M. Gurtenboim 

Elan Guterman 

Mr. Steven L. Gutman 

Dr. Sidney Gutstein 

Ms. Leslie Gyson 

H 

H & M Bar, LLC 

Ms. Rose Haas 

Hachette Book Group 

Hackers for Hope 

Hadassa Antiques, Inc. 

Mrs. Esther Haddad 

Hagedorn Fund 

Dr. Katherine A. Hajjar 

Ms. Lynn Halbfinger 

Ms. Margo Halle 

Mrs. Toula J. Halperin 

Mr. Craig M. Halpin 

Mrs. Doris Hambro 

Dr. Scott M. Hammer 

Mr. Joel Handel 

Mr. Jerry S. Handler 

Mr. Richard Handman 

Mr. James M. Handy 

Mr. Jeffrey R. Hannah 

Ms. Carla Hanson 

Ms. Joann Hanson 

Mr. Matthew Hare 

Mr. James J. Hargadon 

Dr. Ray Hargreaves 

The Harjen Charitable Foundation 

Harmonious Lifestyles, Inc. 

The Harold and Mimi Steinberg 


Harriette A. Gifford Charitable 

Remainder Trust 

Mr. Alan B. Harris 

Ms. Christina Harris 

Ms. Eva Harris 

Ms. Mary Harrity 

Mr. Vincent Hart 

Mr. Gurnee F. Hart 

Mr. Steven W. Hart 

Dr. Barry J. Hartman 

The Harvey and Ruth Gelfenbein 


Mr. Rifat Hasan 

Mr. Jonathan Hassell 

Mr. James Haustein 

Mr. Frank H. Hawrylak 

Dr. Frances G. Haxton 

Mr. Mark Hayman-Martinez 

Ms. Jodi Hazan 

Hazen Polsky Foundation 

Mr. Donald R. Head 

Healthcare Initiatives 

Ms. Katrina Hedlesky 

Ms. Deborah L. Hedwall 

Ms. Dorothy J. Heger 

Mr. Emil Heidkamp 

Ms. Rebecca A. Heidkamp 

Ms. Rose T. Heim 

Mr. Douglas C. Heimburger 

Mr. Melvin L. Heineman 

Mrs. Drue J. Heinz 

Helene Whitman Memorial Cancer 

Fund 

Dr. David C. Helfgott 

Dr. Arthur D. Heller, F.A.C.P. 

The Help for People Foundation Trust 

Dr. Hugh C. Hemmings, Jr. 

Mrs. Pamela Hemphill 


Ms. Ruth Hendel 

Mrs. Judith Henderson 

Ms. Mary Hennigan 

Henry & Ida Richard Foundation 

Henry Schein Cares Foundation, Inc. 

Herbert Rogowsky Foundation, Inc. 

Ms. Anna Herforth 

Mr. Daniel A. Hernandez-Rodriguez 

Mr. John Herold 

Dr. Edmund M. Herrold 

Ms. Lindsay Herron 

Mr. and Mrs. Morton E. Hertzmark 

Ms. Anne-Claire Hervy 

Mr. John Herzog 

Ms. Eileen Hess 

Mr. Jim Hessburg 

Ms. Elizabeth Hester 

Mrs. Tara A. Higgins 

Mr. Robert L. Higgins 

Dr. Shanna S. Hill 

Hillcrest Church of Christ 

The Hilson Fund, Inc. 

Mr. Andrew Himoff 

Mr. Frances M. Hines 

Ms. Lisa A. Hipwell 

Mr. Martin S. Hirsch 

Ms. Joan R. Hirschfeld 

Mr. Brandon Ho 

Dr. David Hochman 

Dr. Eugenia S. Hochman 

Mrs. Leslie C. Hoddeson 

Mr. Frank Hoehne 

Ms. Kathryn Hoenig 

Mr. David Hoffman 

Ms. Ivy Hoffman 

Mr. Joel Hoffman 

Ms. Julie Hoffman 

Mr. Peter Hohendahl 

Ms. Joan Holloway 

Holly Andersen Heart Foundation 

Mr. David Holowka 

Ms. Patricia K. Holt 

Holy Trinity Church 

Mr. James E. Hook 

Dr. Jaleh E. Hoorfar 

Hope Through Healing Hands 

Mr. David Horan 

Ms. Lucy P. Horn 

Mr. Robert A. Horne 

Dr. James M. Horowitz 

Hospital for Special Surgery 

Mr. Eric Houpt 

Mr. Rob Houtenbos 

Mr. Steven Howard 

Howard G. Smith Trust 

Mr. David S. Howe 

Mr. Charles Howell 

Mrs. Monica Howland 

Ms. Francy E. Hoyos 

Mr. Henry H. Hoyt, Jr. 

HSBC Philanthropic Programs 

Mr. Bert Huang 

Mr. Richard Hubbard 

Mrs. Nancy M. Huber 

Ms. Caroline Huddleston 

Hudson News Distributors 

Mr. Robert Huff 

Mr. Mark Huffman 

Mrs. Mary O. Hughes 

Mrs. Mary P. Hulitar 

Mr. Ralf Hulsmann 

Mr. Kenneth Hung 

Ms. Katherine Hunting 

Dr. James R. Hurley 

Mr. Felix Hyppolite 

I 

Ms. Maureen A. Iadevaia 

Ms. Susan Iadevaia 

IBEC Building Corporation 

ICAP Service North America, LLC 

Independence School P.S. 234 

The Indu Foundation 

Infectious Diseases Society of 

America Education and Research 

Foundation 

Dr. Barton Inkeles 

Dr. Lawrence A. Inra 

International Association of 

Physicians in Aids Care 

Mrs. Barbara E. Inturrisi 

Dr. and Mrs. Charles E. Inturrisi 

Ira M. Resnick Foundation, Inc. 

Irene S. Fisher and Barry L. Fisher 


Mr. Robert R. Irving 

Ms. Diana H. Irwin 

Isak & Rose Weinman Foundation 

Ms. Sarah Israel 

J 

J.P. Morgan Chase 

Ms. Beverly Jablons 

Dr. Lois A. Jackson 

Mr. Leonard Jackson 

Ms. Arlene Jacobi 

Mr. and Mrs. Bruce Jacobs 

Mr. Peter B. Jacobs 

Dr. Michael W. Jacobson 

Dr. Ira M. Jacobson 

Ms. Joanne Jacobson 

Jaffe DDS, Duvalsaint DDS & Siegel 

DMD, PC 

Mrs. Jaclyn G. James 

Ms. Holly Janes 

Ms. Carmen Jaquez 

Mr. Andrew Jarecki 

Ms. Katherine Jaris 

Dr. Charles I. Jarowski, Jr. 

Mr. Zachary Jarvis 

Jatoma Charitable Foundation, Inc. 

JB Precious Jewels 

Ms. Ashley Jeanlus 

Mr. Jean P. Jeannet 

Ms. Nancy Jeffries 

Ms. Jean Jenkins 

Ms. Elizabeth Jensen 

Jerome and Laura Dorfman 


Ms. Sandra A. Jerro 

The Jewish Communal Fund 

Mr. Bruce R. Jocz 

John N. Conyngham III & Lou C. 

Conyngham Family Charitable 

Foundation 

Mrs. Judith Johnson 

Ms. Lauren Johnson 

Mr. Manuel Johnson 

Ms. Patricia Johnson 


Johnson & Johnson Corporate 

Ms. Joan Johnston 

Mr. Andrew Johnstone 

Dr. Erica C. Jones 

Ms. Laura Jones 

Ms. Mary G. Jones 

Joodayoh, Inc. 

The Joseph Gluck Foundation 

The Joseph R. Daly Foundation 

Mr. Ragnhild Jost 

Ms. Johanna Joyce 

Julia Green Elementary School 

The Julian Rashkind Trust 

The Junction 

Ms. Susan Jureller 

Justgive.Org 

K 

Ms. Linda Kabumoto-Gras 

Mr. Solomon Kahn 

Mrs. Michelle Kaiser 

Terry Kaiura 

Mr. Jonathan Kalb 

Mr. Peter S. Kalikow 

Dr. Charles J. Kallick 

Mrs. Sheila Kamerman 

Mr. Stephen M. Kaminsky 

Ms. Hazel S. Kandall 

Nivedita Kanjilal 

Dr. Jed S. Kanner 

Mrs. Ann Kanthor 

Mrs. Leah I. Kantor 

Kaplan Living Trust 

Mr. Alon Kaplun 

Ruchi Kapoor 

Ms. Michele Karantsavelos 

Ms. Lucine Karjian 

Ms. Soraya Kashani 

Katherine John Murphy Foundation 

Mr. Bruce Katona 

Mr. Peter J. Katzenstein 

Mr. Eli W. Kaufman 

Masae Kawamura 

Ms. Anne L. Keating 

Mr. Richard J. Keating 

Keck School of Medicine 

Dr. Michael C. Keefer 

Mr. William Keel 

Keene Elm City Rotary Club 

Mrs. Bridget Keepman 

Ms. Virginia Keeshan 

Ms. Marcia Keizs 

Mr. Peter B. Kellner 

Dr. Kevin V. Kelly 

Mr. and Mrs. Daniel C. Kenary 

Dr. Robert O. Kenet 

Ms. Caroline B. Kennedy 

Mr. Tom Kennedy 

Dr. Otto F. Kernberg 

Kevin and Susie Davis Foundation 

Mr. Mohammed A. Khan 

Mr. Sumeet Khetarpal 

Ms. Eva Kiczkowski 

Mrs. Nancy L. Kienzle 

Mr. Robert J. Killie 

Ms. Kelly L. Kim 

Mr. Paul Kim 

Ms. Sue Kim 

Ms. Sunny Kim 

Mr. and Mrs. Stanley M. Kimball 

Ms. Sara Kimbell 

Kimberly-Clark Corporation 

Mr. Michael Kimerling 

Mr. Nils A. Kindwall 

Ms. Diana King 

Ms. Sherry P. King 

Mr. Joel King 

Ms. Janice King 

The Kingsberg Foundation 

Kinray, Inc. 

Ms. Glenda Kirby 

Mr. Garrett Kirk, Jr. 

Mrs. Dorothy D. Kirkman 

The Kirschenbaum Charitable 

Foundation 

Mr. Anand Kishore 

Mr. Sandeep T. Kishore 

Mr. Stephen M. Kittenplan 

Mrs. Cynthia A. Kleeberger 

Dr. and Mrs. Harvey Klein 

Dr. Ludwig Klein 

Mrs. Elizabeth S. Klein 

Ms. Hildabeth Klein 

Ms. Judith M. Kleinberger 

Ms. Kim Kleine 

Dr. Paul D. Kligfield 

Ms. Toni Klimowski 

Mr. Jeffrey A. Klym 

Ms. Pamela A. Knox 

Dr. Albert I. Ko 

Ms. Beryl Koblin 

Mr. Daniel Koch 

Mr. Andreas Koeck 

Mr. Nii O. Koney 

Mrs. Mary Ann M. Koontz 



Mr. Brian Korb 

Korda Herskovits Caplan 

Philanthropic Fund 

Mr. Marvin H. Koslow 

Ms. Rosemary Kraemer 

Ms. Alysa Krain 

Mr. Larry Kramer 

Mrs. Susan Kramer 

Dr. Daniel G. Krauser 

Mr. Keith Krayer 

Ms. Brenda M. Krepol 

Mr. Matthew Kretzer 

Mr. Michael F. Kristoff 

Ms. Ludmila Krivitsky 

Ms. Joan Kron 

Boudewijn Kruithof 

Ms. Kristin Kruse 

Ms. Lori M. Kryspin 

Ms. Brita Kube 

Ms. Judith Kuhn 

Mr. John H. Kuhnle 

Yuichi Kumagai 

Ms. Jill Kunkel 

Ms. Deborah Kurtz 

Ms. Mary Kush 

Ms. Ileana Kutler 

Ms. Sally J. Kuzma 

L 

Mr. Douglas Labar 

Ms. Sandra LaBlance 

Dr. Mark K. Lachs 

Mrs. Julia Lagermesulam 

Mr. Leo Lahm 

Ms. Susan Lake 

Ms. Dwandra N. Lampkin 

Mr. Nicholas Landsman 

Dr. Brian R. Landzberg 

Mrs. Barbara H. Lang 

Ms. Danielle Laraque 

Ms. Christine Larchian 

Mr. Edwin M. Larkin 

Mr. Robert LaRocca 

Dr. Davise H. Larone 

Ms. Christine Lasala 

Ms. Carol Lasek 

Ms. Deborah A. Lasher 

Ms. Margaret Lauck 

Dr. Jack A. Laufer, 

Ms. Megan Laughlin 

Mr. Jeffrey G. Laupus 

Laurence Levine Charitable Fund, Inc. 

Dr. Michael H. Lavyne 

Law Firm of Allen Rothenberg 

Mr. Elliot Lawrence 

Lawrence & Sheri Babbio Foundation 

Lawrence Gelb Foundation 

Mr. Wayne Lawson 

Lazard Capital Markets, LLC 

Jade Le 

Ms. Eileen Leavitt 

Lebensfeld Foundation 

Mr. Michael Lederman 

Mr. Rhoady Lee 

Dr. Thomas C. Lee 

Mr. Tom Lee 

Ms. Minako Y. Lee 

Ms. Linda Lee 

Mr. Darin K. Lee 

Ms. Jane Lee 

Ms. Jacqueline S. Leeds 

Ms. Allison G. Leff 

Mr. David Lefty 

Ms. Sandra Lehrman 

Dr. Marcia E. Leikin 

Ms. Marguerite Lembo 

Ms. Stephanie N. Lemus 

Leo Rosner Foundation, Inc. 

Mr. John Leonard 


Ms. Elaine Leong 

Dr. and Mrs. Bruce B. Lerman 

Ms. Nancy Lerner 

Ms. Susan H. Lerner 

Ms. Jaclyn Lesch 

Ms. Lory Leshin 

Ms. Elizabeth Lesnick 

Mr. Joseph S. Lesser 

Mr. Scott Letendre 

Dr. and Mrs. Howard M. Levin 

Mr. Andrew Levine 

Ms. Beth C. Levine 

Ms. Carol Levine 

Mr. H. F. Levine 

Mr. Irwin R. Levine 

Ms. Linda Levine 

Mr. Michael J. Levine 

Mr. Simon Levine 

Ms. Gloria Levinson 

Levinson Living Trust 

Ms. Ellen Levy 

Ms. Lorriane Levy 

Mr. Richard Levy 

Mr. Todd Levy 

Levy Hermanos Foundation, Inc. 

Mr. Daniel Lewis 

Dr. Daniel M. Libby 

Mr. John N. Lieber 

LifeWatch 

Mr. Richard Lifton 

Lighthouse Financial Group 

The Lightship Group 

Ms. Deborah Lilley 

Yee Lim 

Ms. Tina Lim 

Dr. Harvey A. Lincoff 

Mr. Daniel T. Lindsey 

Ms. Robin B. Linfield 

Mrs. Daniella Lipper-Coules 

Mrs. Lini Lipton 

Mrs. Phyllis Lisi 

Mr. Joseph Lisi 

Ms. Leigh S. Lisowski 

Dr. Harold Litvak 

Mrs. Daniella Livnat-Daids 

Mr. Michael Locher 

Dr. Lia S. Logio 

Mr. Richard Long 

Mr. John G. Long, Jr. 

Mr. Guy Longobardo 

Mr. David Looney 

Dr. Jorge A. Lopez-Ovejero 

Mr. Lherif Loraamm 

Mr. Thomas Loredo 

The Louis K. Brandt Foundation 

Louis & Rachel Rudin Foundation 

Louis & Rose Klosk Fund 

Mr. George T. Lowy 

Mr. Angelo M. Lucrezia 

Mr. Edward J. Ludwig 

Ms. Molly Luetkemeyer 

Ms. Anne Luetkemeyer 

Luetkemeyer Jr. Family Foundation, Inc. 

Mrs. Joy C. Luke 

D. R. Lund 

Mrs. Janet Lupinacci 

Mr. Robert Luskin 

The Lymphoma Foundation 

Mr. James J. Lynch 

Ms. Jennifer Lynham 

Ms. Lisa Lyons 

M 

M & T Logistics, Inc. 

M.A.C. AIDS Fund 

Ms. Jeanne MacAluso 

Ms. Carol MacCorkle 

Ms. Patricia A. MacCubbin 

Ms. Elaine MacDonald 

Mr. John MacDonald 

Mr. Randy MacDonald 

Mrs. Patricia A. Maciel 

Mrs. Jane Mack 

Ms. Ilene Mack 

Ms. Terra Mackintosh 

Mr. Robert L. MacNaughton 

Macy’s Foundation 

Mr. Donald P. Madden 

Mr. David C. Maddux 

The Madeira School 

Ms. Akiko Maeda 

Dr. Richard J. Mahler, FACP 

Mrs. Margaret L. Mallett 

Malone/Kremer, Inc. 

Manatt, Phelps & Phillips, LLP 

Mr. Lewis R. Mandel 

Mr. Joseph M. Mandel 

Dr. Cheriparambil K. Mani 

Dr. Samuel J. Mann 

Ms. Shaila Manyam 

Mr. Steven J. Maranz 

Mrs. Pearl Marcell 


Mr. Charles Marcus 

Ms. Natalie Marcus 

Margaret Ralph & Associates 

Mariner Investment Group, Inc. 

Mr. Stephen Mark 

Dr. Steven M. Markowitz 

Dr. Kristen M. Marks 

MARMA Foundation 

Mr. James C. Marques 

Ms. Camila Marquez 

Ms. Ellen R. Marram 

The Marrus Family Foundation, Inc. 

Mr. and Mrs. Charles J. Marsden 

Mrs. Yvonne Marsh 

Mr. Edgar J. Marston, III 

Ms. Elaine S. Martin 

Mr. Robert G. Martin 

Ms. Rosemary Martin 

Mr. William Martin 

Martin L. Berman Foundation 

Marvin and Barbara Eisenstadt 


Mary A. Furlong Revocable Trust 

Mary W. Harriman Foundation 

Ms. Karen Maschke 

Ms. Susan L. Mascitelli 

Ms. Marie B. Maser 

Ms. Gina Masi 

Dr. Bassem Masri 

Massachusetts Medical Society 

Ms. Ann C. Mathews 

Mr. James Mathews 

Mathis Pfohl Foundation 

Ms. Carol Matthieu 

Mr. John Mattioli 

Mr. David Mauel 

Dr. Frederick Maxfield 

Ms. Catherine P. May 

Ms. Joan May 

Mr. John May 

Mayor’s Fund to Advance 

New York City 

Mr. Robert Mazelin 

Ms. Jessica Mazzeo 

Ms. Diane L. McAleer 

Mr. John McAleer 

Mr. Patrick McAleer 

Dr. Sarah J. McAleer 

Mr. Hawley H. McAuliffe 

Mr. Jonathan E. McBurney 

Mrs. Maria G. McCabe 

Ms. Rachael McClennen 

Mrs. Frances T. McClennen 

Mrs. Joanna McClure 

Ms. Mary Mcclymont 

Mr. Will McConnell 

Mr. Kevin C. McCooey 

Mr. Frederick R. McCord 

Ms. Candice S. McCoy 

Ms. Julia McCullough 

Mr. J. A. McCutchan 

Ms. Jeanne McDermott 

Ms. Barbara B. McGhie 

Mrs. Sally L. McGinn 

Ms. Catherine McGowan 

Ms. Amy McGowan 

Mr. Sean McIntyre 

Mrs. Nancy McKenna 

Ms. Katherine McLaughlin 

Mr. Mark L. McLeland 

Ms. Cara McMillin 

Ms. Catherine S. McMullen 

Mr. Thomas P. McMullen 

Mrs. Elizabeth C. McNicholas 

Ms. Sally McNulty 

Mrs. Kathryn M. McPherson 

Medco Health Solution Charitable 

Match Fund 

Medtronic, Inc. 

Ms. Susan S. Meeker 

Anuj B. Mehta 

Mrs. Ruth Meier 

Dr. and Mrs. Joseph P. Mele 

Dr. Ellen M. Mellow 

Memorix, Inc. 

Mr. Mukund Menda 

Mr. Rich Menendez 

Mr. Gary Mennitt 

Mr. Robert B. Menschel 

Dr. Wendy L. Mercier 

Merck 

Merck Partnership for Giving 

Mercury Communications Group, LLC 

Meredith Corporation 

Mr. Thomas Merkel 

Ms. Margaret Merriam 

Dr. and Mrs. Samuel T. Merrick 

Mrs. Elizabeth N. Merrick 

Mr. Alfredo Mesa 

Mr. Anthony P. Messent 

Ms. Lorrie Messinger 

Ms. Barbara Metch 

Metropolitan Baptist Church 

Ms. Helen N. Mettler 

Ms. Genevieve Meyer 

Mrs. Anne B. Meyercord 

Mr. Richard Mezan 

Ms. Randi Michel 

Dr. Shari R. Midoneck 

Ms. Lucille M. Mikes 

Ms. Ellen Milberg 

Ms. Lillian Miles 

Ms. Roberta Militello 

Mrs. Sharon J. Millard 

Mrs. Amy Miller 

Ms. Angela Miller 

Ms. Barbara L. Miller 

Mr. Dennis Miller 

Ms. Emily Miller 

Ms. Madelyn Miller 

Ms. Margaret Miller 

Mr. Michael C. Miller 

Ms. Rachel Miller 

Mr. Stuart A. Miller 

Ms. Barbara A. Minakakis 

Mr. Eric Mindich 

Mr. Matthew Mirapaul 

Dr. Paul F. Miskovitz 

Mitchell & Margo Blutt Family 

Foundation 

Mr. and Mrs. David M. Modest 

Ms. Kate Moffitt 

Mr. and Mrs. Morris A. Mondschein 

Mrs. Sarah K. Monego 

Mr. Charles M. Monroe 

Ms. Liliana Montano 

Mr. Kenneth Monteiro 

Dr. Anne Moore 

Mr. Benjamin Moore 

Ms. Ellis O. Moore 

Ms. Karen Moore 

Ms. Kate L. Moore 

Ms. Nicole Moore 

Mr. Richard A. Moore, Jr. 

Mr. Daniel Morgan 

Dr. William A. Morgan 

Morgan Stanley 

Morgan Stanley Smith Barney Global 

Impact Funding Trust, Inc. 

Mrs. Maureen A. Mosca 

Mr. Scott Mosser 

Ms. Katie Mostero 

Ms. Nicole Mott 

Mr. Dimitri Moumoutjis 

Ms. Manuela Mozo 

Mr. David Mulgrum 

Ms. Mary B. Mullin 

Mrs. Marian B. Munson 

The Murphy Family Foundation 

Mr. Donald B. Murphy 

Ms. Jane Murphy 

Ms. Patricia Murphy 

Dr. Robert L. Murphy 

Dr. Susan H. Murphy 

Mr. Joseph Murray 

Dr. Joseph F. Murray 

The Murray Alon Charitable 

Foundation 

Sricharan Murugesan 

Muslim Educational and Cultural 

Association 

Dr. Elizabeth C. Muss 

Mrs. Leticia Muttera 

Mr. Robert C. Myers 

Mrs. I. Slayton Myers 

Mrs. Susan H. Mygatt 

Mr. Eric Myser 

N 

Dr. and Mrs. Ralph L. Nachman 

Dr. and Mrs. Jerry Nagler 

Rakesh Nagula 

Ms. Heather A. Nahas 

Yoriko Nakamura 

Mr. Yasumitsu Nakano 

The Nancy and John Hoffmann 

Foundation 

Mr. Robert Nankin 

Ms. Karen F. Nanney 


Mr. Steve Napleton 

Makarushka Napp 

Ms. Joanne Nasuti 

Dr. Carl F. Nathan 

National Alliance for Caregiving 

National Center on Education and 

The Economy 

National Philanthropic Trust 

Ms. Kathryn Neckerman 

Mrs. Fredda A. Neimark 

Mr. Russell Nelson 

Mr. John Nelson 

The Nelson Agency 

Ms. Marguerite Ness 

Mrs. Leonore Neto 

Ms. Irene B. Neuberger 

Ms. Rachel Neugarten 

Mr. Christopher Neukermans 

New Clay Studios, LLC 

New York Cardiology Associates, P.C. 

The New York Community Trust 

NYP/Weill Cornell Medical House 

Staff Fund 

Mrs. Judith B. Newbold 

Mrs. Virginia C. Newman 

Mrs. Maura O. Newman 

Mrs. Holly H. Newman 

Newman Family Foundation, Inc., 

CLAT 

The Newman Foundation Inc. 

News America Marketing 

Mrs. Rosalina N. Nguyen 

Ms. Barbara O. Nichols 

Mr. Gene Nichols 

Ms. Judith Nichols 

Mr. Robert Nichols 

Nicholson & Galloway Inc. 

Mr. Ruben Niesvizky 

Mr. Henry Nigrine 

Ms. Kattia L. Ninahuanca 

Ms. Deborah B. Noble 

Mrs. Karin N. Noll 

Mr. Ronald B. Norris 

Northern Trust Bank, FSB 

Northfield Community LDC 

Northwestern Mutual Foundation 

Ms. Laura Novik 

Mr. and Mrs. Jerry V. Noyce 

Nulsen Family Trust 

Dr. Irwin Nydick 

Dr. Martin L. Nydick 

Ms. Carolyn Nytch 

NYU Occupational Therapy Students 

Class of 2011 

O 

Ms. Mary W. Obrien 

Mrs. Kimberly O. OBrien 

Ms. Anne K. O’Brien 

Oceanic Heritage Foundation 

Ms. Anastasija Ocheretina 

Mr. Stephen O’Connell 

Ms. Margaret O’Connor 

The Octoberwoman Foundation 

Odyssey America Reinsurance 

Corporation 

Oki Data Americas, Inc. 

Ambassador Herbert S. Okun 

Old Parish Church 

Kevin O’Leary 

Dr. Sonja K. Olsen 

Mr. Larry Olsen 

Mr. John D. Olson 

O’Neal, Inc. 

Ms. Dorothy M. O’Neil 

Open Society Institute 

Ms. Sara A. Oppenheimer 

Ms. Mary Opperman 

Ore Originals, Inc. 

Oregon Disaster Medical Team 

Mr. Douglas S. Ornstein 

Ms. Patricia M. Orr 

Ortho-McNeil Pharmaceutical 

Orzo Kitchen and Wine Bar, Inc. 

Ms. June Osborn 

Ms. Marcia A. Osgood 

Mr. Leif Ostberg 

OTR Global Trading 

Per Kristian Ottestad 

Our Savior Lutheran Church 

Carmen Oveissi 

Ms. Mary Owens 

Mr. Jerry W. Owens 

Ms. Donna Owings 

Mr. Patrick C. Oxford 

P 

P. S. 183 PTA 

P.S. 183 Robert Louis 

Stevenson 

Mr. Sabino S. Pace 

Pacific Home Studio, Inc. 

Meera Pahuja 

Ms. Iris T. Palley 

Dr. Lawrence G. Palmer 

Panwy Foundation, Inc. 

Ms. Mary Pao 

Mr. Raymond Parello 

Ms. Susan Parish 

Mrs. Sun O. Park 

Park 55 Medical Associates, PC 

Park East Cardiology Associate, PC 

Parker Lepla, Inc. 

Mrs. Ellen H. Parrill 

Mrs. Barbara J. Parsons 

Mr. Michael Partridge 



Mrs. Roya Pasqualone 

Mr. George O. Pastor 

Ms. Patricia Paszamant 

Ms. Binny Patel 

Mr. Walter J. Patrick 

Ms. Tiffany Patterson 

Dr. Austin M. Pattner 

Patton Boggs, LLP 

Paw Paw Public Schools 

Mrs. Elizabeth A. Peck 

Dr. Mark S. Pecker 

Ms. Sylvia Pecker 

Ms. Rachel L. Pecker 

Mr. Creighton H. Peet 

Ms. Alice N. Pell 

Ms. Kathryn Pellegrino 

Ms. Vita L. Pellettieri 

Ms. Rosana Pellizzari 

Ms. Paula Pelosi 

Pencil Portraits 

Ms. Jane Pepper 

Mr. Paul Peretz 

Mr. Lewis Perin 

Perkin Fund 

Dr. Francis S. Perrone 

Mr. Anthony Perrotta 

Ms. Lisa Perry 

Ms. Gilda F. Pervin 

Mr. Seymour Pestronk 

Peter M. Sacerdote Foundation 

Mr. Timothy R. Peters 

Ms. Sue Peterson 

Mr. Eric Petrone 

The Pfizer Foundation, Inc. 

Ms. Kathleen M. Philbin 

Ms. Charlotte Phillips 

Perry Phipps 

Mr. Adhuna Phogat 

Physicians’ Education Resource 

Group, LP 

Mrs. Sylvie Piccin 

Mrs. Karol Pick 

Ms. Jacklyn Pierce 

Ms. Lynda Pierini 

The Pierre F. Simon Charitable Trust 

Mr. Andrew G. Pietrini 

Ms. Lynn Pike 

Mr. and Mrs. Stephen Platt 

Mr. Adam Platt 

Playa Rienta Property Owners 

Association, Inc. 

Mr. Malcolm Plessis 

Mr. Jacob Plummer 

Ms. Abigail Pogrebin 

Ms. Miriam Pokorski 

Ms. Tara Polen 

Mr. Douglas M. Polley 

Ms. Michele Popadynec 

Mr. Edward K. Portnof 

Ms. Patricia Posner 

The Posner Foundation, Inc. 

Mr. and Mrs. Robert M. Poss 

Ms. Diane Postoian 

Mr. John Pototsky 

Mrs. Paula M. Potter 

Ms. Nicholas Potter 

Ms. Terri L. Powers 

Mr. Pablo Pozo 

Prager Family Charitable Trust 

Dr. Elizabeth M. Prasad 

Ms. Ruth Prenner 

Presbyterian Church in Norwood 

Dr. R. A. Rees Pritchett 

Prostate Cancer Foundation 

Protestant Cooperative Ministry 

Mr. Milton Psaty 

Psychists Inc. 

Mr. Andrew Pugliese 

Mr. Yoram Puius 

Mrs. Lynn C. Purdum 

Ms. Eileen Puterski 

Mr. Robert W. Pyne 

Ms. Stephanie Pyonteck 

Q 

Ms. Laura A. Quinn 

Ms. Patricia Quinn 

Mrs. Amanda J. Quinton 

R 

The Rachel Foundation 

Mrs. Harriet Radar 

Mr. John D. Radice 

Dr. James J. Rahal, Jr. 

Dr. Barrie L. Raik 

Mrs. Joan Raines 

Mr. Atma Ram 

Ms. Christiane A. Ramirez 

T. Rampesaud 

Ranni-Gilbert Agency, Inc. 

Mr. David Ranz 

Mr. Edward J. Rappa 

Ms. Lisa Rasmussen 

Ms. Kathleen M. Rasmussen 

Mr. Mayur Rastogi 

Mr. Michael H. Ratner 

Mr. Norman D. Rau 

The Ravenel and Elizabeth Curry 

Foundation 

Raymond Schinazi Family 


Ms. Sarah Read 

Ms. Betty Reba 

Mr. Gabriel Rebick 

Ms. Gloria Rebovich 

Red Ribbon Foundation 

Ms. Pramela Reddi 

Karin Redmond 

Sarath Rednam 

Mr. Thomas Reed 

Mr. Jon Reed 

Mr. Ronald H. Reede 

Mr. John R. Reese 

Dr. Bonnie S. Reichman 

Ms. Carolyn A. Reid 


Mrs. Linda Reifschneider 

Dr. Brendan M. Reilly 

Mrs. Judith M. Reilly 

Mr. Philip R. Reilly 

Ms. Mary C. Reiser 

Mrs. Gail M. Reiss 

Ms. Stacey Reiss 

Ms. Stephanie Reit 

Mr. Paul Reitemier 

Religious Society of Friends 

Mrs. Joanne E. Renna 

Ms. Susan Reph 

Dr. Gene D. Resnick 

Mr. Peter G. Restler 

Mrs. Robin E. Rex 

Youssef Rezk 

Mr. and Mrs. Richard Riccardi 

Richard & Priscilla M. Schmeelk 

Foundation 

Mrs. Sheila R. Richman 

Mr. James B. Rickert 

Mr. Thomas J. Rietano, III 

Ms. Laura Riihimaki 

Mr. Lee W. Riley 

Mrs. Dorothy W. Rinaldo 

Ms. Adrienne Riofrio 

Ms. Lisa Ripperger 

Rita J. & Stanley H. Kaplan Family 

Foundation 

Mr. Charles A. Rittenour 

Rivermont Collegiate 

Ms. Carol R. Roaman 

Robert W. Baird and Company, Inc. 

Ms. Jill A. Roberts 

Mr. David Robertshaw 

Mr. Michael Robertson 

Dr. Rose Robertson 

The Robertson Foundation 

Detra K. Robinson 

Raime Robinson 

Mrs. Jacqueline J. Robinson 

Mrs. Beatriz Rocha 

Mr. Paul T. Rock 

Rodemeyer Realty 

Dr. Scott A. Rodeo 

Ms. Marie-Yves C. Rodnez 

Mr. William Rodriguez 

Ms. Valentina M. Rodriguez 

Ms. Anita K. Roe 

Roger Weiss Family Foundation 

Mr. Peter Rogers 

Rogosin Institute 

Mr. Chris Roh 

Dr. Mary J. Roman 

Mr. Bryan S. Romano 

Ms. Maria E. Romero 

Mrs. Rebecca L. Romero 

Mr.Jack Romita, Jr. 

Mr. and Mrs. Richard Roob 

Ms. Marie Roos 

Mr. Arnold S. Root 

Ms. Elizabeth Rose 

Rosemont College 

Mrs. Joan S. Rosen 

Ms. Lynne Rosenbaum 

Mrs. Aviva Rosenberg 

Dr. Benjamin A. Rosenberg 

Dr. Howard Rosenberg 

Dr. Isadore Rosenfeld 

Mr. Jack E. Rosenfeld 

Dr. Ralph E. Rosenberg 

Mr. Mordecai Rosenfeld 

Rosenfeld Heart Foundation 

Mrs. Kimberly M. Rosenstock 

Ms. Lisa Rosenthal 

Mr. Philip Ross 

Dr. Albert M. Ross 

Ms. Rita Rossi-Foulkes 

Ms. Johanna Rossman 

Mr. Franklin M. Roth 

Ms. Carrie Rothfeld 

Ms. Felice Rovelli 

Ms. Patricia Rowe 

Ms. Ellin Royds 

Dr. Jia Ruan 

Mr. Mark Rubin 

Ms. Nancy E. Rubinstein 

Mr. Jack Rudin 

Ms. Susan M. Rudin 

Dr. Joseph T. Ruggiero 

Mr. Charles T. Russell, III 

Ruth and Samuel J. Rosenwasser 


Ruth C. Rosen Trust 

The Ruth Stanton Foundation 

Mr. Andrew Ryan 

Mr. Michael S. Ryan 

Mr. Bradley Rymph 

S 

S. Forest Company, Inc. 

Mr. Daniel Sachar 

Mr. William Sachau 

Mrs. Sara Sachs 

Mrs. Toby C. Sacks 

Mr. Bruno Sadum 

Mr. Robert Salant 

Mr. Steven Salant 

Ms. Nadya Salcedo 

Salix Pharmacueticals, Inc. 

Mr. Alberto Salvo 

Mr. Robert J. Salzman 

Samourkas Foundation of New York 

Samuel I. Newhouse Foundation, Inc. 

Ms. Melanie Samuels 

Dr. Ronald C. Samuels 

San Mateo City Employees Federal 

Credit Union 

Ms. Joanne Sanantonio 

Dr. Abraham Sanders 

Mr. Joel S. Sandler 

Ms. Joanne Santangelo 

Dr. Anthony G. Santomauro 

Ms. Elsa A. Santos 

Mr. Michael B. Sapik 

Sarah de C. Ruth Trust 

Mr. Giorgio Sarne 

Sass Foundation for Medical 

Research, Inc. 

Ms. Beryl E. Satter 

Saturday Knight Ltd. 

Mrs. Susan B. Saunders 

Ms. Patricia A. Saunders 

Mr. Ernest Schaal 

Dr. Bruce R. Schackman 

Ms. Dulcie L. Schackman 

Mr. Jeffrey S. Schackner 

Mrs. Gloria Schackner 

Mrs. Pauline S. Schafer 

Ms. Pamela Schaff 

Ms. Miriam Schatz 

Dr. Ronald J. Scheff 

Mrs. Ernestyna Schenker 

Mr. Albert Schlesinger 

Mrs. Phyllis M. Schlisserman 

Mrs. Francesca E. Schlueter 

Ms. Terri Schmidt 

Dr. Bryan J. Schneider 

Mr. and Mrs. David Z. Schneider 

Ms. Jeanne Schoenfelder 

Mr. Robert Schonberg 

Dr. Ann W. Schongalla 

Ms. Carrie Schonwald 

Mr. Hans Schreuder 

Ms. Audrey N. Schuetz 

Ms. Allison R. Schulman 

Dr. Leonard H. Schuyler 

Schwab Charitable Fund 

Mr. Jay M. Schwamm 

Ms. Susannah Schwarcz 

Mr. Max J. Schwartz 

Mr. and Mrs. Robert N. Schwartz 

Mrs. Elizabeth M. Schwartz 

Mr. Stephen J. Schwartz 

Dr. Kenneth V. Schwartz 

Mr. David Schwartz 

Dr. and Mrs. Sergio Schwartzmann 

Ms. Diana Schwatka 

Mrs. Judith S. Schweiger 

Gilead Sciences 

Mr. Eriberto R. Scocimara 

Mr. Jason Scully-Clemmons 

Mr. David Seal 

Sealcoating, Inc. 

Ms. Cynthia Sears 

Mrs. Lucille Sedgeley 

Seevers Family Foundation 

Ms. Mary Seidel 

Mr. Charles B. Selden 

Ms. Naomi O. Seligman 

Mr. Aydin Senkut 

Ms. Lisa Senzel 

Ms. Susan B. Sepelak 

Mrs. Carole M. Sergent 

Ms. Barbara Serota 

Seth Sprague Educational and 


Mr. James Sethna 

Ms. Audrey L. Sevin 

Mr. Richard Seymour 

Ms. Caroline Seymour 

Ms. Monika Shah 

Mr. Sudhin Shah 

Mr. David M. Shandel 

Dr. David A. Shapiro 

Mrs. Alice L. Shapiro 

Mr. Rodney Sharkey 

Mr. Manish Sharma 

The Shaw Family Endowment Fund 

Ms. Stacey Shedden 

Mr. John P. Sheganoski 

Ms. Lorraine Shemesh 

Mr. Ty S. Shen 

Dr. Raymond L. Sherman 

Dr. Eric J. Sherman 

Dr. Melvin R. Shevach 

Mrs. Caroline Shiboski 

Shickman Family Foundation 

Ms. Naomi Shike 

Ms. Nina Shilling 

Dr. Rony Y. Shimony 

Shipley School 

Shirley D. Harris Trust 

Ms. Nancy Shopkorn 

Ms. Nancy G. Shor 

Dr. Tsiporah Shore 

Dr. Morris A. Shorofsky 

Ms. Tanaya Shree 

Ms. Karen D. Shugart 

Ms. Martha Shuman 

Ms. Carrie Shumway 

Ms. Carrie Siegel 

Dr. Lawrence Siegel 

Dr. Eugenia L. Siegler 

Ms. Angela L. Sierra 

Mr. M. S. Silbermann 

Silbert Charitable Fund 

Dr. Alfred M. Sils 

Mrs. Adrienne Silver 

Mr. Martin Silver 

Silverberg Family Foundation, Inc. 

Ms. Helene Silverman 

Mr. Carl Simons 

Ms. Kenishana Simpson 

Ms. Jeanie Sims 

Ms. Deena A. Singer 

Ms. Kavita Singh 

Ms. Garima Singh 

Ms. Althea Sircar 

Mr. Charles Sirey 

Mr. Roman Sivion 

Skadden, Arps, Slate, Meagher & 

Flom, LLP 

Ms. Linda Sklaren 

Ms. Rolly L. Slatt 

Mr. Alexander Slemrod 

Ms. Elaine Slocum 

Mr. David Slottje 

Ms. Dina B. Smallman 

Ms. Brooke N. Smith 

Mrs. Dina Smith 

Dr. James P. Smith 

Mrs. Janet S. Smith 

Mrs. Lynn B. Smith 

Mr. Malcolm A. Smith 

Ms. Margaret Smith 

Ms. Marta Smith 

Ms. Nancy Smith 

Dr. Paul T. Smith 

Howard G. Smith Trust 

Ms. Ann Snead 

Mr. George B. Snell 

Mr. Daniel Soba 

Social & Scientific Systems, Inc. 

Society for Edible Horticulture 

Ms. Nina Solenski 

Mr. Arnold R. Sollar 

The Sollar Foundation, Inc. 

Ms. Kathleen R. Somers 

Ms. Susan L. Sommer 

Mrs. Cindy L. Soper 

Sound Shore Cardiology, PC 

Southern Development 

Ms. Mavis Spectorman 

Ms. Heathir M. Speet 

Mr. James W. Spencer 

Ms. Emily A. Spengler 

Speyer Legacy School 

Mrs. Ann S. Spindel 

Ms. Michele Spring 

Spring OB/GYN, P.C. 

Ms. Valerie Spruell 

Mr. John W. Spurdle, Jr. 

Mrs. Amanada Spyrou 

Mr. Ragini Srinivasan 

St. John’s PTO 

St. Paul’s Radiology Associates 

Mr. Edwin Stack 

Mr. Peter Staley 

Mrs. Jodi Starr 

Ms. Marina Stasenko 

Mrs. Joan Stasior 

Mrs. Shelly D. Staudenmeir 

Ms. Ellen Stebbins 

Mr. Peter Stein 

Mr. Robert Stein 

Dr. Charles R. Steinberg 

Mr. Frank Stella 

Ms. Mary Stengel 

Ms. Darcy G. Stephens 

Mr. Timothy R. Sterling 

Mrs. Joan J. Sterling 

Sterne Agee & Leach, Inc. 

Syman Stevens 

Mr. Mark Stitzer 

Ms. Julie Stofel 

Mr. and Mrs. Fred C. Stoll 

Mr. Andrew D. Stone 

Ms. Patricia Stone 

Mr. James Storelli 

Dr. Carol L. Storey-Johnson 

Ms. Sarah L. Stout 

Ms. Geraldine Stover 

Dr. Adam R. Stracher 

Ms. Phyllis Strauss 

Mrs. Nancy A. Streeter 

Ms. Jane M. Stubenbord 

Ms. Heidi Stuhlmann 

Ms. Paola Styron 

Ms. Susanna Styron 

Ms. Patricia C. Sullivan 

Dr. John F. Sullivan 

Ms. Susan Sullivan 

Mrs. Virginia M. Sullivan 

The Summerhill Foundation 

Sunil Paul and Michelle Odom 

Foundation 

Sunnyside Kiwanis Foundation, Inc. 

Dr. Peggy Supple 

Susan D. Camilli Foundation 

Col. and Mrs. Anthony Suso 


Mrs. Myra Sutro 

Mr. Jack R. Swain, III 

Ms. Amanda Swan 

Ms. Susan Swindells 

Mr. Chris Syphers 

Dr. Andrew J. Szabo 

T 

T. Rowe Price Program for 

Charitable Giving 

Dr. Chin Tang 

Mr. Delbert Tanner 

Ms. Kristina Tarczy-Hornoch 

Mrs. Patricia A. Tarpey 

Mr. David Tarr 

Mr. Suresh S. Tate 

Tate Transport Corporation 

Mrs. Marcia Tatrallyay 

Ms. Sabra Tatum 

Mr. Paul J. Taubman 

Mr. Robert W. Taylor 

Ms. Rachelle Taylor 

Mrs. Ruth Taylor 

Mrs. Anne Alexis Cote Taylor 

Ms. June Teal 

Mr. Thomas J. Templeton 

Ms. Karen Tenser 

Mrs. Carol M. Tepper 

Ms. Kathryn Terry 

Ms. Danielle J. Tesoriero 



Mrs. Elizabeth Theofanidis 

Mr. George E. Thompson 

Ms. Stacy Thompson 

Mrs. Victoria A. Thorman 

Mr. John Thorne 

Ms. Katherine Thurer 

The Tianaderrah Foundation 

Mr. Jerome Tiger 

Ms. Anna Tikhomirova 

Ms. Maryellen Tipton 

Mr. Jeff Titherington 

Mrs. Vanessa A. Toevs 

Ms. Doris Tolins 

Ms. Lucy Tompkins 

Mr. Jeffrey T. Totaro 

Mrs. Aspasia D. Trakis 

Ms. Mindy Tran 

Mr. and Mrs. Jeffrey D. Tranen 

Transport Consultants International, Inc. 

Mr. Seran Trehan 

Mr. Vincent A. Tria, Jr. 

Trident Maritime Agency, Inc. 

Trinity Baptist Church 

Mr. Joseph Trotta 

Mr. Kent G. Troup 

Ms. Jennifer R. Truelove Truist 

Ms. Jennifer Truman 

Honorable Maryanne Trump Barry 

Ms. Paula Trushin 

Ms. Linnet R. Tse 

Mr. Wei Tseng 

Mr. and Mrs. Jun Tsusaka 

Mrs. Marian M. Tsutsui 

Mrs. Elizabeth Tulchin 

Srilaxmi Tumuluri 

Dr. Judy Tung 

Mr. Nicolas Turek 

Dr. Meredith L. Turetz 

Mr. Gary W. Turner 

Mr. Jeffrey Turner 

U 

UCB, Inc. 

Union for Reform Judaism 

Universal City Studios, LLLP 

University Montessori School 

University of Minnesota Alumni 

Association 

University of Virginia Alumni 

Association 

University of Virginia Fund 

Unknown 

Mr. Michael Urkowitz 

The U.S. Charitable Gift Trust 

Mr. Manuel Utset 

V 

Ms. Jessica Vacanti 

Dr. Linda T. Vahdat-Kummen 

Ms. Jennifer Vale 

Mr. James Valentino 

Van Ameringen Foundation 

Mr. Albert W. Van Ness, Jr. 

Ms. Sarah Vanderbilt 

Mr. Peter Vando 

The Vanguard Charitable Endowment 

Program 

Mr. John L. Vanosdall 

Mr. Joseph Varano 

Mr. Frank P. Vella 

Ms. Sharon Verduzco 

Verizon Foundation 

Dr. Sten H. Vermund 

Mrs. Mary J. Vinci 

Vital Projects Fund, Inc. 

Vladimir & Araxia Buckhantz 

Foundation 

Mr. Robert Vollrath 

Mr. Charles Vorkas 

W 

The W. O’Neil Foundation 

Ms. Mary Wachter 

Ms. Wendy Wagner 

Mr. Brian Wahl 

Mr. Laurence Walcott 

Mr. Scott L. Walker 

Ms. Joan Walsh 

Mr. Edmund Walsh 

Mr. Michael Walsh 

Ms. Cora M. Walsh 

Mrs. Harriet Walters 

Mr. Gregory S. Wands 

Mr. Chengbing Wang 

Ms. Suzanne Wapner 

Ms. Kristin Warfield 

Mr. Stephen Warnke 

Ms. Robin Warren 

Dr. Craig H. Warschauer 

Ms. Carol Warshawsky 

Mr. Jonathan Washburn 

Washington Speakers Bureau 

Ms. Nora Wasserman 

Mr. Ben Wasserman 

The Waterfall Family Foundation 

B. Lynn Watson 

The Wayen Charitable Foundation 

Mr. Robert Weaver 

WebMD, LLC 

Dr. Arnold L. Weg 

Mrs. Marie B. Weigl 

Weill Cornell Medical College-Qatar 

Mrs. Susan R. Weiller 

Mr. Ethan Weinberg 


Dr. Daniel E. Weinstein 

Mr. Mark S. Weinstein 

Mr. Marvin Weinstock 

Ms. Selma Weintraub 

Mr. I. Daniel Weisberg 

Ms. Joan Weisberg 

Mrs. Bertha Weiser 

Mr. Mark Weisman 

Mr. Warren A. Weiss 

Ms. Dana A. Weiss 

Mrs. Joan S. Weissman 

Mrs. Helene M. Weld 

Mrs. Jill Wellenbach 

Ms. Marjorie Weller 

Wellington Management 

Company, LLP 

Wells Fargo Foundation 

Mr. Jared Wels 

Ms. Sarah West 

Westside Cardiology, PC 

Ms. Alexis Wheeler 

Ms. Amber L. Wheeler 

Ms. Rebecca A. Whipple 

Dr. Judith Whitcomb 

Mrs. Nieva S. White 

Whitehead Foundation 

Mr. Kenneth L. Whitley 

Mrs. Gail Wichler 

Mr. Mitch Wiedemann 

Mr. Eric S. Wiemann 

Mr. Howard L. Wiener 

Mr. Barrie A. Wigmore 

Mr. David Wilde 

Mr. Carlton Wilde 

Dr. Henry D. Wilde, Jr. 

Ms. Ann Wilde 

Mr. James Wildman 

Mr. Stephen G. Wilkerson 

Mr. Timothy J. Wilkin 

Mr. Jonathan Will 

The William & Mary Greve 


William Brown Foundation 

The William P. Goldman & Brothers 


William T. Foley Foundation 

Ms. Catherine Williams 

Ms. Evette Williams 

Mr. Keith Williams 

Mrs. Nitsa C. Williams 

Mr. Raymond A. Williams 

Willis H. Flick Revocable Trust 

Mr. David R. Wilson 

Ms. Della Wilson 

Mr. Gregory Wilson 

Ms. Judith B. Wilson 

Ms. Kathryn Wilson 

Ms. Teresa Wilson 

Ms. Elizabeth A. Wilson-Anstey 

Ms. Belinda Winn 

Winston Foundation, Inc. 

Mr. Andrew Winston-Brown 

Ms. Ruth Wintobrown 

Dr. Gilbert J. Wise 

Mr. Lawrence Wit 

Dr. James F. Wittmer 

Ms. Racquel Wohlers 

Dr. David J. Wolf 

Wolf Maryles & Associates, LLC 

Ms. Adele Wolinsky 

Mr. Peter Wolk 

Mrs. Jodi Wolkind 

Mrs. Julie Wolman 

Mr. Brian Wong 

Mr. Hon K. Wong 

Mr. Lawrence Woo 

Mr. Gary Wood 

Mr. Jeffrey Wood 

Ms. Barbara Z. Woodring 

Mr. Gary Woodring 

Ms. Beth Woods 

Mrs. Sheila Woods-Romano 

Woodward Gallery 

Elaine Worcester 

Dr. Stefan Worgall 

Mr. John Woschinko 

Dr. Peter F. Wright 

A. Danielle Wright 

Mr. Mark Wright 

Mr. C. J. Wright 

Peng Wu 

X 

Yifan Xu 

Y 

Y.C. Ho/Helen and Michael Chiang 

Foundation 

Ms. Luise Yacono 

Yankee Barn Homes, Inc. 

Mr. Mineo Yasufuku 

Ms. Sarah Yee 

Ms. Min-Jean Yin 

Dr. Cecelia J. Yoon 

Ms. Christina M. Young 

Dr. Charles S. Young 

Ms. Lunna Yu 

Mr. Nick Yuran 

Z 

Mr. William D. Zabel 

Mr. Thaddeus Zelski 

Ms. Xue H. Zhu 

Ms. Marilyn Ziment 

Mr. Scott M. Zimmerman 

Mr. James D. Zirin 

Mr. Martin R. Zonnenberg 

Zoom Information, Inc. 

Ms. Eileen Zore 

Dr. Michael A. Zullo 

Ms. Robin F. Zwerling 

Mr. Edward F. Zwick 

If you have any questions 

or corrections concerning 

these listings, please contact 

the Development Office at 

(800) 345-3015. We regret 

any errors or omissions. 


Chairman’s Office 

Chairman 

Andrew I. Schafer, MD 

Tel: (212) 746-4720 

Executive Vice Chair for Clinical Affairs 

Brendan M. Reilly, MD 

Tel: (212) 746-6420 

Administrative Manager 

Beverly Borg 

Tel: (212) 746-4271 

Administration 

Chief Administrative Officer & Vice Chair 

for Business Affairs 

Tipton (Tip) Ford 

Tel: (212) 746-4271 

Senior Administrator 

Nancy Bennett 

Tel: (212) 746-4007 

Associate Administrator 

Peter Kam 

Tel: (212) 746-4007 

Senior Administrative Manager 

Thu Trang Du 

Tel: (212) 746-4371 

Residency Office 

Vice Chair for Education 

Director of the Internal Medicine 

Residency Program 

Lia Logio, MD 

Tel: (212) 746-4749 

Residency Administrator 

Jeanne Macaluso 

Tel: (212) 746-4749 

Divisional Offices 

Cardiology 

Bruce B. Lerman, MD, Chief 

Ann Matier, Administrator 

Tel: (212) 746-2176 

Clinical Epidemiology and Evaluative 

Sciences Research 

Mary E. Charlson, MD, Chief 

Suzan Toro, Administrator 

Tel: (212) 746-1606 

Clinical Pharmacology 

Marcus M. Reidenberg, MD, Chief 

Tel: (212) 746-6227 

Emergency Medicine 

Neal E. Flomenbaum, MD, Chief 

Georgia Rose, Administrator 

Tel: (212) 746-0780 

Endocrinology, Diabetes & Metabolism 

Julianne Imperato-McGinley, MD, Chief 

Debbie Dimanche, Administrator 

Tel: (212) 746-1503 

Gastroenterology & Hepatology 

Ira M. Jacobson, MD, Chief 

David Berger, Administrator 

Tel: (646) 962-4778 

Geriatrics & Gerontology 

Ronald D. Adelman, MD, Co-Chief 

Mark S. Lachs, MD, MPH, Co-Chief 

Mary Anderson, Administrator 

Tel: (212) 746-1733 


Barbara L. Hempstead, MD, PhD, Co-Chief 

David M. Nanus, MD, Co-Chief 

Paula Goldstein, Administrator 

Tel: (212) 746-4550 

Hospital Medicine 

Arthur T. Evans, MD, MPH, Chief 

Vice Chair of Faculty Development 

Mary Elizabeth Kelser, Administrator 

Tel: (212) 746-4910 

Immunology 

Kendall A. Smith, MD, Chief 

Nadine McLaughlin, Administrator 

Tel: (646) 962-8170 


Roy M. Gulick, MD, MPH, Chief 

Eduardo Baez, Administrator 

Tel: (212) 746-4914 

Iris Cantor Women’s Health Center 

Orli R. Etingin, MD, Director 

D. Anne Stewart, Administrator 

Tel: (212) 821-0558 

Medical Ethics 

Joseph J. Fins, MD, Chief 

Cathleen Acres, Administrator 

Tel: (212) 746-4246 


Manikkam Suthanthiran, MD, Chief 

Anita Mesi, Administrator 

Tel: (212) 746-4430 

Pulmonary & Critical Care Medicine 

Ronald G. Crystal, MD, Chief 

Malika McKenzie, Administrator 

Tel: (646) 962-5569 

Rheumatology 

Mary K. Crow, MD, Chief 

Laughlin Rice, Administrator 

Tel: (212) 606-1845 

Weill Cornell Internal Medicine 

Associates 

Judy Tung, MD, Medical Director 

ThuTrang Du, Faculty Administrator 

Tel: (212) 746-4371 

Managing Editor-Writer 

Suzanne Ross 


Design 

Sundberg Design, Inc. 

Photography 

Roger Tully 

Roger Tully Productions 

Contributing Photography 

Dr. Jennifer Downs 

Robert Essel 

Bud Glick 

Rebecca Heidkamp, PhD 

Patricia Kuharic 

Lt. Vincent Mullen 

Amelia Panico 

Dr. Robert Peck 

Special Thanks to: 

Jessica Arnau 

Dr. Graeme Bailey 

Doug Banquer 

Herbert Barnett 

Beverly Borg 

Talley Henning Brown 

Nicholas Chin 

Brian DeMello 

Division Administrators 

Thu Trang Du 

Dr. Evi Giannakakou 

Al Greenberg 

Alison Holzberg 

Dr. Warren Johnson, Jr. 

Peter Kam 

Dr. Adam Law 

Jeanne Macaluso 

Lt. Vincent Mullen 

Ayad Nagi 

Pete Pizzuti 

Dr. Charles Rice 

Leonard Sadosky, PhD 


Silva Sergenian 

Greg Sundberg 

Nadine Sylvain 

Roger Tully 

Karen Wong 

Maria Wright 

Dr. Christini’s Lab Members 

Dr. Hempstead’s Lab Members 

Dr. Suthanthiran’s Lab Members 




NewYork-Presbyterian Hospital/ 



525 East 68th Street, Box 130 

New York, NY 10065 

www.cornellmedicine.com 

Department of Medicine Annual Report 2010 Weill Cornell Medical College NewYork-Presbyterian Hospital

Weill Cornell Department of Medicine

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?